polymorphism, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, polymorphism

Aarnisalo J, Treszl A, Svec P, Marttila J, Oling V, Simell O, Knip M, Korner A, Madacsy L, Vasarhelyi B, Ilonen J, Hermann R. Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J. Autoimmun. 31: 13-21 (2008).
Abanmi A, Al Harthi F, Zouman A, Kudwah A, Jamal MA, Arfin M, Tariq M. Association of interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo. Dis. Markers 24: 51-57 (2008).
Abanmi A, Harthi FA, Baqami RA, Assaf SA, Zouman A, Arfin M, Tariq M. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch. Dermatol. Res. 298: 347-352 (2006). *
Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V. Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors. Nat. Clin. Pract. Endocrinol. Metab. 2: 694-701 (2006). *
Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, Radha V, Deepa R, Mohan V. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 54: 1207-1213 (2005). *
Abazis-Stamboulieh D, Oikonomou P, Papadoulis N, Panayiotidis P, Vrakidou E, Tsezou A. Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma. Leuk. Lymphoma 48: 2196-2203 (2007).
Abbas OM, Abdel-Rahman MH, Omar NA, Badran HM, Amir EM. Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection. Liver Int. 29: 1422-1430 (2009). *
Abbas S, Brauch H, Chang-Claude J, Dunnebier T, Flesch-Janys D, Hamann U, Hein R, Justenhoven C, Salazar R. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int. J. Cancer Sep 8 [Epub ahead of print] (2009). *
Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 10: R31 (2008). *
Abbott DW, Wilkins A, Asara JM, Cantley LC. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14: 2217-2227 (2004). *
Abboud N, Amin H, Ghazouani L, Khalifa SB, Khalafallah AB, Aded F, Almawi WY, Mahjoub T. Polymorphisms of human platelet alloantigens HPA-1 and HPA-2 associated with severe coronary artery disease. Cardiovasc. Pathol. Jun 8 [Epub ahead of print] (2009).
Abboud N, Ghazouani L, Ben-Hadj-Khalifa S, Anabi F, Added F, Khalfallah A, Nsiri B, Almawi WY, Mahjoub T. Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease. J. Thromb. Thrombolysis Jun 27 [Epub ahead of print] (2009).
Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study. Genet. Test. Mol. Biomarkers Nov 23 [Epub ahead of print] (2009).
Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 4: 450-454 (2003). *
Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. Int. J. Immunogenet. 33: 155-161 (2006). *
Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, Buller HR, Schene AH, Kamphuisen PW. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J. Thromb. Haemost. 6: 2168-2174 (2008).
Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin. Exp. Immunol. 145: 63-70 (2006). *
Abdin AA, Hassanien MA, Ibrahim EA, El-Noeman SE. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy. J. Diabetes Complications Jun 22 [Epub ahead of print] (2009).
Abe K, Klaften M, Narita A, Kimura T, Imai K, Kimura M, Rubio-Aliaga I, Wagner S, Jakob T, Hrabe de Angelis M. Genome-wide search for genes that modulate inflammatory arthritis caused by Ali18 mutation in mice. Mamm. Genome 20: 152-161 (2009). *
Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, Nakashima K, Takagi N, Baba H, Hasegawa Y, Shimokata K. NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J. Infect. 46: 215-220 (2003).
Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, Sakamaki H, Kawasaki E, Awata T, Yamaguchi Y, Eguchi K. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res. Clin. Pract. 46: 169-175 (1999).
Abed RE, Bourdon V, Huiart L, Eisinger F, Khelif A, Frenay M, Gesta P, Demange L, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Sauvan R, Soua Z, Sobol H. Molecular study of CEPBA in familial hematological malignancies. Fam. Cancer 8: 581-584 (2009).
Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S. Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum. Immunol. 67: 612-617 (2006).
Abelson AK, Johansson CM, Kozyrev SV, Kristjansdottir H, Gunnarsson I, Svenungsson E, Jonsen A, Lima G, Scherbarth HR, Gamron S, Allievi A, Palatnik SA, Alvarellos A, Paira S, Graf C, Guilleron C, Catoggio LJ, Prigione C, Battagliotti CG, et al. No evidence of association between genetic variants of the PDCD1 ligands and SLE. Genes Immun. 8: 69-74 (2007). *
Aberle J, Fedderwitz I, Klages N, George E, Beil FU. Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Horm. Metab. Res. 39: 395-397 (2007).
Aberle J, Flitsch J, Beck NA, Mann O, Busch P, Peitsmeier P, Beil FU. Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. Mol. Genet. Metab. 95: 188-191 (2008). *
Aberle J, Hopfer I, Beil FU, Seedorf U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int. J. Obes. (Lond.) 30: 1709-1713 (2006).
Abifadel M, Rabes JP, Jambart S, Halaby G, Gannage-Yared MH, Sarkis A, Beaino G, Varret M, Salem N, Corbani S, Aydenian H, Junien C, Munnich A, Boileau C. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum. Mutat. 30: E682-E691 (2009). *
Abiru N, Kawasaki E, Eguch K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab. Res. Rev. 18: 357-366 (2002). *
Ablin JN, Cohen H, Buskila D. Mechanisms of disease: genetics of fibromyalgia. Nat. Clin. Pract. Rheumatol. 2: 671-678 (2006). *
Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm. Bowel Dis. 12: 641-650 (2006). *
Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 60: 97-110 (2009). *
Abraham E. Alterations in cell signaling in sepsis. Clin. Infect. Dis. 41 Suppl. 7: S459-S464 (2005). *
Abraham J, Earl HM, Pharoah PD, Caldas C. Pharmacogenetics of cancer chemotherapy. Biochim. Biophys. Acta 1766: 168-183 (2006). *
Abraham LJ, Du DC, Zahedi K, Dawkins RL, Whitehead AS. Haplotypic polymorphisms of the TNFB gene. Immunogenetics 33: 50-53 (1991).
Abraham LJ, French MA, Dawkins RL. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin. Exp. Immunol. 92: 14-18 (1993). *
Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukoc. Biol. 66: 562-566 (1999). *
Abraham LJ, Leelayuwat C, Grimsley G, Degli-Esposti MA, Mann A, Zhang WJ, Christiansen FT, Dawkins RL. Sequence differences between HLA-B and TNF distinguish different MHC ancestral haplotypes. Tissue Antigens 39: 117-121 (1992).
Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Exp. Clin. Endocrinol. Diabetes 115: 38-41 (2007).
Abrahamsson A, Gafvels M, Reihner E, Bjorkhem I, Einarsson C, Eggertsen G. Polymorphism in the coding part of the sterol 12alpha-hydroxylase gene does not explain the marked differences in the ratio of cholic acid and chenodeoxycholic acid in human bile. Scand. J. Clin. Lab. Invest. 65: 595-600 (2005). *
Abrahamsson A, Krapivner S, Gustafsson U, Muhrbeck O, Eggertsen G, Johansson I, Persson I, Angelin B, Ingelman-Sundberg M, Bjorkhem I, Einarsson C, Hooft FM. Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. Atherosclerosis 182: 37-45 (2005).
Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489 (2002).
Abreu MT, Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J. Pediatr. 144: 421-429 (2004). *
Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J. Immunol. 174: 4453-4460 (2005). *
Acalovschi M, Tirziu S, Chiorean E, Krawczyk M, Grunhage F, Lammert F. Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls. Lipids 44: 521-526 (2009).
Acevedo F, Hammar H. Complement C3 proteins in psoriasis. Br. J. Dermatol. 121: 329-335 (1989).
Acevedo N, Vergara C, Gusmao L, Jimenez S, Martinez B, Mercado D, Caraballo L. The C-509T promoter polymorphism of the transforming growth factor beta-1 gene is associated with levels of total and specific IgE in a Colombian population. Int. Arch. Allergy Immunol. 151: 237-246 (2009).
Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, Winkler C, Pfluger M, Illig T, Bonifacio E, Ziegler AG. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52: 1881-1888 (2009). *
Achkar JP, Duerr R. The expanding universe of inflammatory bowel disease genetics. Curr. Opin. Gastroenterol. 24: 429-434 (2008). *
Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum. Immunol. 68: 901-907 (2007).
Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B. Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development. Dig. Dis. Sci. 53: 622-629 (2008). *
Acioli-Santos B, Segat L, Dhalia R, Brito CA, Braga-Neto UM, Marques ET, Crovella S. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum. Immunol. 69: 122-128 (2008).
Ackerman HC, Ribas G, Jallow M, Mott R, Neville M, Sisay-Joof F, Pinder M, Campbell RD, Kwiatkowski DP. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun. 4: 476-486 (2003). *
Ackert-Bicknell C, Rosen C. The genetics of PPARG and the skeleton. PPAR Res. 2006: 93258 (2006). *
Actis GC, Pellicano R, Rizzetto M, Ayoubi M, Leone N, Tappero G, Pazienza P, Rosina F. Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease. World J. Gastroenterol. 15: 1420-1426 (2009). *
Adam B, Liebregts T, Holtmann G. Mechanisms of disease: genetics of functional gastrointestinal disorders - searching the genes that matter. Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 102-110 (2007). *
Adam R, Sturrock RD, Gracie JA. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis. Ann. Rheum. Dis. 65: 1099-1101 (2006). *
Adamo KB, Dent R, Langefeld CD, Cox M, Williams K, Carrick KM, Stuart JS, Sundseth SS, Harper ME, McPherson R, Tesson F. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 15: 1068-1075 (2007). *
Adamovic S, Amundsen SS, Lie BA, Gudjonsdottir AH, Ascher H, Ek J, van Heel DA, Nilsson S, Sollid LM, Torinsson Naluai A. Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families. Genes Immun. 9: 364-367 (2008). *
Adamovic S, Amundsen SS, Lie BA, Hellqvist A, Gudjonsdottir AH, Ek J, Nilsson S, Wahlstrom J, Ascher H, Sollid LM, Naluai AT. Fine mapping study in Scandinavian families suggests association between coeliac disease and haplotypes in chromosome region 5q32. Tissue Antigens 71: 27-34 (2008). *
Adams M, Lucock M, Stuart J, Fardell S, Baker K, Ng X. Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci. Lett. 422: 24-29 (2007).
Adamson KA, Cheetham TD, Kendall-Taylor P, Seckl JR, Pearce SH. The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus. Int. J. Immunogenet. 34: 17-21 (2007). *
Adamzik M, Frey UH, Bitzer K, Jakob H, Baba HA, Schmieder RE, Schneider MP, Heusch G, Peters J, Siffert W. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic Res. Cardiol. 103: 598-610 (2008).
Adamzik M, Frey UH, Rieman K, Sixt S, Beiderlinden M, Siffert W, Peters J. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med. 33: 1199-1203 (2007).
Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun. 4: 420-426 (2003). *
Addo A, Le J, Li W, Aksentijevich I, Balow J Jr, Lee A, Gregersen PK, Kastner DL, Remmers EF. Analysis of CARD15/NOD2 haplotypes fails to identify common variants associated with rheumatoid arthritis susceptibility. Scand. J. Rheumatol. 34: 198-203 (2005). *
Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Anto M, Capasso R, Zappia V, Ruggiero G. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology 41: 995-1003 (2005). *
Adjers K, Karjalainen J, Pessi T, Eklund C, Hurme M. Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int. Arch. Allergy Immunol. 138: 251-256 (2005).
Adorini L. Vitamin D receptor polymorphisms in primary biliary cirrhosis: a functional connection? J. Hepatol. 50: 1071-1073 (2009).
Afzal S, Jensen SA, Vainer B, Vogel U, Matsen JP, Sorensen JB, Andersen PK, Poulsen HE. MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer. Ann. Oncol. 20: 1660-1666 (2009).
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. Prostate 68: 740-747 (2008).
Agarwal K, Czaja AJ, Donaldson PT. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens 69: 227-235 (2007). *
Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31: 49-53 (2000). *
Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J. Hepatol. 32: 538-541 (2000). *
Agarwal SK, Gourh P, Shete S, Paz G, Divecha D, Reveille JD, Assassi S, Tan FK, Mayes MD, Arnett FC. Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis. J. Rheumatol. 36: 2715-2723 (2009).
Aggarwal PK, Jain V, Srinivasan R, Jha V. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype. J. Hypertens. 27: 2044-2050 (2009).
Aghamohammadi A, Foroughi F, Rezaei N, Dianat S, Solgi G, Amirzargar AA. Mannose-binding lectin polymorphisms in common variable immunodeficiency. Clin. Exp. Med. 9: 285-290 (2009).
Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J. Infect. Dis. 186: 1522-1525 (2002). *
Agrawal AA, Kapley A, Yeltiwar RK, Purohit HJ. Assessment of single nucleotide polymorphism at IL-1A+4845 and IL-1B+3954 as genetic susceptibility test for chronic periodontitis in Maharashtrian ethnicity. J. Periodontol. 77: 1515-1521 (2006).
Agrawal C, Raghav SK, Gupta B, Das RH, Chaturvedi VP, Goswami K, Das HR. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Arch. Med. Res. 36: 555-559 (2005).
Agrawal S, Dimitrova N, Prasthani N, Udayakumar K, Sailakshmi S, Sriram S, Manjusha N, Sengupta U. T2D-Db: an integrated platform to study the molecular basis of type 2 diabetes. BMC Genomics 9: 320 (2008). *
Agrawal S, Khan F, Bharadwaj U. Human genetic variation studies and HLA class II loci. Int. J. Immunogenet. 34: 247-252 (2007). *
Agrawal S, Srivastava R, Sharma B, Pandya S, Misra R, Aggarwal A. IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to anklyosing spondylitis in Indian patients. Clin. Rheumatol. 27: 573-576 (2008). *
Agrawal SK, Kumar P, Rathi R, Sharma N, Das R, Prasad R, Narang A. UGT1A1 gene polymorphisms in North Indian neonates presenting with unconjugated hyperbilirubinemia. Pediatr. Res. 65: 675-680 (2009).
Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 58: 335-338 (2001). *
Aguilar F, Nunez-Roldan A, Torres B, Wichmann I, Sanchez-Roman J, Gonzalez-Escribano MF. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770-1774 (2003).
Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A, Gonzalez-Escribano MF. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum. Immunol. 64: 936-940 (2003).
Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Blanc P, Schved JF, Larrey D. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48: 836-842 (2001). *
Aguillon JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology 211: 75-84 (2006).
Aguillon JC, Cruzat A, Cuenca J, Cuchacovich M. Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease. Rev. Med. Chil. 130: 1043-1050 (2002).
Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr. Drug Metab. 9: 520-531 (2008).
Agundez JA, Martinez C, Garcia-Martin E, Ladero JM. Cytochrome P450 CYP2C9 polymorphism and NSAID-related acute gastrointestinal bleeding. Gastroenterology 133: 2071-2072 (2007). *
Ahadi AM, Sadeghizadeh M, Houshmand M, Gharagoozli K, Banoei MM, Panahai MS. An A8296G mutation in the MT-TK gene of a patient with epilepsy - a disease-causing mutation or rare polymorphism? Neurol. Neurochir. Pol. 42: 263-266 (2008).
Ahern PP, Izcue A, Maloy KJ, Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol. Rev. 226: 147-159 (2008). *
Aherrahrou Z, Axtner SB, Kaczmarek PM, Jurat A, Korff S, Doehring LC, Weichenhan D, Katus HA, Ivandic BT. A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. Am. J. Pathol. 164: 1379-1387 (2004). *
Ahluwalia M, Gotlieb V, Damerla V, Saif MW. Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease. Yale J. Biol. Med. 79: 173-175 (2006). *
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, Khullar M. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol. 28: 141-150 (2009).
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol. Cell. Biochem. 314: 9-17 (2008). *
Ahmad F, Kannan M, Biswas A, Saxena R. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease. Ann. Hematol. 88: 479-483 (2009). *
Ahmad F, Kannan M, Yadav V, Biswas A, Saxena R. Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease. Clin. Appl. Thromb. Hemost. Dec 2 [Epub ahead of print] (2009).
Ahmad N, Zakaria WR, Abdullah SA, Mohamed R. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. World J. Gastroenterol. 15: 3161-3165 (2009). *
Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, Crawshaw J, Large O, de Silva A, Cook JT, Barnardo M, Cullen S, Welsh KI, Jewell DP. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122: 854-866 (2002). *
Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62: 527-535 (2003). *
Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J. Gastroenterol. 12: 3628-3635 (2006). *
Ahmad T, Marshall SE, Mulcahy-Hawes K, Orchard T, Crawshaw J, Armuzzi A, Neville M, van Heel D, Barnardo M, Welsh KI, Jewell DP, Bunce M. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 60: 164-179 (2002). *
Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 48: 807-813 (2003). *
Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T, Neville M, Kanawati C, Fortune F, Celik A, Stanford M, Jewell DP, Marshall SE. CARD15 polymorphisms in Behcet's disease. Scand. J. Rheumatol. 34: 233-237 (2005).
Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M, Renz H. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J. Allergy Clin. Immunol. 113: 565-567 (2004). *
Ahmed FE. Gene-gene, gene-environment and multiple interactions in colorectal cancer. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24: 1-101 (2006). *
Ahmed FE. Molecular markers that predict response to colon cancer therapy. Expert Rev. Mol. Diagn. 5: 353-375 (2005).
Ahmed N, Majeed AA, Ahmed I, Hussain MA, Alvi A, Devi SM, Rizwan M, Ranjan A, Sechi LA, Megraud F. genoBASE pylori: a genotype search tool and database of the human gastric pathogen Helicobacter pylori. Infect. Genet. Evol. 7: 463-468 (2007).
Ahmed S, Ihara K, Bassuny WM, Kuromaru R, Kohno H, Miyako K, Matsuura N, Iwata I, Nagafuchi S, Hara T. Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population. Genes Immun. 3: 96-101 (2002). *
Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 40: 662-667 (2001). *
Ahmed SS, Tan FK. Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations. Curr. Opin. Rheumatol. 15: 766-771 (2003).
Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE, Rogozkin VA. PPARalpha gene variation and physical performance in Russian athletes. Eur. J. Appl. Physiol. 97: 103-108 (2006).
Ahmetov II, Mozhayskaya IA, Lyubaeva EV, Vinogradova OL, Rogozkin VA. PPARG gene polymorphism and locomotor activity in humans. Bull. Exp. Biol. Med. 146: 630-632 (2008).
Ahn CH, Kim YR, Kim SS, Yoo NJ, Lee SH. Mutational analysis of TTK gene in gastric and colorectal cancers with microsatellite instability. Cancer Res. Treat. 41: 224-228 (2009).
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27: 1876-1882 (2006). *
Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Kim JK, Paik YH, Lee KS, Chon CY, Moon YM, Han KH. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J. Med. Virol. 78: 1564-1571 (2006). *
Ahram M, El-Omar A, Baho Y, Lubad MA. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol. Scand. 120: 430-435 (2009).
Ahuja V, Powers-Lee SG. Human carbamoyl-phosphate synthetase: insight into N-acetylglutamate interaction and the functional effects of a common single nucleotide polymorphism. J. Inherit. Metab. Dis. 31: 481-491 (2008). *
Aird RE, Thomson M, Macpherson JS, Thurston DE, Jodrell DI, Guichard SM. ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136. Pharmacogenomics J. 8: 289-296 (2008).
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441 (2004). *
Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, Jacobson LP, Rabkin CS, Ambinder RF, Martinez-Maza O, Kaslow RA. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. J. Acquir. Immune Defic. Syndr. Aug 3 [Epub ahead of print] (2009).
Aithal GP. Dangerous liaisons: drug, host and the environment. J. Hepatol. 46: 995-998 (2007). *
Aithal GP, Craggs A, Day CP, Welfare M, Daly AK, Mansfield JC, Hudson M. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease. Dig. Dis. Sci. 46: 1520-1525 (2001). *
Aithal GP, Day CP, Leathart J, Daly AK, Hudson M. Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun. 2: 44-47 (2001). *
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39: 1430-1440 (2004). *
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855 (2006). *
Aittoniemi J, Pertovaara M, Hulkkonen J, Pasternack A, Hurme M, Laippala P, Antonen J. The significance of mannan-binding lectin gene alleles in patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 31: 362-365 (2002). *
Aittoniemi J, Soranummi H, Rovio AT, Hurme M, Pessi T, Nieminen M, Karjalainen J. Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults. Clin. Exp. Immunol. 142: 120-124 (2005). *
Aittoniemi J, Turpeinen H, Tiittanen M, Knip M, Simell O, Ilonen J, Vaarala O. Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children. Hum. Immunol. 69: 108-111 (2008).
Aizawa Y, Sutoh S, Matsuoka M, Negishi M, Torii A, Miyakawa Y, Sugisaka H, Nakamura M, Toda G. Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease. Tissue Antigens 65: 88-92 (2005). *
Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, Kuroda T, Nakano M, Gejyo F. SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis. Mod. Rheumatol. 16: 294-299 (2006). *
Ak DG, Kahraman H, Dursun E, Duman BS, Erensoy N, Alagol F, Tanakol R, Yilmazer S. Polymorphisms at the ligand binding site of the vitamin D receptor gene and osteomalacia. Dis. Markers 21: 191-197 (2005).
Akagi K, Stephens RM, Li J, Evdokimov E, Kuehn MR, Volfovsky N, Symer DE. MouseIndelDB: a database integrating genomic indel polymorphisms that distinguish mouse strains. Nucleic Acids Res. 38: D600-D606 (2010). *
Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova JL, Hopkin JM, Tamari M, Mao XQ, Shirakawa T. Association between IFNA genotype and the risk of sarcoidosis. Hum. Genet. 114: 503-509 (2004). *
Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR. Lack of association between vitamin D receptor FokI polymorphism and alopecia areata. Eur. J. Dermatol. 14: 156-158 (2004). *
Akar A, Orkunoglu FE, Tunca M, Tastan HB, Kurumlu Z. Vitamin D receptor gene polymorphisms are not associated with alopecia areata. Int. J. Dermatol. 46: 927-929 (2007). *
Akar N, Hasipek M, Ozturk A, Akar E, Tekin M. Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. J. Nephrol. 19: 318-321 (2006).
Akar N, Koc Y. Single nucleotide polymorphisms that affect homocysteine levels in Turkish population. Clin. Appl. Thromb. Hemost. 15: 701-704 (2009).
Akar N, Ozturk A, Ozel D, Akar E, Ekim M. Is MEFV P706 polymorphism important in familial Mediterranean fever patients? J. Nephrol. 19: 119-120 (2006).
Akashi-Takamura S, Miyake K. Toll-like receptors (TLRs) and immune disorders. J. Infect. Chemother. 12: 233-240 (2006). *
Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Sci. 98: 1139-1146 (2007). *
Akbas SH, Bilgen T, Keser I, Tuncer M, Yucetin L, Tosun O, Gultekin M, Luleci G. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients. Transplant. Proc. 38: 1290-1292 (2006). *
Akcali C, Ozkur M, Erbagci Z, Benlier N, Aynacioglu AS. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response. J. Eur. Acad. Dermatol. Venereol. 22: 83-86 (2008). *
Akcay A, Ozdemir FN, Sezer S, Micozkadioglu H, Arat Z, Atac FB, Verdi H, Sahin F, Haberal M. Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients. Perit. Dial. Int. 25 Suppl. 3: S52-S55 (2005).
Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B, Heering P, Ivens K. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol. Dial. Transplant. 24: 2847-2851 (2009).
Akesson LS, Duffy DL, Phelps SC, Thompson PJ, Kedda MA. A polymorphism in the promoter region of the human interleukin-16 gene is not associated with asthma or atopy in an Australian population. Clin. Exp. Allergy 35: 327-331 (2005). *
Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch. Dermatol. Res. 297: 94-98 (2005). *
Akkad DA, Arning L, Ibrahim SM, Epplen JT. Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels. Genes Immun. 8: 703-706 (2007). *
Akkad DA, Godde R, Epplen JT. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients. J. Neurol. 253: 1365-1366 (2006). *
Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int. J. Immunogenet. 33: 59-61 (2006). *
Akkad DA, Kruse N, Arning L, Gold R, Epplen JT. Genomic NGFB variation and multiple sclerosis in a case control study. BMC Med. Genet. 9: 107 (2008). *
Akkiprik M, Celikel CA, Dusunceli F, Sonmez O, Gulluoglu BM, Sav A, Ozer A. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients. Turk. J. Gastroenterol. 19: 22-27 (2008). *
Akkiz H. Hepatocellular carcinoma pathogenesis: does PPAR alpha polymorphism have a role in hepatocarcinogenesis associated with HBV and HCV infections? Turk. J. Gastroenterol. 19: 231-233 (2008). *
Akkiz H, Bayram S, Bekar A, Akgollu E, Ozdil B. Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma. J. Viral Hepat. Dec 14 [Epub ahead of print] (2009).
Akkiz H, Bayram S, Bekar A, Ozdil B, Akgollu E, Sumbul AT, Demiryurek H, Doran F. G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study. Cancer Epidemiol. 33: 261-264 (2009).
Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br. J. Dermatol. 155: 350-356 (2006). *
Akman A, Sallakci N, Kacaroglu H, Tosun O, Yavuzer U, Alpsoy E, Yegin O. Relationship between periodontal findings and the TNF-alpha gene 1031T/C polymorphism in Turkish patients with Behcet's disease. J. Eur. Acad. Dermatol. Venereol. 22: 950-957 (2008). *
Akoglu B, Kindl P, Weber N, Trojan J, Caspary WF, Faust D. Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation. Eur. J. Clin. Nutr. 62: 430-435 (2008). *
Akomolafe A, Lunetta K, Erlich P, Cupples L, Baldwin C, Huyck M, Green R, Farrer L; MIRAGE Study Group. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin. Genet. 70: 49-56 (2006). *
Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, Henrickson M, Pons-Estel B, O'Shea JJ, Kastner DL. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am. J. Hum. Genet. 69: 301-314 (2001). *
Aksoy H, Aksoy Y, Ozturk N, Aydin HR, Yildirim AK, Akcay F. Fetuin-A gene polymorphism in patients with calcium oxalate stone disease. Urology Nov 19 [Epub ahead of print] (2009).
Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur. J. Dermatol. 19: 576-580 (2009).
Aksu K, Kitapcioglu G, Keser G, Berdeli A, Karabulut G, Kobak S, Ozmen M, Inal V, Kabasakal Y, Oksel F, Kocanaogullari H, Doganavsargil E. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behcet's disease: do they have any clinical implications? Clin. Exp. Rheumatol. 26: S77-S83 (2008).
Akyildiz M, Gunsar F, Nart D, Sahin O, Yilmaz F, Akay S, Ersoz G, Karasu Z, Ilter T, Batur Y, Berdeli A, Akarca U. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. Oct 13 [Epub ahead of print] (2009).
al Sharif F, Ollier WE, Hajeer AH. A rare polymorphism at position -28 in the human RANTES promoter. Eur. J. Immunogenet. 26: 373-374 (1999). *
Al Taji E, Biebermann H, Limanova Z, Hnikova O, Zikmund J, Dame C, Gruters A, Lebl J, Krude H. Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism. Eur. J. Endocrinol. 156: 521-529 (2007). *
Al-Abdulhadi SA, Al-Rabia MW. Association and preferential transmission of the CCR2V64I polymorphism with absence of asthma in high-risk families. Saudi Med. J. 29: 1711-1718 (2008).
Al-Abdulhadi SA, Helms PJ, Main M, Smith O, Christie G. Preferential transmission and association of the -403 G --> A promoter RANTES polymorphism with atopic asthma. Genes Immun. 6: 24-30 (2005). *
Al-Ali AK, Al-Muhana FA, Larbi EB, Abdulmohsen MF, Al-Sultan AI, Al-Maden MS, Al-Ateeq SA. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia. Saudi Med. J. 26: 1886-1888 (2005).
Al-Allawi NA, Avo AS, Jubrael JM. Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke. Neurol. India 57: 631-635 (2009).
Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 55: 97-99 (2000). *
Al-Awadhi AM, Haider MZ, Sharma PN, Hasan EA, Botaiban F, Al-Herz A, Nahar I, Al-Enezi H, Al-Saeid K. Angiotensin-converting enzyme gene polymorphism in Kuwaiti patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 25: 437-442 (2007).
Al-Awadhi AM, Hasan EA, Sharma PN, Haider MZ, Al-Saeid K. Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis. Rheumatol. Int. 27: 1119-1123 (2007). *
Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, McHugh N. Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 41: 525-530 (2002). *
Al-Hoqail IA. Personalized medicine in psoriasis: concept and applications. Curr. Vasc. Pharmacol. Jan 1 [Epub ahead of print] (2010).
Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD. Multiple variants in vascular endothelial growth factor (VEGF) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 56: 2161-2168 (2007). *
Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Al-Yahyaee SA, Grant CS. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer 9: 284-290 (2006). *
Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms - a case-control study in an Omani population. Mol. Carcinog. 48: 1170-1176 (2009).
Al-Muhanna F, Al-Mueilo S, Al-Ali A, Larbi E, Rubaish A, Abdulmohsen MF, Al-Zahrani A, Al-Ateeq S. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients. Saudi J. Kidney Dis. Transpl. 19: 937-941 (2008).
Al-Oanzi ZH, Tuck SP, Mastana SS, Summers GD, Cook DB, Francis RM, Datta HK. Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos. Int. 19: 951-960 (2008). *
Al-Tahan J, Sola R, Ruiz JR, Breidenassel C, Garc�a-Fuentes M, Moreno LA, Castillo M, Pietrzik K, Gonzalez-Gross M. Methylenetetrahydrofolate reductase 677CT polymorphism and cobalamin, folate, and homocysteine status in Spanish adolescents. Ann. Nutr. Metab. 52: 315-321 (2008).
Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology 9: 139-145 (2004).
Aladzsity I, Kovacs M, Semsei A, Falus A, Szilagyi A, Karadi I, Varga G, Fust G, Varkonyi J. Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma. Leuk. Res. 33: 1570-1573 (2009).
Alaez C, Vazquez-Garcia MN, Gorodezky C. DQA1 and DQB1 promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population. Genes Immun. 2: 216-221 (2001). *
Alagarasu K, Selvaraj P, Swaminathan S, Narendran G, Narayanan PR. 5' Regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in South Indian HIV and HIV-TB patients. J. Clin. Immunol. 29: 196-204 (2009).
Alagarasu K, Selvaraj P, Swaminathan S, Raghavan S, Narendran G, Narayanan PR. Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India. Tuberculosis (Edinb.) 87: 535-543 (2007).
Alain K, Karrow NA, Thibault C, St-Pierre J, Lessard M, Bissonnette N. Osteopontin: an early innate immune makers of Escherichia coli mastitis harbors genetic polymorphisms with possible links with resistance to mastitis. BMC Genomics 10: 444 (2009). *
Alakus H, Monig SP, Warnecke-Eberz U, Alakus G, Winde G, Drebber U, Schmitz KJ, Schmid KW, Riemann K, Siffert W, Bollschweiler E, Holscher AH, Metzger R. Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. World J. Gastroenterol. 15: 6061-6067 (2009). *
Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M, Vasisht S. Association of polymorphism in the thermolabile 5,10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol. Cell. Biochem. 310: 111-117 (2008).
Alansari A, Gul A, Inanc M, Ordi J, Teh LS, Ollier WE, Gonzalez-Gay MA, Hajeer AH. Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus. Saudi Med. J. 25: 1445-1448 (2004).
Alansari A, Hajeer A, Teh LS, Bayat A, Mysercough A, Gul A, Inanc M, Ordi-Ros J, Ollier W. Transforming growth factor-12 polymorphism and systemic lupus erythematosus. J. Rheumatol. 29: 1189-1191 (2002).
Alansari A, Hajeer AH, Bayat A, Eyre S, Carthy D, Ollier WE. Two novel polymorphisms in the human transforming growth factor beta 2 gene. Genes Immun. 2: 295-296 (2001). *
Alaya WB, Sfar I, Aouadi H, Jendoubi S, Najjar T, Filali A, Gorgi Y, Abdallah TB, Mouelhi L, Matri S, Ayed K. Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J. Gastroenterol. 15: 29-34 (2009). *
Alayli G, Aydin F, Coban AY, Sullu Y, Canturk F, Bek Y, Durupinar B, Canturk T. T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin. Rheumatol. 26: 1299-1305 (2007). *
Alayli G, Kara N, Tander B, Canturk F, Gunes S, Bagci H. Association of transforming growth factor beta1 gene polymorphism with rheumatoid arthritis in a Turkish population. Joint Bone Spine 76: 20-23 (2009). *
Albala BC, Jimenez RB, Perez B F, Liberman GC. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance. Rev. Med. Chil. 134: 372-379 (2006).
Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Perez-Bravo F. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res. Clin. Pract. 77: 245-250 (2007).
Albani D, Batelli S, Polito L, Prato F, Pesaresi M, Gajo GB, De Angeli S, Zanardo A, Galimberti D, Scarpini E, Gallucci M, Forloni G. Interleukin-6 plasma level increases with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with a sex-specific contribution of rs1800795 polymorphism. Age (Dordr.) 31: 155-162 (2009).
Albers CA, Heskes T, Kappen HJ. Haplotype inference in general pedigrees using the cluster variation method. Genetics 177: 1101-1116 (2007). *
Albers CA, Kappen HJ. Modeling linkage disequilibrium in exact linkage computations: a comparison of first-order Markov approaches and the clustered-markers approach. BMC Proc. 1 Suppl. 1: S159 (2007). *
Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups. Am. Heart J. 157: 777-783.e1 (2009).
Albuquerque MC, Aleixo AL, Benchimol EI, Leandro AC, Neves LB, Vicente RT, Bonecini-Almeida Mda G, Amendoeira MR. The IFN-(3)+874T/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem. Inst. Oswaldo Cruz 104: 451-455 (2009). *
Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, Burton PR, Goldblatt J, Lesouef PN. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin. Exp. Allergy 28: 578-584 (1998).
Alcina A, Ramagopalan SV, Fernandez O, Catala-Rabasa A, Fedetz M, Ndagire D, Leyva L, Arnal C, Delgado C, Lucas M, Izquierdo G, Ebers GC, Matesanz F. Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis. Eur. J. Hum. Genet. Nov 25 [Epub ahead of print] (2009).
Aldersley MA, Hamlin PJ, Jones PF, Markham AF, Robinson PA, Howdle PD. No polymorphism in the tissue transglutaminase gene detected in coeliac disease patients. Scand. J. Gastroenterol. 35: 61-63 (2000). *
Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum. Mol. Genet. 14: 2045-2052 (2005). *
Alenius GM, Friberg C, Nilsson S, Wahlstrom J, Dahlqvist SR, Samuelsson L. Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis. J. Rheumatol. 31: 2230-2235 (2004). *
Alessandro R, Seidita G, Flugy AM, Damiani F, Russo A, Corrado C, Colomba P, Gullotti L, Buettner R, Bruno L, Leo GD. Role of S128R polymorphism of E-selectin in colon metastasis formation. Int. J. Cancer 121: 528-535 (2007). *
Alessio AC, Annichino-Bizzacchi JM, Bydlowski SP, Eberlin MN, Vellasco AP, Hoehr NF. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am. J. Med. Genet. A. 128A: 256-260 (2004).
Alessio AC, Siqueira LH, Bydlowski SP, Hoehr NF, Annichino-Bizzacchi JM. Polymorphisms in the CBS gene and homocysteine, folate and vitamin B12 levels: association with polymorphisms in the MTHFR and MTRR genes in Brazilian children. Am. J. Med. Genet. A. 146A: 2598-2602 (2008).
Alessio AM, Hoehr NF, Siqueira LH, Ozelo MC, de Padua Mansur A, Annichino-Bizzacchi JM. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis. Thromb. Res. 120: 639-645 (2007). *
Alevizaki M, Mantzou E, Cimponeriu A, Saltiki K, Philippou G, Wiersinga W. The Pro(12)Ala PPARgamma gene polymorphism: possible modifier of the activity and severity of thyroid associated orbitopathy (TAO). Clin. Endocrinol. (Oxf.) 70: 464-468 (2009). *
Alexander LS, Qu A, Cutler SA, Mahajan A, Rothschild MF, Cai W, Dekkers JC, Stahl CH. A calcitonin receptor (CALCR) single nucleotide polymorphism is associated with growth performance and bone integrity in response to dietary phosphorus deficiency. J. Anim. Sci. Nov 20 [Epub ahead of print] (2009). *
Alexiou P, Vergoulis T, Gleditzsch M, Prekas G, Dalamagas T, Megraw M, Grosse I, Sellis T, Hatzigeorgiou AG. miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Res. 38: D137-D141 (2010). *
Alfadhli S, Altamimy B, Kharrat N, Alsaeid K, Haider MZ, Rebai A. Molecular analysis of HumDN1 VNTR polymorphism of the human deoxyribonuclease I in systemic lupus erythematosus. Int. J. Immunogenet. Oct 5 [Epub ahead of print] (2009).
Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pirmohamed M. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet. Genomics 16: 287-296 (2006).
Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital-based study. J. Pak. Med. Assoc. 56: 452-456 (2006).
Ali M, Kim H, Cleary S, Cupples C, Gallinger S, Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology 135: 499-507.e1 (2008). *
Ali ME, Ahmed MU, Alam S, Rahman MH. HLA-A, -B and -DRB1 allele frequencies in the Bangladeshi population. Tissue Antigens 72: 115-119 (2008). *
Ali MF, Meza JL, Rogan EG, Chakravarti D. Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncol. Rep. 19: 1033-1038 (2008). *
Ali S, Vollaard AM, Kremer D, de Visser AW, Martina CA, Widjaja S, Surjadi C, Slagboom E, van de Vosse E, van Dissel JT. Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever. J. Interferon Cytokine Res. 27: 271-280 (2007).
Ali SB, Yahia FB, Sediri Y, Kallel A, Ftouhi B, Feki M, Elasmi M, Haj-Taieb S, Souheil O, Sanhagi H, Slimane H, Jemaa R, Kaabachi N. Gender specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. Clin. Biochem. 42: 1642-1647 (2009). *
Alia P, Mana J, Capdevila O, Alvarez A, Navarro MA. Association between ACE gene I/D polymorphism and clinical presentation and prognosis of sarcoidosis. Scand. J. Clin. Lab. Invest. 65: 691-698 (2005). *
Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J. Cyst. Fibros. 7: 102-109 (2008).
Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran. J. Allergy Asthma Immunol. 5: 3-8 (2006).
Alidoust L, Zafarghandi M, Agah M, Sendi H, Alavian SM, Zali MR. Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study. Indian J. Gastroenterol. 26: 97-99 (2007). *
Alifirova VM, Orlova IuIu, Babenko SA, Rudko AA, Puzyrev VP. The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2006 Spec. No 3: 130-135 (2006).
Alkassab F, Gourh P, Tan F, Arnett F, Mayes M. Comment on: an allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis: reply. Rheumatology (Oxford) 47: 557 (2008).
Alkassab F, Gourh P, Tan FK, McNearney T, Fischbach M, Ahn C, Arnett FC, Mayes MD. An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) 46: 1248-1251 (2007). *
Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC. Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 8: 777-780 (1998).
Allan JM, Shorto J, Adlard J, Bury J, Coggins R, George R, Katory M, Quirke P, Richman S, Scott D, Scott K, Seymour M, Travis LB, Worrillow LJ, Bishop DT, Cox A. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int. J. Cancer 123: 2456-2459 (2008). *
Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin. Chim. Acta 350: 51-55 (2004). *
Allayee H, Baylin A, Hartiala J, Wijesuriya H, Mehrabian M, Lusis AJ, Campos H. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am. J. Clin. Nutr. 88: 934-940 (2008). *
Allcock R, Dolecki KJ, Boodhoo A, Abdul Khalil A, Wong AM, Price P. Genomic sequence and expression profile of murine Bat1a and Nfkbil1. DNA Seq. 17: 292-299 (2006).
Allcock RJ, Baluchova K, Cheong KY, Price P. Haplotypic single nucleotide polymorphisms in the central MHC gene IKBL, a potential regulator of NF-kappaB function. Immunogenetics 52: 289-293 (2001).
Allcock RJ, Christiansen FT, Price P. The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15. Immunogenetics 49: 660-665 (1999). *
Allcock RJ, de la Concha EG, Fernandez-Arquero M, Vigil P, Conejero L, Arroyo R, Price P. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum. Immunol. 60: 1266-1273 (1999).
Allcock RJ, Price P, Gaudieri S, Leelayuwat C, Witt CS, Dawkins RL. Characterisation of the human central MHC gene, BAT1: genomic structure and expression. Exp. Clin. Immunogenet. 16: 98-106 (1999).
Allen AS, Satten GA. Genome-wide association analysis of rheumatoid arthritis data via haplotype sharing. BMC Proc. 3 Suppl. 7: S30 (2009). *
Allen AS, Satten GA. Association mapping via a class of haplotype-sharing statistics. BMC Proc. 1 Suppl. 1: S123 (2007). *
Allen KJ, Cheah DM, Wright PF, Gazeas S, Pettigrew-Buck NE, Deal YH, Mercer JF, Williamson R. Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease. J. Gastroenterol. Hepatol. 19: 1283-1290 (2004). *
Allen M, Ameen H, Veal C, Evans J, Ramrakha-Jones VS, Marsland AM, Burden AD, Griffiths CE, Trembath R, Barker JW. The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. J. Invest. Dermatol. 124: 103-106 (2005). *
Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, Ponting CP, Bhattacharyya S, Tinsley J, Zhang Y, Holt R, Jones EY, Lench N, Carey A, Jones H, Dickens NJ, Dimon C, Nicholls R, Baker C, Xue L, Townsend E, Kabesch M, Weiland SK, Carr D et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35: 258-263 (2003). *
Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit. Care Med. 34: 2658-2665 (2006).
Allen-Brady K, Horne BD, Malhotra A, Teerlink C, Camp NJ, Thomas A. Analysis of high-density single-nucleotide polymorphism data: three novel methods that control for linkage disequilibrium between markers in a linkage analysis. BMC Proc. 1 Suppl. 1: S160 (2007). *
Allen-Brady K, Miller J, Matsunami N, Stevens J, Block H, Farley M, Krasny L, Pingree C, Lainhart J, Leppert M, McMahon WM, Coon H. A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol. Psychiatry 14: 590-600 (2009).
Allen-Brady K, Robison R, Cannon D, Varvil T, Villalobos M, Pingree C, Leppert MF, Miller J, McMahon WM, Coon H. Genome-wide linkage in Utah autism pedigrees. Mol. Psychiatry May 19 [Epub ahead of print] (2009).
Aller R, De Luis DA, Fernandez L, Calle F, Velayos B, Izaola O, Gonzalez Sagrado M, Conde R, Gonzalez JM. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. Eur. Rev. Med. Pharmacol. Sci. 13: 357-364 (2009).
Alm JS, Sanjeevi CB, Miller EN, Dabadghao P, Lilja G, Pershagen G, Blackwell JM, Scheynius A. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun. 3: 71-77 (2002). *
Almani M, Raffaeli S, Vider-Shalit T, Tsaban L, Fishbain V, Louzoun Y. Human self-protein CD8(+) T-cell epitopes are both positively and negatively selected. Eur. J. Immunol. 39: 1056-1065 (2009). *
Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes Immun. 7: 401-406 (2006). *
Alonso MJ, Heine-Suner D, Calvo M, Rosell J, Gimenez J, Ramos MD, Telleria JJ, Palacio A, Estivill X, Casals T. Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry. Ann. Hum. Genet. 71: 194-201 (2007). *
Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Agundez JA. The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases. Med. Clin. (Barc.) 126: 697-706 (2006).
Alpay HC, Etem EO, Kaygusuz I, Yuce H, Karlidag T, Keles E, Orhan I, Yalcin S. Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients. Auris. Nasus. Larynx Apr 25 [Epub ahead of print] (2009).
Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex. Hum. Immunol. 67: 73-84 (2006). *
Alper SL. Molecular physiology and genetics of Na+-independent SLC4 anion exchangers. J. Exp. Biol. 212: 1672-1683 (2009). *
Alper SL. Molecular physiology of SLC4 anion exchangers. Exp. Physiol. 91: 153-161 (2006). *
Alsaeid K, Haider MZ, Ayoub EM. Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis. J. Rheumatol. 30: 2705-2709 (2003).
Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF. Genetic Study of Saudi Diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab. Res. Rev. 24: 137-140 (2008).
Altamura C, Squitti R, Pasqualetti P, Tibuzzi F, Silvestrini M, Ventriglia MC, Cassetta E, Rossini PM, Vernieri F. What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? Eur. J. Neurol. 14: 679-682 (2007).
Alter A, de Leseleuc L, Van Thuc N, Thai VH, Huong NT, Ba NN, Cardoso CC, Grant AV, Abel L, Moraes MO, Alcais A, Schurr E. Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum. Genet. Dec 25 [Epub ahead of print] (2009). *
Altes A, Bach V, Ruiz A, Esteve A, Felez J, Remacha AF, Sarda MP, Baiget M. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene. Ann. Hematol. 88: 951-955 (2009).
Altinova AE, Engin D, Akbay E, Akturk M, Toruner F, Ersoy R, Yetkin I, Arslan M. Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to type 1 diabetes in Turkish patients. J. Endocrinol. Invest. Dec 22 [Epub ahead of print] (2009).
Altomare DF, Guanti G, Hoch J, Vician M, Krivokapic Z, Bergamaschi R; for the Colorectal Micrometastases Study Group. Non-colonic cancer stem cells in bone marrow of colorectal cancer patients. Colorectal Dis. Jan 27 [Epub ahead of print] (2009). *
Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P; International HapMap Consortium. A haplotype map of the human genome. Nature 437: 1299-1320 (2005). *
Alvarado-Guerri R, Cabrera CM, Garrido F, Lopez-Nevot MA. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population. Hum. Immunol. 66: 921-930 (2005).
Alvarado-Navarro A, Montoya-Buelna M, Munoz-Valle JF, Lopez-Roa RI, Guillen-Vargas C, Fafutis-Morris M. The 3'UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico. Immunol. Lett. 118: 148-151 (2008).
Alvarez I, Lopez de Castro JA. HLA-B27 and immunogenetics of spondyloarthropathies. Curr. Opin. Rheumatol. 12: 248-253 (2000).
Alvarez L L, Venegas S M, Larrondo L M, Becerra B N, Castro L A, Quera P R. Thiopurine S-methyltransferase gene polymorphism in Chilean blood donors. Rev. Med. Chil. 137: 185-192 (2009).
Alvarez-Blasco F, Martinez-Garcia MA, Luque-Ram�rez M, Parraza N, San Millan JL, Escobar-Morreale HF. Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS ONE 4: e5606 (2009). *
Alvarez-Hernandez D, Naves-Diaz M, Gomez-Alonso C, Coto E, Cannata-Andia JB. Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol. J. Nephrol. 21: 843-849 (2008).
Alvarez-Lafuente R, Martinez A, Garcia-Montojo M, Mas A, De Las Heras V, Dominguez-Mozo MI, Maria Del Carmen C, Lopez-Cavanillas M, Bartolome M, Gomez de la Concha E, Urcelay E, Arroyo R. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur. J. Neurol. Jul 29 [Epub ahead of print] (2009).
Alvarez-Rodriguez L, Carrasco E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-Soto M, Calvo J, Rodriguez-Valverde V, Ruiz T, Blanco R, Corrales A, Martinez-Taboada VM. Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN*2/2 genotype with polymyalgia rheumatica. Hum. Immunol. 70: 49-54 (2009).
Alvarez-Rodriguez L, Mart�nez-Taboada VM, Lopez-Hoyos M, Mata C, Fernandez Prieto L, Agudo-Bilbao M, Calvo J, Ruiz Soto M, Rodriguez-Valverde V, Ruiz T, Blanco R, Corrales A, Carrasco-Mar�n E. Interleukin-12 gene polymorphisim in patients with giant cell arteritis, polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Clin. Exp. Rheumatol. 27: S14-S18 (2009).
Alves C, Meyer I, Toralles MB, Marback RL. Association of human histocompatibility antigens with ophthalmological disorders. Arq. Bras. Oftalmol. 69: 273-278 (2006).
Alves C, Veiga S, Souza T, Toralles MB, da Silva-Bacellar AL. The role of the human histocompatibility antigens in the pathogenesis of neurological disorders. Rev. Neurol. 44: 298-302 (2007).
Alves Correa SA, Ribeiro de Noronha SM, Nogueira-de-Souza NC, Valleta de Carvalho C, Massad Costa AM, Juvenal Linhares J, Vieira Gomes MT, Guerreiro da Silva ID. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J. Renin Angiotensin Aldosterone Syst. 10: 51-58 (2009).
Alves G, Ogurtsov AY, Yu YK. RAId_DbS: mass-spectrometry based peptide identification web server with knowledge integration. BMC Genomics 9: 505 (2008). *
Alves Pedroso ML, Boldt AB, Pereira-Ferrari L, Steffensen R, Strauss E, Jensenius JC, Ioshii SO, Messias-Reason I. Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clin. Exp. Immunol. 152: 258-264 (2008). *
Alvim-Pereira F, Montes CC, Thome G, Olandoski M, Trevilatto PC. Analysis of association of clinical aspects and vitamin D receptor gene polymorphism with dental implant loss. Clin. Oral Implants Res. 19: 786-795 (2008).
Aly HH, Shimotohno K, Hijikata M. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV. Biochem. Biophys. Res. Commun. 379: 330-334 (2009). *
Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE, Kretowski A, Erlich HA, Fain PR, Rewers MJ, Eisenbarth GS. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 57: 770-776 (2008). *
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 55: 1265-1269 (2006). *
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J. Autoimmun. 25: S40-S45 (2005).
Amanatidou V, Sourvinos G, Apostolakis S, Neonaki P, Tsilimigaki A, Krambovitis E, Spandidos DA. RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis. Pediatr. Infect. Dis. J. 27: 38-42 (2008).
Amani D, Farjadian S, Ghaderi A. The frequency of transforming growth factor-beta1 gene polymorphisms in a normal southern Iranian population. Int. J. Immunogenet. 35: 145-151 (2008). *
Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, Ben-Asher E, Karni O, Mujaheed M, Segman RH, Maier W, Macciardi F, Beckmann JS, Lancet D, Lerer B. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur. J. Hum. Genet. 14: 1111-1119 (2006). *
Amano Y, Komiyama K, Makishima M. Vitamin D and periodontal disease. J. Oral Sci. 51: 11-20 (2009). *
Ambrugger P, Stoeva I, Biebermann H, Torresani T, Leitner C, Gruters A. Novel mutations of the thyroid peroxidase gene in patients with permanent congenital hypothyroidism. Eur. J. Endocrinol. 145: 19-24 (2001). *
Ambruzova Z, Mrazek F, Raida L, Stahelova A, Faber E, Indrak K, Petrek M. Possible impact of MAdCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic haematopoietic stem cell transplantation. Hum. Immunol. 70: 457-460 (2009).
Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res. Clin. Pract. 67: 175-179 (2005).
Amcheslavsky A, Zou W, Bar-Shavit Z. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms: implications for osteoclastogenesis. J. Biol. Chem. 279: 54039-54045 (2004). *
Ameen M, Allen MH, Fisher SA, Lewis CM, Cuthbert A, Kondeatis E, Vaughan RW, Murakami H, Nakagawa H, Barker JN. Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations. Clin. Exp. Dermatol. 30: 414-418 (2005). *
Amengual O, Atsumi T, Komano Y, Kataoka H, Horita T, Yasuda S, Koike T. A polymorphism in human platelet antigen 6b and risk of thrombocytopenia in patients with systemic lupus erythematosus. Arthritis Rheum. 56: 2803-2805 (2007). *
Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, Sabahi F, Zali MR, Luedde T, Trautwein C, Tacke F. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. J. Hepatol. 51: 647-654 (2009).
Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum. Immunol. 68: 690-697 (2007).
Amirghofran Z, Jalali SA, Ghaderi A, Hosseini SV. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer Genet. Cytogenet. 190: 21-25 (2009).
Amirzargar A, Mytilineos J, Yousefipour A, Farjadian S, Scherer S, Opelz G, Ghaderi A. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur. J. Immunogenet. 25: 297-301 (1998). *
Amirzargar AA, Naroueynejad M, Khosravi F, Dianat S, Rezaei N, Mytilineos J, Nikbin B. Cytokine single nucleotide polymorphisms in Iranian populations. Eur. Cytokine Netw. 19: 104-112 (2008).
Amirzargar M, Yavangi M, Basiri A, Moghadam SH, Khosravi F, Solgi G, Gholiaf M, Khoshkho F, Dadaras F, Mahmmodi M, Ansaripour B, Amirzargar A, Nikbin B. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients. Transplant. Proc. 39: 954-957 (2007). *
Amlie-Lefond C, Paz DA, Connelly MP, Huffnagle GB, Dunn KS, Whelan NT, Whelan HT. Innate immunity for biodefense: a strategy whose time has come. J. Allergy Clin. Immunol. 116: 1334-1342 (2005). *
Ammendola M, Pietropolli A, Saccucci P, Piccione E, Bottini E, Gloria-Bottini F. Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy. Fertil. Steril. 90: 1203-1205 (2008).
Amoli MM, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis. J. Rheumatol. 32: 74-76 (2005).
Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J. Rheumatol. 31: 2413-2417 (2004). *
Amoli MM, Hand S, Hajeer AH, Jones KP, Rolf S, Sting C, Davies BH, Ollier WE. Polymorphism in the STAT6 gene encodes risk for nut allergy. Genes Immun. 3: 220-224 (2002). *
Amoli MM, Salway F, Ollier WE, Gonzalez-Gay MA. MCP-1 gene haplotype association in biopsy proven giant cell arteritis. J. Rheumatol. 32: 507-510 (2005).
Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, Batliwalla F, Wener M, Remmers E, Kastner DA, Criswell LA, Seldin MF, Gregersen PK. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun. 7: 277-286 (2006). *
Amos CI, Chen WV, Remmers E, Siminovitch KA, Seldin MF, Criswell LA, Lee AT, John S, Shephard ND, Worthington J, Cornelis F, Plenge RM, Begovich AB, Dyer TD, Kastner DL, Gregersen PK. Data for Genetic Analysis Workshop (GAW) 15 Problem 2, genetic causes of rheumatoid arthritis and associated traits. BMC Proc. 1 Suppl. 1: S3 (2007). *
Amos CI, Chen WV, Seldin MF, Remmers EF, Taylor KE, Criswell LA, Lee AT, Plenge RM, Kastner DL, Gregersen PK. Data for Genetic Analysis Workshop 16 Problem 1, association analysis of rheumatoid arthritis data. BMC Proc. 3 Suppl. 7: S2 (2009). *
Amre DK. Going with the flow of autophagy in Crohn's disease: IRGM risk polymorphism found upstream. Inflamm. Bowel Dis. 16: 179-180 (2010). *
Amre DK, Mack D, Israel D, Morgan K, Lambrette P, Law L, Grimard G, Deslandres C, Krupoves A, Bucionis V, Costea I, Bissonauth V, Feguery H, D'Souza S, Levy E, Seidman EG. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am. J. Gastroenterol. 103: 615-620 (2008). *
Amre DK, Mack DR, Israel D, Morgan K, Krupoves A, Costea I, Lambrette P, Grimard G, Deslandres C, Levy E, Seidman EG. Investigation of associations between the pregnane X receptor gene (NR1I2) and Crohn's disease in Canadian children using a gene-wide haplotype-based approach. Inflamm. Bowel Dis. 14: 1214-1218 (2008). *
Amre DK, Mack DR, Morgan K, Fujiwara M, Israel D, Deslandres C, Seidman EG, Lambrette P, Costea I, Krupoves A, Fegury H, Dong J, Grimard G, Levy E. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children. Am. J. Gastroenterol. 104: 2824-2828 (2009). *
Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, Costea I, Krupoves A, Fegury H, Dong J, Grimard G, Deslandres C, Levy E, Seidman EG. Interleukin 10 (IL-10) gene variants and susceptibility for pediatric onset Crohn's disease. Aliment. Pharmacol. Ther. 29: 1025-1031 (2009). *
Amre DK, Mack DR, Morgan K, Krupoves A, Costea I, Lambrette P, Grimard G, Dong J, Feguery H, Bucionis V, Deslandres C, Levy E, Seidman EG. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm. Bowel Dis. 15: 501-507 (2009). *
Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, Ramasawmy R, Brun M, Dulphy N, Krishnamoorthy R, Toubert A, Charron D, Abbadi MC, Tamouza R. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum. Immunol. 66: 1057-1061 (2005).
Amundsen SS, Adamovic S, Hellqvist A, Nilsson S, Gudj�nsd�ttir AH, Ascher H, Ek J, Larsson K, Wahlstrom J, Lie BA, Sollid LM, Naluai AT. A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families. Eur. J. Hum. Genet. 15: 980-987 (2007). *
Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjonsdottir AH, Ascher H, Wijmenga C, Sollid LM. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum. Immunol. 67: 341-345 (2006).
Amundsen SS, Naluai AT, Ascher H, Ek J, Gudjonsdottir AH, Wahlstrom J, Lie BA, Sollid LM. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64: 593-599 (2004). *
Amundsen SS, Rundberg J, Adamovic S, Gudjonsdottir AH, Ascher H, Ek J, Nilsson S, Lie BA, Naluai AT, Sollid LM. Four novel coeliac disease regions replicated in an association study of a Swedish-Norwegian family cohort. Genes Immun. Aug 20 [Epub ahead of print] (2009).
Amundsen SS, Vatn M; the IBSEN study group; Wijmenga C, Sollid LM, Lie BA. Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens 68: 249-252 (2006). *
An P, Feitosa M, Ketkar S, Adelman A, Lin S, Borecki I, Province M. Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: evidence from the Framingham Heart Study. BMC Proc. 3 Suppl. 7: S71 (2009). *
An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA. Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J. Infect. Dis. 198: 1159-1165 (2008). *
Anasetti C. What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation? Best Pract. Res. Clin. Haematol. 21: 691-697 (2008).
Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr. HIV Res. 1: 185-203 (2003).
Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G. Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism. J. Rheumatol. 29: 1874-1876 (2002). *
Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 31: 396-405 (2002). *
Anaya JM, Mantilla RD, Correa PA. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin. Arthritis Rheum. 34: 735-743 (2005). *
Andersen G, Burgdorf KS, Sparso T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 Danish whites. Diabetes 57: 1427-1432 (2008). *
Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 49: 75-82 (2006). *
Andersen V, Agerstjerne L, Jensen D, Ostergaard M, Saebo M, Hamfjord J, Kure E, Vogel U. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Med. Genet. 10: 18 (2009). *
Andersen V, Ostergaard M, Christensen J, Overvad K, Tjonneland A, Vogel U. Polymorphisms in the xenobiotic transporter multidrug resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 9: 407 (2009). *
Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr. Opin. Immunol. 18: 665-669 (2006).
Anderson CA, Massey DC, Barrett JC, Prescott NJ, Tremelling M, Fisher SA, Gwilliam R, Jacob J, Nimmo ER, Drummond H, Lees CW, Onnie CM, Hanson C, Blaszczyk K, Ravindrarajah R, Hunt S, Varma D, Hammond N, Lewis G, Attlesey H, Watkins N, et al. Investigation of Crohn�s disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136: 523-529.e3 (2009). *
Anderson GD, Temkin NR, Dikmen SS, Diaz-Arrastia R, Machamer JE, Farhrenbruch C, Miller JW, Sadrzadeh SM. Haptoglobin phenotype and apolipoprotein E polymorphism: relationship to posttraumatic seizures and neuropsychological functioning after traumatic brain injury. Epilepsy Behav. 16: 501-506 (2009).
Anderson JE, Hansen LL, Mooren FC, Post M, Hug H, Zuse A, Los M. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine. Drug Resist. Updat. 9: 198-210 (2006).
Andersson P, Varenhorst E, Soderkvist P. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk. Eur. J. Cancer 42: 2833-2837 (2006). *
Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55: 158-164 (2006). *
Ando T, Goto Y, Ishiguro K, Maeda O, Watanabe O, Ohmiya N, Niwa Y, Hamajima N, El-Omar E, Goto H. The interaction of host genetic factors and Helicobacter pylori infection. Inflammopharmacology 15: 10-14 (2007).
Ando T, Ishikawa T, Kato H, Yoshida N, Naito Y, Kokura S, Yagi N, Takagi T, Handa O, Kitawaki J, Nakamura N, Hasegawa G, Fukui M, Imamoto E, Nakamura C, Oyamada H, Isozaki Y, Matsumoto N, Nagao Y, Okita M, Nakajima Y, Kurokawa M, Nukina M, Ohta M, et al. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int. J. Cancer 125: 2595-2602 (2009). *
Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm. Bowel Dis. 13: 955-962 (2007). *
Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, Matsui T, Matsumoto T, Benno Y, Fujiyama Y. Fecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment. Pharmacol. Ther. 29: 75-82 (2009). *
Andrade LE. Future perspective for diagnosis in autoimmune diseases. An. Acad. Bras. Cienc. 81: 367-380 (2009).
Andre MF, Aumaitre O, Piette JC, Grateau G, Cardoso MC, Ouchchane L, Kemeny JL, Dastugue B, Delpech M, Creveaux I. Analysis of the NOD2/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease. Dig. Dis. Sci. 53: 490-499 (2008). *
Andreani M, Radio FC, Testi M, De Bernardo C, Troiano M, Majore S, Bertucci P, Polchi P, Rosati R, Grammatico P. Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major. Haematologica 94: 1293-1296 (2009). *
Andreasen CH, Andersen G. Gene-environment interactions and obesity - further aspects of genomewide association studies. Nutrition 25: 998-1003 (2009).
Andreevskii TV, Sudomoina MA, Gusev EI, Boiko AN, Alekseenkov AD, Favorova OO. Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians. Mol. Biol. (Mosk.) 36: 643-648 (2002).
Andren M, Johanneson B, Alarcon-Riquelme ME, Kleinau S. IgG Fc receptor polymorphisms and association with autoimmune disease. Eur. J. Immunol. 35: 3020-3029 (2005). *
Andreoli V, Cittadella R, Valentino P, Condino F, La Russa A, Liguori M, Manna I, Spadafora P, Nistico R, Pirritano D, Clodomiro A, Quattrone A. The role of VLA4 polymorphisms in multiple sclerosis: an association study. J. Neuroimmunol. 189: 125-128 (2007).
Andres AM, Hubisz MJ, Indap A, Torgerson DG, Degenhardt JD, Boyko AR, Gutenkunst RN, White TJ, Green ED, Bustamante CD, Clark AG, Nielsen R. Targets of balancing selection in the human genome. Mol. Biol. Evol. 26: 2755-2764 (2009). *
Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 56: 1181-1186 (2007). *
Andrulionyte L, Laukkanen O, Chiasson JL, Laakso M; STOP-NIDDM Study Group. Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial. J. Mol. Med. 84: 701-708 (2006). *
Andrulionyte L, Peltola P, Chiasson JL, Laakso M. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 55: 2148-2152 (2006). *
Andrulionyte L, Zacharova J, Chiasson JL, Laakso M; for the STOP-NIDDM Study Group. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47: 2176-2184 (2004). *
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study. Eur. J. Epidemiol. 19: 1085-1087 (2004). *
Angeline T, Jeyaraj N, Tsongalis GJ. MTHFR Gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients. Exp. Mol. Pathol. 82: 227-233 (2007). *
Anger T, Ekici AB, Daniel WG, Garlichs CD. Gene polymorphisms leading to calcified and stenotic aortic valves. Herz. 31: 635-643 (2006).
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler. Thromb. Vasc. Biol. 26: 1895-1900 (2006).
Anglicheau D, Legendre C, Beaune P, Thervet E. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update. Pharmacogenomics 8: 835-849 (2007).
Anglicheau D, Legendre C, Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation 78: 311-315 (2004).
Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Buchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin. Pharmacol. Ther. 75: 422-433 (2004). *
Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol. Genet. Metab. 81: 187-195 (2004). *
Anjos SM, Shao W, Marchand L, Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism. Genes Immun. 6: 305-311 (2005). *
Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J. Clin. Endocrinol. Metab. 89: 6257-6265 (2004). *
Annese V, Latiano A, Palmieri O, Lombardi G, Andriulli A; Italian Group of Inflammatory Bowel Disease. NOD2/CARD15 in healthy relatives of IBD patients. Eur. Rev. Med. Pharmacol. Sci. 10: 33-36 (2006).
Annese V, Latiano A, Rossi L, Bossa F, Damonte G, Dallapiccola B, Serafini S, Pierige F, Andriulli A, Magnani M. The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 10: 27-31 (2006).
Annese V, Lombardi G, Perri F, D'Inca R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - an IG-IBD study. Am. J. Gastroenterol. 100: 84-92 (2005). *
Annese V, Palmieri O, Latiano A, Ardizzone S, Castiglione F, Cottone M, D'Inca R, Gionchetti P, Papi C, Riegler G, Vecchi M, Andriulli A; Italian Group for Inflammatory Bowel Disease. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig. Liver Dis. 36: 121-124 (2004).
Annese V, Piepoli A, Andriulli A, Napolitano G, Bisceglia L, Zelante L, Gasparini P. Polymorphism of motilin gene in patients with Crohn's disease. Dig. Dis. Sci. 43: 715-719 (1998). *
Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J. Gastroenterol. 12: 3636-3644 (2006). *
Ano H, Matsumoto T, Suetake T, Nagai T, Tamura Y, Takamatsu I, Iwasaki T, Matsuoka H, Sasada S, Tetsumoto S, Tsuyuguchi I, Kusunoki Y, Takashima T. Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan. Int. J. Tuberc. Lung Dis. 12: 1300-1305 (2008).
Ansari AA, Pattanapanyasat K. Chapter 33. Immunological tolerance in allo- and xenografts. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 433-449 (2007). *
Anstey A, Lear JT. Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs 9: 33-47 (1998).
Antipova AA, Sokolsky TD, Clouser CR, Dimalanta ET, Hendrickson CL, Kosnopo C, Lee CC, Ranade SS, Zhang L, Blanchard AP, McKernan KJ. Polymorphism discovery in high-throughput resequenced microarray-enriched human genomic Loci. J. Biomol. Tech. 20: 253-257 (2009). *
Antoine HJ, Pall M, Trader BC, Chen YD, Azziz R, Goodarzi MO. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil. Steril. 87: 862-869 (2007). *
Antoniades A, Kalvari I, Pattichis C, Jones N, Matthews PM, Domenici E, Muglia P. Discovering genetic polymorphism associated with gene expression levels across the whole genome. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1: 5466-5469 (2009). *
Antoniades C, Shirodaria C, Leeson P, Baarholm OA, Van-Assche T, Cunnington C, Pillai R, Ratnatunga C, Tousoulis D, Stefanadis C, Refsum H, Channon KM. MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119: 2507-2515 (2009). *
Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, Cardelli M, Galeazzi R, Giovagnetti S, Perna GP, Franceschi C. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron. Artery Dis. 16: 489-493 (2005).
Antoniou AN, Powis SJ. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology 124: 1-12 (2008). *
Antoun A, Jobson S, Cook M, Moss P, Briggs D. Ethnic variability in human leukocyte antigen-E haplotypes. Tissue Antigens 73: 39-45 (2009). *
Anuradha S, Radha V, Deepa R, Hansen T, Carstensen B, Pedersen O, Mohan V. A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians. Diabetes Care 28: 2430-2435 (2005). *
Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye Oct 2 [Epub ahead of print] (2009).
Anzai C, Morokawa N, Okada H, Kamidono S, Eto Y, Yoshimura K. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J. Cyst. Fibros. 2: 14-18 (2003).
Aoki CA, Bowlus CL, Gershwin ME. The immunobiology of primary sclerosing cholangitis. Autoimmun. Rev. 4: 137-143 (2005).
Aoki T, Hirota T, Tamari M, Ichikawa K, Takeda K, Arinami T, Shibasaki M, Noguchi E. An association between asthma and TNF-308G/A polymorphism: meta-analysis. J. Hum. Genet. 51: 677-685 (2006). *
Aouacheria A, Navratil V, Lopez-Perez R, Gutierrez NC, Churkin A, Barash D, Mouchiroud D, Gautier C. In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics 8: 2 (2007). *
Aoun E, Muddana V, Papachristou GI, Whitcomb DC. SPINK1 N34S is strongly associated with recurrent acute pancreatitis but is not a risk factor for the first or sentinel acute pancreatitis event. Am. J. Gastroenterol. Nov 3 [Epub ahead of print] (2009). *
Aoyagi H, Okada T, Hasatani K, Mibayashi H, Hayashi Y, Tsuji S, Kaneko Y, Yamagishi M. Impact of cystic fibrosis transmembrane conductance regulator gene mutation on the occurrence of chronic pancreatitis in Japanese patients. J. Int. Med. Res. 37: 378-384 (2009).
Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin. Exp. Res. 30: 1644-1649 (2006). *
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, Andre F, Tursz T, Kroemer G, Zitvogel L. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev. 220: 47-59 (2007). *
Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res. 68: 4026-4030 (2008). *
Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. J. Clin. Virol. 34: 310-314 (2005).
Appenrodt B, Grunhage F, Gentemann MG, Thyssen L, Sauerbruch T, Lammert F. NOD2 variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology [In Press] (2009). *
Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127: 26-39 (2009). *
Apte MV, Pirola RC, Wilson JS. Individual susceptibility to alcoholic pancreatitis. J. Gastroenterol. Hepatol. 23 Suppl. 1: S63-S68 (2008). *
Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Rezvani ME. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. J. Gastroenterol. Hepatol. 25: 90-93 (2010). *
Arabi A, Zahed L, Mahfoud Z, El-Onsi L, Nabulsi M, Maalouf J, Fuleihan GE. Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. Bone 45: 1091-1097 (2009). *
Arai T, Michalski JP, McCombs CC, Elston RC, McCarthy CF, Stevens FM. T cell receptor gamma gene polymorphisms and class II human lymphocyte antigen genotypes in patients with celiac disease from the west of Ireland. Am. J. Med. Sci. 309: 171-178 (1995).
Arakaki PA, Marques MR, Santos MC. MMP-1 polymorphism and its relationship to pathological processes. J. Biosci. 34: 313-320 (2009). *
Arakawa T, Kita Y, Niikura T. A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism. Curr. Med. Chem. 15: 2086-2098 (2008).
Araki A, Hazama S, Oka M, Hinoda Y. Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer. Nippon Rinsho 61 Suppl. 7: 229-232 (2003).
Araki E, Igata M, Motoshima H, Tsuruzoe K. Polymorphisms of PPARs and metabolic disorders. Nippon Rinsho 63: 617-622 (2005).
Araki M, Chung D, Liu S, Rainbow DB, Chamberlain G, Garner V, Hunter KM, Vijayakrishnan L, Peterson LB, Oukka M, Sharpe AH, Sobel R, Kuchroo VK, Wicker LS. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. J. Immunol. 183: 5146-5157 (2009).
Aranyi T, Ratajewski M, Bardoczy V, Pulaski L, Bors A, Tordai A, Varadi A. Identification of a DNA methylation-dependent activator sequence in the pseudoxanthoma elasticum gene, ABCC6. J. Biol. Chem. 280: 18643-18550 (2005). *
Arason GJ, Kramer J, Blasko B, Kolka R, Thorbjornsdottir P, Einarsdottir K, Sigfusdottir A, Siguretharson ST, Sigurethsson G, Ronai Z, Prohaszka Z, Sasvari-Szekely M, Boethvarsson S, Thorgeirsson G, Fust G. Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin. Exp. Immunol. 149: 132-138 (2007). *
Araste JM, Sarvestani EK, Aflaki E, Amirghofran Z. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules. Immunol. Invest. 39: 27-38 (2010).
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S. Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents. Hum. Immunol. 68: 739-743 (2007).
Araujo J, Segat L, Guimaraes RL, Brandao LA, Souza PE, Santos S, Soares TS, Falcao EA, Rodrigues F, Carvalho R Jr, de Lima-Filho JL, Arraes LC, Crovella S. Mannose binding lectin gene polymorphisms and associated auto-immune diseases in type 1 diabetes Brazilian patients. Clin. Immunol. 131: 254-259 (2009). *
Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr. Opin. Pharmacol. 4: 183-188 (2004).
Arayssi TK, Hamdan AR, Touma Z, Shamseddeen W, Uthman IW, Hourani HB, Farra CG. TNF polymorphisms in Lebanese patients with Behcet's disease. Clin. Exp. Rheumatol. 26: S130-S131 (2008).
Arcaroli J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock 24: 300-312 (2005). *
Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, Bell MJ, Brennan RM, Beddoe T, Wilce MC, Clements CS, Purcell AW, McCluskey J, Burrows SR, Rossjohn J. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206: 209-219 (2009). *
Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes J, Jaramillo D, Ceballos G, Uribe A, Rivera N, Rivera D, Fonseca I, Camargo M, Palacio G. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110: 334-342 (2002). *
Ardaillou R. Genetic polymorphisms linked to myocardial ischemia in a Japanese population. Med. Sci. (Paris) 19: 413-414 (2003).
Ardaillou R, Le Gall JY. Mass neonatal screening using biological testing. Gynecol. Obstet. Fertil. 35: 367-374 (2007).
Ardeniz O, Avci CB, Sin A, Ozgen G, Gunsar F, Mete N, Gulbahar O, Kokuludag A. Vitamin D deficiency in the absence of enteropathy in three cases with common variable immunodeficiency. Int. Arch. Allergy Immunol. 147: 74-83 (2008).
Ardizzone S. Ulcerative colitis. Orphanet encyclopedia [http://www.orpha.net/data/patho/GB/uk-UC.pdf] (2003). *
Ardizzone S, Maconi G, Bianchi V, Russo A, Colombo E, Cassinotti A, Penati C, Tenchini ML, Bianchi Porro G. Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm. Bowel Dis. 13: 516-523 (2007). *
Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res. Ther. 10: 218 (2008). *
Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, Mannai I, Zorgati MM, Ben Alaya N, Rebai A, Zouari B, Ben Ammar S, Ben Rayana MC, Hmida S, Blousa-Chabchoub S, Abdelhak S. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J. Renin Angiotensin Aldosterone Syst. 9: 32-36 (2008).
Argano C, Duro G, Corrao S, Di Chiara T, Nuzzo D, Colomba D, Scaglione R, Licata G. Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage. Blood Press. 17: 220-226 (2008).
Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp. Clin. Immunogenet. 14: 118-122 (1997).
Arias-Vasquez A, Isaacs A, Aulchenko YS, Hofman A, Oostra BA, Breteler M, van Duijn CM. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease. Neurogenetics 8: 189-193 (2007).
Arico M. Langerhans cell histiocytosis in adults: more questions than answers? Eur. J. Cancer 40: 1467-1473 (2004). *
Arikan C, Berdeli A, Kilic M, Tumgor G, Yagci RV, Aydogdu S. Polymorphisms of the ICAM-1 gene are associated with biliary atresia. Dig. Dis. Sci. 53: 2000-2004 (2008). *
Arikan C, Berdeli A, Ozgenc F, Tumgor G, Yagci RV, Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia. J. Pediatr. Gastroenterol. Nutr. 42: 77-82 (2006). *
Arikan H, Koc M, Sari H, Tuglular S, Ozener C, Akoglu E. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients. Ren. Fail. 29: 713-719 (2007).
Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y, Mineta M, Takeichi M, Yamada S, Imamura A, Ohara K, Shibuya H, Ohara K, Suzuki Y, Muratake T, Kaneko N, Someya T, Inada T, Yoshikawa T, Toyota T, Yamada K, Kojima T, Takahashi S, et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am. J. Hum. Genet. 77: 937-944 (2005). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int. J. Mol. Med. 19: 143-148 (2007). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J. Clin. Immunol. 28: 44-49 (2008). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol. Rep. 19: 211-216 (2008). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Okubo M, Hirata I, Nakano H. Nrf2 gene promoter polymorphism and gastric carcinogenesis. Hepatogastroenterology 55: 750-754 (2008).
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Okubo M, Sakata M, Wang FY, Hirata I, Nakano H. Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population. Hepatogastroenterology 55: 394-397 (2008).
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Okubo M, Sakata M, Wang FY, Hirata I, Nakano H. Promoter polymorphism of cyclooxygenase-1 (COX1) is not associated with ulcerative colitis in the Japanese population. Hepatogastroenterology 55: 987-990 (2008).
Arlestig L, Wallberg Jonsson S, Stegmayr B, Rantapaa-Dahlqvist S. Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 25: 866-871 (2007).
Arman A, Soylu O, Yildirim A, Furman A, Ercelen N, Aydogan H, Coker A, Tezel T. Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease. Arq. Bras. Cardiol. 91: 293-298 (2008). *
Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24: 643-648 (2006).
Armas JB, Gonzalez S, Martinez-Borra J, Laranjeira F, Ribeiro E, Correia J, Ferreira ML, Toste M, Lopez-Vazquez A, Lopez-Larrea C. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles. Tissue Antigens 53: 237-243 (1999). *
Armbruster D, Moser DA, Strobel A, Hensch T, Kirschbaum C, Lesch KP, Brocke B. Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. Int. J. Neuropsychopharmacol. 12: 393-401 (2009).
Armendariz AD, Krauss RM. Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr. Opin. Lipidol. 20: 106-111 (2009).
Armendariz-Borunda J, Rincon AR, Munoz-Valle JF, Bueno-Topete M, Oregon-Romero E, Islas-Carbajal MC, Medina-Preciado D, Gonzalez-Garcia I, Bautista CA, Garcia-Rocha S, Godoy J, Vazquez-Del Mercado M, Troyo-Sanroman R, Arellano-Olivera I, Lucano S, et al. Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment. J. Investig. Med. 56: 944-953 (2008).
Armstrong DL, Reiff A, Myones BL, Quismorio FP Jr, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, Ojwang JO, Kaufman KM, Kelly JA, Merrill JT, Harley JB, Bae SC, Vyse TJ, Gilkeson GS, Gaffney PM, Moser KL, Putterman C, Edberg JC, et al. Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun. 10: 446-456 (2009).
Armstrong VW, Shipkova M, von Ahsen N, Oellerich M. Analytic aspects of monitoring therapy with thiopurine medications. Ther. Drug Monit. 26: 220-226 (2004).
Armuzzi A, Ahmad T, Ling KL, De Silva A, Cullen S, van Heel D, Orchard TR, Welsh KI, Marshall SE, Jewell DP. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 52: 1133-1139 (2003). *
Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome. Eur. J. Immunogenet. 23: 211-219 (1996).
Arnaiz-Villena A, Martinez-Laso J, Serrano-Vela JI, Reguera R, Moscoso J. HLA-G polymorphism and evolution. Tissue Antigens 69 Suppl. 1: 156-159 (2007). *
Arnaiz-Villena A, Serrano-Vela JI, Reguera R, Perez-Saborido B, Moreno E, Moscoso J. A novel allele, HLA-G*010114, with a non-coding DNA base change in exon 2. Tissue Antigens 71: 258-259 (2008). *
Arnaiz-Villena A, Vargas-Alarcon G, Serrano-Vela JI, Reguera R, Martinez-Laso J, Silvera-Redondo C, Granados J, Moscoso J. HLA-E polymorphism in Amerindians from Mexico (Mazatecans), Colombia (Wayu) and Chile (Mapuches): evolution of MHC-E gene. Tissue Antigens 69 Suppl. 1: 132-135 (2007). *
Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG, Sestu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L, Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A, Mariotti S, Shuldiner AR, et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am. J. Hum. Genet. 82: 1270-1280 (2008). *
Arnedo M, Taffe P, Sahli R, Furrer H, Hirschel B, Elzi L, Weber R, Vernazza P, Bernasconi E, Darioli R, Bergmann S, Beckmann JS, Telenti A, Tarr PE; the Swiss HIV Cohort Study. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenet. Genomics 17: 755-764 (2007).
Arnett FC, Bias WB, McLean RH, Engel M, Duvic M, Goldstein R, Freni-Titulaer L, McKinley TW, Hochberg MC. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J. Rheumatol. 17: 1029-1035 (1990).
Arnett FC, Bias WB, Reveille JD. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2: 403-413 (1989).
Arnett HA, Escobar SS, Gonzalez-Suarez E, Budelsky AL, Steffen LA, Boiani N, Zhang M, Siu G, Brewer AW, Viney JL. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178: 1523-1533 (2007). *
Arnold S, Pelet A, Amiel J, Borrego S, Hofstra R, Tam P, Ceccherini I, Lyonnet S, Sherman S, Chakravarti A. Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association. Hum. Mutat. 30: 771-775 (2009). *
Arnott ID, Ho GT, Nimmo ER, Satsangi J, Franchimont D, Vermeire S, Deviere J, Rutgeerts PJ. Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe (Author's reply). Gut 54: 308-309 (2005). *
Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am. J. Respir. Crit. Care Med. 159: 1464-1468 (1999). *
Aron Y, Swierczewski E, Lockhart A. A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells. Application to human lymphocyte antigen typing in one large family of atopic/asthmatic probands. Allergy 49: 788-790 (1994).
Arraiz N, Bermudez V, Prieto C, Sanchez MP, Escalona C, Sanz E, Rondon N, Reyes F, Velasco M. Association between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in Maracaibo, Zulia State, Venezuela. Am. J. Ther. Dec 16 [Epub ahead of print] (2009).
Arraiz N, Bermudez V, Rondon N, Reyes F, Borjas L, Sol�s E, Mujica E, Prieto C, Reyna N, Velasco M. Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population. Am. J. Ther. Dec 16 [Epub ahead of print] (2009).
Arranz Duran J, Arteaga Gonzalez A, Dom�nguez Garc�a D, Calvo Falcon R, Flores C, Gonzalez-Paredes FJ, Sanz Pereda P, Mendez Alvarez S, Garc�a Cobaleda I, Aguirre Jaime A, Arteaga Gonzalez I, Varona Bosque A, Barrera Gomez M, Soriano Benitez de Lugo A. Polymorphisms of interleukin-6 and tumor necrosis factor gene promoters and cardiorespiratory function following liver transplantation: a preliminary study. Transplant. Proc. 41: 1062-1064 (2009). *
Arredondo M, Jorquera D, Carrasco E, Albala C, Hertrampf E. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus. Am. J. Clin. Nutr. 86: 1347-1353 (2007). *
Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev. Mol. Med. 10: e9 (2008).
Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann. Hepatol. 5: 202-205 (2006). *
Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, Avila C, Lorente F. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatr. Allergy Immunol. 17: 323-328 (2006). *
Arrieta-Aguirre I, Garcia-Etxebarria K, Jugo BM. Optimization of the MhcOvar-DRB1 gene typing. Tissue Antigens 67: 222-228 (2006). *
Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and Toll-like receptor 4: a link between infection and acute coronary events? Heart 90: 983-988 (2004). *
Arshad SH, Karmaus W, Kurukulaaratchy R, Sadeghnejad A, Huebner M, Ewart S. Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood. Br. J. Dermatol. 158: 1315-1322 (2008). *
Arshadi N, Chang B, Kustra R. Predictive modeling in case-control single-nucleotide polymorphism studies in the presence of population stratification: a case study using Genetic Analysis Workshop 16 Problem 1 dataset. BMC Proc. 3 Suppl. 7: S60 (2009). *
Arthur AT, Armati PJ, Bye C, Consortium SM, Heard RN, Stewart GJ, Pollard JD, Booth DR. Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med. Genet. 9: 17 (2008). *
Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br. J. Rheumatol. 35: 732-737 (1996).
Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, Manolopoulos VG. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam. Clin. Pharmacol. 21: 419-426 (2007).
Asada H, Yagihashi T, Furuya M, Kosaki K, Takahashi T, Yoshimura Y. Association between patient age at the time of surgical treatment for endometriosis and aryl hydrocarbon receptor repressor polymorphism. Fertil. Steril. 92: 1240-1242 (2009).
Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, Sterry W. Interleukin-10 promoter polymorphism in psoriasis. J. Invest. Dermatol. 116: 975-978 (2001). *
Asaf R, Blum S, Roguin A, Kalet-Litman S, Kheir J, Frisch A, Miller-Lotan R, Levy AP. Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice. Cardiovasc. Diabetol. 8: 29 (2009). *
Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T. The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese. Ann. N. Y. Acad. Sci. 1079: 47-50 (2006). *
Asano K, Ikegami H, Fujisawa T, Nishino M, Nojima K, Kawabata Y, Noso S, Hiromine Y, Fukai A, Ogihara T. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes. Hum. Immunol. 68: 384-391 (2007).
Aschard H, Bouzigon E, Corda E, Ulgen A, Dizier MH, Gormand F, Lathrop M, Kauffmann F, Demenais F. Sex-specific effect of IL9 polymorphisms on lung function and polysensitization. Genes Immun. 10: 559-565 (2009).
Asensi V, Montes AH, Valle E, Ocana MG, Astudillo A, Alvarez V, Lopez-Anglada E, Solis A, Coto E, Meana A, Gonzalez P, Carton JA, Paz J, Fierer J, Celada A. The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis. Nitric Oxide 16: 44-53 (2007). *
Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, Maruo T. The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum. Reprod. 19: 2509-2514 (2004). *
Ashavaid TF, Kondkar AA, Dherai AJ, Raghavan R, Udani SV, Udwadia ZF, Desai D. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients. Mol. Diagn. 9: 59-66 (2005).
Ashktorab H, Begum R, Akhgar A, Smoot DT, Elbedawi M, Daremipouran M, Zhao A, Momen B, Giardiello FM. Folate status and risk of colorectal polyps in African Americans. Dig. Dis. Sci. 52: 1462-1470 (2007). *
Asimit JL, Yoo YJ, Waggott D, Sun L, Bull SB. Region-based analysis in genome-wide association study of Framingham Heart Study blood lipid phenotypes. BMC Proc. 3 Suppl. 7: S127 (2009). *
Askar E, Bregadze R, Mertens J, Schweyer S, Rosenberger A, Ramadori G, Mihm S. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C. J. Med. Virol. 81: 1204-1211 (2009). *
Askar E, Ramadori G, Mihm S. Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection. World J. Gastroenterol. 15: 3884-3890 (2009). *
Asleh R, Levy AP. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc. Health Risk Manag. 1: 19-28 (2005). *
Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 92: 1193-1200 (2003). *
Assassi S, Mayes MD, McNearney T, Fischbach M, Reveille JD, Arnett FC, Tan FK. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. Am. J. Med. 118: 907-911 (2005). *
Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Curr. Opin. Rheumatol. 17: 761-767 (2005).
Assmann G, Wagner AD, Monika M, Pfoehler C, Pfreundschuh M, Tilgen W, Roemer K. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol. Int. Sep 25 [Epub ahead of print] (2009). *
Assmann G, Wieczorek S, Wibisono D, Roemer K, Arning L, Voswinkel J. The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis. Clin. Exp. Rheumatol. 26: S72-S75 (2008).
Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK. Polymorphisms in the IL-10 but not in the IL-1beta and IL-4 genes are associated with inhibitor development in patients with hemophilia A. Blood 107: 3167-3172 (2006). *
Astermark J, Wang X, Oldenburg J, Berntorp E, Lefvert AK; THE MIBS STUDY GROUP. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J. Thromb. Haemost. 5: 263-265 (2007). *
Asthana S, Roytberg M, Stamatoyannopoulos J, Sunyaev S. Analysis of sequence conservation at nucleotide resolution. PLoS Comput. Biol. 3: e254 (2007). *
Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J. Clin. Periodontol. 33: 699-703 (2006). *
Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, Suomela S, Snellman E, Saarialho-Kere U, Kere J. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9: 1533-1542 (2000). *
Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, Moser M, de Cid R, Ripatti S, Vorechovsky I, Marcusson JA, Nakagawa H, Lazaro C, Estivill X, Capon F, Novelli G, Saarialho-Kere U, Barker J, Trembath R, Kere J; Psoriasis Consortium. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum. Mol. Genet. 11: 589-597 (2002). *
Asuni C, Stochino ME, Cherchi A, Manchia M, Congiu D, Manconi F, Squassina A, Piccardi MP, Del Zompo M. Migraine and tumour necrosis factor gene polymorphism: an association study in a Sardinian sample. J. Neurol. 256: 194-197 (2009).
Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas DL, Karp CL. Association of CTLA4 polymorphism with regulatory T cell frequency. Eur. J. Immunol. 35: 2157-2162 (2005). *
Atalay A, Yildiz-Demirtepe S, Tatlipinar S, Sanli-Erdogan B, Cobankara V, Yildirim C, Bagci H, Atalay EO. HLA-B51 gene and its expression in association with Behcet's disease in Denizli province of Turkey. Mol. Biol. Rep. 35: 345-349 (2008). *
Atan D, Turner SJ, Kilmartin DJ, Forrester JV, Bidwell J, Dick AD, Churchill AJ. Cytokine gene polymorphism in sympathetic ophthalmia. Invest. Ophthalmol. Vis. Sci. 46: 4245-4250 (2005). *
Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Genetic susceptibility to Behcet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol. Int. 29: 787-791 (2009). *
Ates O, Dalyan L, Musellim B, Hatemi G, Turker H, Ongen G, Hamuryudan V, Topal-Sarikaya A. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis. Int. J. Immunogenet. 36: 15-19 (2009). *
Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin. Rheumatol. 27: 1243-1248 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement. J. Clin. Immunol. 28: 73-77 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. J. Clin. Immunol. 28: 232-236 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement. Rheumatol. Int. 28: 1123-1126 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Analysis of TNF polymorphisms in Turkish systemic sclerosis patients with interstitial lung involvement. Biochem. Genet. 46: 696-701 (2008). *
Atik B, Skwor TA, Kandel RP, Sharma B, Adhikari HK, Steiner L, Erlich H, Dean D. Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis. PLoS ONE 3: e3600 (2008). *
Atkinson SH, Rockett KA, Morgan G, Bejon PA, Sirugo G, O'Connell MA, Hanchard N, Kwiatkowski D, Prentice AM. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood 112: 4276-4283 (2008). *
Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, Hajja-Hassouni N, Essakali M. HLA polymorphism and early rheumatoid arthritis in the Moroccan population. Joint Bone Spine 75: 554-558 (2008). *
Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, Thompson J, Infante-Rivard C, Guyatt G. How to use an article about genetic association. A: Background concepts. JAMA 301: 74-81 (2009). *
Atug O, Tahan V, Eren F, Tiftikci A, Imeryuz N, Hamzaoglu HO, Tozun N. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease. J. Gastrointestin. Liver Dis. 17: 433-437 (2008). *
Atzeni F, Boiardi L, Casali B, Farnetti E, Sarzi-Puttini P, Pipitone N, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C. Lack of association of the 463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients. Rheumatology (Oxford) 46: 1547-1550 (2007). *
Audrezet MP, Dabricot A, Le Marechal C, Ferec C. Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. J. Mol. Diagn. 10: 424-434 (2008).
Auguet T, Vidal F, Lopez-Dupla M, Broch M, Gutierrez C, Olona M, Oltra C, Aguilar C, Gonzalez E, Quer JC, Sirvent JJ, Richart C. A study on the TNF-alpha system in Caucasian Spanish patients with alcoholic liver disease. Drug Alcohol Depend. 92: 91-99 (2008).
Aulisa L, Papaleo P, Pola E, Angelini F, Aulisa AG, Tamburrelli FC, Pola P, Logroscino CA. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study. Spine 32: 2700-2702 (2007).
Avbelj M, Tahirovic H, Debeljak M, Kusekova M, Toromanovic A, Krzisnik C, Battelino T. High prevalence of thyroid peroxidase gene mutations in patients with thyroid dyshormonogenesis. Eur. J. Endocrinol. 156: 511-519 (2007). *
Averdam A, Kuhl H, Sontag M, Becker T, Hughes AL, Reinhardt R, Walter L. Genomics and diversity of the common marmoset monkey NK complex. J. Immunol. 178: 7151-7161 (2007). *
Avery CL, Monda KL, North KE. Genetic association studies and the effect of misclassification and selection bias in putative confounders. BMC Proc. 3 Suppl. 7: S48 (2009). *
Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am. J. Respir. Cell. Mol. Biol. 20: 106-112 (1999). *
Awadallah S, Hamad M. A study of haptoglobin phenotypes in patients with chronic renal failure. Ann. Clin. Biochem. 40: 680-683 (2003).
Awadallah S, Hamad M. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent. Cytobios. 101: 145-150 (2000).
Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, Manabe T, Kamoto T, Habuchi T, Ogawa O. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett. 241: 59-63 (2006). *
Awata T, Kanazawa Y. Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res. Clin. Pract. 24: S83-S87 (1994).
Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47: 128-129 (1998).
Awomoyi A, Sirugo G, Newport MJ, Tishkoff S. Global distribution of a novel trinucleotide microsatellite polymorphism (ATA) in intron 8 of the SLC11A1 gene and susceptibility to pulmonary tuberculosis. Int. J. Immunogenet. 33: 11-15 (2006). *
Awomoyi AA, Marchant A, Howson JM, McAdam KP, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J. Infect. Dis. 186: 1808-1814 (2002). *
Axtner J, Sommer S. Gene duplication, allelic diversity, selection processes and adaptive value of MHC class II DRB genes of the bank vole, Clethrionomys glareolus. Immunogenetics 59: 417-426 (2007). *
Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Thromb. Haemost. 98: 777-782 (2007).
Ayala YM, Pagani F, Baralle FE. TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett. 580: 1339-1344 (2006). *
Aydin F, Kara N, Senturk N, Gunes S, Canturk M, Bagci H, Bek Y, Turanli A. Lack of association between leptin G2548A gene polymorphism and Behcet's disease. J. Eur. Acad. Dermatol. Venereol. 21: 68-71 (2007).
Ayed K, Ayed-Jendoubi S, Ben Abdallah T, Bardi R, Gorgi Y, Sfar I, Dhrif B, Abderrahim E, Kheder A. Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction. Transpl. Immunol. 15: 303-309 (2006).
Ayesh S, Abu-Rmaileh H, Nassar S, Al-Shareef W, Abu-Libdeh B, Muhanna A, Al-Kafri F. Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease. Scand. J. Rheumatol. 37: 370-374 (2008).
Aytekin C, Dogu F, Ikinciogullari A, Egin Y, Yuksek M, Bozdogan G, Akar N, Babacan E. TGF-beta1-915G/C and TNF-alpha-308G/A polymorphisms in children with asthma. Tuberk. Toraks. 57: 62-67 (2009).
Azad AK, Rauh R, Vermeulen F, Jaspers M, Korbmacher J, Boissier B, Bassinet L, Fichou Y, Georges MD, Stanke F, De Boeck K, Dupont L, Balascakova M, Hjelte L, Lebecque P, Radojkovic D, Castellani C, Schwartz M, Stuhrmann M, Schwarz M, Skalicka V, et al. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum. Mutat. 30: 1093-1103 (2009).
Azarian M, Busson M, Rocha V, Ribaud P, Peffault de Latour R, Bleux H, Lepage V, Charron D, Toubert A, Socie G, Loiseau P. The PTPN22 R620W polymorphism is associated with severe bacterial infections after human leukocyte antigen geno-identical haematopoietic stem-cell transplantations. Transplantation 85: 1859-1862 (2008).
Azarpira N, Aghdai MH, Raisjalali GA, Darai M, Tarahi MJ. Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection. Mol. Biol. Rep. 36: 1621-1626 (2009). *
Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation. Exp. Clin. Transplant. 4: 416-419 (2006).
Azarpira N, Dehghani M, Aghdaie MH, Darai M. Interleukin-7 receptor-alpha gene polymorphisms in bone marrow transplant recipients. Mol. Biol. Rep. Mar 1 [Epub ahead of print] (2009). *
Azarpira N, Nikeghbalian S, Geramizadeh B, Darai M. Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients. Mol. Biol. Rep. 37: 21-25 (2010). *
Azarpira N, Raisjalali G, Darai M. Polymorphism of the methylenetetrahydrofolate reductase C677T gene with chronic allograft nephropathy in renal transplant recipients. Exp. Clin. Transplant. 6: 54-58 (2008).
Azarpira N, Ramzi M, Aghdaie MH, Darai M, Geramizadeh B. Interleukin-10 gene polymorphism in bone marrow transplant recipients. Exp. Clin. Transplant. 6: 74-79 (2008).
Azarpira N, Ramzi M, Aghdaie MH, Daraie M, Geramizadeh B. Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant. Exp. Clin. Transplant. 5: 693-697 (2007).
Azarpira N, Sagheb MM, Geramizadeh B, Darai M. Vitamin D receptor genotypes and kidney allograft rejection. Mol. Biol. Rep. 36: 2387-2392 (2009). *
Azevedo PM, Bauer R, Caparbo VD, Silva CA, Bonfa E, Pereira RM. Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine Oct 10 [Epub ahead of print] (2009).
Azim K, McManus R, Brophy K, Ryan A, Kelleher D, Reynolds JV. Genetic polymorphisms and the risk of infection following esophagectomy: positive association with TNF-alpha gene -308 genotype. Ann. Surg. 246: 122-128 (2007). *
Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac. J. Allergy Immunol. 22: 159-163 (2004).
Azizi E, Massoud A, Amirzargar AA, Mahmoudi M, Soleimanifar N, Rezaei N, Jamshidi AR, Nikbin B, Nicknam MH. Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis. J. Clin. Immunol. Dec 14 [Epub ahead of print] (2009). *
Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 6: R395-R400 (2004). *
Baars C, Leeb T, von Klopmann T, Tipold A, Potschka H. Allele-specific polymerase chain reaction diagnostic test for the functional MDR1 polymorphism in dogs. Vet. J. 177: 394-397 (2008).
Babalini C, Tarsi T, Martinez-Labarga C, Scano G, Pepe G, De Stefano GF, Rickards O. COL1A2 (type I collagen) polymorphisms in the Colorado Indians of Ecuador. Ann. Hum. Biol. 32: 666-678 (2005).
Babb C, van der Merwe L, Beyers N, Pheiffer C, Walzl G, Duncan K, van Helden P, Hoal EG. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.) 87: 295-302 (2007).
Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 84: 387-391 (2007).
Babula O, Linhares IM, Bongiovanni AM, Ledger WJ, Witkin SS. Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism. Am. J. Obstet. Gynecol. 198: 101.e1-101.e4 (2008). *
Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am. J. Gastroenterol. 101: 1354-1361 (2006). *
Baca V, Velazquez-Cruz R, Salas-Martinez G, Espinosa-Rosales F, Saldana-Alvarez Y, Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun. 7: 693-695 (2006). *
Bacanli A, Sallakci N, Yavuzer U, Alpsoy E, Yegin O. Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet's disease. Clin. Exp. Dermatol. 31: 699-701 (2006). *
Baccar A, Loueslati BY, Troudi W, Hmida S, Dridi A, Jridi A, Mrad K, Ben Romdhane K, Ben Ammar Elgaaied A. Are HLA DQB1 alleles correlated with breast cancer histopronostic parameters in Tunisia? Tunis. Med. 87: 372-374 (2009).
Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10: 375-386 (1997).
Bachvarov DR, Landry M, Houle S, Pare P, Marceau F. Altered frequency of a promoter polymorphic allele of the kinin B1 receptor gene in inflammatory bowel disease. Gastroenterology 115: 1045-1048 (1998). *
Backdahl L, Guo JP, Jagodic M, Becanovic K, Ding B, Olsson T, Lorentzen JC. Definition of arthritis candidate risk genes by combining rat linkage-mapping results with human case control association data. Ann. Rheum. Dis. 68: 1925-1932 (2009). *
Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F. Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res. 69: 723-727 (2009). *
Bacolod MD, Schemmann GS, Wang S, Shattock R, Giardina SF, Zeng Z, Shia J, Stengel RF, Gerry N, Hoh J, Kirchhoff T, Gold B, Christman MF, Offit K, Gerald WL, Notterman DA, Ott J, Paty PB, Barany F. The signatures of autozygosity among patients with colorectal cancer. Cancer Res. 68: 2610-2621 (2008). *
Bacq Y, Gendrot C, Perrotin F, Lefrou L, Chretien S, Vie-Buret V, Brechot MC, Andres C. ABCB4 gene mutations and single nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J. Med. Genet. 46: 711-715 (2009).
Bacsi K, Hitre E, Kosa JP, Horvath H, Lazary A, Lakatos PL, Balla B, Budai B, Lakatos P, Speer G. Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population. BMC Cancer 8: 317 (2008). *
Badenhoop K. Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15 (2004).
Badenhoop K, Donner H, Pani M, Rau H, Siegmund T, Braun J. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population. Exp. Clin. Endocrinol. Diabetes 107 Suppl. 3: S89-S92 (1999).
Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, Bottazzo GF, Usadel KH. Tumor necrosis factor beta gene polymorphisms in Graves' disease. J. Clin. Endocrinol. Metab. 74: 287-291 (1992).
Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, Bottazzo GF. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 445-448 (1989).
Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 80: 2112-2117 (1995). *
Badger SA, Soong CV, O' Donnell ME, Mercer C, Young IS, Hughes AE. C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism. J. Vasc. Surg. 49: 178-184 (2009).
Badii R, Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M, Froguel P, Wareham NJ. Lack of association between the Pro(12)Ala polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol. 45: 15-21 (2008). *
Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res. 28: 1271-1276 (2008).
Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH, Kang JH. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci. 97: 774-779 (2006). *
Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Qui�ones-Berrocal J, Fraser PA, Uko GP, Delgado JC, Clavijo OP, Thim S, Meshnick SR, Nyirenda T, Yunis EJ, Goldfeld AE. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun. 3: 482-487 (2002). *
Baena A, Mootnick AR, Falvo JV, Tsytskova AV, Ligeiro F, Diop OM, Brieva C, Gagneux P, O'Brien SJ, Ryder OA, Goldfeld AE. Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS ONE 2: e621 (2007). *
Baerwald CG, Panayi GS, Lanchbury JS. Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis. J. Rheumatol. 24: 215-216 (1997).
Bafna V, Bansal V. Inference about recombination from haplotype data: lower bounds and recombination hotspots. J. Comput. Biol. 13: 501-521 (2006).
Bafunno V, Santacroce R, Chetta M, D'Andrea G, Pisanelli D, Sessa F, Trotta T, Tagariello G, Peyvandi F, Margaglione M. Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A. Haemophilia Dec 14 [Epub ahead of print] (2009). *
Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC. Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 105: 18976-18981 (2008). *
Bagarolli RA, Saad MJ, Saad ST. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes. J. Diabetes Complications Apr 21 [Epub ahead of print] (2009).
Bagnall RD, Roberts RG, Mirza MM, Torigoe T, Prescott NJ, Mathew CG. Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation. Eur. J. Hum. Genet. 16: 619-625 (2008). *
Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S. Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci. Lett. 418: 262-265 (2007). *
Bagnoli S, Putignano AL, Melean G, Baglioni S, Sestini R, Milla M, d'Albasio G, Genuardi M, Pacini F, Trallori G, Papi L. Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. Inflamm. Bowel Dis. 10: 705-708 (2004). *
Bagos PG, Karnaouri AC, Nikolopoulos GK, Hamodrakas SJ. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Mult. Scler. 13: 156-168 (2007). *
Bahaoddini A, Farrashbandi H, Saadat M. Genetic polymorphism of glutathione S-transferase T1 (GSTT1) and QT-interval in schizophrenia patients. J. Mol. Neurosci. 38: 173-177 (2009).
Bai C, Matsui E, Ohnishi H, Kimata K, Kasahara K, Kaneko H, Kato Z, Fukao T, Kondo N. A novel polymorphism, E254K, in the 5-lipoxygenase gene associated with bronchial asthma. Int. J. Mol. Med. 21: 139-144 (2008). *
Bai J, Jiang L, Lin M, Zeng X, Wang Z, Chen Q. Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 gene with oral lichen planus: a study in a Chinese cohort with Han ethnicity. J. Interferon Cytokine Res. 29: 381-388 (2009).
Bai J, Zhang Y, Lin M, Zeng X, Wang Z, Shen J, Jiang L, Gao F, Chen Q. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort. Tissue Antigens 70: 390-397 (2007). *
Bai JL, Zheng MH, Xia X, Ter-Minassian M, Chen YP, Chen F. MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: a meta-analysis of 3511 cases and 2762 controls. Eur. J. Cancer 45: 1443-1449 (2009). *
Bai Y, Yu Y, Yu B, Ge J, Ji J, Lu H, Wei J, Weng Z, Tao Z, Lu J. Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China. BMC Med. Genet. 10: 125 (2009). *
Baier LJ, Permana PA, Traurig M, Dobberfuhl A, Wiedrich C, Sutherland J, Thuillez P, Luczy-Bachman G, Hara M, Horikawa Y, Hinokio Y, Hanson RL, Bogardus C. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians. Diabetes Care 23: 302-304 (2000). *
Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133: 3748S-3753S (2003). *
Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L, Vohl MC, Engert JC. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes 55: 2896-2902 (2006). *
Bailey-Wilson JE, Almasy L, de Andrade M, Bailey J, Bickeboller H, Cordell HJ, Daw EW, Goldin L, Goode EL, Gray-McGuire C, Hening W, Jarvik G, Maher BS, Mendell N, Paterson AD, Rice J, Satten G, Suarez B, Vieland V, Wilcox M, Zhang H, Ziegler A, et al. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans. BMC Genet. 6 Suppl. 1: S1 (2005). *
Baines M, Ebringer A. HLA and disease. Mol. Aspects Med. 13: 263-378 (1992). *
Baioni CS, de Souza CM, Ribeiro Braosi AP, Luczyszyn SM, Dias da Silva MA, Ignacio SA, Naval Machado MA, Benato Martins WD, Riella MC, Pecoits-Filho R, Trevilatto PC. Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis. J. Periodontal Res. 43: 578-584 (2008).
Baird NA, Etter PD, Atwood TS, Currey MC, Shiver AL, Lewis ZA, Selker EU, Cresko WA, Johnson EA. Rapid SNP discovery and genetic mapping using sequenced RAD markers. PLoS ONE 3: e3376 (2008). *
Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, Leahy DT, Vaughan P, Keegan D, O'Morain C, O'Donoghue D, Shanahan F, Parfrey NA, Quane KA. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur. J. Hum. Genet. 11: 237-244 (2003). *
Baker BS, Powles A, Fry L. Peptidoglycan: a major aetiological factor for psoriasis? Trends Immunol. 27: 545-551 (2006). *
Baker DE. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy. Rev. Gastroenterol. Disord. 3: 150-157 (2003). *
Baker ML, Melman SD, Huntley J, Miller RD. Evolution of the opossum major histocompatibility complex: evidence for diverse alternative splice patterns and low polymorphism among class I genes. Immunology 128: e418-e431 (2009).
Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjornsdottir S, Nystrom L, Agardh CD, Landin-Olsson M, Sundkvist G, Groop LC. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia 51: 2224-2232 (2008). *
Baksh MF, Balding DJ, Vyse TJ, Whittaker JC. Family-based association analysis with ordered categorical phenotypes, covariates and interactions. Genet. Epidemiol. 31: 1-8 (2007).
Balada E, Simeon-Aznar CP, Serrano-Acedo S, Martinez-Lostao L, Selva-O' Callaghan A, Fonollosa-Pla V, Vilardell-Tarres M. Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis. Clin. Exp. Rheumatol. 24: 321-324 (2006).
Balada E, Villarreal-Tolchinsky J, Ordi-Ros J, Labrador M, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarres M. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. Tissue Antigens 68: 432-438 (2006). *
Balaguer F, Castellvi-Bel S, Castells A, Andreu M, Munoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Paya A, Pique JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin. Gastroenterol. Hepatol. 5: 379-387 (2007).
Balas A, Aviles MJ, Alonso-Nieto M, Zarapuz L, Blanco L, Garcia-Sanchez F, Vicario JL. HLA-DQA1 introns 2 and 3 sequencing: DQA1 sequencing-based typing and characterization of a highly polymorphic microsatellite at intron 3 of DQA1*0505. Hum. Immunol. 66: 903-911 (2005).
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. The new HLA-C allele, Cw*0220, shows a new polymorphism at amino acid position 169. Tissue Antigens 71: 93 (2008). *
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. Sequencing of a novel HLA-DRB1*07 allele with a new polymorphism at amino acid position 21 (DRB1*0715). Tissue Antigens 71: 179-180 (2008). *
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. HLA-A*020115 and HLA-Cw*030203 show new synonymous mutations in exon 4. Tissue Antigens 70: 340-341 (2007). *
Balas A, Bustamante L, Garc�a-Sanchez F, Vicario JL. New HLA polymorphism detection by molecular and serologic typing procedures. Complete coding region characterization of Cw*0525, Cw*0825, B*3950 and A*3219N alleles. Tissue Antigens Sep 17 [Epub ahead of print] (2009). *
Balas A, Garcia-Sanchez F, Vicario JL. Sequencing of a new HLA-C allele, HLA-Cw*0742, with a novel HLA polymorphism at exon 3. Tissue Antigens 68: 530-531 (2006). *
Balas A, Sanchez-Gordo F, Garcia-Sanchez F, Prat I, Vicario JL. HLA-B*9523 increases the extremely high B*15-group polymorphism. Tissue Antigens 69: 620-621 (2007). *
Balbi G, Ferrera F, Rizzi M, Piccioli P, Morabito A, Cardamone L, Ghio M, Palmisano GL, Carrara P, Pedemonte S, Sessarego M, De Angioletti M, Notaro R, Indiveri F, Pistillo MP. Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin. Exp. Immunol. 149: 40-47 (2007). *
Balcerzyk A, Zak I, Krauze J. Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease. Acta Cardiol. 62: 233-238 (2007).
Balcerzyk A, Zak I, Krauze J. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease. Arch. Med. Res. 38: 545-550 (2007).
Balci-Peynircioglu B, Taskiran ZE, Turel B, Arici M, Bakkaloglu A, Ozen S, Yilmaz E. The analysis of interleukin-1 receptor antagonist and interleukin-1beta gene polymorphisms in Turkish FMF patients: do they predispose to secondary amyloidosis? Clin. Exp. Rheumatol. 26: S99-S102 (2008).
Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T, Frackelton EC, Otieno FG, Kanterakis S, Shaner JL, Smith RM, Eckert AW, Robinson LJ, Onyiah CC, Abrams DJ, Chiavacci RM, Skraban R, Devoto M, Grant SF, Hakonarson H. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 5: 972-976 (2007).
Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 4: 533-540 (2003). *
Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, FitzGerald O. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 48: 1408-1413 (2003). *
Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, Smith OP. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm.13: 181-187 (2004). *
Baldwin GC, Mickelson EM, Hansen JA, Nisperos B, Antonelli P, Nepom BS, Nepom GT. Electrophoretic variation between class II molecules expressed on HLA-DRw8 homozygous typing cells reveals multiple distinct haplotypes. Immunogenetics 21: 49-60 (1985).
Balic I, Angel B, Codner E, Carrasco E, Perez-Bravo F. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum. Immunol. 70: 116-120 (2009).
Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, List� F, Vasto S, Lio D, Caruso C, Candore G. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr. Pharm. Des. 14: 2672-2677 (2008).
Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, List� F, Vasto S, Lio D, Caruso C, Candore G. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr. Pharm. Des. 14: 2672-2677 (2008).
Balistreri CR, Grimaldi MP, Vasto S, Listi F, Chiappelli M, Licastro F, Lio D, Caruso C, Candore G. Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from northern Italy. Ann. N. Y. Acad. Sci. 1089: 454-461 (2006). *
Balistreri WF. Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Balladares S, Alaez C, Pujol J, Duran C, Navarro JL, Gorodezky C. Distribution of TAP gene polymorphisms and extended MHC haplotypes in Mexican Mestizos and in Seri Indians from northwest Mexico. Genes Immun. 3: 78-85 (2002). *
Ballard DH, Aporntewan C, Lee JY, Lee JS, Wu Z, Zhao H. A pathway analysis applied to Genetic Analysis Workshop 16 genome-wide rheumatoid arthritis data. BMC Proc. 3 Suppl. 7: S91 (2009). *
Ballard DH, Cho J, Zhao H. Comparisons of multi-marker association methods to detect association between a candidate region and disease. Genet. Epidemiol. Oct 6 [Epub ahead of print] (2009).
Balliet RM, Chen G, Dellinger RW, Lazarus P. UGT1A10: activity against the tobacco-specific nitrosamine, NNAL, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility. Drug Metab. Dispos. Dec 14 [Epub ahead of print] (2009). *
Balog A, Gal J, Gyulai Z, Zsilak S, Mandi Y. Tumour necrosis factor-alpha and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. Acta Microbiol. Immunol. Hung. 51: 263-269 (2004).
Balog A, Gyulai Z, Boros LG, Farkas G, Takacs T, Lonovics J, Mandi Y. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 30: e46-e50 (2005).
Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y. Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. Pathobiology 71: 274-280 (2004).
Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43: 3899-3906 (2004). *
Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 17: 2333-2340 (2006). *
Bamshad MJ, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, Watkins WS, Wooding S, Stone AC, Jorde LB, Weiss RB, Ahuja SK. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc. Natl. Acad. Sci. U.S.A. 99: 10539-10544 (2002). *
Ban H, Andoh A, Tanaka A, Tsujikawa T, Sasaki M, Saito Y, Fujiyama Y. Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease. Intern. Med. 47: 1645-1648 (2008). *
Ban JY, Yoon KL, Kim SK, Kang S, Chung JH. Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population. Pediatr. Cardiol. 30: 331-335 (2009).
Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, Wason J, De Jager PL, Hafler D, Rioux JD, et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 17: 1309-1313 (2009).
Ban M, Walton A, Goris A, Gray J, Compston A, Sawcer S. Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis. J. Neurol. 254: 398-399 (2007).
Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 375-380 (2000).
Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 475-480 (2000).
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J. Clin. Endocrinol. Metab. 89: 4562-4568 (2004). *
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4: 586-593 (2003). *
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124 (2003). *
Ban Y, Greenberg DA, Concepcion ES, Tomer Y. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12: 1079-1083 (2002).
Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab. 85: 4639-4643 (2000). *
Ban Y, Taniyama M, Tozaki T, Tomita M, Ban Y. Estrogen receptor alpha dinucleotide repeat polymorphism in Japanese patients with autoimmune thyroid diseases. BMC Med. Genet. 1: 1 (2000). *
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Tomita M, Ban Y. SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases. Thyroid 11: 335-338 (2001).
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Tomita M, Ban Y. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population. Autoimmunity 34: 39-43 (2001).
Ban Y, Tozaki T, Taniyama M, Nakano Y, Ban Y, Hirano T. Genomic polymorphism in the interferon-induced helicase (IFIH1) gene does not confer susceptibility to autoimmune thyroid disease in the Japanese population. Horm. Metab. Res. 42: 70-72 (2010).
Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama KI, Ban Y, Hirano T. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 42: 126-130 (2009).
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.) 61: 263-268 (2004). *
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity 38: 151-153 (2005).
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Lack of association between estrogen receptor beta dinucleotide repeat polymorphism and autoimmune thyroid diseases in Japanese patients. BMC Med. Genet. 2: 1 (2001). *
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15: 1115-1118 (2005).
Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun. 28: 201-207 (2007).
Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: a gender-specific effect? World J. Biol. Psychiatry Jul 10 [Epub ahead of print] (2007).
Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P, Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res. Bull. 75: 158-165 (2008).
Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J. Hum. Genet. 52: 205-219 (2007). *
Banerjee S, Oneda B, Yap LM, Jewell DP, Matters GL, Fitzpatrick LR, Seibold F, Sterchi EE, Ahmad T, Lottaz D, Bond JS. MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunol. 2: 220-231 (2009). *
Bangel N, Dahlhoff C, Sobczak K, Weber WM, Kusche-Vihrog K. Upregulated expression of ENaC in human CF nasal epithelium. J. Cyst. Fibros. 7: 197-205 (2008).
Baniasadi V, Narain N, Goswami R, Das SN. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67: 383-389 (2006). *
Banoei MM, Chaleshtori MH, Sanati MH, Panahi MS, Majidizadeh T, Rostami M, Manshadi MD, Golalipour M. Diversity and relationship between Iranian ethnic groups: human dopamine transporter gene (DAT1) VNTR genotyping. Am. J. Hum. Biol. 19: 821-826 (2007).
Bantis C, Heering PJ, Aker S, Schwandt C, Grabensee B, Ivens K. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy. J. Nephrol. 21: 941-946 (2008).
Bantis C, Heering PJ, Aker S, Siekierka M, Kuhr N, Grabensee B, Ivens K. Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am. J. Nephrol. 26: 12-15 (2006).
Banus S, Bottema RW, Siezen CL, Vandebriel RJ, Reimerink J, Mommers M, Koppelman GH, Hoebee B, Thijs C, Postma DS, Kimman TG, Stelma FF. A Toll-like receptor 4 polymorphism is associated with the response to whole-cell pertussis vaccination in children from the KOALA study. Clin. Vaccine Immunol. 14: 1377-1380 (2007).
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR. Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family. Ann. N. Y. Acad. Sci. 1005: 348-351 (2003). *
Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y. PolymiRTS database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res. 35: D51-D54 (2007). *
Baragiotta A, Floreani A, Agarwal K, Venturi C, Craggs A, Jones DEJ, Donaldson PT, Bassendine MF. Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study. Liver Int. 24: 646-650 (2004). *
Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126: 74-78 (2006). *
Baran W, Szepietowski JC, Mazur G, Baran E. A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol. Alp. Panonica Adriat. 15: 113-118 (2006). *
Baran W, Szepietowski JC, Mazur G, Baran E. TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine 38: 8-11 (2007).
Baran W, Szepietowski JC, Mazur G, Baran E. IFN-gamma promoter gene polymorphism in psoriasis vulgaris. Biomarkers 13: 52-58 (2008).
Baran W, Szepietowski JC, Mazur G, Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm. Venereol. 88: 113-116 (2008). *
Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham EM, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR. The association of the PTPN22 620W polymorphism with Behcet's disease. Ann. Rheum. Dis. 66: 1531-1533 (2007). *
Barbaux S, Poirier O, Godefroy T, Kleinert H, Blankenberg S, Cambien F, Tiret L. Differential haplotypic expression of the interleukin-18 gene. Eur. J. Hum. Genet. 15: 856-863 (2007). *
Barbaux S, Tregouet DA, Nicaud V, Poirier O, Perret C, Godefroy T, Francomme C, Combadiere C, Arveiler D, Luc G, Ruidavets JB, Evans AE, Kee F, Morrison C, Tiret L, Brand-Herrmann SM, Cambien F. Polymorphisms in 33 inflammatory genes and risk of myocardial infarction - a system genetics approach. J. Mol. Med. 85: 1271-1280 (2007). *
Barber RC, Aragaki CC, Chang LY, Purdue GF, Hunt JL, Arnoldo BD, Horton JW. CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock 27: 232-237 (2007). *
Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, Aragaki CC. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res. 4: 250-255 (2006). *
Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Schiattarella C, Siciliano S, Lemme P, Paolisso G. The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients. Atherosclerosis 201: 117-123 (2008).
Barbosa FA, de Labio RW, de Oliveira S Rigolin V, Minett T, Bertolucci PH, de Arruda Cardoso Smith M, Payao SL. Apolipoprotein A-V gene polymorphism -1131T>C and Alzheimer's disease. J. Alzheimers Dis. 10: 365-369 (2006).
Barbosa PR, Stabler SP, Machado AL, Braga RC, Hirata RD, Hirata MH, Sampaio-Neto LF, Allen RH, Guerra-Shinohara EM. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur. J. Clin. Nutr. 62: 1010-1021 (2008). *
Barbosa PR, Stabler SP, Trentin R, Carvalho FR, Luchessi AD, Hirata RD, Hirata MH, Allen RH, Guerra-Shinohara EM. Evaluation of nutritional and genetic determinants of total homocysteine, methylmalonic acid and S-adenosylmethionine/S-adenosylhomocysteine values in Brazilian childbearing-age women. Clin. Chim. Acta 388: 139-147 (2008). *
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann. Neurol. 55: 793-800 (2004).
Barcellos LF, Ramsay PP, Caillier SJ, Sawcer S, Haines J, Schmidt S, Pericak-Vance M, Compston DA, Gabatto P, Hauser SL, Oksenberg JR. Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes Immun. 9: 493-500 (2008). *
Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 51: 281-288 (2000).
Barclay AN. Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. Curr. Opin. Immunol. 21: 47-52 (2009).
Bardon S, Benelli C, Bernard-Gallon D, Blottiere H, Demarquoy J, Duee PH, Forest C. Dietary fatty acids and cancer: potential cellular and molecular mechanisms. Bull. Cancer 92: 697-707 (2005).
Bari R, Bell T, Leung WH, Vong QP, Chan WK, Das Gupta N, Holladay M, Rooney B, Leung W. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 114: 5182-5190 (2009). *
Baricordi OR, Govoni M, Rizzo R, Trotta F. In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment. Ann. Rheum. Dis. 66: 1125-1126 (2007). *
Baricordi OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases. Inflamm. Allergy Drug Targets 7: 67-74 (2008).
Barile S, Medda E, Nistico L, Bordignon V, Cordiali-Fei P, Carducci M, Rainaldi A, Marinelli R, Bonifati C. Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp. Dermatol. 15: 368-376 (2006). *
Baris N, Akdeniz B, Ozerkan F, Onder RM, Akarca U, Guneri S. The relationship between hypertensive retinopathy and angiotensin converting enzyme gene polymorphism. Cardiovasc. Hematol. Disord. Drug Targets 6: 57-61 (2006).
Baris S, Celkan T, Batar B, Guven M, Ozdil M, Ozkan A, Apak H, Yildiz I. Association between genetic polymorphism in DNA repair genes and risk of B-cell lymphoma. Pediatr. Hematol. Oncol. 26: 467-472 (2009).
Barisani D, Ceroni S, Meneveri R, Cesana BM, Bardella MT. IL-10 polymorphisms are associated with early-onset celiac disease and severe mucosal damage in patients of Caucasian origin. Genet. Med. 8: 169-174 (2006).
Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, Christopher States J, Hein DW. Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1. Pharmacogenet. Genomics 16: 515-525 (2006). *
Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS. Two single nucleotide polymorphisms identify highest-risk diabetes human leukocyte antigen genotype: potential for rapid screening. Diabetes 57: 3152-3155 (2008). *
Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR, Mahmoudi M, Keramati MR, Habibollahi P, Bashashati M, Ebrahimi-Daryani N, Amirzargar AA. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J. Clin. Immunol. Oct 21 [Epub ahead of print] (2009). *
Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green AA, Ferdowsian H. D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition 25: 58-65 (2009). *
Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, Lamb J, Bailey AJ, Monaco AP; International Molecular Genetics Study of Autism Consortium. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am. J. Hum. Genet. 76: 950-966 (2005). *
Barnes KC, Caraballo L, Munoz M, Zambelli-Weiner A, Ehrlich E, Burki M, Jimenez S, Mathias RA, Stockton ML, Deindl P, Mendoza L, Hershey GK, Nickel R, Wills-Karp M. A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populations. Clin. Exp. Allergy 34: 736-744 (2004). *
Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J. Allergy Clin. Immunol. 118: 70-77 (2006). *
Barnes KC, Grant AV, Baltadzhieva D, Zhang S, Berg T, Shao L, Zambelli-Weiner A, Anderson W, Nelsen A, Pillai S, Yarnall DP, Dienger K, Ingersoll RG, Scott AF, Fallin MD, Mathias RA, Beaty TH, Garcia JG, Wills-Karp M. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. Genes Immun. 7: 27-35 (2006). *
Barnes MR. SNP and mutation data on the web - hidden treasures for uncovering. Comp. Funct. Genomics 3: 67-74 (2002). *
Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies. Tissue Antigens 68: 390-398 (2006). *
Baron M. The search for complex disease genes: fault by linkage or fault by association? Mol. Psychiatry 6: 143-149 (2001).
Baroncelli GI, Bereket A, El Kholy M, Audi L, Cesur Y, Ozkan B, Rashad M, Fernandez-Cancio M, Weisman Y, Saggese G, Hochberg Z. Rickets in the Middle East: role of environment and genetic predisposition. J. Clin. Endocrinol. Metab. 93: 1743-1750 (2008). *
Baroudi Ouederni T, Sanchez-Corona J, Flores Martinez SE, Ben Maiz H, Aounallah Skhiri H, Kammoun Abid H, Benammar-Elgaaied A. The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin. Biochem. 42: 1169-1173 (2009). *
Baroudi T, Bouhaha R, Moran-Moguel C, Sanchez-Corona J, Ben Maiz H, Kammoun Abid H, Benammar-Elgaaied A. Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia. J. Renin Angiotensin Aldosterone Syst. 10: 35-40 (2009).
Barr M, Mackenzie SM, Wilkinson DM, Holloway CD, Friel EC, Miller S, Macdonald T, Fraser R, Connell JM, Davies E. Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene. Clin. Endocrinol. (Oxf.) 65: 816-825 (2006). *
Barr R, Macdonald H, Stewart A, McGuigan F, Rogers A, Eastell R, Felsenberg D, Gluer C, Roux C, Reid DM. Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos. Int. Jul 24 [Epub ahead of print] (2009). *
Barral S, Haynes C, Levenstien MA, Gordon D. Precision and type I error rate in the presence of genotype errors and missing parental data: a comparison between the original transmission disequilibrium test (TDT) and TDTae statistics. BMC Genet. 6 Suppl. 1: S150 (2005). *
Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. Natural selection has driven population differentiation in modern humans. Nat. Genet. 40: 340-345 (2008). *
Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur. J. Hum. Genet. 12: 620-626 (2004). *
Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'Rahilly S, Wareham NJ. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49: 501-505 (2006). *
Barroso I, Luan J, Wheeler E, Whittaker P, Wasson J, Zeggini E, Weedon MN, Hunt S, Venkatesh R, Frayling TM, Delgado M, Neuman RJ, Zhao J, Sherva R, Glaser B, Walker M, Hitman G, McCarthy MI, Hattersley AT, Permutt MA, Wareham NJ, Deloukas P. Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies. Diabetes 57: 3161-3165 (2008). *
Barry E, Derhammer T, Elsea SH. Prevalence of three hereditary hemochromatosis mutant alleles in the Michigan Caucasian population. Community Genet. 8: 173-179 (2005).
Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation. Transpl. Infect. Dis. 8: 108-112 (2006). *
Bartelds GM, Wijbrandts CA, Nurmohamed MT, Wolbink GJ, de Vries N, Tak PP, Dijkmans BA, Crusius JB, Vand der Horst-Bruinsma IE. Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms. Arthritis Rheum. 60: 2541-2542 (2009). *
Bartels AL, van Berckel BN, Lubberink M, Luurtsema G, Lammertsma AA, Leenders KL. Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease. Parkinsonism Relat. Disord. 14: 505-508 (2008).
Bartfai Z, Gaede KI, Russell KA, Murakozy G, Muller-Quernheim J, Specks U. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin. Immunol. 109: 330-337 (2003). *
Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemkova D, et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA 302: 1076-1083 (2009). *
Bartnicka L, Kurzawski M, Drozdzik A, Plonska-Gosciniak E, Gornik W, Drozdzik M. Effect of ABCB1 (MDR1) 3435C >T and 2677G >A,T polymorphisms and P-glycoprotein inhibitors on salivary digoxin secretion in congestive heart failure patients. Pharmacol. Rep. 59: 323-329 (2007). *
Bartoli F, Angotti C, Fatini C, Conforti ML, Guiducci S, Blagojevic J, Melchiorre D, Fiori G, Generini S, Damjanov N, Rednic S, Pignone A, Castellani S, Abbate R, Matucci Cerinic M. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 46: 772-775 (2007). *
Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S, Worthington J. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50: 1117-1121 (2004). *
Barton A, Bowes J, Eyre S, Symmons D, Worthington J, Silman A. Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis. Ann. Rheum. Dis. 64: 1311-1315 (2005). *
Barton A, Eyre S, Bowes J, Ho P, John S, Worthington J. Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. Arthritis Rheum. 52: 752-758 (2005). *
Barton A, Jury F, Eyre S, Bowes J, Hinks A, Ward D, Worthington J. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum. 50: 748-752 (2004). *
Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J, Donn R. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4: 487-491 (2003). *
Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology (Oxford) 39: 63-66 (2000). *
Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M, Lunt M, Zeggini E, Eyre S, Hinks A, Tellam D, Brintnell B, Ollier W, Worthington J, Silman A. Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann. Rheum. Dis. 63: 280-284 (2004). *
Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, Silman A. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J. Rheumatol. 31: 442-447 (2004). *
Barton A, Woolmore JA, Ward D, Eyre S, Hinks A, Ollier WE, Strange RC, Fryer AA, John S, Hawkins CP, Worthington J. Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population. Brain 127: 1717-1722 (2004). *
Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med. Genet. 5: 29 (2004). *
Bartunkova J, Kayserova J, Shoenfeld Y. Allergy and autoimmunity: parallels and dissimilarity. The Yin and Yang of immunopathology. Autoimmun. Rev. 8: 302-308 (2009).
Basar Y, Salmayenli N, Aksoy M, Seckin S, Aydin M, Ozkok E. ACE gene polymorphism in peripheral vascular disease. Horm. Metab. Res. 39: 534-537 (2007).
Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA, Erlich HA, Eisenbarth GS; Diabetes Genetics Consortium. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes. Metab. 11 Suppl. 1: 25-30 (2009). *
Baschal EE, Eisenbarth GS. Extreme genetic risk for type 1A diabetes in the post-genome era. J. Autoimmun. 31: 1-6 (2008).
Baseggio L, Bartholin L, Chantome A, Charlot C, Rimokh R, Salles G. Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Eur. J. Immunogenet. 31: 15-19 (2004). *
Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J. Allergy Clin. Immunol. 114: 80-87 (2004).
Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7: 277-300 (2006). *
Basic S, Hajnsek S, Bozina N, Filipcic I, Sporis D, Mislov D, Posavec A. The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy. Seizure 17: 524-530 (2008).
Basic S, Hajnsek S, Poljakovic Z, Basic M. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 47: 449 (2006). *
Baslund B, Gregers J, Nielsen CH. Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells. Rheumatology (Oxford) 47: 451-453 (2008). *
Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, Vaira D. Helicobacter pylori infection: anything new should we know? Aliment. Pharmacol. Ther. 20 Suppl. 2: 31-41 (2004).
Bassi C, Xavier Dj, Palomino G, Nicolucci P, Soares C, Sakamoto-Hojo E, Donadi E. Efficiency of the DNA repair and polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus erythematosus. Lupus 17: 988-995 (2008). *
Bassols J, Botas P, Moreno-Navarrete JM, Delgado E, Ortega F, Ricart W, Fernandez-Real JM. Environmental and genetic factors influence the relationship between circulating IL-10 and obesity phenotypes. Obesity (Silver Spring) Oct 1 [Epub ahead of print] (2009). *
Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM. Characterization of herpes virus entry mediator as a factor linked to obesity. Obesity (Silver Spring) Aug 13 [Epub ahead of print] (2009). *
Bassuny WM, Ihara K, Matsuura N, Ahmed S, Kohno H, Kuromaru R, Miyako K, Hara T. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes. Immunogenetics 54: 282-285 (2002). *
Basta-Kaim A, Budziszewska B, Lason W. Effects of antiepileptic drugs on immune system. Przegl. Lek. 65: 799-802 (2008).
Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) 46: 683-689 (2007). *
Bastone L, Reilly M, Rader DJ, Foulkes AS. MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum. Hered. 58: 82-92 (2004).
Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect. Genet. Evol. 8: 20-25 (2008).
Basu D, Lopez I, Kulkarni A, Sellin JH. Impact of race and ethnicity on inflammatory bowel disease. Am. J. Gastroenterol. 100: 2254-2261 (2005). *
Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37: 493-503 (2003). *
Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, Kaufman KM, James JA, Gilkeson GS, Kelly JA, Humphrey MB, Harley JB, Gray-McGuire C, Moser KL, Gaffney PM. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. 10: 470-477 (2009).
Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur. J. Gastroenterol. Hepatol. 12: 1329-1333 (2000).
Bathi RJ, Rao R, Mutalik S. GST null genotype and antioxidants: risk indicators for oral pre-cancer and cancer. Indian J. Dent. Res. 20: 298-303 (2009).
Bathum L, Hansen H, Teisner B, Koch C, Garred P, Rasmussen K, Wang P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol. Immunol. 43: 473-479 (2006). *
Batikhan H, Gokcan MK, Beder E, Akar N, Ozturk A, Gerceker M. Association of the tumor necrosis factor-alpha -308 G/A polymorphism with nasal polyposis. Eur. Arch. Otorhinolaryngol. Dec 14 [Epub ahead of print] (2009).
Batley J, Jewell E, Edwards D. Automated discovery of single nucleotide polymorphism and simple sequence repeat molecular genetic markers. Methods Mol. Biol. 406: 473-494 (2007).
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur. J. Immunogenet. 30: 223-227 (2003). *
Battistelli S, Vittoria A, Stefanoni M, Bing C, Roviello F. Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. World J. Gastroenterol. 12: 6128-6132 (2006). *
Bauduer F, Scribans C, Degioanni A, Renoux M, Dutour O. Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque Country. Ann. Hematol. 84: 99-102 (2005). *
Bauer K, Yu X, Wernhoff P, Koczan D, Thiesen HJ, Ibrahim SM. Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum. 50: 3721-3728 (2004). *
Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3: 170-176 (2002). *
Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 361: 1111-1118 (2003). *
Baumert TF. Novel vaccine strategies. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper�s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 58-59. October 20 - 21 (2003). *
Baumgart DC, Buning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, Gentz E, Molnar T, Nagy F, Lonovics J, Lochs H, Wiedenmann B, Nickel R, Witt H, Dignass A. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of Toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion 76: 196-202 (2007). *
Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depress. Anxiety 25: 920-925 (2007).
Baune BT, Ponath G, Rothermundt M, Riess O, Funke H, Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 33: 68-76 (2008).
Baurecht H, Irvine AD, Novak N, Illig T, Buhler B, Ring J, Wagenpfeil S, Weidinger S. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J. Allergy Clin. Immunol. 120: 1406-1412 (2007). *
Bay JT, Garred P. Rapid bead-based immunoassay for measurement of mannose-binding lectin. Scand. J. Immunol. 69: 570-575 (2009). *
Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br. J. Plast. Surg. 56: 328-333 (2003).
Bayat A, Watson JS, Stanley JK, Alansari A, Shah M, Ferguson MW, Ollier WE. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease. J. Bone Joint Surg. Br. 84: 211-215 (2002).
Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren disease: association of Zf9 transcription factor gene. Plast. Reconstr. Surg. 111: 2133-2139 (2003).
Bayazit YA. Genetics of headache and catechol-O-methyltransferase gene polymorphism. J. Headache Pain 7: 60 (2006). *
Bayazit YA, Yilmaz M. An overview of hereditary hearing loss. ORL J. Otorhinolaryngol. Relat. Spec. 68: 57-63 (2006).
Bayley JP, Baggen JM, van der Pouw-Kraan T, Crusius JB, Huizinga TW, Verweij CL. Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis. Tissue Antigens 62: 170-174 (2003). *
Bayley JP, Bakker AM, Kaijzel EL, Huizinga TW, Verweij CL. Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis. Rheumatology (Oxford) 42: 969-971 (2003). *
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun. 5: 315-329 (2004). *
Baylin A, Ruiz-Narvaez E, Kraft P, Campos H. alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am. J. Clin. Nutr. 85: 554-560 (2007). *
Bayou N, M'rad R, Ahlem B, Bechir Helayem M, Chaabouni H. Autism: an overview of genetic aetiology. Tunis. Med. 86: 573-578 (2008).
Bayoumi RA, Simsek M, Yahya TM, Bendict S, Al-Hinai A, Al-Barwani H, Hassan MO. Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis. Hum. Biol. 78: 103-108 (2006).
Baz K, Emin Erdal M, Yazici AC, Soylemez F, Guvenc U, Tasdelen B, Ikizoglu G. Association between tumor necrosis factor-alpha gene promoter polymorphism at position -308 and acne in Turkish patients. Arch. Dermatol. Res. 300: 371-376 (2008). *
Bazilio AP, Viana VS, Toledo R, Woronik V, Bonfa E, Monteiro RC. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol. Dial. Transplant. 19: 1427-1431 (2004). *
Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun. 3: 302-305 (2002). *
Beagle B, Yang TL, Hung J, Cogger EA, Moriarty DJ, Caudill MA. The glycine N-methyltransferase (GNMT) 1289 C->T variant influences plasma total homocysteine concentrations in young women after restricting folate intake. J. Nutr. 135: 2780-2785 (2005). *
Beall SS, Biddison WE, McFarlin DE, McFarland HF, Hood LE. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes. J. Neuroimmunol. 45: 53-60 (1993).
Beasley WD, Beynon J, Jenkins GJ, Parry JM. Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study. Int. J. Colorectal Dis. 23: 375-381 (2008). *
Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J. Immunol. 176: 6055-6064 (2006). *
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol. 24: 2283-2289 (2006). *
Beck S, Trowsdale J. The human major histocompatability complex: lessons from the DNA sequence. Annu. Rev. Genomics Hum. Genet. 1: 117-137 (2000). *
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Ch Stricker BH. Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy. Pharmacoepidemiol. Drug Saf. 19: 75-81 (2009).
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J. 9: 242-247 (2009).
Becker T, Jansen S, Tamm S, Wienker TF, Tummler B, Stanke F. Transmission ratio distortion and maternal effects confound the analysis of modulators of cystic fibrosis disease severity on 19q13. Eur. J. Hum. Genet. 15: 774-778 (2007). *
Beckly JB, Hancock L, Geremia A, Cummings JR, Morris A, Cooney R, Pathan S, Guo C, Jewell DP. Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease. Inflamm. Bowel Dis. 14: 500-507 (2008). *
Beckman L, Beckman G, Frolander N. Population studies in northern Sweden. XII. The haptoglobin polymorphism. Hum. Hered. 33: 371-376 (1983).
Beckmann L, Ziegler A, Duggal P, Bailey-Wilson JE. Haplotypes and haplotype-tagging single-nucleotide polymorphism: presentation Group 8 of Genetic Analysis Workshop 14. Genet. Epidemiol. 29: S59-S71 (2005).
Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur. J. Endocrinol. 148: 13-18 (2003). *
Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum. Immunol. 65: 632-639 (2004).
Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U, Hiromatsu Y, Nauman J. Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin. Endocrinol. (Oxf.) 59: 519-525 (2003). *
Beetstra S, Suthers G, Dhillon V, Salisbury C, Turner J, Altree M, McKinnon R, Fenech M. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer. Cancer Epidemiol. Biomarkers Prev. 17: 2565-2571 (2008). *
Beghe B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin. Exp. Allergy 33: 1111-1117 (2003). *
Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol. Biomarkers Prev. 15: 2422-2426 (2006). *
Begovich AB, Caillier SJ, Alexander HC, Penko JM, Hauser SL, Barcellos LF, Oksenberg JR. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am. J. Hum. Genet. 76: 184-187 (2005). *
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337 (2004). *
Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J, Hauser SL, Oksenberg JR. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum. Immunol. 68: 934-937 (2007).
Begovich AB, Chang M, Schrodi SJ. Meta-analysis evidence of a differential risk of the FCRL3 -169T-->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum. 56: 3168-3171 (2007). *
Behrens TW, Graham RR, Kyogoku C, Baechler EC, Ramos PS, Gillett C, Bauer J, Ortmann WA, Hippen KL, Peterson E, Langefeld CD, Moser KL, Gaffney PM, Gregersen PK. Progress towards understanding the genetic pathogenesis of systemic lupus erythematosus. Novartis Found. Symp. 267: 145-160 (2005).
Bei T, Tilkeridis C, Garantziotis S, Boikos S, Kazakos K, Simopoulos C, Stratakis C. A novel, non-functional, COL1A1 polymorphism is not associated with lumbar disk disease in young male Greek subjects unlike that of the Sp1 site. Hormones (Athens) 7: 251-254 (2008).
Bekker V, O'Brien TR, Chanock S. Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry. Hum. Hered. 67: 206-216 (2008).
Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels. Exp. Clin. Endocrinol. Diabetes 115: 221-228 (2007).
Bekris LM, Shephard C, Peterson M, Hoehna J, Yserloo BV, Rutledge E, Farin F, Kavanagh TJ, Lernmark A. Glutathione-S-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 38: 567-575 (2005).
Bel Hadj Jrad B, Chatti A, Laatiri A, Ahmed SB, Romdhane A, Ajimi S, Chouchane L. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur. J. Haematol. 78: 117-122 (2007). *
Bel Hadj Jrad B, Mahfouth W, Bouaouina N, Gabbouj S, Ahmed SB, Ltaief M, Jalbout M, Chouchane L. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett. 233: 21-27 (2006). *
Belcastro V, Gaetano G, Italiano D, Oteri G, Caccamo D, Pisani LR, Striano P, Striano S, Ientile R, Pisani F. Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients. Epilepsia 48: 1990-1994 (2007).
Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D. Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun. 5: 505-512 (2004). *
Belguith H, Tlili A, Dhouib H, Ben Rebeh I, Lahmar I, Charfeddine I, Driss N, Ghorbel A, Ayadi H, Masmoudi S. Mutation in gap and tight junctions in patients with non-syndromic hearing loss. Biochem. Biophys. Res. Commun. 385: 1-5 (2009). *
Belguith-Maalej S, Hadj Kacem H, Rebai A, Mnif M, Abid M, Ayadi H. Thyroglobulin polymorphisms in Tunisian patients with autoimmune thyroid diseases (AITD). Immunobiology 213: 577-583 (2008).
Belguith-Maalej S, Hadj-Kacem H, Kaddour N, Bahloul Z, Ayadi H. DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjogren syndrome and healthy subjects. Rheumatol. Int. Apr 10 [Epub ahead of print] (2009). *
Belisle SE, Leka LS, Delgado-Lista J, Jacques PF, Ordovas JM, Meydani SN. Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly. J. Nutr. 139: 1855-1860 (2009).
Belitsky GA, Yakubovskaya MG. Genetic polymorphism and variability of chemical carcinogenesis. Biochemistry (Mosc.) 73: 543-554 (2008).
Belkahla R, Omezzine A, Kchok K, Rebhi L, Ben Hadj Mbarek I, Rejeb J, Ben Rejeb N, Slimane N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A. Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population. Ann. Cardiol. Angeiol. (Paris) 57: 219-224 (2008).
Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1: 1058-1060 (1986).
Bell JI. The molecular genetics of HLA-related disorders. Ciba Found. Symp. 130: 197-214 (1987).
Bell JJ, Divekar RD, Ellis JS, Cascio JA, Haymaker CL, Jain R, Tartar DM, Hoeman CM, Hardaway JC, Zaghouani H. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis. J. Immunol. 180: 1508-1516 (2008). *
Bell JT. A two-dimensional genome scan for rheumatoid arthritis susceptibility loci. BMC Proc. 1 Suppl. 1: S63 (2007). *
Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, Hardell L. The growing incidence of cancer: role of lifestyle and screening detection (review). Int. J. Oncol. 30: 1037-1049 (2007). *
Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J. Virol. 79: 12507-12514 (2005). *
Ben Aleya W, Sfar I, Mouelhi L, Aouadi H, Makhlouf M, Ayed-Jendoubi S, Matri S, Filali A, Najjar T, Ben Abdallah T, Ayed K, Gorgi Y. Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD. World J. Gastroenterol. 15: 3643-3648 (2009). *
Ben Ali S, Kallel A, Ftouhi B, Sediri Y, Feki M, Slimane H, Jemaa R, Kaabachi N. The -2548G/A LEP polymorphism is associated with blood pressure in Tunisian obese patients. Blood Press. 17: 278-283 (2008).
Ben Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Usher S, Peretz H, Shapira I, Bornstein NM. Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb. Res. 124: 458-462 (2009). *
Ben Dhifallah I, Chelbi H, Braham A, Hamzaoui K, Houman MH. CTLA-4 +49A/G polymorphism is associated with Behcet's disease in a Tunisian population. Tissue Antigens 73: 213-217 (2009). *
Ben Dhifallah I, Karray EF, Sassi F, Hamzaoui K. Intercellular adhesion molecule 1 K469E gene polymorphism is associated with presence of skin lesions in Tunisian Behcet's disease patients. Tissue Antigens Nov 10 [Epub ahead of print] (2009). *
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11: 625-626 (2004). *
Bendicho MT, Guedes JC, Silva NN, Santana GO, dos Santos RR, Lyra AC, Lyra LG, Meyer R, Lemaire DC. Polymorphism of cytokine genes (TGF-beta1, IFN-gamma, IL-6, IL-10, and TNF-alpha) in patients with chronic pancreatitis. Pancreas 30: 333-336 (2005).
Bendlova B, Vejralkova D, Vcelak J, Lukalova P, Burkonova D, Kunelova M, Vrbikova J, Dvorakova K, Vondra K, Vankova M. PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2. Physiol. Res. 57 Suppl. 1: S77-S90 (2008). *
Bene J, Magyari L, Talian G, Komlosi K, Gasztonyi B, Tari B, Varkonyi A, Mozsik G, Melegh B. Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World J. Gastroenterol. 12: 5550-5553 (2006). *
Benedek G, Brautbar C, Vardi P, Sharon N, Weintrob N, Zung A, Israel S. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel. Tissue Antigens 73: 33-38 (2009). *
Benesova Y, Vasku A, Stourac P, Hladikova M, Beranek M, Kadanka Z, Novotna H, Bednarik J. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis. J. Neuroimmunol. 205: 105-109 (2008).
Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F. The onset of psychiatric disorders and Wilson's disease. Encephale 33: 924-932 (2007).
Benito JM. New insights into the mechanisms driving immune activation in HIV. AIDS Rev. 10: 254 (2008).
Bennani N, Atouf O, Benseffaj N, Brick C, Essakalli M. HLA polymorphism and Behcet's disease in Moroccan population. Pathol. Biol. (Paris) 57: 403-409 (2009).
Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Franks S, Elliott P, Jarvelin MR, McCarthy MI. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth. Diabetologia 51: 82-85 (2008). *
Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ. HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Hum. Immunol. 60: 886-893 (1999).
Bennetts BH, Teutsch SM, Heard RN, Dunckley H, Stewart GJ. TAP2 polymorphisms in Australian multiple sclerosis patients. J. Neuroimmunol. 59: 113-121 (1995).
Benrick A, Jirholt P, Wernstedt I, Gustafsson M, Scheller J, Eriksson AL, Boren J, Hedner T, Ohlsson C, Hard T, Rose-John S, Jansson JO. A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population. Regul. Pept. 146: 189-196 (2008).
Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, Erlich HA. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 74: 393-403 (2009). *
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53: 3007-3012 (2004). *
Benton JL, Ding J, Tsai MY, Shea S, Rotter JI, Burke GL, Post W. Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 193: 352-360 (2007).
Bentz EK, Hefler LA, Denschlag D, Pietrowski D, Buerkle B, Tempfer CB. A polymorphism of the interleukin-1 beta gene is associated with sperm pathology in humans. Fertil. Steril. 88: 751-753 (2007).
Benyamina A, Saffroy R, Blecha L, Pham P, Karila L, Debuire B, Lemoine A, Reynaud M. Association between MTHFR 677C-T polymorphism and alcohol dependence according to Lesch and Babor typology. Addict. Biol. 14: 503-505 (2009).
Beranek H, Teich N, Witt H, Schulz HU, Mossner J, Keim V. Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur. J. Gastroenterol. Hepatol. 15: 1223-1227 (2003).
Beranek M, Kolar P, Tschoplova S, Kankova K, Vasku A. Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy. Diabetes Res. Clin. Pract. 79: 362-367 (2008).
Berce V, Potocnik U. Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma. Biomarkers Nov 9 [Epub ahead of print] (2009).
Bercot B, Kannengiesser C, Oudin C, Grandchamp B, Sanson-le Pors MJ, Mouly S, Elbim C. First description of NOD2 variant associated with defective neutrophils responses in a woman with granulomatous mastitis related to corynebacteria. J. Clin. Microbiol. 47: 3034-3037 (2009). *
Berdeli A, Cam FS. Prevalence of the angiotensin I converting enzyme gene insertion/deletion polymorphism in a healthy Turkish population. Biochem. Genet. 47: 412-420 (2009). *
Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J. Mol. Med. 83: 535-541 (2005). *
Berdeli A, Gurkan A, Emingil G, Atilla G, Kose T. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in periodontal diseases. J. Periodontol. 77: 1348-1354 (2006).
Berdeli A, Ozyurek AR, Ulger Z, Gurses D, Levent E, Salar K, Gurpinar AR. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol. Int. 26: 726-731 (2006). *
Berdeli A, Tabel Y, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. Lack of association between TNFalpha gene polymorphism at position -308 and risk of acute rheumatic fever in Turkish patients. Scand. J. Rheumatol. 35: 44-47 (2006). *
Bereket A. Vitamin D receptor polymorphism in nutritional rickets. Pediatr. Endocrinol. Rev. 3 Suppl. 3: 476-479 (2006).
Beretta L, Cappiello F, Barili M, Bertolotti F, Scorza R. T-889C IL-1alpha promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis. Clin. Rheumatol. 26: 88-91 (2007). *
Beretta L, Cappiello F, Moore JH, Barili M, Greene CS, Scorza R. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum. 59: 974-983 (2008). *
Beretta L, Cappiello F, Moore JH, Scorza R. Interleukin-1 gene complex single nucleotide polymorphisms in systemic sclerosis: a further step ahead. Hum. Immunol. 69: 187-192 (2008).
Beretta L, Cossu M, Marchini M, Cappiello F, Artoni A, Motta G, Scorza R. A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation. Arthritis Res. Ther. 10: R103 (2008). *
Beretta L, Santaniello A, Cappiello F, Barili M, Scorza R. No evidence for a role of the proximal IL-6 G/C -174 single nucleotide polymorphism in Italian patients with systemic sclerosis. J. Cell. Mol. Med. 11: 896-898 (2007). *
Beretta L, Scorza R. 5HT2A polymorphism His452Tyr in a German Caucasian systemic sclerosis population - authors' response. Arthritis Res. Ther. 11: 404 (2009).
Berg KK, Madsen HO, Garred P, Wiseth R, Gunnes S, Videm V. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand. J. Immunol. 69: 36-42 (2009). *
Bergasa NV. The pruritus of cholestasis. J. Hepatol. 43: 1078-1088 (2005). *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *
Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, Cohen JC. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43: 486-494 (2002). *
Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Transpl. Infect. Dis. 11: 211-219 (2009).
Berger BM, Schroy PC 3rd, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin. Colorectal Cancer 5: 338-343 (2006).
Berger CT, Carlson JM, Brumme CJ, Hartman KL, Brumme ZL, Henry LM, Rosato PC, Piechocka-Trocha A, Brockman MA, Harrigan PR, Heckerman D, Kaufmann DE, Brander C. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J. Exp. Med. Jan 11 [Epub ahead of print] (2010).
Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum. Genet. 121: 169-178 (2007). *
Berghofer B, Frommer T, Konig IR, Ziegler A, Chakraborty T, Bein G, Hackstein H. Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance. Clin. Exp. Allergy 35: 1147-1154 (2005).
Bergholdt R, Brorsson C, Boehm B, Morahan G, Pociot F. No association of the IRS1 and PAX4 genes with type I diabetes. Genes Immun. 10: S49-S53 (2009).
Bergholdt R, Larsen ZM, Andersen NA, Johannesen J, Kristiansen OP, Mandrup-Poulsen T, Nerup J, Pociot F; Danish Study Group of IDDM in Childhood; Danish IDDM Epidemiology and Genetics Group. Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level. Genes Immun. 1: 495-500 (2000). *
Bergholdt R, Nerup J, Pociot F. Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes. J. Med. Genet. 42: 17-25 (2005). *
Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. J. Leukoc. 77: 579-585 (2005). *
Berglund J, Pollard KS, Webster MT. Hotspots of biased nucleotide substitutions in human genes. PLoS Biol. 7: e26 (2009). *
Bergman A, Atzmon G, Ye K, Maccarthy T, Barzilai N. Buffering mechanisms in aging: a systems approach toward uncovering the genetic component of aging. PLoS Comput. Biol. 3: e170 (2007). *
Bergmann A, Li J, Selisko T, Reimann M, Fischer S, Grassler J, Schulze J, Bornstein SR, Schwarz PE. The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF-1alpha) is associated with insulin sensitivity and beta-cell function. Exp. Clin. Endocrinol. Diabetes 116 Suppl. 1: S50-S55 (2008).
Bergstrom TF, Josefsson A, Erlich HA, Gyllensten U. Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat. Genet. 18: 237-242 (1998). *
Beringer PM, Kriengkauykiat J, Zhang X, Hidayat L, Liu S, Louie S, Synold T, Burckart GJ, Rao PA, Shapiro B, Gill M. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. Pharmacotherapy 28: 883-894 (2008).
Beringer PM, Slaughter RL. Transporters and their impact on drug disposition. Ann. Pharmacother. 39: 1097-1108 (2005).
Berka N, Bland GN, Erabhaoui el H, Dunston GM. Heat-shock protein gene is not associated with type-1 diabetes in African Americans. J. Natl. Med. Assoc. 99: 715-717 (2007). *
Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM. IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes. J. Natl. Med. Assoc. 96: 1042-1046 (2004).
Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology 84: 346-352 (2006).
Berkun Y, Atta IA, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. J. Rheumatol. 34: 1664-1669 (2007).
Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol. Aging 25: 465-474 (2004).
Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J. Hepatol. 29: 53-59 (1998). *
Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J. Hepatol. 30: 237-241 (1999). *
Bernard D, Christophe A, Delanghe J, Langlois M, De Buyzere M, Comhaire F. The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism. Redox Rep. 8: 41-46 (2003).
Bernardinelli L, Murgia SB, Bitti PP, Foco L, Ferrai R, Musu L, Prokopenko I, Pastorino R, Saddi V, Ticca A, Piras ML, Cox DR, Berzuini C. Association between the ACCN1 gene and multiple sclerosis in Central East Sardinia. PLoS ONE 2: e480 (2007). *
Bernbom N, Norrung B, Saadbye P, Molbak L, Vogensen FK, Licht TR. Comparison of methods and animal models commonly used for investigation of fecal microbiota: effects of time, host and gender. J. Microbiol. Methods 66: 87-95 (2006). *
Berndt SI, Dodson JL, Huang WY, Nicodemus KK. A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J. Urol. 175: 1613-1623 (2006).
Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis 28: 1965-1970 (2007). *
Berndt SI, Huang WY, Yeager M, Weissfeld JL, Chanock SJ, Hayes RB. Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia. Cancer Causes Control 20: 487-490 (2009). *
Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev. Mol. Diagn. 6: 319-331 (2006).
Bernstein JM, Anon JB, Rontal M, Conroy J, Wang C, Sucheston L. Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis. Laryngoscope 119: 1258-1264 (2009).
Berrahmoune H, Herbeth B, Siest G, Visvikis-Siest S. Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles. Genes Immun. 8: 352-359 (2007). *
Berro M, Mayor NP, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh SG, Madrigal AA, Shaw BE. Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. Haematologica Aug 27 [Epub ahead of print] (2009). *
Berry A, Tector M, Oaks MK. Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. J. Negat. Results Biomed. 7: 8 (2008). *
Bertalan R, Patocs A, Nagy B, Derzsy Z, Gullai N, Szappanos A, Rigo J Jr, Racz K. Overrepresentation of BclI polymorphism of the glucocorticoid receptor gene in pregnant women with HELLP syndrome. Clin. Chim. Acta 405: 148-152 (2009). *
Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. Clin. Chim. Acta 399: 112-116 (2009). *
Berthold HK, Laaksonen R, Lehtimaki T, Gylling H, Krone W, Gouni-Berthold I. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment. Exp. Clin. Endocrinol. Diabetes 116: 262-267 (2008).
Bertinetto FE, Dall'omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int. J. Immunogenet. 33: 375-384 (2006). *
Bertoli AM, Fernandez M, McGwin G Jr, Alarcon GS, Tan FK, Reveille JD, Vila LM. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum. 54: 1703-1704 (2006). *
Bertolo F, De Vita S, Dolcetti R, Carbone A, Ferraccioli GF, Bartoli E, Boiocchi M. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjogren's syndrome and type II mixed cryoglobulinemia. Clin. Exp. Rheumatol. 17: 339-342 (1999).
Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, Elliott KJ, Velicelebi G, Moscarillo T, Hyman BT, Wagner SL, Becker KD, Blacker D, Tanzi RE. Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med. 352: 884-894 (2005). *
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39: 17-23 (2007). *
Bertram L, Mullin K, Parkinson M, Hsiao M, Moscarillo TJ, Wagner SL, Becker KD, Velicelebi G, Blacker D, Tanzi RE. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene? J. Med. Genet. 44: e63 (2007). *
Bertrand-Thiebault C, Berrahmoune H, Thompson A, Marie B, Droesch S, Siest G, Foernzler D, Visvikis-Siest S. Genetic polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann. Hum. Genet. 72: 178-183 (2008). *
Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis Rheum. 60: 207-218 (2009). *
Besenbacher S, Pedersen CN, Mailund T. A fast algorithm for genome-wide haplotype pattern mining. BMC Bioinformatics 10 Suppl. 1: S74 (2009). *
Bessa SS, Hamdy SM, Ali EM. Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study. Eur. J. Intern. Med. 18: 489-495 (2007).
Bessard G, Hardy G, Chartier A, Stanke-Labesque F. Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine. Therapie 59: 71-75 (2004).
Bessler H, Osovsky M, Beilin B, Alcalay Y, Sirota L. The existence of gender difference in IL-1Ra gene polymorphism. J. Interferon Cytokine Res. 27: 931-935 (2007).
Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lonn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol. Biomarkers Prev. 17: 1195-1202 (2008). *
Bettencourt BF, Santos MR, Fialho RN, Couto AR, Peixoto MJ, Pinheiro JP, Spinola H, Mora MG, Santos C, Brehm A, Bruges-Armas J. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics 9: 68 (2008). *
Bettens F, Nicoloso de Faveri G, Tiercy JM. HLA-B51 and haplotypic diversity of B-Cw associations: implications for matching in unrelated hematopoietic stem cell transplantation. Tissue Antigens 73: 316-325 (2009). *
Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 37: 449-454 (1993).
Betz RC, Konig K, Flaquer A, Redler S, Eigelshoven S, Kortum AK, Hanneken S, Hillmer A, Tuting T, Lambert J, De Weert J, Kruse R, Lutz G, Blaumeiser B, Nothen MM. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br. J. Dermatol. 158: 389-391 (2008). *
Beulens JW, Rimm EB, Hendriks HF, Hu FB, Manson JE, Hunter DJ, Mukamal KJ. Alcohol consumption and type 2 diabetes: influence of genetic variation in alcohol dehydrogenase. Diabetes 56: 2388-2394 (2007). *
Beuten J, Garcia D, Brand TC, He X, Balic I, Canby-Hagino E, Troyer DA, Baillargeon J, Hernandez J, Thompson IM, Leach RJ, Naylor SL. Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis. J. Urol. 182: 1614-1620 (2009).
Beutler B, Beutler E. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347: 1978-1980 (2002).
Beutler E, Beutler L, Lee PL, Barton JC. The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol. Dis. 33: 344-345 (2004).
Beutler E, Gelbart T, Lee P. Haptoglobin polymorphism and iron homeostasis. Clin. Chem. 48: 2232-2235 (2002). *
Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology (Am. Soc. Hematol. Educ. Program) 2003: 40-61 (2003). *
Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK. Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann. Rheum. Dis. 55: 66-68 (1996). *
Beyene J, Tritchler D, Asimit JL, Hamid JS. Gene- or region-based analysis of genome-wide association studies. Genet. Epidemiol. 33 Suppl. 1: S105-S110 (2009).
Beygo J, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S. No evidence of an association between polymorphisms in the IRAK-M gene and atopic dermatitis in a German cohort. Mol. Cell. Probes 23: 16-19 (2009).
Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J. Am. Coll. Cardiol. 41: 2130-2137 (2003). *
Bezalel Y, Gershoni-Baruch R, Dagan E, Lidar M, Livneh A. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever. Clin. Exp. Rheumatol. 27: S103-S104 (2009).
Bezemer ID, Arellano AR, Tong CH, Rowland CM, Ireland HA, Bauer KA, Catanese J, Reitsma PH, Doggen CJ, Devlin JJ, Rosendaal FR, Bare LA. F9 Malmo, factor IX and deep vein thrombosis. Haematologica 94: 693-699 (2009). *
Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch. Intern. Med. 167: 497-501 (2007). *
Bezerra FF, Cabello GM, Mendonca LM, Donangelo CM. Bone mass and breast milk calcium concentration are associated with vitamin D receptor gene polymorphisms in adolescent mothers. J. Nutr. 138: 277-281 (2008). *
Bhaduri N, Mukhopadhyay K. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci. Lett. 402: 12-16 (2006). *
Bhagwat M. Identification of disease genes: example-driven web-based tutorial. Methods Mol. Biol. 396: 371-394 (2007).
Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol. 6: 42 (2006). *
Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, et al. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am. J. Gastroenterol. 104: 2233-2240 (2009). *
Bhat YM, Papachristou GI, Park JS, Lamb J, Slivka A, Whitcomb DC. Gunctional polymorphisms of the GSTT-1 gene do not predict the severity of acute pancreatitis in the United States. Pancreatology 7: 180-186 (2007).
Bhatnagar V, Xu G, Hamilton BA, Truong DM, Eraly SA, Wu W, Nigam SK. Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J. Hum. Genet. 51: 575-580 (2006). *
Bhattacharya P, Sengupta S. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 70: 283-293 (2007). *
Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J. Gastroenterol. 12: 1607-1612 (2006). *
Bialecka M, Hnatyszyn G, Bielicka-Cymerman J, Drozdzik M. The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy. Neurol. Neurochir. Pol. 39: 476-481 (2005).
Bialecka M, Klodowska-Duda G, Honczarenko K, Gawronska-Szklarz B, Opala G, Safranow K, Drozdzik M. Polymorphisms of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. Parkinsonism Relat. Disord. 13: 224-229 (2007).
Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Gorzkowska A, Opala G, Bialecki P, Sagan L, Drozdzik M. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients. Parkinsonism Relat. Disord. 14: 636-640 (2008).
Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Opala G, Bialecki P, Safranow K, Drozdzik M. Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch. Med. Res. 38: 858-863 (2007).
Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Juzwiak S, Kurzawski G, Tan EK, Drozdzik M. CARD15 variants in patients with sporadic Parkinson's disease. Neurosci. Res. 57: 473-476 (2007). *
Biasiotto G, Camaschella C, Forni GL, Polotti A, Zecchina G, Arosio P. New TFR2 mutations in young Italian patients with hemochromatosis. Haematologica 93: 309-310 (2008). *
Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol. Dis. 33: 338-343 (2004).
Biason-Lauber A, Boehm B, Lang-Muritano M, Gauthier BR, Brun T, Wollheim CB, Schoenle EJ. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48: 900-905 (2005). *
Bicek A, Zaletel K, Krhin B, Stopar TG, Hojker S. 49A/G and CT60 polymorphisms of the CTLA-4 gene associated with autoimmune thyroid disease. Hum. Immunol. 70: 820-824 (2009).
Bickston SJ, Comerford LW, Cominelli F. Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523 (2003).
Bid HK, Chaudhary H, Mittal RD. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr. Nephrol. 20: 773-776 (2005). *
Bid HK, Konwar R, Aggarwal CG, Gautam S, Saxena M, Nayak VL, Banerjee M. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J. Med. Sci. 63: 187-194 (2009). *
Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J. Med. Sci. 62: 259-266 (2008). *
Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun. 2: 61-70 (2001). *
Biebl A, Muendlein A, Kazakbaeva Z, Heuberger S, Sonderegger G, Drexel H, Lau S, Nickel R, Kabesch M, Simma B. CD14 C-159T and Toll-like receptor 4 Asp299Gly polymorphisms in surviving meningococcal disease patients. PLoS One 4: e7374 (2009). *
Bielawska K, Liss J, Nocon K, Lukaszuk K. Detection of selected mutations in the CFTR gene in single cells for the use in preimplantation genetic diagnosis of cystic fibrosis. Ginekol. Pol. 80: 348-353 (2009).
Bielinski SJ, Pankow JS, Boerwinkle E, Bray MS, Kao WH, Folsom AR. Lack of association between uncoupling protein-2 Ala55Val polymorphism and incident diabetes in the atherosclerosis risk in communities study. Acta Diabetol. 45: 179-182 (2008).
Bierbaum S, Nickel R, Zitnik S, Ahlert I, Lau S, Deichmann KA, Wahn U, Heinzmann A. Confirmation of association of IL-15 with pediatric asthma and comparison of different controls. Allergy 61: 576-580 (2006). *
Bierbaum S, Sengler C, Gerhold K, Berner R, Heinzmann A. Polymorphisms within interleukin 15 are associated with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 24: 219 (2006).
Biernacka JM, Charoen P, Cordell HJ. Joint linkage and association analysis for identification of potentially causal polymorphisms in GAW15 data. BMC Proc. 1 Suppl. 1: S36 (2007). *
Biernacka JM, Cordell HJ. Exploring causality via identification of SNPs or haplotypes responsible for a linkage signal. Genet. Epidemiol. 31: 727-740 (2007).
Biernacka JM, Cordell HJ. A composite-likelihood approach for identifying polymorphisms that are potentially directly associated with disease. Eur. J. Hum. Genet. 17: 644-650 (2009). *
Bierut LJ. Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol. Sci. 31: 46-51 (2010). *
Bigatti MP, Santovito A. Glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) polymorphisms in a sample of the population in Northern Italy. Genetika 43: 827-830 (2007).
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun. 7: 550-554 (2006). *
Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann. N. Y. Acad. Sci. 958: 321-324 (2002). *
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L. HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann. N. Y. Acad. Sci. 1005: 314-318 (2003). *
Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L. HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 60: 71-76 (2002). *
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 1037: 133-137 (2004). *
Bilinska M, Frydecka I, Noga L, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Pokryszko-Dragan A. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Acta Neurol. Scand. 110: 67-71 (2004).
Bilitewski U. DNA microarrays: an introduction to the technology. Methods Mol. Biol. 509: 1-14 (2009).
Billaut-Laden I, Allorge D, Crunelle-Thibaut A, Rat E, Cauffiez C, Chevalier D, Houdret N, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human thiosulfate sulfurtransferase (Rhodanese), a cyanide and H(2)S detoxification enzyme. Toxicology 225: 1-11 (2006). *
Billaut-Laden I, Rat E, Allorge D, Crunelle-Thibaut A, Cauffiez C, Chevalier D, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme. Toxicol. Lett. 165: 101-111 (2006).
Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Muller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur. Respir. J. 28: 1085-1091 (2006).
Bin C, Zhirong Z, Xiaoqin W, Minhu C, Mei L, Xiang G, Baili C, Pinjin H. Contribution of rs11465788 in IL23R gene to Crohn's disease susceptibility and phenotype in Chinese population. J. Genet. 88: 191-196 (2009). *
Binder A. Identification of genes for a complex trait: examples from hypertension. Curr. Pharm. Biotechnol. 7: 1-13 (2006).
Binder EB, Holsboer F. Pharmacogenomics. Handb. Exp. Pharmacol. 169: 527-546 (2005).
Binion DG, Kugathasan S, Dwinell MB. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup. Am. J. Gastroenterol. 101: 107-109 (2006). *
Biondi ML, Turri O, Leviti S, Seminati R, Cecchini F, Bernini M, Ghilardi G, Guagnellini E. MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem. 46: 2023-2024 (2000). *
Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110 (1996).
Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102: 379-383 (1995). *
Biral AC, Magalhaes RF, Wastowski IJ, Simoes R, Donadi EA, Simoes AL, Mendes-Junior CT, Kraemer MH. Extensive genetic polymorphism in the haplotype STR-TNF and HLA class I with the onset and evolution of psoriasis vulgaris. J. Dermatol. Sci. 55: 137-138 (2009).
Biral AC, Magalhaes RF, Wastowski IJ, Simoes R, Donadi EA, Simoes AL, Mendes-Junior CT, Tanaka AM, Kraemer MH. Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients. Eur. J. Dermatol. 16: 523-529 (2006).
Birinci A, Bilgici A, Kuru O, Durupinar B. HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis. Rheumatol. Int. 26: 285-287 (2006). *
Birklein F, Depmeier C, Rolke R, Hansen C, Rautenstrauss B, Prawitt D, Magerl W. A family-based investigation of cold pain tolerance. Pain 138: 111-118 (2008).
Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das PK. Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community. Acta Derm. Venereol. 86: 209-214 (2006). *
Birlea SA, Gowan K, Fain PR, Spritz RA. Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J. Invest. Dermatol. Nov 5 [Epub ahead of print] (2009). *
Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res. 22: 230-234 (2009).
Birmingham DJ, Irshaid F, Gavit KF, Nagaraja HN, Yu CY, Rovin BH, Hebert LA. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding. Mol. Immunol. 44: 3510-3516 (2007). *
Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA. Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum. 54: 3291-3299 (2006). *
Biros E, Clancy P, Norman PE, Golledge J. A genetic polymorphism in transforming growth factor beta receptor-2 is associated with serum osteopontin. Int. J. Immunogenet. 36: 241-244 (2009). *
Biselli JM, Goloni-Bertollo EM, Haddad R, Eberlin MN, Pavarino-Bertelli EC. The MTR A2756G polymorphism is associated with an increase of plasma homocysteine concentration in Brazilian individuals with Down syndrome. Braz. J. Med. Biol. Res. 41: 34-40 (2008). *
Biselli PM, Guerzoni AR, de Godoy MF, Eberlin MN, Haddad R, Carvalho VM, Vannucchi H, Pavarino-Bertelli EC, Goloni-Bertollo EM. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J. Thromb. Thrombolysis 29: 32-40 (2010).
Biselli PM, Sanches de Alvarenga MP, Abbud-Filho M, Ferreira-Baptista MA, Galbiatti AL, Goto MT, Cardoso MA, Eberlin MN, Haddad R, Goloni-Bertollo EM, Pavarino-Bertelli EC. Effect of folate, vitamin B(6), and vitamin B(12) intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients. Transplant. Proc. 39: 3163-3165 (2007). *
Bisgaard H, Bonnelykke K, Sleiman PM, Brasholt M, Chawes B, Kreiner-Moller E, Stage M, Kim C, Tavendale R, Baty F, Pipper CB, Palmer CN, Hakonarsson H. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am. J. Respir. Crit. Care Med. 179: 179-185 (2009). *
Bishof NA, Welch TR, Beischel LS, Carson D, Donnelly PA. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus. Pediatr. Nephrol. 7: 243-246 (1993).
Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res. 60: 4602-4609 (2000). *
Biswas D, Gupta SK, Sindhwani G, Patras A. TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res. Notes 2: 162 (2009). *
Bittencourt PL, Farias AQ, Porta G, Cancado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J. Clin. Gastroenterol. 42: 300-305 (2008).
Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut 51: 609-610 (2002). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am. J. Gastroenterol. 98: 1616-1620 (2003). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Drigo S, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J. Hepatol. 35: 24-28 (2001). *
Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 18: 1061-1066 (2003). *
Bjerregaard LT, Nederby NJ, Fredholm L, Brandslund I, Munkholm P, Hey H. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 37: 62-67 (2002). *
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27: 140-144 (2006).
Bjornvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Carlsen KC, Carlsen KH, Undlien DE. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma. Genes Immun. 10: 181-187 (2009).
Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Ronningen KS, Stene LC. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 51: 589-596 (2008). *
Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, Hartiala J, Lehtinen AB, Haffner SM, Bergman RN, McEachin RC, Kjos SL, Lawrence JM, Buchanan TA, Watanabe RM. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57: 1048-1056 (2008). *
Black MH, Watanabe RM. A principal-components-based clustering method to identify multiple variants associated with rheumatoid arthritis and arthritis-related autoantibodies. BMC Proc. 3 Suppl. 7: S129 (2009). *
Black S, Teixeira AS, Loh AX, Vinall L, Holloway JW, Hardy R, Swallow DM. Contribution of functional variation in the IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort. Allergy 64: 1172-1178 (2009).
Blackwell JM, Searle S. Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg). Immunol. Lett. 65: 73-80 (1999).
Blackwell JM, Searle S, Mohamed H, White JK. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 85: 197-203 (2003).
Blaisdell CJ, Howard TD, Stern A, Bamford P, Bleecker ER, Stine OC. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity. BMC Med. Genet. 5: 26 (2004). *
Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37: 1380-1385 (1994).
Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116: 536-547 (2006). *
Blanco Y, Gomez-Choco M, Arostegui JL, Casanova B, Martinez-Rodriguez JE, Bosca I, Munteis E, Yague J, Graus F, Saiz A. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neurosci. Lett. 396: 217-219 (2006). *
Blanco-Barca O, Gomez-Lado C, Rodrigo-Saez E, Curros-Novos C, Briones-Godino P, Eiris-Punal J, Castro-Gago M. Pyruvate dehydrogenase deficit associated to the C515T mutation in exon 6 of the E1alpha gene. Rev. Neurol. 43: 341-345 (2006).
Blanco-Gelaz MA, Suarez-Alvarez B, Diaz-Pena R, Lopez-Larrea C. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol. Immunol. 46: 1304-1311 (2009). *
Blank MC, Stefanescu RN, Masuda E, Marti F, King PD, Redecha PB, Wurzburger RJ, Peterson MG, Tanaka S, Pricop L. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum. Genet. 117: 220-227 (2005). *
Blasko B, Banlaki Z, Gyapay G, Pozsonyi E, Sasvari-Szekely M, Rajczy K, Fust G, Szilagyi A. Linkage analysis of the C4A/C4B copy number variation and polymorphisms of the adjacent steroid 21-hydroxylase gene in a healthy population. Mol. Immunol. 46: 2623-2629 (2009). *
Bleiber G, May M, Suarez C, Martinez R, Marzolini C, Egger M, Telenti A; Swiss HIV Cohort Study. MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment. J. Infect. Dis. 189: 583-586 (2004). *
Bleich A, Buchler G, Beckwith J, Petell LM, Affourtit JP, King BL, Shaffer DJ, Roopenian DC, Hedrich HJ, Sundberg JP, Leiter EH. Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. Inflamm. Bowel Dis. Oct 23 [Epub ahead of print] (2009).
Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M. Natural selection on genes that underlie human disease susceptibility. Curr. Biol. 18: 883-889 (2008).
Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 850-858 (2008).
Blokhuis JH, Doxiadis GG, Bontrop RE. A splice site mutation converts an inhibitory killer cell Ig-like receptor into an activating one. Mol. Immunol. 46: 640-648 (2009). *
Blomhoff A, Helen Kemp E, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res. 18: 55-58 (2005). *
Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 89: 3474-3476 (2004). *
Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1(*)03 and DRB1(*)04 haplotypes. Genes Immun. 7: 130-140 (2006). *
Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria. J. Clin. Gastroenterol. 39: S167-S175 (2005).
Boccia S, Cadoni G, La Torre G, Arzani D, Volante M, Cattel C, Gianfagna F, Paludetti G, Almadori G, Ricciardi G. A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer. J. Cancer Res. Clin. Oncol. 132: 466-472 (2006). *
Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'Ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 12: 635-644 (2007).
Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 55: 2626-2630 (2006). *
Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP, Aderem A, Boeckh M. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 359: 1766-1777 (2008). *
Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170: 3451-3454 (2003). *
Bock HH, Lammert F. Nuclear xeno-sensors as receptors for cholestatic bile acids: the second line of defense. Hepatology 35: 232-234 (2002). *
Bocko D, Bilinska M, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Gruszka E, Frydecka I. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Arch. Immunol. Ther. Exp. (Warsz.) 51: 201-205 (2003).
Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet. Med. 8: 518-524 (2006).
Bodano A, Gonzalez A, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility. Ann. Rheum. Dis. 66: 560-561 (2007). *
Bodano A, Gonzalez A, Ferreiros-Vidal I, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility. Rheumatology (Oxford) 45: 819-823 (2006). *
Bodhini D, Radha V, Deepa R, Ghosh S, Majumder PP, Rao MR, Mohan V. The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians. Int. J. Obes. (Lond.) 31: 97-102 (2007). *
Bodhini D, Radha V, Dhar M, Narayani N, Mohan V. The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metabolism 56: 1174-1178 (2007). *
Boe Wolff AS, Oftedal B, Johansson S, Bruland O, Lovas K, Meager A, Pedersen C, Husebye ES, Knappskog PM. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes Immun. 9: 130-136 (2008). *
Boehm BO, Manfras B, Rosak C, Schoffling K, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus. Klin. Wochenschr. 69: 146-150 (1991).
Boesgaard TW, Zilinskaite J, Vanttinen M, Laakso M, Jansson PA, Hammarstedt A, Smith U, Stefan N, Fritsche A, H�ring H, Hribal M, Sesti G, Zobel DP, Pedersen O, Hansen T; for the EUGENE 2 Consortium. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study. Diabetologia 51: 816-820 (2008). *
Boger CA, Stubanus M, Haak T, Gotz AK, Christ J, Hoffmann U, Riegger GA, Kramer BK. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol. Dial. Transplant. 22: 154-162 (2007).
Bogner J, Lutz B, Klein H, Pollerer C, Troendle U, Goebel F. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type. HIV Med. 5: 264-272 (2004).
Bogunia-Kubik K, Jaskula E, Lange A. The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 40: 145-150 (2007).
Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int. J. Immunogenet. 33: 135-140 (2006). *
Bogunia-Kubik K, Middleton P, Norden J, Dickinson A, Lange A. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Int. J. Immunogenet. 35: 207-213 (2008). *
Bogunia-Kubik K, Uklejewska A, Dickinson A, Jarvis M, Lange A. HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease. Transplantation 82: 1116-1117 (2006).
Bohan A, Boyer JL. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin. Liver Dis. 22: 123-136 (2002).
Bohanec Grabar P, Grabnar I, Rozman B, Logar D, Tomsic M, Suput D, Trdan T, Peterlin Masic L, Mrhar A, Dolzan V. Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on A771726 pharmacokinetics in leflunomide treated patients with rheumatoid arthritis. Drug Metab. Dispos. 37: 2061-2068 (2009). *
Bohanec Grabar P, Logar D, Lestan B, Dolzan V. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Eur. J. Clin. Pharmacol. 64: 1057-1068 (2008). *
Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V. Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis. Clin. Exp. Rheumatol. 27: 229-236 (2009).
Bohlouli A, Ebrahimzadeh ME, Kafil HS, Asgharzadeh M. Evaluation mannose-binding lectin gene and promoter polymorphism in renal transplant recipients. J. Pak. Med. Assoc. 58: 294-298 (2008).
Bohme M, Nitz I, Doring F, Klapper M. Analysis of the transcriptional regulation of the FABP2 promoter haplotypes by PPARgamma/RXRalpha and Oct-1. Biochim. Biophys. Acta 1779: 616-621 (2008). *
Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279: 27233-27238 (2004). *
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J. Rheumatol. 33: 703-708 (2006).
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Grazia Catanoso M, Pattacini L, Salvarani C. Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum. 54: 4011-4017 (2006). *
Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni L. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. J. Rheumatol. 28: 1283-1287 (2001).
Boiocchi C, Zorzetto M, Sbarsi I, Pirotta A, Schirinzi S, Falcone C, Cuccia M. CR1 genotype and haplotype involvement in coronary artery disease: the pivotal role of hypertension and dyslipidemia. Int. J. Mol. Med. 24: 181-187 (2009).
Boitard C, Debray-Sachs M, Bach JF. Autoimmune disorders in diabetes. Adv. Nephrol. Necker Hosp. 15: 281-305 (1986).
Boke O, Gunes S, Kara N, Aker S, Sahin AR, Basar Y, Bagci H. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population. DNA Cell Biol. 26: 527-531 (2007).
Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann. Rheum. Dis. 52: 517-519 (1993). *
Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum. 35: 749-755 (1992).
Bokodi G, Treszl A, Kovacs L, Tulassay T, Vasarhelyi B. Dysplasia: a review. Pediatr. Pulmonol. 42: 954-963 (2007).
Bokor S, Csernus K, Erhardt E, Burus I, Molnar D, Decsi T. Association of n-6 long-chain polyunsaturated fatty acids to -866 G/A genotypes of the human uncoupling protein 2 gene in obese children. Acta Paediatr. 96: 1350-1354 (2007). *
Boldt AB, Culpi L, Tsuneto LT, de Souza IR, Kun JF, Petzl-Erler ML. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum. Immunol. 67: 722-734 (2006).
Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 7: 393-400 (2006). *
Bolsover WJ, Hall MA, Vaughan RW, Welsh KI, Ciclitira PJ. A family study confirms that the HLA-DP associations with celiac disease are the result of an extended HLA-DR3 haplotype. Hum. Immunol. 31: 100-108 (1991).
Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J. Rheumatol. 27: 2397-2405 (2000).
Bolu SE, Orkunoglu Suer FE, Deniz F, Uckaya G, Imirzalioglu N, Kutlu M. The vitamin D receptor fokI start codon polymorphism and bone mineral density in male hypogonadotrophic hypogonadism. J. Endocrinol. Invest. 28: 810-814 (2005).
Bombell S, McGuire W. Tumour necrosis factor (-308A) polymorphism in pre-eclampsia: meta-analysis of 16 case-control studies. Aust. N. Z. J. Obstet. Gynaecol. 48: 547-551 (2008).
Bombieri C, Giorgi S, Carles S, de Cid R, Belpinati F, Tandoi C, Pallares-Ruiz N, Lazaro C, Ciminelli BM, Romey MC, Casals T, Pompei F, Gandini G, Claustres M, Estivill X, Pignatti PF, Modiano G. A new approach for identifying non-pathogenic mutations. An analysis of the cystic fibrosis transmembrane regulator gene in normal individuals. Hum. Genet. 106: 172-178 (2000). *
Bonafe M, Olivieri F. Genetic polymorphism in long-lived people: cues for the presence of an insulin/IGF-pathway-dependent network affecting human longevity. Mol. Cell. Endocrinol. 299: 118-123 (2009).
Bonanno CT, Cigna D, Danna C, D'Anna RP, Di Sano C, Matranga D, Raffa M, Impeduglia A, Salerno A. HLA class I and class II polymorphism in three Sicilian populations. Hum. Biol. 79: 339-354 (2007).
Bondy B. Common genetic factors for depression and cardiovascular disease. Dialogues Clin. Neurosci. 9: 19-28 (2007).
Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, de Jonge S, Kruger M, Engel RR, Farber L, Pongratz DE, Ackenheil M. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol. Dis. 6: 433-439 (1999).
Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536 (2003). *
Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun. 5: 142-146 (2004). *
Bongardt F, Schopfer-Wendels A, Huth C, Heid I, Rathmann W, Martin S, Vollmert C, Holle R, Thorand B, Wichmann HE, Koenig W, Kolb H, Herder C. Genetics of type 2 diabetes: impact of interleukin-6 gene variants. Gesundheitswesen 67 Suppl. 1: 122-126 (2005).
Bonhomme-Faivre L, Devocelle A, Saliba F, Chatled S, Maccario J, Farinotti R, Picard V. MDR-1 C3435T polymorphism influences cyclosporine A dose requirement in liver-transplant recipients. Transplantation 78: 21-25 (2004).
Bonhomme-Faivre L, Picard V, Saliba F, Abbara C, Fodil M, Chaunoy M, Farinotti R. Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. Am. J. Health Syst. Pharm. 66: 1645-1651 (2009).
Bonifati DM, Willcox N, Vincent A, Beeson D. Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis. Muscle Nerve 29: 436-439 (2004). *
Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J. Mol. Med. 83: 308-315 (2005). *
Boniotto M, Braida L, Ventura A, Percopo S, Amoroso A, Crovella S. Promoter polymorphisms of the CD14 gene in Italian patients with coeliac disease. J. Med. Genet. 40: e108 (2003). *
Bonne-Tamir B, Bodmer JG, Bodmer WF, Pickbourne P, Brautbar C, Gazit E, Nevo S, Zamir R. HLA polymorphism in Israel. 9. An overall comparative analysis. Tissue Antigens 11: 235-250 (1978).
Bonnefoy A, Moura R, Hoylaerts MF. Thrombospondins: from structure to therapeutics: the evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell. Mol. Life Sci. 65: 713-727 (2008). *
Bonnen PE, Wang PJ, Kimmel M, Chakraborty R, Nelson DL. Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res. 12: 1846-1853 (2002). *
Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M; on behalf of the EGIR-RISC Study group. Influence of the ACE gene I/D polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care 31: 789-794 (2008). *
Bonnycastle LL, Willer CJ, Conneely KN, Jackson AU, Burrill CP, Watanabe RM, Chines PS, Narisu N, Scott LJ, Enloe ST, Swift AJ, Duren WL, Stringham HM, Erdos MR, Riebow NL, Buchanan TA, Valle TT, Tuomilehto J, Bergman RN, Mohlke KL, Boehnke M, Collins FS. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes 55: 2534-2540 (2006). *
Bono JL. Genotyping Escherichia coli O157:H7 for its ability to cause disease in humans. Curr. Protoc. Microbiol. Chapter 5: Unit 5A.3 (2009).
Bontrop RE. Comparative genetics of MHC polymorphisms in different primate species: duplications and deletions. Hum. Immunol. 67: 388-397 (2006).
Bontrop RE, Watkins DI. MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol. 26: 227-233 (2005). *
Bonyadi M, Esmaeili M, Jalali H, Somi MH, Ghaffari A, Rafeey M, Sakha K, Lotfalizadeh N, Pourhassan A, Khoshbaten M, Ardalan MR, Laghaeian N. MEFV mutations in Iranian Azeri Turkish patients with familial Mediterranean fever. Clin. Genet. 76: 477-480 (2009). *
Bonyadi M, Jahanafrooz Z, Esmaeili M, Kolahi S, Khabazi A, Ebrahimi AA, Hajialilo M, Dastgiri S. TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's disease. Rheumatol. Int. Sep 23 [Epub ahead of print] (2009). *
Bonzheim I, Geissinger E, Chuang WY, Roth S, Strobel P, Marx A, Reimer P, Wilhelm M, Puppe B, Rosenwald A, Muller-Hermelink HK, Rudiger T. Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. J. Hematop. 1: 11-21 (2008). *
Boo NY, Wong FL, Wang MK, Othman A. Homozygous variant of UGT1A1 gene mutation and severe neonatal hyperbilirubinemia. Pediatr. Int. 51: 488-493 (2009).
Boodhoo A, Wong AM, Williamson D, Voon D, Lee S, Allcock RJ, Price P. A promoter polymorphism in the central MHC gene, IKBL, influences the binding of transcription factors USF1 and E47 on disease-associated haplotypes. Gene Expr. 12: 1-11 (2004).
Boomgaarden I, Bosy-Westphal A, Muller MJ, Doring F. Influence of a type 2 diabetes associated prostaglandin E synthase 2 polymorphism on blood prostaglandin E2 levels. Prostaglandins Leukot. Essent. Fatty Acids 80: 185-188 (2009). *
Boon M, Nolte IM, De Keyser J, Buys CH, te Meerman GJ. Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive. Hum. Genet. 115: 280-284 (2004). *
Boonsrirat U, Angsuthum S, Vannaprasaht S, Kongpunvijit J, Hirankarn N, Tassaneeyakul W, Avihingsanon Y. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Lupus 17: 132-134 (2008). *
Boonstra AM, Kooij JJ, Buitelaar JK, Oosterlaan J, Sergeant JA, Heister JG, Franke B. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 397-402 (2007).
Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, Armati PJ, Pollard JD, Heard RN, Stewart GJ; The Southern MS Genetics Consortium. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J. Mol. Med. 83: 822-830 (2005). *
Bora G, Ozkan B, Dayangac-Erden D, Erdem-Yurter H, Coskun T. Vitamin D receptor gene polymorphisms in Turkish children with vitamin D deficient rickets. Turk. J. Pediatr. 50: 30-33 (2008).
Bora NS, Jha P, Bora PS. The role of complement in ocular pathology. Semin. Immunopathol. 30: 85-95 (2008). *
Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M, Hozo I, Puljiz Z, Terzic J. Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin. Genet. 70: 156-160 (2006). *
Boraska V, Skrabic V, Culic VC, Becic K, Kapitanovic S, Zemunik T. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol. Res. 41: 157-163 (2008). *
Boraska V, Skrabic V, Zeggini E, Groves CJ, Buljubalic M, Peruzovic M, Zemunik T. Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in the population of South Croatia. J. Hum. Genet. 53: 210-214 (2008). *
Boraska V, Terzic J, Skrabic V, Cacev T, Bucevic-Popovic V, Peruzovic M, Markotic A, Zemunik T. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia. Croat. Med. J. 47: 571-578 (2006). *
Boraska V, Zeggini E, Groves CJ, Rayner NW, Skrabic V, Diakite M, Rockett KA, Kwiatkowski D, McCarthy MI, Zemunik T. Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia. Hum. Immunol. 70: 195-199 (2009).
Borges MA, de Figueiredo LC, de Brito RB Jr, Faveri M, Feres M. Microbiological composition associated with vitamin D receptor gene polymorphism in chronic periodontitis. Braz. Oral Res. 23: 203-208 (2009). *
Borggreve SE, de Vries R, Dallinga-Thie GM, Wolffenbuttel BH, Groen AK, van Tol A, Dullaart RP. The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin:cholesterol acyltransferase activity. Biochim. Biophys. Acta 1781: 10-15 (2008). *
Borghaei RC, Gorski G, Javadi M, Chambers M. NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter. Biochem. Biophys. Res. Commun. 382: 269-273 (2009). *
Borghi A, Fogli E, Stignani M, Melchiorri L, Altieri E, Baricordi O, Rizzo R, Virgili A. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch. Dermatol. Res. 300: 551-559 (2008). *
Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, Capon F, Nistico S, Chimenti S, Pallone F, Novelli G. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur. J. Dermatol. 12: 540-542 (2002). *
Borglum AD, Flint T, Madsen P, Celis JE, Kruse TA. Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21. Hum. Genet. 96: 592-596 (1995).
Borgmann S, Endisch G, Urban S, Sitter T, Fricke H. A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis. Clin. Immunol. 98: 244-248 (2001). *
Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin. Exp. Rheumatol. 22 (6 Suppl. 36): S79-S86 (2004).
Borhani Haghighi A, Ghahramani S, Azarpira N, Pourjafar M, Nikseresht AR. Cytotoxic T lymphocyte associated antigen-4 exon 1 A/G polymorphism in Iranian patients with multiple sclerosis. Eur. J. Neurol. 15: 862-864 (2008).
Borm ME, Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int. J. Immunogenet. 32: 401-405 (2005). *
Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, Tarnow J, Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101: 16695-16700 (2004). *
Borowski LC, Lopes RP, Gonzalez TP, Dummer LA, Chies JA, Silveira IG, Keisermann M, Bauer ME. Is steroid resistance related to multidrug resistance-I (MDR-I) in rheumatoid arthritis? Int. Immunopharmacol. 7: 836-844 (2007).
Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin. Immunol. May 23 [Epub ahead of print] (2009). *
Bos JD. Psoriasis, innate immunity, and gene pools. J. Am. Acad. Dermatol. 56: 468-471 (2007).
Bosch A, Minan A, Vescina C, Degrossi J, Gatti B, Montanaro P, Messina M, Franco M, Vay C, Schmitt J, Naumann D, Yantorno O. Fourier transform infrared spectroscopy for rapid identification of nonfermenting Gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 46: 2535-2546 (2008). *
Bosch TM, Deenen M, Pruntel R, Smits PH, Schellens JH, Beijnen JH, Meijerman I. Screening for polymorphisms in the PXR gene in a Dutch population. Eur. J. Clin. Pharmacol. 62: 395-399 (2006). *
Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. Clin. Cancer Res. 12: 5786-5793 (2006). *
Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am. J. Med. Genet. A. 121A: 219-224 (2003).
Bosco P, Gueant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, Caraci F, Ferri R, Gueant JL. Association of homocysteine (but not of MTHFR 677 C>T, MTR 2756 A>G, MTRR 66 A>G and TCN2 776 C>G) with ischaemic cerebrovascular disease in Sicily. Thromb. Haemost. 96: 154-159 (2006).
Bosse Y, Lemire M, Poon AH, Daley D, He JQ, Sandford A, White JH, James AL, Musk AW, Palmer LJ, Raby BA, Weiss ST, Kozyrskyj AL, Becker A, Hudson TJ, Laprise C. Asthma and genes encoding components of the vitamin D pathway. Respir. Res. 10: 98 (2009). *
Bosse Y, Weisnagel SJ, Bouchard C, Despres JP, Perusse L, Vohl MC. Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Quebec Family Study. J. Hum. Genet. 48: 614-621 (2003). *
Bossu P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, Caltagirone C, Spalletta G. Interleukin-18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 78: 807-811 (2007). *
Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer K, Proesmans M, Raes M, De Boeck K. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin. Chem. 53: 124-130 (2007). *
Bostik P, Kobkitjaroen J, Tang W, Villinger F, Pereira LE, Little DM, Stephenson ST, Bouzyk M, Ansari AA. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in Simian immunodeficiency virus-infected Rhesus macaques with high viral loads. J. Immunol. 182: 3638-3649 (2009).
Botella C, Marin L, Moya-Quiles R, Miras M, Sanchez-Bueno F, Minguela A, Bermejo J, Parrilla P, Alvarez-Lopez R, Muro M. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome. Transpl. Int. 19: 98-104 (2006). *
Bott C, Lembcke B, Stein J. Colorectal cancer and folate. Z. Gastroenterol. 41: 263-270 (2003).
Bottcher S, Ritgen M, Bruggemann M, Raff T, Luschen S, Humpe A, Kneba M, Pott C. Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism. J. Immunol. Methods 306: 128-136 (2005). *
Bottema RW, Postma DS, Reijmerink NE, Thijs C, Stelma FF, Smit HA, van Schayck CP, Brunekreef B, Koppelman GH, Kerkhof M. Interaction of T-cell and antigen presenting-cell co-stimulatory genes in childhood IgE. Eur. Respir. J. Jul 2 [Epub ahead of print] (2009).
Bottiger AK, Hurtig-Wennlof A, Sjostrom M, Yngve A, Nilsson TK. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents. Int. J. Mol. Med. 19: 659-665 (2007). *
Bottini E, Bergamaschi A, Magrini A, Spina C, Ammendola L, Grassi S, Bottini N, Gloria-Bottini F. Allergy and ACP1 genetic polymorphism. Allergy Asthma Proc. 28: 87-92 (2007).
Bottini N, Gloria-Bottini F, Amante A, Saccucci P, Bottini E. Genetic polymorphism and Th1/Th2 orientation. Int. Arch. Allergy Immunol. 138: 328-333 (2005).
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338 (2004). *
Bottini N, Stefanini L, Lucarelli P, Bottini E. Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms. Am. J. Phys. Anthropol. 128: 194-198 (2005). *
Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18: 207-213 (2006). *
Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur. J. Hum. Genet. 11: 671-678 (2003). *
Bouali H, Nietert P, Nowling TM, Pandey J, Dooley MA, Cooper G, Harley J, Kamen DL, Oates J, Gilkeson G. Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J. Rheumatol. 34: 2028-2034 (2007).
Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 haplotype) polymorphisms. Exp. Mol. Pathol. 83: 480-483 (2007).
Bouchard L, Tremblay A, Bouchard C, Perusse L. Contribution of several candidate gene polymorphisms in the determination of adiposity changes: results from the Quebec Family Study. Int. J. Obes. (Lond.) 31: 891-899 (2007).
Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J. Autoimmun. 23: 75-80 (2004).
Bougacha-Elleuch N, Tamouza R, Bellassouad M, Jouida J, Abid M, Maalej A, Makni H, Ayadi H. Analysis of heat shock protein polymorphisms in a large family with autoimmune thyroid diseases. Arch. Inst. Pasteur Tunis. 77: 23-24 (2000).
Boukouaci W, Busson M, Peffault de Latour R, Rocha V, Suberbielle C, Bengoufa D, Dulphy N, Haas P, Scieux C, Amroun H, Gluckman E, Krishnamoorthy R, Toubert A, Charron D, Socie G, Tamouza R. MICA-129 genotype, soluble MICA and anti-MICA antibodies as biomarkers of chronic graft versus host disease. Blood 114: 5216-5224 (2009). *
Boukouvala S, Fakis G. Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab. Rev. 37: 511-564 (2005).
Boulling A, Le Gac G, Dujardin G, Chen JM, Ferec C. The c.1275A>G putative chronic pancreatitis-associated synonymous polymorphism in the glycoprotein 2 (GP2) gene decreases exon 9 inclusion. Mol. Genet. Metab. Oct 23 [Epub ahead of print] (2009). *
Boulouiz R, Li Y, Abidi O, Bolz H, Chafik A, Kubisch C, Roub H, Wollnik B, Barakat A. Analysis of MYO7A in a Moroccan family with Usher syndrome type 1B: novel loss-of-function mutation and non-pathogenicity of p.Y1719C. Mol. Vis. 13: 1862-1865 (2007). *
Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, Kostense PJ, Meuwissen SG, Pena AS. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin. Exp. Immunol. 115: 294-300 (1999). *
Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43: 456-463 (1996).
Bouma G, Pena AS. Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases. Ned. Tijdschr. Geneeskd. 143: 2414-2420 (1999).
Bouma G, Poen AC, Garcia-Gonzalez MA, Schreuder GM, Felt-Bersma RJ, Meuwissen SG, Pena AS. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 47: 451-455 (1998).
Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103: 391-396 (1996). *
Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, Comas D. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun. 4: 132-137 (2003). *
Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298 (2002). *
Bourgey M, Leutenegger AL, Cousin E, Bourgain C, Babron MC, Clerget-Darpoux F. Modeling the effect of a genetic factor for a complex trait in a simulated population. BMC Genet. 6 Suppl. 1: S87 (2005). *
Bournet B, Souque A, Senesse P, Assenat E, Barthet M, Lesavre N, Aubert A, O'Toole D, Hammel P, Levy P, Ruszniewski P, Bouisson M, Escourrou J, Cordelier P, Buscail L. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy 41: 552-557 (2009).
Bournissen FG, Moretti ME, Juurlink DN, Koren G, Walker M, Finkelstein Y. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Epilepsia 50: 898-903 (2009).
Bouwhuis MG, Gast A, Figl A, Eggermont AM, Hemminki K, Schadendorf D, Kumar R. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis? Cancer Immunol. Immunother. Aug 12 [Epub ahead of print] (2009). *
Bouwman LH, Eerligh P, Terpstra OT, Daha MR, de Knijff P, Ballieux BE, Bruining GJ, van der Slik AR, Roos A, Roep BO. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes 54: 3002-3006 (2005). *
Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, van der Slik AR, Doxiadis II, Roep BO, Schaapherder AF. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 129: 408-414 (2005). *
Bouzigon E, Corda E, Aschard H, Dizier MH, Boland A, Bousquet J, Chateigner N, Gormand F, Just J, Le Moual N, Scheinmann P, Siroux V, Vervloet D, Zelenika D, Pin I, Kauffmann F, Lathrop M, Demenais F. Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med. 359: 1985-1994 (2008). *
Bowes JD, Potter C, Gibbons LJ, Hyrich K, Plant D, Morgan AW, Wilson AG, Isaacs JD, Worthington J, Barton A; BRAGGSS. Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients. Pharmacogenet. Genomics 19: 319-323 (2009).
Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M; the IBSEN study group; Schrumpf E, Lie BA, Boberg KM. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J. Hepatol. 45: 704-710 (2006). *
Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, Klersy C, Clementi R, De Juli E, Ferster A, Wallace D, Arico M, Danesino C, Tchilian E. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr. Res. 55: 478-484 (2004). *
Boxall S, Stanton T, Hirai K, Ward V, Yasui T, Tahara H, Tamori A, Nishiguchi S, Shiomi S, Ishiko O, Inaba M, Nishizawa Y, Dawes R, Bodmer W, Beverley PC, Tchilian EZ. Disease associations and altered immune function in CD45 138G variant carriers. Hum. Mol. Genet. 13: 2377-2384 (2004). *
Boyle B, Koranyi K, Patocs A, Liko I, Szappanos A, Bertalan R, Racz K, Balazs C. Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy. Br. J. Ophthalmol. 92: 131-134 (2008).
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ. Health Perspect. 114: 1547-1552 (2006). *
Boyles AL, Wilcox AJ, Taylor JA, Shi M, Weinberg CR, Meyer K, Fredriksen A, Ueland PM, Johansen AM, Drevon CA, Jugessur A, Trung TN, Gjessing HK, Vollset SE, Murray JC, Christensen K, Lie RT. Oral facial clefts and gene polymorphisms in metabolism of folate/one-carbon and vitamin A: a pathway-wide association study. Genet. Epidemiol. 33: 247-255 (2009).
Boyton RJ, Reynolds C, Wahid FN, Jones MG, Ozerovitch L, Ahmad T, Chaudhry A, Jewell DP, Kon OM, Smith J, Rose M, Newman-Taylor AJ, Cole P, Wilson R, Altmann DM. IFNgamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 68: 325-330 (2006). *
Bozina N, Bradamante V, Lovric M. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh. Hig. Rada. Toksikol. 60: 217-242 (2009).
Bozkurt O, de Boer A, Grobbee DE, Kroon AA, Schiffers P, de Leeuw P, Klungel OH. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes. J. Renin Angiotensin Aldosterone Syst. 10: 101-108 (2009).
Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J. Hum. Hypertens. 22: 774-780 (2008).
Bozzi A, Pereira PP, Reis BS, Goulart MI, Pereira MC, Pedroso EP, Leite MF, Goes AM. Interleukin-10 and tumor necrosis factor-alpha single nucleotide gene polymorphism frequency in paracoccidioidomycosis. Hum. Immunol. 67: 931-939 (2006).
Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, Spek A, van Kampen A, van Deventer S, Peppelenbosch M, Hommes D. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J. Mol. Med. 83: 601-609 (2005). *
Brabcova I, Petrasek J, Hribova P, Hyklova K, Bartosova K, Lacha J, Viklicky O. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation 84: 1037-1044 (2007).
Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234 (1997). *
Braeckman L, De Bacquer D, Delanghe J, Claeys L, De Backer G. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 143: 383-388 (1999).
Brajao de Oliveira K, Vissoci Reiche EM, Kaminami Morimoto H, Pelegrinelli Fungaro MH, Estevao D, Pontello R, Franco Nasser T, Watanabe MA. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis. J. Cutan. Pathol. 34: 27-32 (2007). *
Brambila-Tapia AJ, Davalos-Rodriguez IP. Fcgamma receptors polymorphisms and systemic lupus erythematosus. Rev. Invest. Clin. 61: 66-72 (2009).
Brand O, Gough S, Heward J. HLA , CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev. Mol. Med. 7: 1-15 (2005).
Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. (Oxf.) 66: 508-512 (2007). *
Brand S, Crispin A. C-reactive protein polymorphism and Crohn's disease: authors' reply. Aliment. Pharmacol. Ther. 25: 520-521 (2007).
Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Goke B, Ochsenkuhn T, Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype. Am. J. Gastroenterol. 101: 99-106 (2006). *
Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Goke B, Lohse P, Ochsenkuhn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm. Bowel Dis. 11: 645-652 (2005). *
Brandao LA, Guimaraes RL, Araujo J, Arraes LC, Segat L, Crovella S. Association between MBL2 polymorphism and T1D: does ethnicity play a role in the susceptibility of this multifactorial disease? Hum. Immunol. 69: 577-579 (2008).
Brant SR. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology 136: 396-399 (2009). *
Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet.73: 1282-1292 (2003). *
Braun C, Zahn R, Martin K, Albert E, Folwaczny C. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin. Immunol. 101: 357-360 (2001). *
Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51: 563-566 (1998).
Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica. J. Rheumatol. 36: 2269-2276 (2009).
Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Gurman A. Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatol. Int. Dec 23 [Epub ahead of print] (2009). *
Braverman I, Ben David J, Shupak A. MTHFR polymorphism: associated intralabyrinthine hemorrhage. Otolaryngol. Head Neck Surg. 141: 541-542 (2009).
Bravo MJ, Colmenero JD, Martin J, Alonso A, Caballero A. Polymorphism of the transmembrane region of the MICA gene and human brucellosis. Tissue Antigens 69: 358-360 (2007). *
Bravo MJ, Colmenero JD, Queipo-Ortuno MI, Alonso A, Caballero A. TGF-beta1 and IL-6 gene polymorphism in Spanish brucellosis patients. Cytokine 44: 18-21 (2008).
Bravo-Villalta HV, Yamamoto K, Nakamura K, Baya A, Horiuchi R. A novel intronic mutation that may affect genotyping result of CYP2C8 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) is strongly associated with CYP2C8*3 in a South American population. J. Hum. Genet. 52: 195-199 (2007). *
Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Wilson AF, Becker LC, Becker DM. Heritability of platelet function in families with premature coronary artery disease. J. Thromb. Haemost. 5: 1617-1623 (2007). *
Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin. Immunol. 121: 350-357 (2006). *
Bream JH, Ping A, Zhang X, Winkler C, Young HA. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun. 3: 165-169 (2002). *
Breen DP, Marinaki AM, Arenas M, Hayes PC. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl. 11: 826-833 (2005). *
Bregenzer N, Schaffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Scholmerich J, Andus T. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease. Exp. Clin. Endocrinol. Diabetes 114: 1-5 (2006).
Brenmoehl J, Holler E, Rogler G. Polymorphisms within epithelial receptors: NOD2/CARD15. Methods Mol. Med. 134: 115-122 (2007).
Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 348: 106-109 (1996). *
Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD. Single nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 28: 2543-2547 (2007). *
Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, Gulko PS. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 52: 322-332 (2005). *
Brenol CV, Chies JA, Brenol JC, Monticielo OA, Franciscatto P, Birriel F, Neves AG, Xavier RM. Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations. Clin. Rheumatol. 28: 201-205 (2009).
Brenzovich J, Macey M, Fernando J, Chong HJ, Barnstein B, Mirmonsef P, Morales JK, Kimura A, Cruz TD, Ryan JJ. IgE signaling suppresses FcvarepsilonRIbeta expression. J. Leukoc. Biol. 86: 1351-1358 (2009). *
Breulmann B, Bantis C, Siekierka M, Blume C, Aker S, Kuhr N, Grabensee B, Ivens K. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin. Transplant. 21: 615-621 (2007). *
Breunis WB, Tarazona-Santos E, Chen R, Kiley M, Rosenberg SA, Chanock SJ. Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade. J. Immunother. 31: 586-590 (2008).
Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M, Roos D, de Haas M, Koene HR, Kuijpers TW. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 111: 1029-1038 (2008). *
Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, de Haas M, de Boer M, Roos D, Kuijpers TW. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum. Mutat. 30: E640-E650 (2009). *
Brezzi B, Del Prete D, Lupo A, Magistroni R, Gomez-Lira M, Bernich P, Anglani F, Mezzabotta F, Turco A, Furci L, Ceol M, Antonucci F, Abaterusso C, Bonfante L, D'Angelo A, Albertazzi A, Gambaro G. Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients. J. Nephrol. 22: 747-759 (2009).
Brickner AG. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms. Immunol. Res. 36: 33-42 (2006). *
Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J. Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum. 46: 2045-2050 (2002). *
Briggs D, Stephens C, Vaughan R, Welsh K, Black C. A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis. Arthritis Rheum. 36: 943-954 (1993).
Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 29: 141-145 (1987).
Brinkmann U, Eichelbaum M. Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenomics J. 1: 59-64 (2001). *
Brintnell W, Zeggini E, Barton A, Thomson W, Eyre S, Hinks A, Silman AJ, Worthington J. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p. Arthritis Rheum. 50: 3823-3830 (2004). *
Brinza D, Zelikovsky A. Design and validation of methods searching for risk factors in genotype case-control studies. J. Comput. Biol. 15: 81-90 (2008).
Brockton NT. Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control 17: 1005-1016 (2006). *
Brodowska A, Starczewski A, Brodowski J, Szydlowska I, Nawrocka-Rutkowska J. The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes. Gynecol. Endocrinol. 25: 315-323 (2009).
Broen J, Gourh P, Rueda B, Coenen M, Mayes M, Martin J, Arnett FC, Radstake TR; European Consortium on Systemic Sclerosis Genetics. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes. Arthritis Rheum. 60: 3815-3820 (2009). *
Bronson PG, Criswell LA, Barcellos LF. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6,861 patients and 9,270 controls reveals no evidence for association. Ann. Rheum. Dis. 67: 933-936 (2008).
Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60: 1053-1061 (2006). *
Brooksbank R, Badenhorst D, Sliwa K, Norton G, Woodiwiss A. The G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy. Cardiovasc. J. Afr. 19: 254-258 (2008).
Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM, O'Morain C, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun. 7: 19-26 (2006). *
Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F; Diabetes Genetics Consortium. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes. Metab. 11 Suppl. 1: 60-66 (2009). *
Brosbol-Ravnborg A, Hvas CL, Agnholt J, Dahlerup JF, Vind I, Till A, Rosenstiel P, Hollsberg P. Clinical immunology review series: Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clin. Exp. Immunol. 155: 487-495 (2009). *
Brosnan JT, da Silva R, Brosnan ME. Amino acids and the regulation of methyl balance in humans. Curr. Opin. Clin. Nutr. Metab. Care 10: 52-57 (2006).
Brouns R, Ursem N, Lindemans J, Hop W, Pluijm S, Steegers E, Steegers-Theunissen R. Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defects. Prenat. Diagn. 28: 485-493 (2008).
Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, Rietzschel E, Bernard D, Blaton V. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176: 189-195 (2004).
Broux B, Hellings N, Venken K, Rummens JL, Hensen K, Van Wijmeersch B, Stinissen P. Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants. Genes Immun. Jan 14 [Epub ahead of print] (2010).
Brown EE, Zhang M, Zarin-Pass R, Bernig T, Tseng FC, Xiao N, Yeager M, Edlin BR, Chanock SJ, O'Brien TR. MBL2 and hepatitis C virus infection among injection drug users. BMC Infect. Dis. 8: 57 (2008). *
Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279: 34674-34681 (2004). *
Brown KS, Nackos E, Morthala S, Jensen LE, Whitehead AS, VON Feldt JM. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. J. Rheumatol. 34: 740-746 (2007).
Brown MA. Genetics and the pathogenesis of ankylosing spondylitis. Curr. Opin. Rheumatol. 21: 318-323 (2009).
Brown RA, Gralewski JH, Razonable RR. The R753Q polymorphism abrogates Toll-like receptor 2 signaling in response to human cytomegalovirus. Clin. Infect. Dis. 49: e96-e99 (2009). *
Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr. Opin. Pediatr. 21: 523-528 (2009).
Brown SJ, Abreu MT. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease. Curr. Opin. Drug Discov. Devel. 8: 160-168 (2005).
Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, Li L, Venkatesh RB, Hunt S, Mychaleckyj JC, Deloukas P; Diabetes Genetics Consortium. Overview of the MHC fine mapping data. Diabetes Obes. Metab. 11 Suppl. 1: 2-7 (2009). *
Brown WM, Pierce JJ, Hilner JE, Perdue LH, Lohman K, Lu L, de Bakker PI, Irenze K, Ziaugra L, Mirel DB. Overview of the Rapid Response data. Genes Immun. 10: S5-S15 (2009).
Browning BL, Huebner C, Petermann I, Demmers P, McCulloch A, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. Inflamm. Bowel Dis. 13: 1069-1076 (2007). *
Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Has Toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am. J. Gastroenterol. 102: 2504-2512 (2007). *
Browning SR, Briley JD, Briley LP, Chandra G, Charnecki JH, Ehm MG, Johansson KA, Jones BJ, Karter AJ, Yarnall DP, Wagner MJ. Case-control single-marker and haplotypic association analysis of pedigree data. Genet. Epidemiol. 28: 110-122 (2005). *
Brozek W, Bises G, Fabjani G, Cross HS, Peterlik M. Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells. BMC Cancer 8: 13 (2008). *
Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta F, Betterle C, De Bellis A, Arnaldi G, Toscano V, Arvat E, Bellastella A, Mantero F, Falorni A. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. Eur. J. Endocrinol. Nov 2 [Epub ahead of print] (2009).
Bruck P, Bartsch W, Penna-Martinez M, Kahles H, Seidl C, Bohme A, Badenhoop K, Ramos-Lopez E. Polymorphisms of CXCR3-binding chemokines in type 1 diabetes. Hum. Immunol. 70: 552-555 (2009).
Bruck P, Ramos-Lopez E, Bartsch W, Bohme A, Badenhoop K. TIM-3 polymorphisms in type 1 diabetes families. J. Hum. Genet. 53: 559-564 (2008). *
Brugere JF, Gobron S, Baud E, Cailloux F. Single-tube genotyping using a solid-phase method that combines alpha-phosphorothioate-mediated primer extension and ExoIII: proof of concept with the F508del cystic fibrosis diagnosis. Mol. Cell. Probes 22: 320-323 (2008).
Brumm H, Pfeufer A, Biebermann H, Schnabel D, Deiss D, Gruters A. Congenital central hypothyroidism due to homozygous thyrotropin beta 313 Delta T mutation is caused by a Founder effect. J. Clin. Endocrinol. Metab. 87: 4811-4816 (2002). *
Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4: e6687 (2009). *
Brun P, Castagliuolo I, Floreani AR, Buda A, Blasone L, Palu G, Martines D. Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut 55: 1212 (2006). *
Brun T, Gauthier BR. A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease. J. Mol. Endocrinol. 40: 37-45 (2008). *
Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH Jr. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am. J. Psychiatry 163: 2148-2156 (2006). *
Brune S, Kolsch H, Ptok U, Majores M, Schulz A, Schlosser R, Rao ML, Maier W, Heun R. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease. J. Neural. Transm. 110: 1041-1050 (2003). *
Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet. 1: e83 (2005). *
Bruno F, Damin F, Vincenza C, Galbiati S, Di Carlo G, Seia M, Porcaro L, Ferrari M, Chiari M, Cremonesi L. High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma. Clin. Chem. Lab. Med. 47: 818-823 (2009). *
Bruns T, Stallmach A. Drug monitoring in inflammatory bowel disease: helpful or dispensable? Dig. Dis. 27: 394-403 (2009).
Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Krippeit-Drews P, Aguilar-Bryan L. ABCC8 and ABCC9: ABC transporters that regulate K(+) channels. Pflugers Arch. 453: 703-718 (2007). *
Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2: e664 (2007). *
Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res. Treat. 99: 257-265 (2006). *
Bubnova LN, Pavlova IE, Berkos MV, Solovyeva OI, Simanenkov VI. HLA II class polymorphism in patients with ulcerative colitis. Hum. Immunol. 64 (10 Suppl.): S149 (2003).
Bucheton B, Abel L, Kheir MM, Mirgani A, El-Safi SH, Chevillard C, Dessein A. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun. 4: 104-109 (2003). *
Bucheton B, Argiro L, Chevillard C, Marquet S, Kheir MM, Mergani A, El-Safi SH, Dessein AJ. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun. 8: 79-83 (2007). *
Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2: 222-228 (2001). *
Buchwald P, Juhasz A, Bell C, Patfalusi M, Kovacs P, Hochhaus G, Howes J, Bodor N. Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants. Pharmazie 61: 125-134 (2006).
Bucin D, Truedsson L, Hammarstrom L, Smith CI, Sjoholm AG. C4 polymorphism and major histocompatibility complex haplotypes in IgA deficiency: association with C4A null haplotypes. Exp. Clin. Immunogenet. 8: 233-241 (1991).
Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H. Analysis of the C/T(-1)) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens 68: 335-338 (2006). *
Buckova D, Holla LI, Znojil V, Vasku A. Polymorphisms of the CD14 gene and atopic phenotypes in Czech patients with IgE-mediated allergy. J. Hum. Genet. 51: 977-983 (2006). *
Bucova M, Bernadic M, Buckingham T. C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl. Lek. Listy. 109: 333-340 (2008).
Buda G, Maggini V, Galimberti S, Martino A, Giuliani N, Morabito F, Genestreti G, Iacopino P, Rizzoli V, Barale R, Rossi AM, Petrini M. MDR1 polymorphism influences the outcome of multiple myeloma patients. Br. J. Haematol. 137: 454-456 (2007). *
Buda G, Martino A, Maggini V, Orciuolo E, Galimberti S, Gentile M, Morabito F, Antognoni F, Brunori M, Barale R, Rossi AM, Petrini M. MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma. Acta Haematol. 122: 42-45 (2009).
Budak F, Goral G, Heper Y, Yilmaz E, Aymak F, Basturk B, Tore O, Ener B, Oral HB. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine 38: 32-36 (2007).
Bugawan TL, Angelini G, Larrick J, Auricchio S, Ferrara GB, Erlich HA. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 339: 470-473 (1989). *
Bugawan TL, Horn GT, Long CM, Mickelson E, Hansen JA, Ferrara GB, Angelini G, Erlich HA. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J. Immunol. 141: 4024-4030 (1988).
Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am. J. Hum. Genet. 72: 1505-1514 (2003). *
Bugeja MJ, Booth D, Bennetts B, Heard R, Rubio J, Stewart G. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med. Genet. 7: 64 (2006). *
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Burgner D, Stewart GJ. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. Eur. J. Hum. Genet. 13: 815-822 (2005). *
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Stewart GJ. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians. Mult. Scler. 12: 710-722 (2006). *
Buhler S, Di Cristofaro J, Frassati C, Basire A, Galicher V, Chiaroni J, Picard C. High levels of molecular polymorphism at the KIR2DL4 locus in French and Congolese populations: impact for anthropology and clinical studies. Hum. Immunol. 70: 953-959 (2009).
Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn�s disease: role of CARD15 3020insC mutation? Gut 55: 342-347 (2006). *
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7: 153 (2006). *
Buijtels PC, van de Sande WW, Parkinson S, Petit PL, van der Sande MA, van Soolingen D, Verbrugh HA, van Belkum A. Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int. J. Tuberc. Lung Dis. 12: 1485-1488 (2008).
Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J. Hepatobiliary Pancreat. Surg. 13: 517-524 (2006). *
Buis CI, van der Steege G, Visser DS, Nolte IM, Hepkema BG, Nijsten M, Slooff MJ, Porte RJ. Heme oxygenase-1 genotype of the donor is associated with graft survival after liver transplantation. Am. J. Transplant. 8: 377-385 (2008).
Bukulmez H, Fife M, Tsoras M, Thompson SD, Twine NA, Woo P, Olson JM, Elston RC, Glass DN, Colbert RA. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study. Arthritis Res. Ther. 7: R285-R290 (2005). *
Buning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H. DLG5 variants in inflammatory bowel disease. Am. J. Gastroenterol. 101: 786-792 (2006). *
Buning C, Genschel J, Weltrich R, Lochs H, Schmidt H. The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region: no association with inflammatory bowel disease. Eur. J. Immunogenet. 30: 329-333 (2003). *
Buning C, Molnar T, Nagy F, Lonovics J, Weltrich R, Bochow B, Genschel J, Schmidt H, Lochs H. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different? World J. Gastroenterol. 11: 407-411 (2005). *
Buning C, Schmidt HH, Molnar T, DE Jong DJ, Fiedler T, Buhner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Buttner J, Lochs H, Witt H. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment. Pharmacol. Ther. 26: 1025-1033 (2007). *
Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron. Physiol. 106: 69-75 (2007).
Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum. Immunol. 70: 121-124 (2009).
Buraczynska M, Jozwiak L, Ksiazek P, Borowicz E, Mierzicki P. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl. Res. 150: 101-105 (2007). *
Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol. Dial. Transplant. 22: 827-832 (2007).
Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients. Clin. Immunol. 132: 285-290 (2009). *
Buraczynska M, Mierzicki P, Buraczynska K, Dragan M, Ksiazek A. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol. Diagn. Ther. 11: 257-263 (2007). *
Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A. Heat-shock protein gene polymorphisms and the risk of nephropathy in type 2 diabetes patients. Clin. Sci. (Lond.) 116: 81-86 (2009). *
Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN. A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children. J. Clin. Endocrinol. Metab. 94: 2587-2593 (2009). *
Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, Johnson LJ, Butzkueven H, Booth D, Bahlo M, Tait BD, Taylor BV, Speed TP, Heard R, Stewart GJ, Foote SJ, Kilpatrick TJ, Rubio JP. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 71: 42-50 (2008). *
Burguete-Garcia AI, Cruz-Lopez M, Madrid-Marina V, Lopez-Ridaura R, Hernandez-Avila M, Cortina B, Gomez RE, Velasco-Mondragon E. Association of Gly972Arg polymorphism of IRS1 gene with type 2 diabetes mellitus in lean participants of a national health survey in Mexico: a candidate gene study. Metabolism 59: 38-45 (2010). *
Burim RV, Canalle R, Martinelli Ad A, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 19: 291-298 (2004). *
Burkart KM, Barton SJ, Holloway JW, Yang IA, Cakebread JA, Cruikshank W, Little F, Jin X, Farrer LA, Clough JB, Keith TP, Holgate S, Center DM, O'Connor GT. Association of asthma with a functional promoter polymorphism in the IL16 gene. J. Allergy Clin. Immunol. 117: 86-91 (2006). *
Burke DF, Worth CL, Priego EM, Cheng T, Smink LJ, Todd JA, Blundell TL. Genome bioinformatic analysis of nonsynonymous SNPs. BMC Bioinformatics 8: 301 (2007). *
Burkhardt J, Petit-Teixeira E, Teixeira VH, Kirsten H, Garnier S, Ruehle S, Oeser C, Wolfram G, Scholz M, Migliorini P, Balsa A, Westhovens R, Barrera P, Alves H, Pascual-Salcedo D, Bombardieri S, Dequeker J, Radstake TR, Van Riel P, van de Putte L, et al. Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. J. Rheumatol. 36: 2149-2157 (2009).
Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, Thiel E. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20: 1223-1229 (2004).
Burmer GC, Crispin DA, Kolli VR, Haggitt RC, Kulander BG, Rubin CE, Rabinovitch PS. Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun. 3: 167-172 (1991).
Burnik FS, Yalcin S. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy 55: 381-385 (2009).
Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J. Infect. Dis. 192: 344-349 (2005). *
Burr ML, Naseem H, Hinks A, Eyre S, Gibbons L, Bowes J, Consortium B, Consortium Y, Wilson AG, Maxwell J, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth BP, Harrison P, Thomson W, Worthington J, Barton A. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann. Rheum. Dis. May 25 [Epub ahead of print] (2009).
Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 66: 1373-1383 (2006).
Burzynski M, Duriagin S, Mostowska M, Wudarski M, Chwalinska-Sadowska H, Jagodzinski PP. MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Lupus 16: 450-454 (2007).
Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Todd Hubisz M, Glanowski S, Tanenbaum DM, White TJ, Sninsky JJ, Hernandez RD, Civello D, Adams MD, Cargill M, Clark AG. Natural selection on protein-coding genes in the human genome. Nature 437: 1153-1157 (2005). *
Bustamante M, Nogues X, Agueda L, Jurado S, Wesselius A, Caceres E, Carreras R, Ciria M, Mellibovsky L, Balcells S, Diez-Perez A, Grinberg D. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck BMD in Spanish postmenopausal women. Calcif. Tissue Int. 81: 327-332 (2007). *
Bustamante M, Nogues X, Mellibovsky L, Agueda L, Jurado S, Caceres E, Blanch J, Carreras R, Diez-Perez A, Grinberg D, Balcells S. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur. J. Endocrinol. 157: 677-684 (2007). *
Buster EH, van Vuuren HJ, Zondervan PE, Metselaar HJ, Tilanus HW, de Man RA. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine. Eur. J. Gastroenterol. Hepatol. 20: 68-72 (2008).
Butcher LM, Davis OS, Craig IW, Plomin R. Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays. Genes Brain Behav. 7: 435-446 (2008).
Butland SL, Devon RS, Huang Y, Mead CL, Meynert AM, Neal SJ, Lee SS, Wilkinson A, Yang GS, Yuen MM, Hayden MR, Holt RA, Leavitt BR, Ouellette BF. CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 8: 126 (2007). *
Butler P, McIntyre N, Mistry PK. Molecular diagnosis of Wilson disease. Mol. Genet. Metab. 72: 223-230 (2001). *
Butt C, Gladman D, Rahman P. PPAR-gamma gene polymorphisms and psoriatic arthritis. J. Rheumatol. 33: 1631-1633 (2006). *
Butt C, Lim S, Greenwood CM, Rahman P. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet. Disord. 8: 1 (2007). *
Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res. Ther. 8: R27-R30 (2006). *
Butt C, Rahman P, Siannis F, Farewell VT, Gladman DD. Corneodesmosin polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 44: 684-685 (2005). *
Butt C, Sun S, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of nuclear factor-kappaB in psoriatic arthritis. J. Rheumatol. 32: 1742-1744 (2005).
Buttmann M, Nowak E, Kroner A, Hemmer B, Lesch KP, Rieckmann P. Analysis of the stathmin rs182455 single nucleotide promoter polymorphism in patients with multiple sclerosis. J. Neurogenet. 22: 181-186 (2008).
Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock NJ, Carroll L, Corfas G, Davis KL, Owen MJ, Harroch S, Sakurai T, O'Donovan MC. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol. Psychiatry 13: 162-172 (2008).
Buyukasik Y, Akman U, Buyukasik NS, Goker H, Kilicarslan A, Shorbagi AI, Hascelik G, Haznedaroglu IC. Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome. Am. J. Med. Sci. 335: 115-119 (2008).
Buzkova H, Pechandova K, Slanar O, Perlik F. Genetic polymorphism of cytochrome P450 and methods for its determination. Prague Med. Rep. 107: 383-393 (2006).
Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, Arca M, Leonetti F, Mario UD. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. Eur. J. Hum. Genet. 12: 1050-1054 (2004). *
Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens 72: 49-53 (2008). *
Byers J, Sladen RN. Renal function and dysfunction. Curr. Opin. Anaesthesiol. 14: 699-706 (2001).
Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, Mieli-Vergani G, Thompson RJ. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49: 553-567 (2009).
Byth BC, Billingsley GD, Cox DW. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Am. J. Hum. Genet. 55: 126-133 (1994). *
Byun E, Caillier SJ, Montalban X, Villoslada P, Fernandez O, Brassat D, Comabella M, Wang J, Barcellos LF, Baranzini SE, Oksenberg JR. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch. Neurol. 65: 337-344 (2008).
Caamano JM, Pacheco A, Lanas F, Salazar LA. Single nucleotide polymorphisms in ABCG5 and ABCG8 genes in Chilean subjects with polygenic hypercholesterolemia and controls. Clin. Chem. Lab. Med. 46: 1581-1585 (2008). *
Caballeria J. Current concepts in alcohol metabolism. Ann. Hepatol. 2: 60-68 (2003). *
Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin. Exp. Immunol. 121: 480-483 (2000). *
Cabello GM, Cabello PH, Lopez-Camelo JS, Llerena JC Jr, Fernandes O. Haplotype distribution of and linkage disequilibrium between four polymorphic markers near the CFTR locus in Brazilian cystic fibrosis patients. Hum. Biol. 77: 853-865 (2005).
Cabello GM, Cabello PH, Otsuki K, Gombarovits ME, Llerena JC Jr, Fernandes O. Molecular analysis of 23 exons of the CFTR gene in Brazilian patients leads to the finding of rare cystic fibrosis mutations. Hum. Biol. 77: 125-135 (2005).
Caca K, Ferenci P, Kuhn HJ, Polli C, Willgerodt H, Kunath B, Hermann W, Mossner J, Berr F. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J. Hepatol. 35: 575-581 (2001). *
Cacev T, Radosevic S, Spaventi R, Pavelic K, Kapitanovic S. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 54: 1129-1135 (2005). *
Cadoni G, Boccia S, Scipione S, Arzani D, Cianfagna F, Ricciardi G, Paludetti G, Agostino S. Glutathione S-transferase gene polymorphisms in Italian patients with sudden sensorineural hearing loss. Otol. Neurotol. 27: 1166-1169 (2006).
Cadwell K, Patel KK, Komatsu M, Virgin HW 4th, Stappenbeck TS. A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease. Autophagy 5: 250-252 (2009).
Cadwell K, Stappenbeck TS, Virgin HW. Role of autophagy and autophagy genes in inflammatory bowel disease. Curr. Top. Microbiol. Immunol. 335: 141-167 (2009).
Caffrey C, Hitman GA, Niven MJ, Cassell PG, Kumar P, Fry L, Mackintosh P, Gallagher R, Feighery C, Weir D, et al. HLA-DP and coeliac disease: family and population studies. Gut 31: 663-667 (1990). *
Cagliani R, Fumagalli M, Riva S, Pozzoli U, Comi GP, Menozzi G, Bresolin N, Sironi M. The signature of long-standing balancing selection at the human defensin beta-1 promoter. Genome Biol. 9: R143 (2008). *
Cai LQ, Wang ZX, Lu WS, Han JW, Sun LD, Du WH, Zhang SM, Zuo XB, Zhang XJ, Yang S. A single-nucleotide polymorphism of the TNFAIP3 gene is associated with systemic lupus erythematosus in Chinese Han population. Mol. Biol. Rep. Sep 23 [Epub ahead of print] (2009). *
Cai M, Yan L, Cheng H, Ding H, Fu Z. Antigen transporter gene polymorphism and predisposition to Graves disease: a preliminary analysis. Zhonghua Nei Ke Za Zhi 41: 758-761 (2002).
Cai PC, Hu LH, Cui TP, Li YR, Chen FH, Wu QW. Association of TIM4 promoter polymorphism -1419G>A with childhood asthma in a Chinese Han population. Tissue Antigens 74: 11-16 (2009). *
Caillat-Zucman S. Molecular mechanisms of HLA association with autoimmune diseases. Tissue Antigens 73: 1-8 (2009). *
Caillat-Zucman S, Daniel S, Djilali-Saiah I, Timsit J, Garchon HJ, Boitard C, Bach JF. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum. Immunol. 44: 80-87 (1995).
Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR; Multiple Sclerosis Genetics Group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 4: 312-315 (2003). *
Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Vina M, Ramsay PP, Khan O, Royal W 3rd, Hauser SL, Barcellos LF, Oksenberg JR. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J. Immunol. 181: 5473-5480 (2008). *
Calafell F, Almasy L, Sabater-Lleal M, Buil A, Mordillo C, Ram�rez-Soriano A, Sikora M, Souto JC, Blangero J, Fontcuberta J, Soria JM. Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels. Hum. Mol. Genet. Nov 23 [Epub ahead of print] (2009).
Calderaro A, Villanacci V, Bommezzadri S, Gorrini C, Piccolo G, Aquilano MC, Incaprera M, Viviani G, Dettori G, Chezzi C. Colonic amoebiasis and spirochetosis: morphological, ultrastructural and microbiological evaluation. J. Gastroenterol. Hepatol. 22: 64-67 (2007). *
Calguneri OM, Ozturk MA, Kiraz S, Ertenli I, Onat AM, Ureten K, Ozbalkan Z, Haznedaroglu IC. Lack of association between familial Mediterranean fever and angiotensin converting enzyme gene polymorphism. Joint Bone Spine 73: 334-336 (2006). *
Caliz R, Atsumi T, Kondeatis E, Amengual O, Khamashta MA, Vaughan RW, Lanchbury JS, Hughes GR. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology (Oxford) 40: 31-36 (2001). *
Callaghan MJ, Rockett K, Banner C, Haralambous E, Betts H, Faust S, Maiden MC, Kroll JS, Levin M, Kwiatkowski DP, Pollard AJ. Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease. Genes Immun. 9: 30-37 (2008). *
Callejas JL, Sabio JM, Haro MD, Camps M, Ramon ED, Garcia-Hernandez FJ, Koeleman B, Martin J, Gonzalez-Escribano MF. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45: 1044-1046 (2006). *
Calverley DC, Baldermann LV, Moran K, Chen NN, McFann K. Platelet FcgammaRIIA expression is associated with the alpha(2) integrin C807T gene polymorphism in type 2 diabetes. Platelets 17: 78-83 (2006).
Calvo-Alen J, Alarcon GS, Tew MB, Tan FK, McGwin G Jr, Fessler BJ, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum. 54: 1940-1945 (2006). *
Camacho JA, Mardach R, Rioseco-Camacho N, Ruiz-Pesini E, Derbeneva O, Andrade D, Zaldivar F, Qu Y, Cederbaum SD. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Pediatr. Res. 60: 423-429 (2006). *
Camarena A, Juarez A, Mejia M, Estrada A, Carrillo G, Falfan R, Zuniga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am. J. Respir. Crit. Care Med. 163: 1528-1533 (2001). *
Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 5: 609-614 (2004). *
Cambien F, Tiret L. Atherosclerosis: from genetic polymorphisms to system genetics. Cardiovasc. Toxicol. 5: 143-152 (2005).
Cambon-Thomsen A, Roth MP. Genetics of autoimmune diseases. Rev. Prat. 44: 43-52 (1994).
Cambra A, Munoz-Saa I, Cresp� C, Serra A, Etxagibel A, Matamoros N, Mila J, Julia MR. MICA-HLA-B haplotype diversity and linkage disequilibrium in a population of Jewish descent from Majorca (Balearic Islands). Hum. Immunol. 70: 513-517 (2009).
Cameron EA, Martinez-Marignac VL, Chan A, Valladares A, Simmonds LV, Wacher N, Kumate J, McKeigue P, Shriver MD, Kittles R, Cruz M, Parra EJ. MGEA5-14 polymorphism and type 2 diabetes in Mexico City. Am. J. Hum. Biol. 19: 593-596 (2007).
Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, Wright AL, Halonen M, Klimecki WT, Vercelli D. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J. Immunol. 177: 8633-8642 (2006). *
Camilleri M, Carlson P, McKinzie S, Grudell A, Busciglio I, Burton D, Baxter K, Ryks M, Zinsmeister AR. Genetic variation in endocannabinoid metabolism, gastrointestinal motility and sensation. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G13-G19 (2008). *
Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zucchelli M, D'Amato M. Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology 138: 98-107.e4 (2010). *
Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio IA, Burton DD, Zaki EA, Boles RG. Mitochondrial DNA, gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G510-G516 (2009). *
Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin. Pharmacol. Ther. 83: 559-566 (2008).
Campa D, Vodicka P, Pardini B, Novotny J, Forsti A, Hemminki K, Barale R, Canzian F. Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk? Eur. J. Cancer 44: 854-857 (2008). *
Campagnoli MF, Garbarini L, Quarello P, Garelli E, Carando A, Baravalle V, Doria A, Biava A, Chiocchetti A, Rosolen A, Dufour C, Dianzani U, Ramenghi U. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients. Haematologica 91: 538-541 (2006). *
Campalani E, Arenas M, Marinaki AM, Lewis CM, Barker JN, Smith CH. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. J. Invest. Dermatol. 127: 1860-1867 (2007). *
Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Trancassini M, Tovagliari D, et al. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J. Clin. Microbiol. 43: 5136-5142 (2005). *
Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance. Sci. Prog. 88: 157-202 (2005).
Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM, Levitt P. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 123: 1018-1024 (2009). *
Campelo V, Dantas RO, Simoes RT, Mendes-Junior CT, Sousa SM, Simoes AL, Donadi EA. TNF microsatellite alleles in Brazilian Chagasic patients. Dig. Dis. Sci. 52: 3334-3339 (2007). *
Campo DS, Dimitrova Z, Mitchell RJ, Lara J, Khudyakov Y. Coordinated evolution of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 105: 9685-9690 (2008). *
Campo I, Morbini P, Zorzetto M, Tinelli C, Brunetta E, Villa C, Bombieri C, Cuccia M, Agostini C, Bozzi V, Facoetti A, Ferrarotti I, Mazzola P, Scabini R, Semenzato G, Pignatti PF, Pozzi E, Luisetti M. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am. J. Respir. Crit. Care Med. 175: 498-506 (2007). *
Campos Alberto EJ, Shimojo N, Suzuki Y, Mashimo Y, Arima T, Matsuura T, Inoue Y, Yamaide A, Tomiita M, Fujii K, Hata A, Kohno Y. IL-10 gene polymorphism, but not TGF-beta1 gene polymorphisms, is associated with food allergy in a Japanese population. Pediatr. Allergy Immunol. 19: 716-721 (2008).
Campos E, Shimojo N, Inoue Y, Arima T, Suzuki S, Tomiita M, Matsuura T, Hata A, Suzuki Y, Aoyagi M, Kohno Y. No association of polymorphisms in the 5' region of the CD14 gene and food allergy in a Japanese population. Allergol. Int. 56: 23-27 (2007).
Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol. Clin. Exp. Res. 29: 1206-1213 (2005). *
Canadas C, Sanchez-de-Abajo A, Fernandez JM, Martin M, Diaz-Rubio E, Caldes T, de la Hoya M. Molecular haplotyping of tandem single nucleotide polymorphisms by allele-specific PCR. Anal. Biochem. 364: 153-158 (2007). *
Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes 54: 3326-3330 (2005). *
Candore G, Aquino A, Balistreri CR, Bulati M, Di Carlo D, Grimaldi MP, Listi F, Orlando V, Vasto S, Caruso M, Colonna-Romano G, Lio D, Caruso C. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann. N. Y. Acad. Sci. 1067: 282-287 (2006). *
Candore G, Balistreri CR, Colonna-Romano G, Lio D, Caruso C. Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal. Exp. Gerontol. 39: 645-652 (2004). *
Canedo P, Corso G, Pereira F, Lunet N, Suriano G, Figueiredo C, Pedrazzani C, Moreira H, Barros H, Carneiro F, Seruca R, Roviello F, Machado JC. The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut 57: 1504-1508 (2008).
Canedo P, Duraes C, Pereira F, Regalo G, Lunet N, Barros H, Carneiro F, Seruca R, Rocha J, Machado JC. Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol. Biomarkers Prev. 17: 2416-2420 (2008). *
Canete JD, Suarez B, Hernandez MV, Sanmarti R, Rego I, Celis R, Moll C, Pinto JA, Blanco FJ, Lozano F. Influence of variants of Fcgamma receptors IIA and IIIA on the ACR and EULAR responses to anti-TNFalpha therapy in rheumatoid arthritis. Ann. Rheum. Dis. 68: 1547-1552 (2009).
Canhao H, Fonseca JE, Caetano-Lopes J, Saldanha C, Queiroz MV. Assessment of laboratory measurements and -308 TNFalpha gene promoter polymorphisms in normal bone mineral density. Clin. Rheumatol. 27: 301-307 (2008). *
Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Richiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV, Holc�tov� I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, et al. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res. 69: 2956-2965 (2009). *
Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, Baeten D. Functional haplotypes of PADI4: relevance for rheumatoid arthritis-specific synovial intracellular citrullinated proteins and anti-citrullinated protein antibodies. Ann. Rheum. Dis. 64: 1316-1320 (2005). *
Cantaert T, Stone MA, Terborg M, Mog R, de Vries N, Wilson AG, Tak PP, Baeten D. A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis. Ann. Rheum. Dis. 67: 720-722 (2008).
Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42: 1093-1100 (1999). *
Canto E, Ricart E, Busquets D, Monfort D, Garcia-Planella E, Gonzalez D, Balanzo J, Rodriguez-Sanchez JL, Vidal S. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J. Gastroenterol. 13: 5446-5453 (2007). *
Canton I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF, Weetman AP, Kemp EH. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun. 6: 584-587 (2005). *
Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol. 100: 1134-1142 (2005). *
Canzian F, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, Bingham S, Boeing H, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Dossus L, Spencer Feigelson H, Haiman CA, Hankinson SE, Hoover R, Hunter DJ, Isaacs C, Lenner P, Lund E, et al. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer 9: 257 (2009). *
Cao B, Liu X, Hou F, Li W, Han Z, Zhang Q, Dai Y, Xu C, Qi H. The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population. Liver Int. 29: 1383-1388 (2009). *
Cao HX, Li M, Nie J, Wang W, Zhou SF, Yu XQ. Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han Chinese. Am. J. Nephrol. 28: 684-691 (2008).
Cao HX, Zhao L, Zhou LX. HLA-DRB1 allele polymorphosm associated with susceptibility to leukemia in Han nationality of Gansu. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13: 788-792 (2005).
Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC, Tomasi JP. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 105: 628-633 (1996).
Cao Q, Shen XL, Zhou W, Wang JG. The relationship of nature killer cell 2D gene polymorphisms and ulcerative colitis in the Chinese. Zhonghua Nei Ke Za Zhi 45: 824-826 (2006).
Cao Q, Zhu Q, Shang Y, Gao M, Si J. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Digestion 79: 58-63 (2009).
Cao Q, Zhu Q, Wu ML, Hu WL, Gao M, Si JM. Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphisms. Chin. Med. J. (Engl.) 119: 1198-1203 (2006). *
Cao TM, Lazzeroni LC, Tsai S, Pang WW, Kao A, Camp NJ, Thomas A, Shizuru JA. Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice. J. Immunol. 183: 462-469 (2009).
Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, Reuter V, Scher H, Cordon-Cardo C, Figlin RA, Belldegrun A, Zhang ZF. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104: 2400-2408 (2005). *
Cao XB, Qiu Y, Qiu XS, Chen ZJ, Chen HO, Chen WJ. FBN3 gene polymorphisms in adolescent idiopathic scoliosis patients. Stud. Health Technol. Inform. 140: 321 (2008).
Cao Z, Li C, Jin L, Corbet EF. Association of matrix metalloproteinase-1 promoter polymorphism with generalized aggressive periodontitis in a Chinese population. J. Periodontal Res. 40: 427-431 (2005). *
Cao Z, Song JH, Park YK, Maeng EJ, Nam SW, Lee JY, Park WS. The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients. Neoplasma 56: 114-118 (2009).
Capilla A, Donat E, Planelles D, Espinos C, Ribes-Koninckx C, Palau F. Genetic analyses of celiac disease in a Spanish population confirm association with CELIAC3 but not with CELIAC4. Tissue Antigens 70: 324-329 (2007). *
Capittini C, Pasi A, Bergamaschi P, Tinelli C, De Silvestri A, Mercati MP, Badulli C, Garlaschelli F, Sbarsi I, Guarene M, Martinetti M, Salvaneschi L, Cuccia M. HLA haplotypes and birth weight variation: is your future going to be light or heavy? Tissue Antigens 74: 156-163 (2009). *
Capoluongo E, Almadori G, Concolino P, Bussu F, Santonocito C, Vendittelli F, Galli J, Zuppi C, Ameglio F, Paludetti G, Giardina B. GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio region. Clin. Chim. Acta 376: 174-178 (2007). *
Caponi L, Petit-Teixeira E, Sebbag M, Bongiorni F, Moscato S, Pratesi F, Pierlot C, Osorio J, Chapuy-Regaud S, Guerrin M, Cornelis F, Serre G, Migliorini P; ECRAF. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann. Rheum. Dis. 64: 587-593 (2005). *
Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A. Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes. J. Neuroimmunol. 177: 112-118 (2006).
Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, Yeager M, Chen C, Jacobs K, Wheeler W, Landi MT, Ziegler RG, Hunter DJ, Chanock S, Hankinson S, Kraft P, Bergen AW. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS ONE 4: e4653 (2009). *
Caprilli R. Why does Crohn's disease usually occur in terminal ileum? Journal of Crohn's and Colitis 2: 352-356 (2008).
Capron A, Lerut J, Verbaandert C, Mathys J, Ciccarelli O, Vanbinst R, Roggen F, De Reyck C, Lemaire J, Wallemacq PE. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection. Ther. Drug Monit. 29: 340-348 (2007).
Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F. Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians. Ann. Hum. Genet. 71: 843-848 (2007). *
Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, Cedola FN, Targovnik HM, Frechtel GD. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 38: 277-281 (2005).
Caputo M, Cerrone GE, Mazza C, Cedola N, Targovnik HM, Gustavo DF. No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes. Immunol. Invest. 36: 259-270 (2007).
Cara Terribas CJ, Gonzalez Guijarro L. Hypomethylation and multiple sclerosis, the susceptibility factor? Neurologia 17: 132-135 (2002).
Caramori G, Adcock I. Gene-environment interactions in the development of chronic obstructive pulmonary disease. Curr. Opin. Allergy Clin. Immunol. 6: 323-328 (2006).
Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br. J. Haematol. 120: 135-141 (2003).
Cardelli M, Cavallone L, Marchegiani F, Oliveri F, Dato S, Montesanto A, Lescai F, Lisa R, De Benedictis G, Franceschi C. A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism. J. Gerontol. A. Biol. Sci. Med. Sci. 63: 454-460 (2008).
Cardon LR. Genetics. Delivering new disease genes. Science 314: 1403-1405 (2006). *
Cargill EJ, Womack JE. Detection of polymorphisms in bovine Toll-like receptors 3, 7, 8, and 9. Genomics 89: 745-755 (2007). *
Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80: 273-390 (2007). *
Carlberg C, Dunlop TW. An integrated biological approach to nuclear receptor signaling in physiological control and disease. Crit. Rev. Eukaryot. Gene Expr. 16: 1-22 (2006).
Carless MA, Kraska T, Lintell N, Neale RE, Green AC, Griffiths LR. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. Br. J. Dermatol. 159: 804-810 (2008). *
Carlo-Stella N, Bozzini S, De Silvestri A, Sbarsi I, Pizzochero C, Lorusso L, Martinetti M, Cuccia M. Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int. J. Immunopathol. Pharmacol. 22: 745-754 (2009).
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429: 446-452 (2004). *
Carlson CS, Heagerty PJ, Nord AS, Pritchard DK, Ranchalis J, Boguch JM, Duan H, Hatsukami TS, Schwartz SM, Rieder MJ, Nickerson DA, Jarvik GP. TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects. Hum. Genet. 121: 65-75 (2007). *
Carlsson M, Sjoholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, Truedsson L. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin. Exp. Immunol. 139: 306-313 (2005). *
Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, Begovich AB. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet. 77: 567-581 (2005). *
Carlton VE, Ireland JS, Useche F, Faham M. Functional single nucleotide polymorphism-based association studies. Hum. Genomics 2: 391-402 (2006).
Carmichael SL, Shaw GM, Iovannisci DM, Yang W, Finnell RH, Cheng S, Lammer EJ. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am. J. Med. Genet. A. 140: 2433-2440 (2006).
Carney G, Wei S, Rizzo WB. Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum. Mutat. 24: 186 (2004). *
Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S, Lesch KP, Gross C. Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol. Psychiatry 63: 840-846 (2008). *
Caron-Dorval D, Paquet P, Paradis AM, Rudkowska I, Lemieux S, Couture P, Vohl MC. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids. J. Nutrigenet. Nutrigenomics 1: 205-212 (2008).
Carpenter SL, Lieff S, Howard TA, Eggleston B, Ware RE. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am. J. Hematol. 83: 800-803 (2008). *
Carr DF, Alfirevic A, Tugwood JD, Barratt BJ, Sherwood J, Smith J, Pirmohamed M, Kevin Park B. Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity. Pharmacogenet. Genomics 17: 961-972 (2007).
Carr DF, Whiteley G, Alfirevic A, Pirmohamed M. Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review. Pharmacogenomics J. 9: 291-305 (2009).
Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229 (2005). *
Carreira PE, Gonzalez-Crespo MR, Ciruelo E, Pablos JL, Santiago B, Gomez-Camara A, Gomez-Reino JJ. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population. Arthritis Rheum. 52: 3015-3019 (2005). *
Carrell DT, De Jonge C, Lamb DJ. The genetics of male infertility: a field of study whose time is now. Arch. Androl. 52: 269-274 (2006).
Carrick DM, Chulada P, Donn R, Fabris M, McNicholl J, Whitworth W, Blackshear PJ. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J. Autoimmun. 26: 182-196 (2006).
Carrier CM, Mollen N, Rothman WC, Rodriguez de Cordoba S, Rey-Campos J, Ginsberg-Fellner F, Carpenter C, Rubinstein P. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships. Hum. Immunol. 24: 51-63 (1989).
Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr. Top. Microbiol. Immunol. 298: 225-257 (2006).
Carrington M, Martin MP, van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol. 16: 620-627 (2008). *
Carrion F, Figueroa F, Martinez ME, Massardo L, Perez T, Foster C, Mancilla C, Neira O, Guzman L, Valenzuela V, Urrutia R, Carmona S, Figueroa M, Lubiano A, Wainstein E. Study of polymorphism of Fc gamma IIa receptors in Chilean patients with systemic lupus erythematosus. Rev. Med. Chil. 131: 11-18 (2003).
Carroll L, Frazer IH, Turner M, Marwick T, Thomas R. The receptor for advanced glycation end products glycine 82 serine polymorphism and the risk of cardiovascular events in rheumatoid arthritis. Arthritis Res. Ther. 9: R39 (2007). *
Carroll L, Hannawi S, Marwick T, Thomas R. Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products. Wien. Med. Wochenschr. 156: 42-52 (2006).
Carter CJ. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochem. Int. 50: 12-38 (2007).
Carter MJ, Di Giovine FS, Cox A, Goodfellow P, Jones S, Shorthouse AJ, Duff GW, Lobo AJ. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 121: 805-811 (2001). *
Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, Duff GW. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 48: 461-467 (2001). *
Carter MJ, Jones S, Camp NJ, Cox A, Mee J, Warren B, Duff GW, Lobo AJ, Di Giovine FS. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun. 5: 8-15 (2004). *
Cartier KC, Miscimarra L, Dazard JE, Song Y, Iyengar SK, Rao JS. Studying genetic determinants of natural variation in human gene expression using Bayesian ANOVA. BMC Proc. 1 Suppl. 1: S115 (2007). *
Carulli MT, Spagnolo P, Fonseca C, Welsh KI, Dubois RM, Black CM, Denton CP. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis. J. Rheumatol. 35: 839-844 (2008).
Caruso C, Aquino A, Candore G, Scola L, Colonna-Romano G, Lio D. Looking for immunological risk genotypes. Ann. N. Y. Acad. Sci. 1019: 141-146 (2004). *
Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M, Falzetti F, Bistoni F, Aversa F, Pitzurra L, Rodrigues F, Romani L. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp. Hematol. 37: 1022-1029 (2009).
Carvalho A, Marques A, Maciel P, Rodrigues F. Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: a novel method applied to the analysis of the Portuguese population. Mol. Cell. Probes 21: 316-320 (2007).
Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis. J. Infect. Dis. 197: 618-621 (2008). *
Carvalho AP, Ventura GM, Pereira CB, Leao RS, Folescu TW, Higa L, Teixeira LM, Plotkowski MC, Merquior VL, Albano RM, Marques EA. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production. APMIS 115: 311-318 (2007). *
Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries S, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935 (2006). *
Cascino I, Paladini F, Belfiore F, Cauli A, Angelini C, Fiorillo MT, Mathieu A, Sorrentino R. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum. 56: 2640-2651 (2007). *
Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet. 47: 359-363 (2004).
Casey B, Glatt CE, Tottenham N, Soliman F, Bath K, Amso D, Altemus M, Pattwell S, Jones R, Levita L, McEwen B, Magari�os AM, Gunnar M, Thomas KM, Mezey J, Clark AG, Hempstead BL, Lee FS. Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development Neuroscience 164: 108-120 (2009).
Castaldo G, Polizzi A, Tomaiuolo R, Cazeneuve C, Girodon E, Santostasi T, Salvatore D, Raia V, Rigillo N, Goossens M, Salvatore F. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann. Hum. Genet. 69: 15-24 (2005). *
Castano G, Burgueno A, Fernandez Gianotti T, Pirola CJ, Sookoian S. Influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy. Aliment. Pharmacol. Ther. Dec 3 [Epub ahead of print] (2009). *
Castano-Rodriguez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun. Rev. 7: 322-330 (2008).
Castellani C, Malerba G, Sangalli A, Delmarco A, Petrelli E, Rossini M, Assael BM, Mottes M. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes. J. Cyst. Fibros. 5: 229-235 (2006).
Castellanos-Rubio A, Martin-Pagola A, Santin I, Hualde I, Aransay AM, Castano L, Vitoria JC, Bilbao JR. Combined functional and positional gene information for the identification of susceptibility variants in celiac disease. Gastroenterology 134: 738-746 (2008). *
Castelli EC, Mendes-Junior CT, Deghaide NH, de Albuquerque RS, Muniz YC, Simoes RT, Carosella ED, Moreau P, Donadi EA. The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun. Oct 1 [Epub ahead of print] (2009). *
Castelli EC, Mendes-Junior CT, Donadi EA. HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens 70: 62-68 (2007). *
Castelli L, Comi C, Chiocchetti A, Nicola S, Mesturini R, Giordano M, D'Alfonso S, Cerutti E, Galimberti D, Fenoglio C, Tesser F, Yagi J, Rojo JM, Perla F, Leone M, Scarpini E, Monaco F, Dianzani U. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution. J. Neuroimmunol. 186: 193-198 (2007).
Castellon R, Hamdi HK. Demystifying the ACE polymorphism: from genetics to biology. Curr. Pharm. Des. 13: 1191-1198 (2007).
Castiblanco J, Anaya JM. The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjogren's syndrome. Hum. Immunol. 69: 45-51 (2008).
Castiblanco J, Varela DC, Castano-Rodriguez N, Rojas-Villarraga A, Hincapie ME, Anaya JM. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect. Genet. Evol. 8: 541-544 (2008).
Castillejo A, Rothman N, Murta-Nascimento C, Malats N, Garcia-Closas M, Gomez-Martinez A, Lloreta J, Tardon A, Serra C, Garcia-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, Soto JL, Real FX. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. Int. J. Cancer 124: 608-613 (2008). *
Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann. Rheum. Dis. 60: 791-795 (2001). *
Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, Kumar R, Forsti A, Kjellberg L, Hallmans G, Lehtinen M, Hemminki K, Pawlita M. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int. J. Cancer 125: 1851-1858 (2009). *
Castro-Giner F, Kogevinas M, Machler M, de Cid R, Steen KV, Imboden M, Schindler C, Berger W, Gonzalez JR, Franklin KA, Janson C, Jarvis D, Omenaas E, Burney P, Rochat T, Estivill X, Anto JM, Wjst M, Probst-Hensch NM. TNFA-308 in two international population-based cohorts shows increased risk for asthma. Eur. Respir. J. 32: 350-361 (2008).
Castro-Marrero J, Balada E, Vilardell-Tarres M, Ordi-Ros J. Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br. J. Haematol. 147: 289-296 (2009).
Castro-Santos P, Mozo L, Gutierrez C, Suarez A. TNFalpha genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type. Clin. Immunol. 121: 305-313 (2006). *
Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am. J. Gastroenterol. 101: 1039-1047 (2006). *
Castro-Santos P, Suarez A, Mozo L, Gutierrez C. Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis. Clin. Immunol. 122: 108-114 (2007). *
Catakoglu AB, Duman BS, Kurtoglu H, Ersoz M, Sener M, Celebi H, Cagatay P, Aytekin V, Aytekin S. Common variants in the ATP-binding cassette transporter 1 gene with decreased HDL-cholesterol levels and coronary artery disease. Arch. Med. Res. 39: 735-742 (2008).
Catalano M, Cortelazzo A, Santi R, Contino L, Demicheli M, Yilmaz Y, Zorzetto M, Campo I, Lanati N, Emanuele E. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clin. Biochem. 41: 981-985 (2008). *
Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mule AM, Corazza GR; Groups of the SIGEP and "Club del Tenue". Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am. J. Gastroenterol. 98: 850-856 (2003). *
Catano G, Agan BK, Kulkarni H, Telles V, Marconi VC, Dolan MJ, Ahuja SK. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J. Infect. Dis. 198: 72-80 (2008). *
Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3: e3636 (2008). *
Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. 85: 777-782 (2007). *
Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P, Meyre D. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med. Genet. 9: 45 (2008). *
Caudill MA, Dellschaft N, Solis C, Hinkis S, Ivanov AA, Nash-Barboza S, Randall KE, Jackson B, Solomita GN, Vermeylen F. Choline intake, plasma riboflavin, and the phosphatidylethanolamine N-methyltransferase G5465A genoref-type predict plasma homocysteine in folate-deplete Mexican-American men with the methylenetetrahydrofolate reductase 677TT genoref-type. J. Nutr. 139: 727-733 (2009).
Cauffiez C, Pottier N, Tournel G, Lo-Guidice JM, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly F. CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica 35: 661-669 (2005). *
Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin. Chem. Lab. Med. 41: 1345-1350 (2003).
Cavan DA, Jacobs KH, Penny MA, Kelly MA, Mijovic C, Jenkins D, Fletcher JA, Barnett AH. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia 36: 252-257 (1993).
Cavestro GM, Frulloni L, Neri TM, Seghini P, Nouvenne A, Zanetti A, Bovo P, Di Mario F, Okolicsanyi L, Cavallini G. Association of HLA-DRB1*0401 allele with chronic pancreatitis. Pancreas 26: 388-391 (2003).
Cavestro GM, Zuppardo RA, Bertolini S, Sereni G, Frulloni L, Okolicsanyi S, Calzolari C, Singh SK, Sianesi M, Del Rio P, Leandro G, Franze A, Di Mario F. Connections between genetics and clinical data: role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am. J. Gastroenterol. 105: 199-206 (2010). *
Cawood AL, Carroll MP, Wootton SA, Calder PC. Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr. Opin. Clin. Nutr. Metab. Care 8: 153-159 (2005).
Cayan F, Ayaz L, Aras-Ates N, Dilekci E, Dilek S, Tamer-Gumus L. N-acetyltransferase 2 gene polymorphism in patients with cervical cancer. Int. J. Gynecol. Cancer 19: 1186-1189 (2009).
Cebecauerova D, Jirasek T, Budisova L, Mandys V, Volf V, Novotna Z, Subhanova I, Hrebicek M, Elleder M, Jirsa M. Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome. Gastroenterology 129: 315-320 (2005). *
Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol. Behav. 88: 227-233 (2006). *
Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, Vedin I, Wretlind B, Grimble RF, Palmblad J. Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J. Intern. Med. 262: 215-223 (2007). *
Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 29: 407-414 (2008).
Cejkova P, Novota P, Cerna M, Kololtova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. KCNJ11 E23K polymorphism and diabetes mellitus with adult onset in Czech patients. Folia Biol. (Praha) 53: 173-175 (2007).
Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Int. J. Immunogenet. 35: 133-140 (2008). *
Celebi Kobak A, Kobak S, Kabasakal Y, Akarca US. Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever. Clin. Rheumatol. 26: 908-910 (2007). *
Celik U, Yildizdas D, Alhan E, Celik T, Attila G, Sertdemir Y, Tepe T. Genetic dilemma: eNOS gene intron 4a/b VNTR polymorphism in sepsis and its clinical features in Turkish children. Turk. J. Pediatr. 50: 114-119 (2008).
Celik Y, Dagli U, Yalin Kilic M, Toruner M, Ceren Ozen S, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Mithat Bozdayi A. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand. J. Gastroenterol. 41: 559-565 (2006). *
Cellini L, Grande R, Di Campli E, Di Bartolomeo S, Capodicasa S, Marzio L. Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. Scand. J. Gastroenterol. 41: 280-287 (2006). *
Cereda C, Baiocchi C, Bongioanni P, Cova E, Guareschi S, Metelli MR, Rossi B, Sbalsi I, Cuccia MC, Ceroni M. TNF and sTNFR1/2 plasma levels in ALS patients. J. Neuroimmunol. 194: 123-131 (2008).
Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol. Biomarkers Prev. 17: 3161-3169 (2008). *
Cerhan JR, Novak AJ, Fredericksen ZS, Wang AH, Liebow M, Call TG, Dogan A, Witzig TE, Ansell SM, Habermann TM, Kay NE, Slager SL. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. Br. J. Haematol. 145: 614-623 (2009). *
Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions. Ann. N. Y. Acad. Sci. 1110: 140-150 (2007). *
Cerri AP, Arosio B, Viazzoli C, Confalonieri R, Teruzzi F, Annoni G. -308(G/A) TNF-alpha gene polymorphism and risk of depression late in the life. Arch. Gerontol. Geriatr. 49 Suppl. 1: 29-34 (2009).
Cerri AP, Arosio B, Viazzoli C, Confalonieri R, Vergani C, Annoni G. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly. Int. J. Geriatr. Psychiatry Jul 17 [Epub ahead of print] (2009).
Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults. Mol. Diagn. 8: 43-49 (2004).
Cerundolo V, Salio M. Harnessing NKT cells for therapeutic applications. Curr. Top. Microbiol. Immunol. 314: 325-340 (2007).
Cervilla JA, Rivera M, Molina E, Torres-Gonzalez F, Bellon JA, Moreno B, de Dios Luna J, Lorente JA, de Diego-Otero Y, King M, Nazareth I, Gutierrez B. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141: 912-917 (2006).
Cervino AC, Gosink M, Fallahi M, Pascal B, Mader C, Tsinoremas NF. A comprehensive mouse IBD database for the efficient localization of quantitative trait loci. Mamm. Genome 17: 565-574 (2006). *
Cha RH, Yang SH, Kim HS, Kim SM, Park MH, Ha J, Kim YS. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Nephrol. Dial. Transplant. 24: 2919-2925 (2009).
Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum. 56: 1454-1463 (2007). *
Cha S, Koo I, Choi SM, Park BL, Kim KS, Kim JR, Shin HD, Kim JY. Association analyses of the INSIG2 polymorphism in the obesity and cholesterol levels of Korean populations. BMC Med. Genet. 10: 96 (2009). *
Cha SH, Lee WK, Kwak JO, Hwang JS, Suh CK. Identification and characterization of single nucleotide polymorphisms of SLC22A11 (hOAT4) in Korean women osteoporosis patients. Mol. Cells 25: 265-271 (2008).
Chaar V, Keclard L, Etienne-Julan M, Diara JP, Elion J, Krishnamoorthy R, Romana M. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia. Am. J. Hematol. 81: 377-379 (2006). *
Chabchoub G, Maalej A, Petit-Teixeira E, Glikmans E, Rebai A, Farid NR, Cornelis F, Ayadi H. Polymorphisms in the protein tyrosine phosphatase (PTPN22) gene is not associated with autoimmune thyroid in a large affected Tunisian family. Clin. Immunol. 120: 235-236 (2006). *
Chabchoub G, Teixiera EP, Maalej A, Hamad MB, Bahloul Z, Cornelis F, Ayadi H. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann. Hum. Biol. 36: 342-349 (2009).
Chadha S, Miller K, Farwell L, Lightstone LB, Daly MJ, Rioux JD, Vyse TJ. Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur. J. Hum. Genet. 13: 669-676 (2005). *
Chadha S, Miller K, Farwell L, Sacks S, Daly MJ, Rioux JD, Vyse TJ. Haplotype analysis of tumour necrosis factor receptor genes in 1p36: no evidence for association with systemic lupus erythematosus. Eur. J. Hum. Genet. 14: 69-78 (2006). *
Chae SC, Lee YC, Park YR, Shin JS, Song JH, Oh GJ, Hong ST, Pae HO, Choi BM, Chung HT. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochem. Biophys. Res. Commun. 320: 131-137 (2004). *
Chae SC, Li CS, Kim KM, Yang JY, Zhang Q, Lee YC, Yang YS, Chung HT. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J. Hum. Genet. 52: 355-361 (2007). *
Chae SC, Park BL, Park CS, Ryu HJ, Yang YS, Lee SO, Choi YH, Kim EM, Uh ST, Kim YH, Kim KK, Oh B, Chung HT, Kimm K, Shin HD. Putative association of RUNX1 polymorphisms with IgE levels in a Korean population. Exp. Mol. Med. 38: 583-588 (2006). *
Chae SC, Park YR, Lee YC, Lee JH, Chung HT. The association of TIM-3 gene polymorphism with atopic disease in Korean population. Hum. Immunol. 65: 1427-1431 (2004).
Chae SC, Park YR, Li CS, Lee JH, Yang YS, Zhang Q, Kim KS, Chung HT. Analysis of the variations in IL-28RA gene and their association with allergic rhinitis. Exp. Mol. Med. 38: 302-309 (2006). *
Chae SC, Park YR, Shim SC, Lee IK, Chung HT. Eotaxin-3 gene polymorphisms are associated with rheumatoid arthritis in a Korean population. Hum. Immunol. 66: 314-320 (2005).
Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol. Lett. 95: 91-95 (2004).
Chae SC, Park YR, Song JH, Shim SC, Yoon KS, Chung HT. The polymorphisms of Tim-1 promoter region are associated with rheumatoid arthritis in a Korean population. Immunogenetics 56: 696-701 (2005). *
Chae SC, Shim SC, Chung HT. Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis. Exp. Mol. Med. 41: 33-41 (2009). *
Chae SC, Yu JI, Oh GJ, Choi CS, Choi SC, Yang YS, Yun KJ. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol. Cells Dec 7 [Epub ahead of print] (2009).
Chae SJ, Kim H, Jee BC, Suh CS, Kim SH, Kim JG. Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am. J. Reprod. Immunol. 60: 432-439 (2008). *
Chaganti S, Ma CS, Bell AI, Croom-Carter D, Hislop AD, Tangye SG, Rickinson AB. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+ CD27+ B cells harbour the virus in X-linked lymphoproliferative disease patients. Blood 112: 672-679 (2008). *
Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac. J. Cancer Prev. 7: 136-139 (2006).
Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect. Prev. 32: 386-394 (2009).
Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 100: 3455-3460 (2003). *
Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br. J. Pharmacol. 157: 220-233 (2009). *
Chan A, Newman DL, Shon AM, Schneider DH, Kuldanek S, Ober C. Variation in the type I interferon gene cluster on 9p21 influences susceptibility to asthma and atopy. Genes Immun. 7: 169-178 (2006). *
Chan AO, Chu KM, Huang C, Lam KF, Leung SY, Sun YW, Ko S, Xia HH, Cho CH, Hui WM, Lam SK, Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 56: 595-597 (2007). *
Chan CC, Ross RJ, Shen D, Ding X, Majumdar Z, Bojanowski CM, Zhou M, Salem N Jr, Bonner R, Tuo J. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res. 40: 124-128 (2008).
Chan E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis 187: 309-315 (2006).
Chan EY. Next-generation sequencing methods: impact of sequencing accuracy on SNP discovery. Methods Mol. Biol. 578: 95-111 (2009).
Chan HL, Tse AM, Chim AM, Wong VW, Choi PC, Yu J, Zhang M, Sung JJ. Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B. J. Gastroenterol. Hepatol. 23: 783-789 (2008). *
Chan IH, Lee DL, Ho OY, Wong EW, Lam YY, Tang NL, Chan MH, Abdullah VJ, Wong CK, Lam CW. High-level expression of early growth response-1 and association of polymorphism with total IgE and atopy in allergic rhinitis adults. Clin. Chim. Acta 411: 67-71 (2010). *
Chan IH, Tang NL, Leung TF, Huang W, Lam YY, Wong GW, Chan JC, Chan MH, Wong CK, Zhang YP, Lam CW. Association of early growth response-1 gene polymorphisms with total IgE and atopy in asthmatic children. Pediatr. Allergy Immunol. 20: 142-150 (2009). *
Chan IH, Tang NL, Leung TF, Lam YY, Wong GW, Wong CK, Lam CW. Association of plasma soluble CTLA-4 with lung function and gene polymorphism in Chinese asthmatic children. Int. Arch. Allergy Immunol. 152: 113-121 (2009).
Chan IH, Tang NL, Leung TF, Ma SL, Zhang YP, Wong GW, Wong CK, Lam CW. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children. Allergy 62: 802-809 (2007).
Chanda P, Zhang A, Brazeau D, Sucheston L, Freudenheim JL, Ambrosone C, Ramanathan M. Information-theoretic metrics for visualizing gene-environment interactions. Am. J. Hum. Genet. 81: 939-963 (2007). *
Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, Ma HJ, Chou MC, Tsai HT, Yang SF. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin. Chem. Lab. Med. 47: 412-418 (2009). *
Chang CC, Lu RB, Ma KH, Chang HA, Chen CL, Huang CC, Lin WW, Huang SY. Association study of the norepinephrine transporter gene polymorphisms and bipolar disorder in Han Chinese population. World J. Biol. Psychiatry 8: 188-195 (2007).
Chang CC, Silvia EA, Ho EK, Vlad G, Suciu-Foca N, Vasilescu ER. Polymorphism and linkage disequilibrium of immunoglobulin-like transcript 3 gene. Hum. Immunol. 69: 284-290 (2008).
Chang CH, Chiu CF, Liang SY, Wu HC, Chang CL, Tsai CW, Wang HC, Lee HZ, Bau DT. Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res. 29: 1275-1279 (2009). *
Chang H, Rha SY, Jeung HC, Im CK, Noh SH, Kim JJ, Chung HC. Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. Oncol. Rep. 23: 271-278 (2010).
Chang HK, Jang WC, Park SB, Nam YH, Lee SS, Park YW, Kim SK. The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behcet's disease. Scand. J. Rheumatol. 36: 216-221 (2007). *
Chang HS, Kim JS, Lee JH, Cho JI, Rhim TY, Uh ST, Park BL, Chung IY, Park CS, Shin HD. A single nucleotide polymorphism on the promoter of eotaxin1 associates with its mRNA expression and asthma phenotypes. J. Immunol. 174: 1525-1531 (2005). *
Chang HW, Yang CH, Chang PL, Cheng YH, Chuang LY. SNP-RFLPing: restriction enzyme mining for SNPs in genomes. BMC Genomics 7: 30 (2006). *
Chang JB, Zhou ZX, Xue R, Zhu GS, Tian YL, Zhao W. The relationship between alpha-IFN anti-virus treatment and HLA-DRB1*11 gene mononucleotide polymorphism. Zhonghua Gan Zang Bing Za Zhi 16: 646-648 (2008).
Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 48: 1711-1717 (2007). *
Chang JL, Bigler J, Schwarz Y, Li SS, Li L, King IB, Potter JD, Lampe JW. UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial. J. Nutr. 137: 890-897 (2007). *
Chang LY, Chang IS, Chen WJ, Huang YC, Chen GW, Shih SR, Juang JL, Shih HM, Hsiung CA, Lin TY, Huang LM. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 122: 1271-1276 (2008). *
Chang M, Li Y, Yan C, Callis-Duffin KP, Matsunami N, Garcia VE, Cargill M, Civello D, Bui N, Catanese JJ, Leppert MF, Krueger GG, Begovich AB, Schrodi SJ. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun. 9: 176-181 (2008). *
Chang M, Tsuchiya K, Batchelor RH, Rabinovitch PS, Kulander BG, Haggitt RC, Burmer GC. Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas. Am. J. Pathol. 144: 1-6 (1994). *
Chang MC, Chang YT, Tien YW, Liang PC, Jan IS, Wei SC, Wong JM. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin. Chem. 53: 1700-1705 (2007). *
Chang MC, Chang YT, Tien YW, Liang PC, Wei SC, Wong JM. Association of tumour necrosis factor-alpha promoter haplotype with chronic pancreatitis. Gut 55: 1674-1676 (2006). *
Chang MC, Chang YT, Wei SC, Kuo CH, Liang PC, Wong JM. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status. Pancreas 38: 442-446 (2009).
Chang PM, Tzeng CH, Chen PM, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS. ERCC1 codon 118 C-->T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma. Cancer Sci. 100: 278-283 (2009). *
Chang SC, Lin PC, Lin JK, Yang SH, Wang HS, Fen-Yau Li A. Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int. J. Colorectal Dis. 22: 483-489 (2007). *
Chang SC, Rashid A, Gao YT, Andreotti G, Shen MC, Wang BS, Han TQ, Zhang BH, Sakoda LC, Leitzmann MF, Chen BE, Rosenberg P, Chen J, Chanock S, Hsing AW. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 29: 944-948 (2008). *
Chang SJ, Chen CJ, Tsai FC, Lai HM, Tsai PC, Tsai MH, Ko YC. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene. Rheumatology (Oxford) 47: 617-621 (2008). *
Chang SJ, Tsai PC, Chen CJ, Lai HM, Ko YC. The polymorphism -863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout. Rheumatology (Oxford) 46: 1662-1666 (2007). *
Chang WW, Su H, He L, Zhao KF, Wu JL, Xu ZW. Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) Jan 4 [Epub ahead of print] (2010).
Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44: 40-50 (2005). *
Chang YC, Wu WM, Chen CH, Hu CF, Hsu LA. Association between P478S polymorphism of the filaggrin gene and risk of psoriasis in a Chinese population in Taiwan. Arch. Dermatol. Res. 300: 133-137 (2008). *
Chang YC, Wu WM, Chen CH, Lee SH, Hong HS, Hsu LA. Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan. Br. J. Dermatol. 156: 642-645 (2007).
Chang YH, Huang CN, Wu CY, Shiau MY. Association of Interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum. Immunol. 66: 1258-1263 (2005).
Chang YH, Lee DS, Jo HS, Cho SI, Yoon HJ, Shin S, Yoon JH, Kim HY, Hong YJ, Hong SI, Cho HI. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 36: 45-50 (2006).
Chang YK, Yang W, Zhao M, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Ng IO, Lee TL, Ho MH, Lee PP, Wong WH, Lau CS, Sham PC, Lau YL. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun. 10: 414-420 (2009). *
Chang YT, Chang MC, Su TC, Liang PC, Su YN, Kuo CH, Wei SC, Wong JM. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin. Chem. 54: 131-138 (2008). *
Chang YT, Chou CT, Shiao YM, Lin MW, Yu CW, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, Tsai SF. Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes. Br. J. Dermatol. 155: 663-669 (2006). *
Chang YT, Chou CT, Yu CW, Lin MW, Shiao YM, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, Tsai SF. Cytokine gene polymorphisms in Chinese patients with psoriasis. Br. J. Dermatol. 156: 899-905 (2007). *
Chang YT, Hsu CY, Chou CT, Lin MW, Shiao YM, Tsai CY, Yu CW, Shiue JJ, Lee YF, Huang CH, Chen CC, Lee DD, Wang WJ, Liu HN, Tsai SF. The genetic polymorphisms of POU5F1 gene are associated with psoriasis vulgaris in Chinese. J. Dermatol. Sci. 46: 153-156 (2007).
Chang YT, Lee WR, Yu CW, Liu HN, Lin MW, Huang CH, Chen CC, Lee DD, Wang WJ, Hu CH, Tsai SF. No association of cytokine gene polymorphisms in Chinese patients with atopic dermatitis. Clin. Exp. Dermatol. 31: 419-423 (2006). *
Chang YT, Liu HN, Shiao YM, Lin MW, Lee DD, Liu MT, Wang WJ, Wu S, Lai CY, Tsai SF. A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis. Br. J. Dermatol. 153: 90-96 (2005). *
Chang YT, Liu HN, Yu CW, Lin MW, Huang CH, Chen CC, Liu MT, Lee DD, Wang WJ, Tsai SF. Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population. Br. J. Dermatol. 154: 79-84 (2006).
Chang YT, Shiao YM, Chin PJ, Liu YL, Chou FC, Wu S, Lin YF, Li LH, Lin MW, Liu HN, Tsai SF. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 150: 1104-1111 (2004). *
Chang YT, Tsai SF, Lee DD, Shiao YM, Huang CY, Liu HN, Wang WJ, Wong CK. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br. J. Dermatol. 148: 418-423 (2003). *
Chang YT, Tsai SF, Lin MW, Liu HN, Lee DD, Shiao YM, Chin PJ, Wang WJ. SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene. Exp. Dermatol. 12: 307-314 (2003). *
Chang Z, Guo CL, Ahronowitz I, Stemmer-Rachamimov AO, Maccollin M, Nunes FP. A role for the p53 pathway in the pathology of meningiomas with NF2 loss. J. Neurooncol. 91: 265-270 (2009).
Chanson M, Kwak BR. Connexin37: a potential modifier gene of inflammatory disease. J. Mol. Med. 85: 787-795 (2007). *
Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15: 979-987 (2006). *
Chao YC, Chu HC, Chang WK, Huang HH, Hsieh TY. CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis. World J. Gastroenterol. 11: 6043-6048 (2005). *
Chao YL, Shen YC, Liao DL, Chen JY, Wang YC, Lai IC, Liou YJ, Chen CH. Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan. Prog. Neuropsychopharmacol. Biol. Psychiatry 32: 1834-1837 (2008).
Chaouni I, Lefranc MP, d'Angeac AD, Zanin C, Pellet F, Clot J, Combe B, Sany J, Reme T. T cell receptor gamma variable gene locus polymorphism in patients with rheumatoid arthritis. Arthritis Rheum. 35: 756-760 (1992).
Chapman K, Takahashi A, Meulenbelt I, Watson C, Rodriguez-Lopez J, Egli R, Tsezou A, Malizos KN, Kloppenburg M, Shi D, Southam L, van der Breggen R, Donn R, Qin J, Doherty M, Slagboom PE, Wallis G, Kamatani N, Jiang Q, Gonzalez A, Loughlin J, Ikegawa S. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum. Mol. Genet. 17: 1497-1504 (2008). *
Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Segal S, Moore CE, Davies RJ, Day NP, Peshu N, Crook DW, Berkley JA, Williams TN, Scott JA, Hill AV. NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immun. Oct 1 [Epub ahead of print] (2009).
Chappell S, Guetta-Baranes T, Hadzic N, Stockley R, Kalsheker N. Polymorphism in the endoplasmic reticulum mannosidase I (MAN1B1) gene is not associated with liver disease in individuals homozygous for the Z variant of the alpha1-antitrypsin protease inhibitor (PiZZ individuals). Hepatology 50: 1315 (2009).
Chappell S, Hadzic N, Stockley R, Guetta-Baranes T, Morgan K, Kalsheker N. A polymorphism of the alpha(1)-antitrypsin gene represents a risk factor for liver disease. Hepatology 47: 127-132 (2008). *
Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, Dekosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrieze F, Dartigues JF, Tzourio C, Buee L, Pasquier F, Berr C, et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry 14: 1004-1016 (2009).
Charli-Joseph Y, Cruz-Fuentes C, Orozco-Topete R. Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele. J. Eur. Acad. Dermatol. Venereol. 23: 788-792 (2009). *
Charmley P, Nelson JL, Hansen JA, Branchaud A, Barrington RA, Templin D, Boyer G, Lanier AP, Concannon P. T-cell receptor polymorphisms in Tlingit Indians with rheumatoid arthritis. Autoimmunity 19: 247-251 (1994).
Charmley P, Nepom BS, Concannon P. HLA and T cell receptor beta-chain DNA polymorphisms identify a distinct subset of patients with pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 37: 695-701 (1994).
Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E, Sassolas A, Moulin P, Marcais C. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin. Chim. Acta 394: 99-103 (2008). *
Charron D. Immunogenomics of hematopoietic stem cell transplantation. Pathol. Biol. (Paris) 53: 171-173 (2005).
Charron DJ. New aspects of HLA: perspectives for rheumatoid arthritis. Clin. Exp. Rheumatol. 10: 293-296 (1992).
Chatterjee A, Rathore A, Dhole TN. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians. J. Med. Virol. 81: 959-965 (2009). *
Chatterjee A, Rathore A, Sivarama P, Yamamoto N, Dhole TN. Genetic association of IL-10 gene promoter polymorphism and HIV-1 infection in North Indians. J. Clin. Immunol. 29: 71-77 (2009). *
Chatterjee N, Wacholder S. Invited commentary: efficient testing of gene-environment interaction. Am. J. Epidemiol. 169: 231-233 (2009). *
Chatterjee R, Batra J, Das S, Sharma SK, Ghosh B. Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels. J. Allergy Clin. Immunol. 122: 202-208.e7 (2008).
Chatterjee R, Batra J, Ghosh B. A common exonic variant of interleukin-21 confers susceptibility to atopic asthma. Int. Arch. Allergy Immunol. 148: 137-146 (2008).
Chatterjee R, Batra J, Kumar A, Mabalirajan U, Nahid S, Niphadkar PV, Ghosh B. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clin. Exp. Allergy 35: 914-919 (2005).
Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin. Exp. Rheumatol. 27: 645-648 (2009).
Chatzikyriakidou A, Georgiou I, Voulgari PV, Georgiadis AN, Argyriou ES, Drosos AA. Glucocorticoid receptor variants may predispose to rheumatoid arthritis susceptibility. Scand. J. Rheumatol. 38: 1-5 (2009). *
Chatzikyriakidou A, Georgiou I, Voulgari PV, Papadopoulos CG, Tzavaras T, Drosos AA. Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy. Rheumatol. Int. 27: 1057-1061 (2007). *
Chatzikyriakidou A, Georgiou I, Voulgari PV, Venetsanopoulou AI, Drosos AA. Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism. Rheumatology (Oxford) 46: 1034-1035 (2007). *
Chatzikyriakidou A, Vakalis KV, Kolaitis N, Kolios G, Naka KK, Michalis LK, Georgiou I. Distinct association of SLC19A1 polymorphism -43T>C with red cell folate levels and of MTHFR polymorphism 677C>T with plasma folate levels. Clin. Biochem. 41: 174-176 (2008). *
Chatzipapas C, Boikos S, Drosos GI, Kazakos K, Tripsianis G, Serbis A, Stergiopoulos S, Tilkeridis C, Verettas DA, Stratakis CA. Polymorphisms of the vitamin D receptor gene and stress fractures. Horm. Metab. Res. 41: 635-640 (2009).
Chaudhry AS, Kochhar R, Kohli KK. Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians. Indian J. Med. Res. 130: 437-443 (2009).
Chaudhry AS, Urban TJ, Lamba JK, Birnbaum AK, Remmel RP, Subramanian M, Strom S, You JH, Kasperaviciute D, Catarino CB, Radtke RA, Sisodiya SM, Goldstein DB, Schuetz EG. CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin auto-induction of clearance and maintenance dose. J. Pharmacol. Exp. Ther. Oct 23 [Epub ahead of print] (2009). *
Chauffert M, Cisse A, Chevenne D, Parfait B, Michel S, Trivin F. HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal. Diabetes Care 18: 677-680 (1995).
Chauhan M, McGuire W. Interleukin-6 (-174C) polymorphism and the risk of sepsis in very-low-birth-weight infants: meta-analysis. Arch. Dis. Child. Fetal Neonatal Ed. 93: F427-F429 (2008).
Checa M, Ruiz V, Montano M, Velazquez-Cruz R, Selman M, Pardo A. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 124: 465-472 (2008). *
Chen B, Cao L, Zhou Y, Yang P, Wan HW, Jia GQ, Liu L, Wu XT. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig. Dis. Sci. Dec 4 [Epub ahead of print] (2009). *
Chen B, Fang J, Zhang W, Jin Z, Yu Z, Cai W. Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR. J. Clin. Lab. Anal. 23: 110-116 (2009).
Chen B, Liu S, Wang XL, Xu W, Li Y, Zhao WH, Wu JQ. TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis. Eur. J. Cancer 45: 2598-2605 (2009). *
Chen B, Zeng Z, Hou J, Chen M, Gao X, Hu P. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population. Scand. J. Gastroenterol. 44: 720-726 (2009). *
Chen CC, Huang CY, Huang FY, Dang CW, Lin CL, Lo FS, Lin CH, Tsang CC, Li HJ, Liu HF, Chu CC, Lin M, Lee YJ. The CBLB gene and Graves' disease in children. J. Pediatr. Endocrinol. Metab. 18: 1119-1126 (2005).
Chen CC, Isomoto H, Narumi Y, Sato K, Oishi Y, Kobayashi T, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population. Clin. Immunol. 126: 165-171 (2008). *
Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, Liu HW. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol. Lett. 55: 1-3 (1997).
Chen CM, Chen IC, Chang KH, Chen YC, Lyu RK, Liu YT, Hu FJ, Chao CY, Lee-Chen GJ, Wu YR. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144: 458-462 (2007).
Chen D, Hsieh C, Chen K, Chen Y, Lin F, Lan J. Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 18: 29-37 (2009). *
Chen D, Jin G, Wang Y, Wang H, Liu H, Liu Y, Fan W, Ma H, Miao R, Hu Z, Sun W, Qian J, Jin L, Wei Q, Shen H, Huang W, Lu D. Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population. Carcinogenesis 29: 342-350 (2008). *
Chen D, Tian T, Wang H, Liu H, Hu Z, Wang Y, Liu Y, Ma H, Fan W, Miao R, Sun W, Wang Y, Qian J, Jin L, Wei Q, Shen H, Huang W, Lu D. Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet. Genomics 19: 25-34 (2009). *
Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL. Functional association of interleukin 18 gene -607 (C/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease. J. Rheumatol. 36: 2284-2289 (2009).
Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gotz J. Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101: 7687-7692 (2004). *
Chen FJ, Yu H, Fan F, Lu JX. Mitochondrial D-loop gene polymorphisms in the patients with type 2 diabetes mellitus. Yi Chuan 31: 265-272 (2009).
Chen GG, Ho RL, Wong J, Lee KF, Lai PB. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC). Eur. J. Surg. Oncol. 33: 882-886 (2007).
Chen H, Cui B, Wang S, Zhao Z, Sun H, Gu X, Zhao Y, Li X, Ning G. The common variants of E-selectin gene in Graves' disease. Genes Immun. 9: 182-186 (2008). *
Chen H, Toh TK, Szeverenyi I, Ong RT, Theng CT, McLean WH, Seielstad M, Lane EB. Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J. Invest. Dermatol. 129: 606-614 (2009). *
Chen H, Yang Z, Gibbs D, Yang X, Hau V, Zhao P, Ma X, Zeng J, Luo L, Pearson E, Constantine R, Kaminoh Y, Harmon J, Tong Z, Stratton CA, Cameron DJ, Tang S, Zhang K. Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration. Vision Res. 48: 690-694 (2008).
Chen HH, Lee WJ, Fann CS, Bouchard C, Pan WH. Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese. Am. J. Clin. Nutr. 90: 255-262 (2009). *
Chen HL, Liu YJ, Su YN, Wang NY, Wu SH, Ni YH, Hsu HY, Wu TC, Chang MH. Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography. J. Pediatr. 153: 825-832.e2 (2008). *
Chen HL, Su HJ, Wang YJ, Guo YL, Liao PC, Lee CC. Interactive effects between CYP1A1 genotypes and environmental polychlorinated dibenzo-p-dioxins and dibenzofurans exposures on liver function profile. J. Toxicol. Environ. Health A. 69: 269-281 (2006).
Chen HO, Chen ZJ, Qiu Y, Qiu XS, Cao XB, Liu Z, Li WG. Investigation on the association between estrogen beta receptor gene polymorphisms and the susceptibility of adolescent idiopathic scoliosis. Stud. Health Technol. Inform. 140: 322 (2008).
Chen HY, Cui B, Wang S, Zhao ZF, Sun H, Zhao YJ, Li XY, Ning G. L-Selectin gene polymorphisms in Graves' disease. Clin. Endocrinol. (Oxf.) 67: 145-151 (2007). *
Chen J, Amos CI, Merriman KW, Wei Q, Sen S, Killary AM, Frazier ML. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic whites: a case-control study. Pancreas 39: 1-4 (2010).
Chen J, Compton C, Cheng E, Fromowitz F, Viola MV. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 102: 1983-1987 (1992).
Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864 (1996). *
Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J. Nutr. 129: 560S-564S (1999). *
Chen J, Huang XF. Interleukin-6 promotes carcinogenesis through multiple signal pathways - comment on: clinical significance of interleukin-6 gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig. Dis. Sci. 54: 1373-1374 (2009). *
Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. Cancer Lett. 272: 32-39 (2008).
Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, Selhub J, Hunter DJ, Ma J. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int. J. Cancer 110: 617-620 (2004). *
Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12: 339-342 (2002).
Chen J, Xu Z, Ou X, Wang M, Yang X, Li Q. Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children. Eur. J. Pediatr. 168: 1305-1313 (2009). *
Chen JY, Wang CM, Lu SC, Chou YH, Luo SF. Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients. Clin. Exp. Immunol. 143: 281-287 (2006). *
Chen JY, Wang CM, Ma CC, Chow YH, Luo SF. The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun. 6: 123-128 (2005). *
Chen JY, Wang CM, Ma CC, Hsu LA, Ho HH, Wu YJ, Kuo SN, Wu J. A transmembrane polymorphism in FcgammaRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA. Genes Immun. 9: 680-688 (2008). *
Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP, Wu J. Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients. Arthritis Rheum. 54: 3908-3917 (2006). *
Chen JY, Wang CM, Wu JM, Ho HH, Luo SF. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin. Exp. Immunol. 144: 10-16 (2006). *
Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J. Urol. 175: 108-112 (2006).
Chen L, Brosnan CF. Regulation of immune response by P2X7 receptor. Crit. Rev. Immunol. 26: 499-513 (2006).
Chen L, Davey Smith G, Evans DM, Cox A, Lawlor DA, Donovan J, Yuan W, Day IN, Martin RM, Lane A, Rodriguez S, Davis M, Zuccolo L, Collin SM, Hamdy F, Neal D, Lewis SJ. Genetic variants in the vitamin D receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol. Biomarkers Prev. 18: 2874-2881 (2009).
Chen L, Zhong M, Chen WV, Amos CI, Fan R. A genome-wide association scan for rheumatoid arthritis data by Hotelling's T2 tests. BMC Proc. 3 Suppl. 7: S6 (2009). *
Chen LS, Wei JB, Zhou YC, Zhang S, Liang JL, Cao YF, Tang ZJ, Zhang XL, Gao F. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer. World J. Gastroenterol. 11: 6120-6124 (2005). *
Chen M, Peyrin-Biroulet L, Xia B, Rodriguez-Gueant RM, Bronowicki JP, Bigard MA, Gueant JL. Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. BMC Med. Genet. 9: 78 (2008). *
Chen M, Xia B, Chen B, Guo Q, Li J, Ye M, Hu Z. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. Can. J. Gastroenterol. 21: 155-158 (2007). *
Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev. Diabet. Stud. 3: 21-30 (2006). *
Chen PJ, Wei CC, Wang C, Chen FW, Hsu YH, Chang MS. Promoter analysis of interleukin 19. Biochem. Biophys. Res. Commun. 344: 713-720 (2006). *
Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, Yang WS, Chang TC. Linkage of Graves' disease to the human leucocyte antigen region in the Chinese-Han population in Taiwan. Clin. Endocrinol. (Oxf.) 66: 646-651 (2007). *
Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, Yang WS, Chang TC. Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan. Genes Immun. 9: 87-92 (2008). *
Chen Q, Kamboh MI. Complete DNA sequence variation in the apolipoprotein H (beta-glycoprotein I) gene and identification of informative SNPs. Ann. Hum. Genet. 70: 1-11 (2006). *
Chen QB, Fan LY, Zhong RQ, Tu XQ, Yuan Y, Zhu Y, Ye WM, Lu HQ, Han HX. A study on the relationship between interleukin-10 promoter polymorphism and autoimmune liver disease. Zhonghua Gan Zang Bing Za Zhi 12: 356-358 (2004).
Chen QX, Lv C, Huang LX, Cheng BL, Xie GH, Wu SJ, Fang XM. Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun. 8: 439-443 (2007). *
Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J. Clin. Endocrinol. Metab. 85: 1545-1549 (2000). *
Chen R, Fang M, Cai Q, Duan S, Lv K, Cheng N, Ren D, Shen J, He D, He L, Sun S. Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China. Rheumatol. Int. 28: 121-126 (2007). *
Chen RH, Chang CT, Chen HY, Chen WC, Tsai CH, Tsai FJ. Association between vitamin-D receptor gene FokI polymorphism and Graves' disease among Taiwanese Chinese. J. Clin. Lab. Anal. 21: 173-177 (2007).
Chen RH, Chang CT, Wang TY, Chen CC, Tsai CH, Tsai FJ. Lack of association between interleukin-4 gene polymorphisms and autoimmune thyroid diseases amongst Taiwanese Chinese. Endocrine 32: 170-174 (2007).
Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. J. Clin. Lab. Anal. 22: 321-326 (2008).
Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19: 133-138 (2005).
Chen RH, Chen WC, Chen CC, Tsai CH, Tsai FJ. Association between the TAP1 gene codon 637 polymorphism and Graves' disease. Endocrine 25: 137-140 (2004).
Chen RH, Chen WC, Wang TY, Tsai CH, Tsai FJ. Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves' disease. Int. J. Immunogenet. 32: 343-347 (2005). *
Chen RH, Wang TY, Chen WC, Tsai CH, Tsai FJ. Association between the TAP2 gene codon 665 polymorphism and Graves' disease. J. Clin. Lab. Anal. 20: 93-97 (2006).
Chen S, Li W, Hu Q, Liu Z, Xu Y, Xu A. Polymorphism of HLA class I genes in Meizhou Han population of Guangdong, China. Int. J. Immunogenet. 34: 131-136 (2007). *
Chen S, Li Y, Li S, Yu C. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio. J. Gastroenterol. Hepatol. 23: 1415-1418 (2008). *
Chen S, Ren X, Liu Y, Hu Q, Hong W, Xu A. Human leukocyte antigen class I polymorphism in Miao, Bouyei, and Shui ethnic minorities of Guizhou, China. Hum. Immunol. 68: 928-933 (2007).
Chen SF, Lu XF, Yan WL, Huang JF, Gu DF. Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chin. Med. J. (Engl.) 120: 2218-2223 (2007).
Chen SH, Li YM, Yu CH, Jiang LL. The association of Val227Ala polymorphism of the peroxisome proliferator activated receptor alpha (PPAR alpha) gene with non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 15: 64-65 (2007).
Chen SY, Wan L, Huang YC, Sheu JJ, Lan YC, Lai CH, Lin CW, Chang JS, Tsai Y, Liu SP, Lin YJ, Tsai FJ. Interleukin-18 gene 105A/C genetic polymorphism is associated with the susceptibility of Kawasaki disease. J. Clin. Lab. Anal. 23: 71-76 (2009).
Chen TJ, Ji CY, Zheng XY, Hu YH. Association of beta3 adrenergic receptor and peroxisome proliferator-activated receptor gamma 2 polymorphisms with insulin sensitivity: a twin study. Biomed. Environ. Sci. 20: 99-105 (2007).
Chen W, Ye W, Su P, Ding Y, Peng Y, Liang A, Huang D, Li G. The vitamin D receptor gene TruI polymorphisms and its effect on the detection of BsmI polymorphisms in Han nationality. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 338-340 (2007).
Chen WC, Nie JS. Genetic polymorphism of MCP-1-2518, IL-8-251 and susceptibility to acute pancreatitis: a pilot study in population of Suzhou, China. World J. Gastroenterol. 14: 5744-5748 (2008). *
Chen WJ, Qiu Y, Cao XB, Qiu XS, Chen ZJ, Chen HO. Vitamin D receptor gene polymorphisms: no association with low bone mineral density in adolescent idiopathic scoliosis girls. Stud. Health Technol. Inform. 140: 323 (2008).
Chen WJ, Qiu Y, Zhu F, Zhu ZZ, Sun X, Liu Z, Chen ZJ. Vitamin D receptor gene polymorphisms: no association with low bone mineral density in adolescent idiopathic scoliosis girls. Zhonghua Wai Ke Za Zhi 46: 1183-1186 (2008).
Chen WV, Amos CI, Etzel CJ, Shete S, Gregersen PK. Comparison of genome-wide single-nucleotide polymorphism linkage analyses in Caucasian and Hispanic NARAC families. BMC Proc. 1 Suppl. 1: S97 (2007). *
Chen X, Guan J, Song Y, Chen P, Zheng H, Tang C, Wu Q. IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis. J. Hum. Genet. 53: 227-238 (2008). *
Chen X, Katoh Y, Nakamura K, Oyama N, Kaneko F, Endo Y, Fujita T, Nishida T, Mizuki N. Single nucleotide polymorphisms of Ficolin 2 gene in Behcet's disease. J. Dermatol. Sci. 43: 201-205 (2006).
Chen X, Liu CT, Zhang M, Zhang H. A forest-based approach to identifying gene and gene gene interactions. Proc. Natl. Acad. Sci. U.S.A. 104: 19199-19203 (2007). *
Chen X, Wang H, Xie W, Liang R, Wei Z, Zhi L, Zhang X, Hao B, Zhong S, Zhou G, Zhang L, Gao X, Zhu Y, He F. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China. Pharmacogenet. Genomics 16: 219-227 (2006).
Chen X, Wang L, Zhi L, Zhou G, Wang H, Zhang X, Hao B, Zhu Y, Cheng Z, He F. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clin. Pharmacol. Ther. 78: 249-259 (2005). *
Chen XQ, Huang HG, Zhou YN, Li Y, Chen YC. The study of the relationship between interleukin gene polymorphism and the morbidity of patients with acute pancreatitis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21: 99-102 (2009).
Chen XQ, Wang LL, Shan QW, Tang Q, Lian SJ. Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis. World J. Gastroenterol. 15: 5855-5858 (2009). *
Chen XR, Feng YL, Ma Y, Zhang ZD, Li CY, Wen FQ, Tang XY, Su ZG. Study on the association of two polymorphisms of the vitamin D receptor (VDR) gene with the susceptibility to pulmonary tuberculosis (PTB) in Chinese Tibetans. Sichuan Da Xue Xue Bao Yi Xue Ban 37: 847-851 (2006).
Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72: 335-341 (2008). *
Chen Y, Chen W, Cobb MH, Zhao Y. PTMap - a sequence alignment software for unrestricted, accurate, and full-spectrum identification of post-translational modification sites. Proc. Natl. Acad. Sci. U.S.A. 106: 761-766 (2009). *
Chen Y, Cicciarelli J, Pravica V, Hutchinson IV. Long-range linkage on chromosome 6p of VEGF, FKBP5, HLA and TNF alleles associated with transplant rejection. Mol. Immunol. 47: 96-100 (2009). *
Chen Y, Jia L, Wei C, Wang F, Lv H, Jia J. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease. Brain Res. 1233: 196-202 (2008).
Chen Y, Jiang XY, Xu L, Li X, Cao FF, Li L, Lu M, Jin L, Wang XF. Association of ER-alpha gene polymorphism with metabolic phenotypes in Chinese Hans. Lipids 44: 719-723 (2009).
Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP, Morel L. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J. Immunol. 175: 1080-1089 (2005). *
Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455: 971-974 (2008). *
Chen Y, Zhou B, Peng Y, Wang Y, Li C, Ding X, He X, Xu J, Huang L, Rao L. Interleukin-23 receptor gene polymorphisms is associated with dilated cardiomyopathy in Chinese Han population. Tissue Antigens 73: 330-334 (2009). *
Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 16: 1982-1989 (2007). *
Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 65: 11771-11778 (2005). *
Chen YH, Lin JJ, Jeansonne BG, Tatum R, Lu Q. Analysis of claudin genes in pediatric patients with Bartter's syndrome. Ann. N. Y. Acad. Sci. 1165: 126-134 (2009). *
Chen YJ, Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH. Solute carrier family 11 member A1 gene polymorphisms in reactive arthritis. J. Clin. Immunol. 27: 46-52 (2007). *
Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J. Am. Acad. Dermatol. 60: 225-230 (2009).
Chen YL, Chang YS, Chang JG, Wu SM. Genotyping of K-ras codons 12 and 13 mutations in colorectal cancer by capillary electrophoresis. J. Chromatogr. A. 1216: 5147-5154 (2009).
Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension. Chin. Med. J. (Engl.) 119: 719-724 (2006). *
Chen Z, Ma G, Qian Q, Yao Y, Feng Y, Tang C. Toll-like receptor 8 polymorphism and coronary artery disease. Mol. Biol. Rep. 36: 1897-1901 (2009). *
Chen Z, Takahashi M, Naruse T, Nakajima T, Chen YW, Inoue Y, Ishikawa I, Iwai T, Kimura A. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum. Genet. 122: 367-372 (2007). *
Chen Z, Tang NL, Cao X, Qiao D, Yi L, Cheng JC, Qiu Y. Promoter polymorphism of matrilin-1 gene predisposes to adolescent idiopathic scoliosis in a Chinese population. Eur. J. Hum. Genet. 17: 525-532 (2009).
Chen Z, Zhou Z, Chen X, Xu J, Liu A, Du W, Gu D, Ge J, Guo Z, Wang X, Dong X, Ren Q, Yang R. Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population. J. Clin. Immunol. 28: 399-404 (2008). *
Chen ZC, Shin SJ, Kuo KK, Lin KD, Yu ML, Hsiao PJ. Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance. J. Hum. Genet. 53: 757-763 (2008). *
Chen ZT, Wang IJ, Shih YF, Lin LL. The association of haplotype at the lumican gene with high myopia susceptibility in Taiwanese patients. Ophthalmology 116: 1920-1927 (2009).
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140-143 (2006). *
Cheng CH, Huang YC, Chen FP, Chou MC, Tsai TP. B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia. Eur. J. Nutr. 47: 491-498 (2008). *
Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res. Treat. 111: 145-155 (2008). *
Cheng JC, Tang NL, Yeung HY, Miller N. Genetic association of complex traits: using idiopathic scoliosis as an example. Clin. Orthop. Relat. Res. 462: 38-44 (2007).
Cheng L, Enomoto T, Hirota T, Shimizu M, Takahashi N, Akahoshi M, Matsuda A, Dake Y, Doi S, Enomoto K, Yamasaki A, Fukuda S, Mao XQ, Hopkin JM, Tamari M, Shirakawa T. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen. Clin. Exp. Allergy 34: 1192-1201 (2004). *
Cheng L, Zhang SZ, Xiao CY, Hou YP, Li L, Luo HC, Jiang HY, Zuo WQ. The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br. J. Dermatol. 143: 324-329 (2000).
Cheng PL, Eng HL, Chou MH, You HL, Lin TM. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl. Res. 150: 311-318 (2007). *
Cheng S, Afif H, Martel-Pelletier J, Benderdour M, Pelletier JP, Hilal G, Haraoui P, Raynauld JP, Choquette D, Fahmi H. Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee. Ann. Rheum. Dis. 65: 1394-1397 (2006). *
Cheng SL, Yu CJ, Yang PC. Genetic polymorphisms of cytochrome P450 and matrix metalloproteinase in chronic obstructive pulmonary disease. Biochem. Genet. 47: 591-601 (2009). *
Cheng X, Xu G. Association between aldosterone synthase CYP11B2 polymorphism and essential hypertension in Chinese: a meta-analysis. Kidney Blood Press. Res. 32: 128-140 (2009).
Cheng XJ, Xu W, Zhang QY, Zhou RL. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Ann. Oncol. 19: 527-532 (2008).
Cheng YK, Lin CD, Chang WC, Hwang GY, Tsai SW, Wan L, Tsai MH, Tsai JJ, Tsai FJ. Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis. Arch. Otolaryngol. Head Neck Surg. 132: 285-290 (2006).
Cheon JH, Kim JH, Kim BY, Kim SW, Hong SY, Eun CS, Hong SS, Byeon JS, Kim TI, Han DS, Yang SK, Lee KR, Kim WH. Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases. Hepatogastroenterology 56: 421-423 (2009).
Cheong HS, Kim LH, Park BL, Choi YH, Park HS, Hong SJ, Choi BW, Park CS, Shin HD. Association analysis of interleukin 5 receptor alpha subunit (IL5RA) polymorphisms and asthma. J. Hum. Genet. 50: 628-634 (2005). *
Cheong HS, Lee SO, Choi CB, Sung YK, Shin HD, Bae SC. MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients. Rheumatology (Oxford) 46: 209-214 (2007). *
Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem. Genet. 44: 246-255 (2006). *
Cheong JY, Cho SW, Lim SK, Shin do H, Yoon SK, Lee JE, Hahm KB, Kim JH. Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J. Korean Med. Sci. 20: 65-69 (2005). *
Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes. Hum. Immunol. 62: 1363-1370 (2001).
Chermesh I, Azriel A, Alter-Koltunoff M, Eliakim R, Karban A, Levi BZ. Crohn's disease and SLC11A1 promoter polymorphism. Dig. Dis. Sci. 52: 1632-1635 (2007). *
Chernavsky AC, Paez MC, Periolo N, Correa P, Guillen L, Niveloni SI, Maurino E, Bai JC, Anaya JM. The simultaneous presence of IL-1B and TNFA two-positions risk haplotypes enhances the susceptibility for celiac disease. Cytokine 42: 48-54 (2008).
Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28: 822-832 (2008). *
Cheung VG, Spielman RS. Data for Genetic Analysis Workshop (GAW) 15, Problem 1: genetics of gene expression variation in humans. BMC Proc. 1 Suppl. 1: S2 (2007). *
Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 437: 1365-1369 (2005). *
Cheung YF, Huang GY, Chen SB, Liu XQ, Xi L, Liang XC, Huang MR, Chen S, Huang LS, Liu XQ, Chan KW, Lau YL. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122: e608-e614 (2008). *
Cheung YH, Loh C, Pau E, Kim J, Wither J. Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models. Semin. Immunol. 21: 372-382 (2009). *
Chevalier-Porst F, Souche G, Bozon D. Identification and characterization of three large deletions and a deletion/polymorphism in the CFTR gene. Hum. Mutat. 25: 504 (2005). *
Chiang CH, Tang YC, Lin MW, Chung MY. Association between the IL-4 promoter polymorphisms and asthma or severity of hyperresponsiveness in Taiwanese. Respirology 12: 42-48 (2007).
Chiang HS, Lu JF, Liu CH, Wu YN, Wu CC. CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis. Clin. Genet. 76: 282-286 (2009). *
Chiang JM, Chen HW, Tang RP, Chen JS, Changchien CR, Hsieh PS, Wang JY. Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families. Fam. Cancer Sep 19 [Epub ahead of print] (2009).
Chiappelli M, Tumini E, Porcellini E, Licastro F. Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies. Expert Rev. Neurother. 6: 1327-1336 (2006).
Chien CC, Chen SH, Liu CC, Lee CL, Yang RN, Yang SH, Huang CJ. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC). Transl. Res. 149: 96-102 (2007). *
Child NJ, Yang IA, Pulletz MC, de Courcy-Golder K, Andrews AL, Pappachan VJ, Holloway JW. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 31: 652-653 (2003). *
Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac. J. Clin. Nutr. 13: S24-S25 (2004).
Chinoy H, Lamb JA, Ollier WE, Cooper RG. An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond. Curr. Opin. Rheumatol. 21: 588-593 (2009).
Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, Fertig N, Varsani H, Davidson J, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum. 58: 3247-3254 (2008). *
Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG; for the UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 46: 1411-1416 (2007). *
Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J. Clin. Microbiol. 24: 357-363 (1986). *
Chioza BA, Aicardi J, Aschauer H, Brouwer O, Callenbach P, Covanis A, Dooley JM, Dulac O, Durner M, Eeg-Olofsson O, Feucht M, Friis ML, Guerrini R, Kjeldsen MJ, Nabbout R, Nashef L, Sander T, Siren A, Wirrell E, McKeigue P, Robinson R, Gardiner RM, et al. Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14. Epilepsy Res. 87: 247-255 (2009).
Chistiakov D, Zotova E, Savost'anov K, Bursa T, Galeev I, Strokov Ia, Nosikov V. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab. 32: 63-68 (2006).
Chistiakov DA. Thyroid-stimulating hormone receptor and its role in Graves' disease. Mol. Genet. Metab. 80: 377-388 (2003). *
Chistiakov DA, Potapov VA, Khodirev DC, Shamkhalova MS, Shestakova MV, Nosikov VV. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes. Acta Diabetol. 46: 43-49 (2009).
Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet. 2: 6 (2001). *
Chistiakov DA, Savost'anov KV, Shestakova MV, Chugunova LA, Samkhalova MSh, Dedov II, Nosikov VV. Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res. Clin. Pract. 66: 79-86 (2004).
Chistiakov DA, Savost'anov KV, Turakulov RI. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol. Genet. Metab. 83: 264-270 (2004). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Efremov IA, Demurov LM. Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease. Clin. Immunol. 118: 233-242 (2006). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI, Nosikov VV. Further studies of genetic susceptibility to Graves' disease in a Russian population. Med. Sci. Monit. 8: CR180-CR184 (2002). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab. Res. Rev. 20: 219-224 (2004).
Chistiakov DA, Savost'ianov KV, Chugunova LA, Shamkhalova MSh, Shestakova MV, Milen'kaia TM, Nosikov VV, Dedov II, Debabov VG. Associative analysis of the connection between mutation C1167T in the catalase gene and polymorphic marker D6S392 nearby the Mn-dependent superoxide dismutase gene with diabetic microangiopathies. Ter. Arkh. 74: 28-30 (2002).
Chistiakov DA, Seryogin YA, Turakulov RI, Savost'anov KV, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set. J. Autoimmun. 24: 243-250 (2005).
Chistiakov DA, Spitsina EV, Nikitin AG, Strokov IA, Nosikov VV. A splice variant of GNB3 and peripheral polyneuropathy in type 1 diabetes. Dis. Markers. 26: 111-117 (2009).
Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J. Mol. Endocrinol. 31: 21-36 (2003). *
Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV. Complex association analysis of Graves disease using a set of polymorphic markers. Mol. Genet. Metab. 70: 214-218 (2000). *
Chiu MM, Ko YJ, Tsou AP, Chau GY, Chau YP. Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma. Histol. Histopathol. 24: 1223-1232 (2009). *
Chiu YF, Liu SY, Tsai YY. A comparison in association and linkage genome-wide scans for alcoholism susceptibility genes using single-nucleotide polymorphisms. BMC Genet. 6 Suppl. 1: S89 (2005). *
Chmaisse HN, Fakhoury HA, Salti NN, Makki RF. The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behcets disease in the Lebanese population. Saudi Med. J. 27: 604-607 (2006).
Chmaisse HN, Jammal M, Fakhoury H, Fakhoury R. A study on the association between angiotensin-I converting enzyme I/D dimorphism and type-2 diabetes mellitus. Saudi J. Kidney Dis. Transpl. 20: 1038-1046 (2009).
Cho EK, Tchinda J, Freeman JL, Chung YJ, Cai WW, Lee C. Array-based comparative genomic hybridization and copy number variation in cancer research. Cytogenet. Genome Res. 115: 262-272 (2006).
Cho HJ, Chung JH, Kim IS, Kim HJ, Cho SH, Ki CS, Kim JW. Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans. Thyroid 16: 237-241 (2006).
Cho J. Genetic advances in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 9: 191-200 (2006).
Cho J. Update on inflammatory bowel disease genetics. Curr. Gastroenterol. Rep. 2: 434-439 (2000).
Cho JH. Update on the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 3: 458-463 (2001).
Cho JH, Abraham C. Inflammatory bowel disease genetics: Nod2. Annu. Rev. Med. 58: 401-416 (2007). *
Cho JH, Bang S, Park SW, Chung JB, Song SY. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. Pancreas 36: 337-340 (2008).
Cho JH, Huh S, Kwon TG, Choi JY, Hur IK, Lee EY, Park SH, Kim YL, Kim CD. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients. Transplant. Proc. 40: 2355-2360 (2008). *
Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology 133: 1327-1339 (2007). *
Cho JK, Kim YH, Park IY, Shin JC, Oh MK, Park SJ, Kim NH, Kim IS. Polymorphism of haptoglobin in patients with premature rupture of membrane. Yonsei Med. J. 50: 132-136 (2009). *
Cho SC, Yim SH, Yoo HK, Kim MY, Jung GY, Shin GW, Kim BN, Hwang JW, Kang JJ, Kim TM, Chung YJ. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization. Psychiatr. Genet. 19: 177-185 (2009).
Cho SE, Sook Hong K, Shin GJ, Chung WS. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea. Clin. Chem. Lab. Med. 44: 1070-1075 (2006). *
Cho SM, Kim J, Ryu HJ, Kim JJ, Kim HH, Park JH, Kim HT, Kim KH, Cho HY, Oh B, Park C, Kimm K, Jo I, Lee JE, Shin HD, Lee JK. Identification of single nucleotide polymorphisms in the tumor necrosis factor (TNF) and TNF receptor superfamily in the Korean population. Hum. Immunol. 65: 710-718 (2004).
Cho YG, Choi BJ, Kim CJ, Song JH, Zhang C, Nam SW, Lee JY, Park WS. Genetic analysis of the DBC2 gene in gastric cancer. Acta Oncol. 47: 366-371 (2008).
Chocano-Bedoya P, Ronnenberg AG. Vitamin D and tuberculosis. Nutr. Rev. 67: 289-293 (2009). *
Choi BY, Alper SL, Griffith AJ. Response to: The c.-103T>C variant in the 5'-UTR of SLC26A4 gene: a pathogenic mutation or coincidental polymorphism? Hum. Mutat. 30: 1471 (2009).
Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum. 54: 3838-3841 (2006). *
Choi HB, Han H, Youn JI, Kim TY, Kim TG. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. Tissue Antigens 56: 548-550 (2000). *
Choi JH, Ahn BM, Yi J, Lee JH, Lee JH, Nam SW, Chon CY, Han KH, Ahn SH, Jang IJ, Cho JY, Suh Y, Cho MO, Lee JE, Kim KH, Lee MG. MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet. Genomics 17: 403-415 (2007).
Choi JH, Kim SH, Cho BY, Lee SK, Kim SH, Suh CH, Park HS. Association of TNF-alpha promoter polymorphisms with aspirin-induced urticaria. J. Clin. Pharm. Ther. 34: 231-238 (2009).
Choi JW, Park CS, Hwang M, Nam HY, Chang HS, Park SG, Han BG, Kimm K, Kim HL, Oh B, Kim Y. A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli. J. Allergy Clin. Immunol. 122: 1119-1126.e7 (2008). *
Choi MK, Song IS. Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab. Pharmacokinet. 23: 243-253 (2008).
Choi SW, Gu BH, Ramakrishna S, Park JM, Baek KH. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 145: 85-88 (2009).
Choi YS, Hong JM, Lim S, Ko KS, Pak YK. Impaired coactivator activity of the Gly(482) variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. Biochem. Biophys. Res. Commun. 344: 708-712 (2006). *
Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest. Ophthalmol. Vis. Sci. 49: 2409-2415 (2008). *
Chong KT, Ho WF, Koo SH, Thompson P, Lee EJ. Distribution of the FcgammaRIIIa 176 F/V polymorphism amongst healthy Chinese, Malays and Asian Indians in Singapore. Br. J. Clin. Pharmacol. 63: 328-332 (2007). *
Chong WP, Ip WE, Tso GH, Ng MW, Wong WH, Law HK, Yung RW, Chow EY, Au K, Chan EY, Lim W, Peiris JM, Lau YL. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect. Dis. 6: 82 (2006). *
Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun. 5: 484-492 (2004). *
Choonhakarn C, Romphruk A, Puapairoj C, Jirarattanapochai K, Romphruk A, Leelayuwat C. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int. J. Dermatol. 41: 330-334 (2002).
Choquet H, Cavalcanti-Proenca C, Lecoeur C, Dina C, Cauchi S, Vaxillaire M, Hadjadj S, Horber F, Potoczna N, Charpentier G, Ruiz J, Hercberg S, Maimaitiming S, Roussel R, Boenhnke M, Jackson AU, Patsch W, Krempler F, Voight BF, Altshuler D, Groop L, et al. The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49,279 subjects. Hum. Mol. Genet. 18: 2495-2501 (2009).
Chou LS, Lyon E, Wittwer CT. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am. J. Clin. Pathol. 124: 330-338 (2005).
Chouchane L, Sfar I, Bousaffara R, El Kamel A, Sfar MT, Ismail A. A repeat polymorphism in interleukin-4 gene is highly associated with specific clinical phenotypes of asthma. Int. Arch. Allergy Immunol. 120: 50-55 (1999).
Choudhry S, Avila PC, Nazario S, Ung N, Kho J, Rodriguez-Santana JR, Casal J, Tsai HJ, Torres A, Ziv E, Toscano M, Sylvia JS, Alioto M, Salazar M, Gomez I, Fagan JK, Salas J, Lilly C, Matallana H, Castro RA, Selman M, Weiss ST, Ford JG, Drazen JM, et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. Am. J. Respir. Crit. Care Med. 172: 173-182 (2005). *
Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 25: 231-259 (2006). *
Choudhury K, McQuillin A, Puri V, Pimm J, Datta S, Thirumalai S, Krasucki R, Lawrence J, Bass NJ, Quested D, Crombie C, Fraser G, Walker N, Nadeem H, Johnson S, Curtis D, St Clair D, Gurling HM. A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia. Am. J. Hum. Genet. 80: 664-672 (2007). *
Choudhury Y, Sharan RN. Ultrastructural alterations in liver of mice exposed chronically and transgenerationally to aqueous extract of betel nut: implications in betel nut-induced carcinogenesis. Microsc. Res. Tech. Oct 16 [Epub ahead of print] (2009).
Choukem SP, Boudou P, Sobngwi E, Villette JM, Ibrahim F, Moulin P, Hadjadj S, Eberle D, Foufelle F, Vexiau P, Gautier JF. The polymorphism Arg585Gln in the gene of the sterol regulatory element binding protein-1 (SREBP-1) is not a determinant of ketosis prone type 2 diabetes (KPD) in Africans. Diabetes Metab. 35: 20-24 (2009).
Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am. J. Gastroenterol. 104: 2704-2713 (2009). *
Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, Cowie S, Nasioulas S, du Sart D, Young J, Leggett B, Jass J, Macrae F. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131: 30-39 (2006). *
Chowdhury ZM, McDermott MF, Davey S, Hassan Z, Sinnott PJ, Hemmatpour SK, Sherwin S, Ali L, Aganna E, Allotey RA, North BV, Cassell PG, Azad Khan AK, Hitman GA. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study. Genes Immun. 3: 5-8 (2002). *
Christiani DC, Mehta AJ, Yu CL. Genetic susceptibility to occupational exposures. Occup. Environ. Med. 65: 430-436 (2008).
Chrzanowska M, Kurzawski M, Drozdzik M, Mazik M, Oko A, Czekalski S. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients. Pharmacol. Rep. 58: 973-978 (2006). *
Chu CC, Ho HT, Lee HL, Chan YS, Chang FJ, Wang CL, Lin M. Anti-"Mi" immunization is associated with HLA-DRB1*0901. Transfusion 49: 472-478 (2009).
Chu CH, Yang AM, Kao JH, Liu CY, Chang WH, Yang WS. Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients. J. Gastroenterol. Hepatol. 24: 1559-1561 (2009). *
Chu JH, Weiss ST, Carey VJ, Raby BA. A graphical model approach for inferring large-scale networks integrating gene expression and genetic polymorphism. BMC Syst. Biol. 3: 55 (2009). *
Chu LW, Li Y, Li Z, Tang AY, Cheung BM, Leung RY, Yik PY, Jin DY, Song YQ. A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144: 1007-1013 (2007).
Chu NF. Plasma hyperhomocysteinemia, MTHFR polymorphism and thromboembolic disease: an example of gene-nutrition interactions in chronic disease. J. Chin. Med. Assoc. 68: 557-559 (2005).
Chu X, Dong C, Lei R, Sun L, Wang Z, Dong Y, Shen M, Wang Y, Wang B, Zhang K, Yang L, Li Y, Yuan W, Wang Y, Song H, Jin L, Xiong M, Huang W. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. Genes Immun. 10: 260-266 (2009).
Chu X, Dong Y, Shen M, Sun L, Dong C, Wang Y, Wang B, Zhang K, Hua Q, Xu S, Huang W. Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence. BMC Med. Genet. 10: 26 (2009). *
Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, Mao CZ, Chu JY, Tokunaga K. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63: 21-27 (2004). *
Chua KH, Hilmi I, Ng CC, Eng TL, Palaniappan S, Lee WS, Goh KL. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J. Dig. Dis. 10: 124-130 (2009). *
Chua KH, Kee BP, Tan SY, Lian LH. Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. Braz. J. Med. Biol. Res. 42: 551-555 (2009). *
Chua KH, Puah SM, Chew CH, Tan SY, Lian LH. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann. Hum. Biol. Dec 2 [Epub ahead of print] (2009).
Chuang CZ, Boyles A, Legardeur B, Su J, Japa S, Lopez SA. Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects. Am. J. Med. Sci. 331: 65-71 (2006).
Chuang JH, Chou MH, Wu CL, Du YY. Implication of innate immunity in the pathogenesis of biliary atresia. Chang Gung Med. J. 29: 240-250 (2006). *
Chuang WY, Strobel P, Belharazem D, Rieckmann P, Toyka KV, Nix W, Schalke B, Gold R, Kiefer R, Klinker E, Opitz A, Inoue M, Kuo TT, Muller-Hermelink HK, Marx A. The PTPN22(gain-of-function)+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis. Genes Immun. 10: 667-672 (2009).
Chui MH, Papanikolaou Y, Fontaine-Bisson B, Turcotte J, Wolever TM, El-Sohemy A, Chiasson JL, Rabasa-Lhoret R, Maheux P, Ryan E, Greenwood CE. The TNF-alpha-238A single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes. Behav. Neurosci. 121: 619-624 (2007).
Chun JK, Kang DW, Yoo BW, Shin JS, Kim DS. Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki disease. Eur. J. Pediatr. 169: 181-185 (2010). *
Chung BS, Lee JK, Choi MH, Park MH, Choi D, Hong ST. Single nucleotide polymorphisms of cytokine genes are associated with fibrosis of the intrahepatic bile duct wall in human clonorchiasis. Korean J. Parasitol. 47: 145-151 (2009).
Chung CC, Magalhaes W, Gonzalez-Bosquet J, Chanock SJ. Genome-wide association studies in cancer - current and future directions. Carcinogenesis Nov 11 [Epub ahead of print] (2009). *
Chung EK, Wu YL, Yang Y, Zhou B, Yu CY. Human complement components C4A and C4B genetic diversities: complex genotypes and phenotypes. Curr. Protoc. Immunol. Chapter 13: Unit 13.8 (2005).
Chung EY, Liu J, Zhang Y, Ma X. Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1. Genes Immun. 8: 577-589 (2007). *
Chung HT, Kim LH, Park BL, Lee JH, Park HS, Choi BW, Hong SJ, Chae SC, Kim JJ, Park CS, Shin HD. Association analysis of novel TBX21 variants with asthma phenotypes. Hum. Mutat. 22: 257 (2003). *
Chung SA, Criswell LA. PTPN22: its role in SLE and autoimmunity. Autoimmunity 40: 582-590 (2007).
Chung SL, Chiou KR, Charng MJ. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B(12) is associated with coronary in-stent restenosis. Catheter Cardiovasc. Interv. 67: 349-355 (2006).
Chung Y, Dong C. Don�t leave home without it: the IL-23 visa to TH-17 cells. Nat. Immunol. 10: 236-238 (2009). *
Chung YS, Cha HE, Kang IG, Hwang YJ, Kim ST. Polymorphism at the glutathione S-transferase P1 locus in Korean patients with perennial allergic rhinitis. Am. J. Rhinol. 20: 648-651 (2006).
Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, Peralta S, Franco V, Giardina E, Craxi A, Pitzalis C, Triolo G. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 60: 955-965 (2009). *
Cichoz-Lach H, Celinski K, Slomka M. Alcohol-metabolizing enzyme gene polymorphisms and alcohol chronic pancreatitis among Polish individuals. HPB (Oxford) 10: 138-143 (2008). *
Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M. The influence of genetic polymorphism of CYP2E1 on the development of alcohol liver cirrhosis. Wiad. Lek. 59: 757-761 (2006).
Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M, Wojcierowski J. Genetic polymorphism of alcohol dehydrogenase 3 in alcohol liver cirrhosis and in alcohol chronic pancreatitis. Alcohol Alcohol. 41: 14-17 (2006).
Cichy M, Adamek-Guzik T, Uracz D, Uracz W, Czerniawska-Mysik G, Korbut R, Guzik TJ. The functional relevance of Arg16Gly and Gln27Glu-beta2-adrenoreceptor polymorphism in patients with asthma and allergic rhinitis. Folia. Med. Cracov. 46: 33-51 (2005).
Ciernikova S, Tomka M, Kovac M, Stevurkova V, Zajac V. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Neoplasma 53: 97-102 (2006). *
Cimaz R, Cazalis MA, Raynaud C, Gerloni V, Zulian F, Biggioggero M, Martini G, Pontikaki I, Fantini F, Mougin B, Miossec P. IL-1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors. Ann. Rheum. Dis. 66: 900-904 (2007). *
Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population. Cas. Lek. Cesk. 143: 318-322 (2004).
Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M, Sumnik Z. No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res. Clin. Pract. 76: 297-303 (2007).
Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, Slavcev A. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J. Rheumatol. 31: 1206-1210 (2004).
Cipriano C, Caruso C, Lio D, Giacconi R, Malavolta M, Muti E, Gasparini N, Franceschi C, Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 32: 13-18 (2005). *
Cirillo G, Di Domenico MR, Corsi I, Gagliardo T, Del Giudice EM, Perrone L, Tolone C. Do MYO9B genetic variants predispose to coeliac disease? An association study in a cohort of South Italian children. Dig. Liver Dis. 39: 228-231 (2007).
Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, Sarissky M, Mojzis J, Mirossay L, Mirossay A. MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J. Sep 15 [Epub ahead of print] (2009).
Claas FH, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen DL, Duquesnoy RJ, Doxiadis II. Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl. Immunol. 14: 187-191 (2005).
Clappers N, van Oijen MG, Sundaresan S, Brouwer MA, Te Morsche RH, Keuper W, Peters WH, Drenth JP, Verheugt FW. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid. Thromb. Haemost. 100: 70-75 (2008).
Clarizia AD, Bastos-Rodrigues L, Pena HB, Anacleto C, Rossi B, Soares FA, Lopes A, Rocha JC, Caballero O, Camargo A, Simpson AJ, Pena SD. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet. Mol. Res. 5: 315-322 (2006). *
Clark DW. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29: 342-375 (1985).
Clark NM, Marinis JM, Cobb BA, Abbott DW. MEKK4 sequesters RIP2 to dictate NOD2 signal specificity. Curr. Biol. 18: 1402-1408 (2008).
Clark TG, Andrew T, Cooper GM, Marguiles EH, Mullikin JC, Balding DJ. Functional constraint and small insertions and deletions in the ENCODE regions of the human genome. Genome Biol. 8: R180 (2007). *
Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A, Richardson A, Small K, Teo YY, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J. Infect. Dis. 199: 569-575 (2009). *
Clark VJ, Dean M. Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation. Hum. Genomics 1: 195-207 (2004).
Clark VJ, Dean M. Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes. Hum. Genomics 1: 255-273 (2004).
Clarke E, Rahman N, Page N, Rolph MS, Stewart GJ, Jones GJ. Functional characterization of the atopy-associated gene PHF11. J. Allergy Clin. Immunol. 121: 1148-1154.e3 (2008). *
Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc. Natl. Acad. Sci. U.S.A. 104: 7169-7174 (2007). *
Clausmeyer S, Hesse V, Clemens PC, Engelbach M, Kreuzer M, Becker-Rose P, Spital H, Schulze E, Raue F. Mutational analysis of the PHEX gene: novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets. Calcif. Tissue Int. 85: 211-220 (2009).
Claustres M. Molecular pathology of the CFTR locus in male infertility. Reprod. Biomed. Online 10: 14-41 (2005).
Claustres M, Altieri JP, Guittard C, Templin C, Chevalier-Porst F, Des Georges M. Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med. Genet. 5: 19 (2004). *
Clementi M, Gianantonio ED. Genetic susceptibility to infectious diseases. Reprod. Toxicol. 21: 345-349 (2006).
Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Gren S, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett. 260: 209-215 (2008).
Clot F, Fulchignoni-Lataud MC, Renoux C, Percopo S, Bouguerra F, Babron MC, Djilali-Saiah I, Caillat-Zucman S, Clerget-Darpoux F, Greco L, Serre JL. Linkage and association study of the CTLA-4 region in coeliac disease for Italian and Tunisian populations. Tissue Antigens 54: 527-530 (1999). *
Coban C, Ishii KJ, Akira S. Immune interventions of human diseases through Toll-like receptors. Adv. Exp. Med. Biol. 655: 63-80 (2009). *
Cobb JE, White SJ, Harrap SB, Ellis JA. Androgen receptor copy number variation and androgenetic alopecia: a case-control study. PLoS ONE 4: e5081 (2009). *
Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088 (2004). *
Cochery-Nouvellon E, Vitry F, Cornillet-Lefebvre P, Hezard N, Gillot L, Nguyen P. Interleukin-10 promoter polymorphism and venous thrombosis: a case-control study. Thromb. Haemost. 96: 24-28 (2006).
Coelho A, Matos A, Catarino R, Pinto D, Sousa H, Pereira D, Medeiros R. The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol. Obstet. Invest. 64: 208-212 (2007).
Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305: 869-872 (2004). *
Cohen K, Grant A, Dandara C, McIlleron H, Pemba L, Fielding K, Charalombous S, Churchyard G, Smith P, Maartens G. Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa. Antivir. Ther. 14: 687-695 (2009).
Cohen N, Brautbar C, Font MP, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23: 84-89 (1986).
Cohen R, Metzger S, Nahir M, Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behcet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann. Rheum. Dis. 61: 157-160 (2002). *
Cohn JA, Neoptolemos JP, Feng J, Yan J, Jiang Z, Greenhalf W, McFaul C, Mountford R, Sommer SS. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers. Hum. Mutat. 26: 303-307 (2005).
Cole SM, Long JC. A coalescent simulation of marker selection strategy for candidate gene association studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147: 86-93 (2008).
Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol. 401: 9-42 (2005).
Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Res. Treat. 119: 437-442 (2010).
Collins JE, Heward JM, Howson JM, Foxall H, Carr-Smith J, Franklyn JA, Gough SC. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United kingdom. J. Clin. Endocrinol. Metab. 89: 6336-6339 (2004). *
Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf.) 60: 618-624 (2004). *
Collins M, Posthumus M, Schwellnus MP. The COL1A1 gene and acute soft tissue ruptures. Br. J. Sports Med. Feb 4 [Epub ahead of print] (2009).
Collins RW, Stephens HA, Clare MA, Vaughan RW. High resolution molecular phototyping of MICA and MICB alleles using sequence specific primers. Hum. Immunol. 63: 783-794 (2002).
Colobran R, Casamitjana N, Roman A, Faner R, Pedrosa E, Arostegui JI, Pujol-Borrell R, Juan M, Palou E. Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation. Genes Immun. 10: 254-259 (2009).
Colobran R, Comas D, Faner R, Pedrosa E, Anglada R, Pujol-Borrell R, Bertranpetit J, Juan M. Population structure in copy number variation and SNPs in the CCL4L chemokine gene. Genes Immun. 9: 279-288 (2008). *
Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc. Natl. Acad. Sci. U.S.A. 89: 3932-3936 (1992). *
Colucci R, Blandizzi C, Bellini M, Ghisu N, Tonini M, Del Tacca M. The genetics of the serotonin transporter and irritable bowel syndrome. Trends Mol. Med. 14: 295-304 (2008). *
Comabella M, Altet L, Peris F, Villoslada P, Sanchez A, Montalban X. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients. Mult. Scler. 10: 618-620 (2004). *
Comabella M, Craig DW, Camina-Tato M, Morcillo C, Lopez C, Navarro A, Rio J; BiomarkerMS Study Group, Montalban X, Martin R. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3: e3490 (2008). *
Combarros O, Infante J, Rodriguez E, Llorca J, Pena N, Fernandez-Viadero C, Berciano J. CD14 receptor polymorphism and Alzheimer's disease risk. Neurosci. Lett. 380: 193-196 (2005). *
Combarros O, Riancho JA, Infante J, Sanudo C, Llorca J, Zarrabeitia MT, Berciano J. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement. Geriatr. Cogn. Disord. 20: 153-157 (2005).
Combarros O, Rodriguez-Rodriguez E, Mateo I, Vazquez-Higuera JL, Infante J, Berciano J, Sanchez-Juan P. APOE dependent-association of PPAR-gamma genetic variants with Alzheimer's disease risk. Neurobiol. Aging Aug 4 [Epub ahead of print] (2009).
Comets E, Verstuyft C, Lavielle M, Jaillon P, Becquemont L, Mentre F. Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters. Eur. J. Clin. Pharmacol. 63: 437-449 (2007). *
Cominelli F, Pizarro TT. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10 Suppl. 2: 49-53 (1996).
Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, et al. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin. Cancer Res. 15: 5338-5349 (2009). *
Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome. Nat. Genet. 38: 75-81 (2006). *
Conrad DJ, Stenbit AE, Zettner EM, Wick I, Eckhardt C, Hardiman G. Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population. Pharmacogenet. Genomics 18: 1095-1102 (2008).
Conrad S, Kauffmann HM, Ito K, Deeley RG, Cole SP, Schrenk D. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J. Hum. Genet. 46: 656-663 (2001).
Conseil G, Deeley RG, Cole SP. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet. Genomics 15: 523-533 (2005).
Constantin A, Dieude P, Lauwers-Cances V, Jamard B, Mazieres B, Cambon-Thomsen A, Cornelis F, Cantagrel A. Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis Rheum. 50: 742-747 (2004). *
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A. Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J. Rheumatol. 29: 15-20 (2002). *
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum. 46: 1754-1762 (2002). *
Constantin A, Navaux F, Lauwers-Cances V, Abbal M, van Meerwijk JP, Mazieres B, Cambon-Thomsen A, Cantagrel A. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet 358: 2051-2052 (2001). *
Contreras J, Hare L, Camarena B, Glahn D, Dassori A, Medina R, Contreras S, Ramirez M, Armas R, Munoz R, Mendoza R, Raventos H, Ontiveros A, Nicolini H, Palmer R, Escamilla M. The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatr. Scand. 119: 117-127 (2009).
Contu D, Morelli L, Santoni F, Foster JW, Francalacci P, Cucca F. Y-chromosome based evidence for pre-neolithic origin of the genetically homogeneous but diverse Sardinian population: inference for association scans. PLoS ONE 3: e1430 (2008). *
Contu SS, Agnes G, Damin AP, Contu PC, Rosito MA, Alexandre CO, Damin DC. Lack of correlation between p53 codon 72 polymorphism and anal cancer risk. World J. Gastroenterol. 15: 4566-4570 (2009). *
Conway BR, Savage DA, Brady HR, Maxwell AP. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility. Nephron. Exp. Nephrol. 105: e75-e79 (2007).
Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979 (2004). *
Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KP, Sow O, Lienhardt C, Hill AV. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 174: 339-343 (2006). *
Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 30: 851-856 (1999). *
Cooley P, Taylor KH, Czika W, Seifer C, Taylor JF. Analysis of a biomarker for Wegener's granulomatosis. Int. J. Immunogenet. 32: 237-243 (2005). *
Coolman M, de Maat M, Van Heerde WL, Felida L, Schoormans S, Steegers EA, Bertina RM, de Groot CJ. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia. Placenta 28: 709-713 (2007).
Coon CI, Fiering S, Gaudet J, Wyatt CA, Brinckerhoff CE. Site controlled transgenic mice validating increased expression from human matrix metalloproteinase (MMP-1) promoter due to a naturally occurring SNP. Matrix Biol. 28: 425-431 (2009).
Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 68: 613-618 (2007).
Cooney R, Cummings JR, Pathan S, Beckly J, Geremia A, Hancock L, Guo C, Morris A, Jewell DP. Association between genetic variants in myosin IXB and Crohn's disease. Inflamm. Bowel Dis. 15: 1014-1021 (2009). *
Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research. Environ. Health Perspect. 107 Suppl. 5: 693-700 (1999).
Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med. Genet. 8: 71 (2007). *
Cope N, Harold D, Hill G, Moskvina V, Stevenson J, Holmans P, Owen MJ, O'Donovan MC, Williams J. Strong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia. Am. J. Hum. Genet. 76: 581-591 (2005). *
Coppede F. Reflections on the possible role of the methionine synthase reductase (MTRR) A66G polymorphism as a maternal risk factor for Down syndrome in Italy. Am. J. Obstet. Gynecol. Oct 19 [Epub ahead of print] (2009).
Coppede F, Colognato R, Bonelli A, Astrea G, Bargagna S, Siciliano G, Migliore L. Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. Am. J. Med. Genet. A. 143: 2006-2015 (2007).
Coppola G, Geschwind DH. Technology insight: querying the genome with microarrays-progress and hope for neurological disease. Nat. Clin. Pract. Neurol. 2: 147-158 (2006).
Coppotelli G, Summers A, Chidakel A, Ross JM, Celi FS. Functional characterization of the 258 A/G (D2-ORFa-Gly3Asp) human type-2 deiodinase polymorphism: a naturally occurring variant increases the enzymatic activity by removing a putative repressor site in the 5' UTR of the gene. Thyroid 16: 625-632 (2006).
Corbetta S, Eller-Vainicher C, Frigerio M, Valaperta R, Costa E, Vicentini L, Baccarelli A, Beck-Peccoz P, Spada A. Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl- oxalate transporter in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 160: 283-288 (2009).
Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Orefice F, Teixeira AL. TNF-alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. Br. J. Ophthalmol. 92: 986-988 (2008).
Cordeiro Q, Cappi C, Sampaio AS, Palacios SA, Pereira CA, Shavitt RG, Miguel EC, Guilherme L, Hounie AG. Association study between the -62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder. Rev. Bras. Psiquiatr. 31: 131-135 (2009).
Cordell HJ. Genome-wide association studies: detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 10: 392-404 (2009). *
Corder EH, Blennow K, Prince JA. Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci. Rejuvenation Res. 11: 667-679 (2008).
Corder EH, Hefler LA. Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma. Rejuvenation Res. 9: 56-60 (2006).
Cordero EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 74: 308-313 (2009). *
Cordoba-Lanus E, de-Torres JP, Lopez-Aguilar C, Rodriguez-Perez MC, Maca-Meyer N, Montejo-de-Garcini A, Aguirre-Jaime A, Perez-Mendez L, Casanova C. Association of IL-6 gene polymorphisms and COPD in a Spanish Population. Respir. Med. 102: 1805-1811 (2008).
Cordonnier-Pratt MM, Liang C, Wang H, Kolychev DS, Sun F, Freeman R, Sullivan R, Pratt LH. MAGIC database and interfaces: an integrated package for gene discovery and expression. Comp. Funct. Genomics 5: 268-275 (2004). *
Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404. Tissue Antigens 65: 448-458 (2005). *
Corella D, Gonzalez JI, Bullo M, Carrasco P, Portoles O, Diez-Espino J, Covas MI, Ruiz-Gutierrez V, Gomez-Gracia E, Aros F, Fiol M, Herrera MC, Santos JM, Saez G, Lamuela R, Lahoz C, Vinyoles E, Ros E, Estruch R. Polymorphisms cyclooxygenase-2 -765G>C and interleukin-6 -174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J. Nutr. 139: 128-134 (2009). *
Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr. 25: 341-390 (2005). *
Corella D, Qi L, Tai ES, Deurenberg-Yap M, Tan CE, Chew SK, Ordovas JM. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care 29: 1313-1319 (2006). *
Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6: D1321-D1357 (2001).
Cork MJ, Crane AM, Duff GW. Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. Dermatol. Clin. 14: 671-678 (1996).
Corleto VD, Pagnini C, Margagnoni G, Guagnozzi D, Torre MS, Martorelli M, Latiano A, Annese V, Caprilli R, Delle Fave G. IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: an Italian population study and meta-analysis of European studies. Dig. Liver Dis. Jul 28 [Epub ahead of print] (2009).
Cormier C, Bosse Y, Mfuna L, Hudson TJ, Desrosiers M. Polymorphisms in the tumour necrosis factor alpha-induced protein 3 (TNFAIP3) gene are associated with chronic rhinosinusitis. J. Otolaryngol. Head Neck Surg. 38: 133-141 (2009).
Cornelis MC, Bae SC, Kim I, El-Sohemy A. CYP1A2 genotype and rheumatoid arthritis in Koreans. Rheumatol. Int. Jul 5 [Epub ahead of print] (2009). *
Cornelis MC, El-Sohemy A, Campos H. GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. Am. J. Clin. Nutr. 86: 752-758 (2007). *
Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am. J. Clin. Nutr. 89: 1256-1262 (2009). *
Corominas H, Figuls R, Riera M, Baiget M. Phenotype of ulcerative colitis, rheumatoid arthritis, and interleukin-10 gene polymorphism. Rev. Esp. Enferm. Dig. 98: 704-705 (2006).
Corpechot C, Benlian P, Barbu V, Chazouilleres O, Poupon RE, Poupon R. Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? J. Hepatol. 35: 324-328 (2001). *
Corpechot C, Poupon R. Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis. Hepatology 35: 242-243 (2002). *
Corpeleijn E, van der Kallen CJ, Kruijshoop M, Magagnin MG, de Bruin TW, Feskens EJ, Saris WH, Blaak EE. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance. Diabet. Med. 23: 907-911 (2006). *
Correa I, Veny M, Esteller M, Pique JM, Yague J, Panes J, Salas A. Defective IL-10 production in severe phenotypes of Crohn's disease. J. Leukoc. Biol. 85: 896-903 (2009). *
Correa PA, Gomez LM, Anaya JM. Polymorphism of TNF-alpha in autoimmunity and tuberculosis. Biomedica 24 Supp. 1: 43-51 (2004).
Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J. Rheumatol. 32: 219-224 (2005).
Correa PA, Molina JF, Pinto LF, Arcos-Burgos M, Herrera M, Anaya JM. TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus. Ann. Rheum. Dis. 62: 363-365 (2003). *
Correa PA, Tobon GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 24: 140-152 (2004).
Correia AP, Pinto JP, Dias V, Mascarenhas C, Almeida S, Porto G. CAT53 and HFE alleles in Alzheimer's disease: a putative protective role of the C282Y HFE mutation. Neurosci. Lett. 457: 129-132 (2009).
Cortes LM, Baltazar LM, Lopez-Cardona MG, Olivares N, Ramos C, Salazar M, Sandoval L, Lorenz MG, Chakraborty R, Paterson AD, Rivas F. HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum. Immunol. 65: 1469-1476 (2004).
Corthesy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Muller M, van Belzen N, van Ommen B. Nutrigenomics: the impact of biomics technology on nutrition research. Ann. Nutr. Metab. 49: 355-365 (2005).
Cortina-Borja M, Smith AD, Combarros O, Lehmann DJ. The synergy factor: a statistic to measure interactions in complex diseases. BMC Res. Notes 2: 105 (2009). *
Corvalan A, Ding S, Koriyama C, Carrascal E, Carrasquilla G, Backhouse C, Urzua L, Argandona J, Palma M, Eizuru Y, Akiba S. Association of a distinctive strain of Epstein-Barr virus with gastric cancer. Int. J. Cancer 118: 1736-1742 (2005). *
Corvol H, Boelle PY, Brouard J, Knauer N, Chadelat K, Henrion-Caude A, Flamant C, Muselet-Charlier C, Boule M, Fauroux B, Vallet C, Feingold J, Ratjen F, Grasemann H, Clement A. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr. Pulmonol. 43: 1224-1232 (2008).
Corvol H, Nathan N, Charlier C, Chadelat K, Le Rouzic P, Tabary O, Fauroux B, Henrion-Caude A, Feingold J, Boelle PY, Clement A. Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis. Respir. Res. 8: 88 (2007). *
Corydon TJ, Haagerup A, Jensen TG, Binderup HG, Petersen MS, Kaltoft K, Vestbo J, Kruse TA, Borglum AD. A functional CD86 polymorphism associated with asthma and related allergic disorders. J. Med. Genet. 44: 509-515 (2007).
Corzo D, Salazar M, Granja CB, Yunis EJ. Advances in HLA genetics. Exp. Clin. Immunogenet. 12: 156-170 (1995).
Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ. The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups. Blood 86: 3835-3840 (1995). *
Cosan D, Kurt E, Kurt H, Degirmenci I, Kucukarabaci B, Metintas M, Kucuk MU, Gunes HV, Colak E. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma. Genet. Test. Mol. Biomarkers 13: 543-546 (2009).
Cosan F, Oku B, Cakiris A, Duymaz-Tozkir J, Mercanoglu F, Saruhan-Direskeneli G, Ustek D, Gul A. No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet's disease. Clin. Rheumatol. 28: 1385-1388 (2009). *
Cosentino A, Gambelunghe G, Tortoioli C, Falorni A. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 958: 337-340 (2002). *
Coskun M, Bacanli A, Sallakci N, Alpsoy E, Yavuzer U, Yegin O. Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease. Exp. Dermatol. 14: 124-129 (2005). *
Costa AM, Guimaraes MC, de Souza ER, Nobrega OT, Bezerra AC. Interleukin-6 (G-174C) and tumour necrosis factor-alpha (G-308A) gene polymorphisms in geriatric patients with chronic periodontitis. Gerodontology Jun 25 [Epub ahead of print] (2009).
Costa JE, Gomes CC, Cota LO, Pataro AL, Silva JF, Gomez RS, Costa FO. Polymorphism in the promoter region of the gene for 5-HTT in individuals with aggressive periodontitis. J. Oral Sci. 50: 193-198 (2008). *
Costa N, Paramanathan S, Donald DM, Wierzbicki AS, Hampson G. Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Cytokine 46: 376-381 (2009).
Costa NR, Mendes N, Marcos NT, Reis CA, Caffrey T, Hollingsworth MA, Santos-Silva F. Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H. pylori adhesion to gastric epithelial cells. World J. Gastroenterol. 14: 1411-1414 (2008). *
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res. Treat. 103: 209-217 (2007). *
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8: 32 (2008). *
Costa V, Casamassimi A, Esposito K, Villani A, Capone M, Iannella R, Schisano B, Ciotola M, Di Palo C, Corrado FC, Santangelo F, Giugliano D, Ciccodicola A. Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy. J. Biomed. Biotechnol. 2009: 126917 (2009). *
Costa-Mallen P, Checkoway H, Zabeti A, Edenfield MJ, Swanson PD, Longstreth WT Jr, Franklin GM, Smith-Weller T, Sadrzadeh SM. The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 216-222 (2008).
Costabile M, Quach A, Ferrante A. Molecular approaches in the diagnosis of primary immunodeficiency diseases. Hum. Mutat. 27: 1163-1173 (2006). *
Costas J, Carrera N, Dom�nguez E, Vilella E, Martorell L, Valero J, Gutierrez-Zotes A, Labad A, Carracedo A. A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia. Hum. Genet. 124: 607-613 (2009). *
Costas J, Perez-Pampin E, Ferreiros-Vidal I, Torres M, Phillips C, Vicario JL, Pablos JL, Carracedo A, Gomez-Reino JJ, Gonzalez A. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis. J. Rheumatol. 33: 1048-1051 (2006).
Costas J, Salas A, Phillips C, Carracedo A. Human genome-wide screen of haplotype-like blocks of reduced diversity. Gene 349: 219-225 (2005). *
Coste AT, Turner V, Ischer F, Morschhauser J, Forche A, Semelcki A, Berman J, Bille J, Sanglard D. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172: 2139-2156 (2006). *
Costello P, FitzGerald O. Disease mechanisms in psoriasis and psoriatic arthritis. Curr. Rheumatol. Rep. 3: 419-427 (2001).
Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW. PTPN22, PADI-4 and CTLA-4 genetic polymorphisms and risk of rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res. Ther. 10: R52 (2008). *
Coto-Segura P, Alvarez V, Soto-Sanchez J, Morales B, Coto E, Santos-Juanes J. Lack of association between angiotensin I-converting enzyme insertion/deletion polymorphism and psoriasis or psoriatic arthritis in Spain. Int. J. Dermatol. 48: 1320-1323 (2009). *
Coto-Segura P, Coto E, Alvarez V, Morales B, Soto-Sanchez J, Corao AI, Santos-Juanes J. Apolipoprotein epsilon4 allele is associated with psoriasis severity. Arch. Dermatol. Res. Nov 13 [Epub ahead of print] (2009). *
Cotte S, von Ahsen N, Kruse N, Huber B, Winkelmann A, Zettl UK, Starck M, Konig N, Tellez N, Dorr J, Paul F, Zipp F, Luhder F, Koepsell H, Pannek H, Montalban X, Gold R, Chan A. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain 132: 2517-2530 (2009).
Cottin V, Thibout Y, Bey-Omar F, Durieu I, Laoust L, Morel Y, Cordier JF. Late CF caused by homozygous IVS8-5T CFTR polymorphism. Thorax 60: 974-975 (2005). *
Cotton RT, Li D, Scherer SE, Muzny DM, Hodges SE, Catania RL, Witkiewicz AK, Brody JR, Kennedy EP, Yeo CJ, Brunicardi FC, Gibbs RA, Gingras MC, Fisher WE. Single nucleotide polymorphism in RECQL and survival in resectable pancreatic adenocarcinoma. HPB (Oxford) 11: 435-444 (2009). *
Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol. Biomarkers Prev. 16: 1416-1421 (2007). *
Coulter-Mackie M, Gagnier L. Two new polymorphisms in the arylsulfatase A gene and their haplotype associations with normal, metachromatic leukodystrophy and pseudodeficiency alleles. Am. J. Med. Genet. 73: 32-35 (1997). *
Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109: 2806-2814 (2007). *
Courivaud C, Bamoulid J, Loupy A, Deschamps M, Ferrand C, Le Corre D, Tiberghien P, Chalopin JM, Legendre C, Thervet E, Saas P, Ducloux D. Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism -765 on graft loss after renal transplantation. Am. J. Transplant. 9: 2752-2757 (2009).
Courivaud C, Ferrand C, Deschamps M, Tiberghien P, Chalopin JM, Duperrier A, Saas P, Ducloux D. No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation. Transplantation 81: 1212-1215 (2006).
Court MH, Hazarika S, Krishnaswamy S, Finel M, Williams JA. Novel polymorphic human UDP-glucuronosyltransferase (UGT) 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol. Pharmacol. 74: 744-754 (2008). *
Courtney JM, Plant BJ, Morgan K, Rendall J, Gallagher C, Ennis M, Kalsheker N, Elborn S, O'Connor CM. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin. Pediatr. Pulmonol. 41: 584-591 (2006).
Courville P, Chaloupka R, Cellier MF. Recent progress in structure-function analyses of Nramp proton-dependent metal-ion transporters. Biochem. Cell. Biol. 84: 960-978 (2006). *
Couturier N, Gourraud PA, Cournu-Rebeix I, Gout C, Bucciarelli F, Edan G, Babron MC, Clerget-Darpoux F, Clanet M, Fontaine B, Brassat D. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur. J. Hum. Genet. 17: 844-847 (2009).
Couvert P, Giral P, Dejager S, Gu J, Huby T, Chapman MJ, Bruckert E, Carrie A. Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. Pharmacogenomics 9: 1217-1227 (2008).
Cox DG, Buring J, Hankinson SE, Hunter DJ. A polymorphism in the 3' UTR of PTGS2 is not associated with an increase in breast cancer risk: a nested case-control study. Breast Cancer Res. 9: R3 (2007). *
Cox DG, Crusius JB, Peeters PH, Bueno-de-Mesquita HB, Pena AS, Canzian F. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease. World J. Gastroenterol. 11: 6003-6008 (2005). *
Cox SE, Doherty C, Atkinson SH, Nweneka CV, Fulford AJ, Ghattas H, Rockett KA, Kwiatkowski DP, Prentice AM. Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. PLoS ONE 2: e362 (2007). *
Cox ST, Marsh SG, Scott I, Clayton J, Arguello JR, McWhinnie AJ, Prokupek B, Holman R, Madrigal JA, Little AM. HLA-A, -B, -C polymorphism in a UK Ashkenazi Jewish potential bone marrow donor population. Tissue Antigens 53: 41-50 (1999). *
Cozar JM, Romero JM, Aptsiauri N, Vazquez F, Vilchez JR, Tallada M, Garrido F, Ruiz-Cabello F. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum. Immunol. 68: 698-704 (2007).
Crabtree MD, Fletcher C, Churchman M, Hodgson SV, Neale K, Phillips RK, Tomlinson IP. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut 53: 271-276 (2004). *
Craggs A, West S, Curtis A, Welfare M, Hudson M, Donaldson P, Mansfield J. Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England. Scand. J. Gastroenterol. 36: 1173-1178 (2001). *
Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).
Craig DW, Pearson JV, Szelinger S, Sekar A, Redman M, Corneveaux JJ, Pawlowski TL, Laub T, Nunn G, Stephan DA, Homer N, Huentelman MJ. Identification of genetic variants using bar-coded multiplexed sequencing. Nat. Methods 5: 887-893 (2008). *
Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L, Siminovitch KA, Wordsworth BP, Calin A, Brown MA. Role of NOD2 variants in spondylarthritis. Arthritis Rheum. 46: 1629-1633 (2002). *
Craven NM, Jackson CW, Kirby B, Perrey C, Pravica V, Hutchinson IV, Griffiths CE. Cytokine gene polymorphisms in psoriasis. Br. J. Dermatol. 144: 849-853 (2001). *
Crawford NP, Eichenberger MR, Colliver DW, Lewis RK, Cobbs GA, Petras RE, Galandiuk S. Evaluation of Slc11a1 as an inflammatory bowel disease candidate gene. BMC Med. Genet. 6: 10 (2005). *
Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, Lowy DR, Anton-Culver H, Hunter KW. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet. 3: e214 (2007). *
Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, Bar-Or A, Tong C, Hauser SL, Oksenberg JR. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch. Neurol. 66: 226-233 (2009).
Crescenti A, Gasso P, Mas S, Abellana R, Deulofeu R, Parellada E, Bernardo M, Lafuente A. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population. Psychiatry Res. 165: 175-180 (2009).
Cresci S. PPAR genomics and pharmacogenomics: implications for cardiovascular disease. PPAR Res. 2008: 374549 (2008). *
Crettol S, Petrovic N, Murraya M. Pharmacogenetics of phase I and phase II drug metabolism. Curr. Pharm. Des. Oct 15 [Epub ahead of print] (2009).
Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann. Rheum. Dis. 61: 678-681 (2002). *
Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford) 42: 1295-1298 (2003). *
Crimmins NA, Martin LJ. Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obes. Rev. 8: 419-423 (2007).
Crispim JC, Mendes-Junior CT, Wastowski IJ, Costa R, Castelli EC, Saber LT, Donadi EA. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens 71: 35-41 (2008). *
Crisponi L, Crisponi G, Meloni A, Toliat MR, Nurnberg G, Usala G, Uda M, Masala M, Hohne W, Becker C, Marongiu M, Chiappe F, Kleta R, Rauch A, Wollnik B, Strasser F, Reese T, Jakobs C, Kurlemann G, Cao A, Nurnberg P, Rutsch F. Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1. Am. J. Hum. Genet. 80: 971-981 (2007). *
Criswell LA, Gregersen PK. Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developments. Rheumatology (Oxford) 44 Suppl. 4: iv9-iv13 (2005). *
Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. 50: 2750-2756 (2004). *
Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76: 561-571 (2005). *
Criswell LA, Saag KG, Mikuls TR, Cerhan JR, Merlino LA, Lum RF, Pfeiffer KA, Woehl B, Seldin MF. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann. Rheum. Dis. 65: 1163-1167 (2006). *
Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, Raimondi C, Noto LD, Bongiovanni A, Accardo A, Candore G, Palmeri L, Verna R, Caruso C, Lio D, Palmeri S. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann. N. Y. Acad. Sci. 1089: 98-103 (2006). *
Croiseau P, Bardel C, Genin E. Efficiency of multiple imputation to test for association in the presence of missing data. BMC Proc. 1 Suppl. 1: S24 (2007). *
Crosdale DJ, Ollier WE, Thomson W, Dyer PA, Jensenious J, Johnson RW, Poulton KV. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur. J. Immunogenet. 27: 111-117 (2000). *
Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J. Infect. Dis. 184: 653-656 (2001). *
Cross JT, Poole EM, Ulrich CM. A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia. Pharmacogenomics J. 8: 237-247 (2008).
Croucher PJ, Mascheretti S, Foelsch UR, Hampe J, Schreiber S. Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology 125: 1919-1920 (2003). *
Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, Lu T, Nikolaus S, Yang SK, Krawczak M, Kim WH, Schreiber S. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 11: 6-16 (2003). *
Crouthamel MH, Wu D, Yang Z, Ho RJ. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells. J. Pharm. Sci. 95: 2767-2777 (2006). *
Cruyssen BV, Peeters H, Hoffman IE, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, De Vos M, De Keyser F. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in Caucasian Crohn's disease patients. Clin. Exp. Immunol. 140: 354-359 (2005). *
Cruz-Robles D, Chavez-Gonzalez JP, Cavazos-Quero MM, Perez-Mendez O, Reyes PA, Vargas-Alarcon G. Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility. Immunol. Invest. 38: 231-239 (2009).
Csaszar A, Abel T. Receptor polymorphisms and diseases. Eur. J. Pharmacol. 414: 9-22 (2001). *
Csejtei A, Tibold A, Ember I, Kiss I. Genetic polymorphism in patients with colorectal and with head and neck cancer. Orv. Hetil. 150: 1545-1549 (2009).
Csongei V, Jaromi L, Safrany E, Sipeky C, Magyari L, Farago B, Bene J, Polgar N, Lakner L, Sarlos P, Varga M, Melegh B. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. World J. Gastroenterol. 16: 176-183 (2010). *
Cucchiara S, Latiano A, Palmieri O, Canani RB, D'Inca R, Guariso G, Vieni G, De Venuto D, Riegler G, De'Angelis GL, Guagnozzi D, Bascietto C, Miele E, Valvano MR, Bossa F, Annese V; Italian Society of Pediatric Gastroenterology and Nutrition. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 44: 171-179 (2007). *
Cucchiara S, Latiano A, Palmieri O, Staiano AM, D'Inca R, Guariso G, Vieni G, Rutigliano V, Borrelli O, Valvano MR, Annese V. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. World J. Gastroenterol. 13: 1221-1229 (2007). *
Cuchacovich M, Ferreira L, Aliste M, Soto L, Cuenca J, Cruzat A, Gatica H, Schiattino I, Perez C, Aguirre A, Salazar-Onfray F, Aguillon J. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand. J. Rheumatol. 33: 228-232 (2004). *
Cuchacovich M, Soto L, Edwardes M, Gutierrez M, Llanos C, Pacheco D, Sabugo F, Alamo M, Fuentealba C, Villanueva L, Gatica H, Schiattino I, Salazaro L, Catalan D, Valenzuela O, Salazar-Onfray F, Aguillon JC. Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis. Scand. J. Rheumatol. 35: 435-440 (2006).
Cuddihy RM, Bahn RS. Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J. Clin. Endocrinol. Metab. 81: 4476-4478 (1996). *
Cuddihy RM, Dutton CM, Bahn RS. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5: 89-95 (1995).
Cuddihy RM, Schaid DS, Bahn RS. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease. Thyroid 6: 261-265 (1996).
Cuenca J, Cuchacovich M, Perez C, Ferreira L, Aguirre A, Schiattino I, Soto L, Cruzat A, Salazar-Onfray F, Aguillon JC. The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford) 42: 308-313 (2003). *
Cuenca J, Perez CA, Aguirre AJ, Schiattino I, Aguillon JC. Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol. Res. 34: 237-241 (2001).
Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2: 410-417 (2004). *
Cui J, Wang W, Lai MD, Xu EP, Lv BJ, Lin J, Ruan WJ, Ma Y, Yao C. Identification of a novel VNTR polymorphism in C6orf37 and its association with colorectal cancer risk in Chinese population. Clin. Chim. Acta 368: 155-159 (2006). *
Cui Y, Kang G, Sun K, Qian M, Romero R, Fu W. Gene-centric genomewide association study via entropy. Genetics 179: 637-650 (2008). *
Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev. 15: 1427-1437 (2006). *
Cui YH, Liu TS, Zhuang RY, Gao HJ, Li H. Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer. J. Dig. Dis. 10: 118-123 (2009). *
Cukjati M, Vaupotic T, Rupreht R, Curin Serbec V. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay. BMC Med. Genet. 8: 69 (2007). *
Cukovic-Cavka S, Vermeire S, Hrstic I, Claessens G, Kolacek S, Jakic-Razumovic J, Krznaric Z, Grubelic K, Radic D, Misak Z, Jadresin O, Rutgeerts P, Vucelic B. NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship. Eur. J. Gastroenterol. Hepatol. 18: 895-899 (2006).
Cullen M, Malasky M, Harding A, Carrington M. High-density map of short tandem repeats across the human major histocompatibility complex. Immunogenetics 54: 900-910 (2003). *
Culpan D, Cram D, Chalmers K, Cornish A, Palmer L, Palmer J, Hughes A, Passmore P, Craigs D, Wilcock GK, Kehoe PG, Love S. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease. Neurobiol. Aging 30: 1052-1060 (2009).
Culver DA, Newman LS, Kavuru MS. Gene-environment interactions in sarcoidosis: challenge and opportunity. Clin. Dermatol. 25: 267-275 (2007).
Culverhouse R, Hinrichs AL, Jin CH, Suarez BK. Gene x gene and gene x environment interactions for complex disorders. BMC Proc. 1 Suppl. 1: S72 (2007). *
Culverhouse R, Jin W, Jin CH, Hinrichs AL, Suarez BK. Power and false-positive rates for the restricted partition method (RPM) in a large candidate gene data set. BMC Proc. 3 Suppl. 7: S74 (2009). *
Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P; on behalf of the UK Haemophilia Centre Doctors' Organisation. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb. Haemost. 96: 630-641 (2006).
Cummings JR, Cooney R, Pathan S, Anderson CA, Barrett JC, Beckly J, Geremia A, Hancock L, Guo C, Ahmad T, Cardon LR, Jewell DP. Confirmation of the role of ATG16l1 as a Crohn's disease susceptibility gene. Inflamm. Bowel Dis. 13: 941-946 (2007). *
Cunha-Neto E, Nogueira LG, Teixeira PC, Ramasawmy R, Drigo SA, Goldberg AC, Fonseca SG, Bilate AM, Kalil J. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem. Inst. Oswaldo Cruz 104: 252-258 (2009). *
Cunningham S, O'Doherty C, Patterson C, McDonnell G, Hawkins S, Marrosu MG, Vandenbroeck K. The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis. J. Neuroimmunol. 183: 208-213 (2007).
Cunningham S, Patterson CC, McDonnell G, Hawkins S, Vandenbroeck K. Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis. Genes Immun. 6: 265-270 (2005). *
Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J. Immunol. 176: 1978-1987 (2006). *
Cuppens H, Cassiman JJ. CFTR mutations and polymorphisms in male infertility. Int. J. Androl. 27: 251-256 (2004). *
Curley CR, Monsuur AJ, Wapenaar MC, Rioux JD, Wijmenga C. A functional candidate screen for coeliac disease genes. Eur. J. Hum. Genet. 14: 1215-1222 (2006). *
Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Azim DM, Cai G, Mahaney MC, Comuzzie AG, Dyer TD, Walder KR, Zimmet P, Maccluer JW, Collier GR, Kissebah AH, Blangero J. Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37: 1234-1241 (2005). *
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 13: 285-292 (2004). *
Curtin K, Samowitz WS, Wolff RK, Caan BJ, Ulrich CM, Potter JD, Slattery ML. MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol. Carcinog. 48: 989-994 (2009).
Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol. Biomarkers Prev. 18: 3384-3388 (2009). *
Curtin K, Ulrich CM, Samowitz WS, Bigler J, Caan B, Potter JD, Slattery ML. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int. J. Cancer 120: 2226-2232 (2007). *
Curtin K, Wong J, Allen-Brady K, Camp NJ. Meta-genetic association of rheumatoid arthritis and PTPN22 using PedGenie 2.1. BMC Proc. 1 Suppl. 1: S12 (2007). *
Curtis BR. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Semin. Thromb. Hemost. 34: 539-548 (2008).
Cusack S, Molgaard C, Michaelsen KF, Jakobsen J, Lamberg-Allardt CJ, Cashman KD. Vitamin D and estrogen receptor-alpha genotype and indices of bone mass and bone turnover in Danish girls. J. Bone Miner. Metab. 24: 329-336 (2006). *
Cusatis G, Gregorc V, Li J, Spreafico A, Ingersoll RG, Verweij J, Ludovini V, Villa E, Hidalgo M, Sparreboom A, Baker SD. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J. Natl. Cancer Inst. 98: 1739-1742 (2006). *
Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. J. Clin. Oncol. 25: 3596-3602 (2007). *
Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev. 7: 59-64 (2007).
Cuyper H, Mortier G. Polymorphism in rheumatology. J. Belge. Rhumatol. Med. Phys. 30: 93-101 (1975).
Cvetkovic JT, Wiklund PG, Ahmed E, Weinehall L, Hallmans G, Lefvert AK. Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case-control study of their association with risk for stroke. J. Stroke Cerebrovasc. Dis. 14: 29-35 (2005).
Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, Wolkow P, Skupien J, Bobrek J, Czogala M, Klupa T, Sieradzki J. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol. 43: 114-119 (2006). *
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 16: 262-270 (2000).
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 17: 268-275 (2001).
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 23: 255-262 (2007).
Czaja AJ. Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis. Minerva Gastroenterol. Dietol. 53: 43-78 (2007).
Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).
Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 6: 379-388 (2008).
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240 (2004).
Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol. Dietol. 51: 313-333 (2005).
Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev. Gastroenterol. Hepatol. 1: 113-128 (2007).
Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leukocyte antigens and disease severity in chronic hepatitis C. J. Hepatol. 24: 666-673 (1996). *
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J. Hepatol. 24: 52-59 (1996). *
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108: 157-164 (1995). *
Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 117: 645-652 (1999). *
Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol. Rev. 174: 250-259 (2000). *
Czaja AJ, Santrach PJ, Moore SB. HLA-DQ associations in type 1 autoimmune hepatitis. Mayo Clin. Proc. 70: 1154-1160 (1995). *
Czerny B, Kaminski A, Kurzawski M, Kotrych D, Safranow K, Dziedziejko V, Bohatyrewicz A, Pawlik A. The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. Eur. J. Obstet. Gynecol. Reprod. Biol. Jan 6 [Epub ahead of print] (2010).
Czerski PM, Rybakowski F, Kapelski P, Rybakowski JK, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Slopien A, Skibinska M, Kaczmarkiewicz-Fass M, Hauser J. Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology 57: 88-94 (2008).
Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr. Pharm. Des. 11: 1017-1030 (2005).
Czupryniak L, Mlynarski W, Pawlowski M, Saryusz-Wolska M, Borkowska A, Klich I, Bodalski J, Loba J. Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism. Diabetes Res. Clin. Pract. 80: 386-391 (2008).
d'Abramo C, Zingg JM, Pizzuti A, Argellati F, Pronzato MA, Ricciarelli R. In vitro effect of PPAR-gamma2 Pro12Ala polymorphism on the deposition of Alzheimer's amyloid-beta peptides. Brain Res. 1173: 1-5 (2007).
D'Addabbo A, Latiano A, Palmieri O, Creanza MT, Maglietta R, Annese V, Ancona N. Association of genetic profiles to Crohn's disease by linear combinations of single nucleotide polymorphisms. Artif. Intell. Med. 46: 131-138 (2009).
D'Addabbo A, Latiano A, Palmieri O, Maglietta R, Annese V, Ancona N. Regularized least squares classifiers may predict Crohn's disease from profiles of single nucleotide polymorphisms. Ann. Hum. Genet. 71: 537-549 (2007). *
D'Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L, Indelicato M, Giacopelli F, Marchini M, Scorza R, Danieli MG, Cappelli M, Migliaresi S, Bigliardo B, Sabbadini MG, Baldissera E, Galeazzi M, Sebastiani GD, Minisola G, Ravazzolo R. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 52: 539-547 (2005). *
D'Alfonso S, Bolognesi E, Guerini FR, Barizzone N, Bocca S, Ferrante D, Castelli L, Bergamaschi L, Agliardi C, Ferrante P, Naldi P, Leone M, Caputo D, Ballerini C, Salvetti M, Galimberti D, Massacesi L, Trojano M, Momigliano-Richiardi P. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun. 9: 7-15 (2008). *
D'Amato M, Bruce S, Bresso F, Zucchelli M, Ezer S, Pulkkinen V, Lindgren C, Astegiano M, Rizzetto M, Gionchetti P, Riegler G, Sostegni R, Daperno M, D'Alfonso S, Momigliano-Richiardi P, Torkvist L, Puolakkainen P, Lappalainen M, Paavola-Sakki P, et al. Neuropeptide S receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 133: 808-817 (2007). *
D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb. Haemost. 83: 563-570 (2000). *
D'Angelo G. Ethnic and genetic causes of neutropenia: clinical and therapeutic implications. Lab. Hematol. 15: 25-29 (2009).
D'Apice MR, Gambardella S, Russo S, Lucidi V, Nardone AM, Pietropolli A, Novelli G. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism. Prenat. Diagn. 24: 981-983 (2004). *
da Costa CE, Szuhai K, van Eijk R, Hoogeboom M, Sciot R, Mertens F, Bjorgvinsdottir H, Debiec-Rychter M, de Krijger RR, Hogendoorn PC, Egeler RM, Annels NE. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes Cancer 48: 239-249 (2008). *
da Costa MZ, Guarita DR, Ono-Nita SK, Nogueira JD, Nita ME, Paranagua-Vezozzo DC, de Souza MT, do Carmo EP, Teixeira AC, Carrilho FJ. CFTR polymorphisms in patients with slcoholic chronic pancreatitis. Pancreatology 9: 173-181 (2008).
da Cruz Castelli E, Moreau P, Oya E Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L, Giuliatti S, Carosella ED, Donadi EA. In silico analysis of microRNAs targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum. Immunol. 70: 1020-1025 (2009).
Daans M, Lories RJ, Luyten FP. Absence of GDF5 does not interfere with LPS Toll-like receptor signaling. Clin. Exp. Rheumatol. 27: 495-498 (2009).
Dagan E, Brik R, Broza Y, Gershoni-Baruch R. Henoch-Schonlein purpura: polymorphisms in thrombophilia genes. Pediatr. Nephrol. 21: 1117-1121 (2006). *
Dagan E, Laitman Y, Levanon N, Feuer A, Sidi AA, Baniel J, Korach Y, Baruch GB, Friedman E, Gershoni-Baruch R. The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel. Fam. Cancer 5: 389-395 (2006). *
Daha NA, Kurreeman FA, Marques RB, Stoeken-Rijsbergen G, Verduijn W, Huizinga TW, Toes RE. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum. 60: 1255-1260 (2009). *
Dahlman I, Nilsson M, Jiao H, Hoffstedt J, Lindgren CM, Humphreys K, Kere J, Gustafsson JA, Arner P, Dahlman-Wright K. Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet. Genomics 16: 881-889 (2006).
Dai CY, Chuang WL, Lee LP, Pan WC, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML. Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C. Transl. Res. 152: 151-156 (2008). *
Dai H, Zhang X, Zhao X, Deng T, Dong B, Wang J, Li Y. Identification of five novel mutations in the long isoform of the USH2A gene in Chinese families with Usher syndrome type II. Mol. Vis. 14: 2067-2075 (2008). *
Dai JY, Leblanc M, Smith NL, Psaty B, Kooperberg C. SHARE: an adaptive algorithm to select the most informative set of SNPs for candidate genetic association. Biostatistics 10: 680-693 (2009). *
Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33: e175 (2005). *
Dai Q, Shrubsole MJ, Ness RM, Schlundt D, Cai Q, Smalley WE, Li M, Shyr Y, Zheng W. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am. J. Clin. Nutr. 86: 743-751 (2007). *
Dai S, Crawford F, Marrack P, Kappler JW. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. Proc. Natl. Acad. Sci. U.S.A. 105: 11893-11897 (2008). *
Dai Y, Hebert MF, Isoherranen N, Davis CL, Marsh C, Shen DD, Thummel KE. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab. Dispos. 34: 836-847 (2006). *
Dai Y, Huang Y, He X, Wang S, Huang R, Tang M, Hu C. Clinical and genetic mapping of X chromosome in the X-linked dominant inherited Alport's syndrome. Saudi J. Kidney Dis. Transpl. 19: 767-774 (2008).
Dai Y, Leng S, Li L, Niu Y, Huang H, Liu Q, Duan H, Cheng J, Liu Q, Zheng Y. Effects of genetic polymorphisms of N-acetyltransferase on trichloroethylene-induced hypersensitivity dermatitis among exposed workers. Ind. Health 47: 479-486 (2009).
Daimon M, Oizumi T, Toriyama S, Karasawa S, Jimbu Y, Wada K, Kameda W, Susa S, Muramatsu M, Kubota I, Kawata S, Kato T. Association of the Ser326Cys polymorphism in the OGG1 gene with type 2 DM. Biochem. Biophys. Res. Commun. 386: 26-29 (2009). *
Daimon M, Sato H, Sasaki S, Toriyama S, Emi M, Muramatsu M, Hunt SC, Hopkins PN, Karasawa S, Wada K, Jimbu Y, Kameda W, Susa S, Oizumi T, Fukao A, Kubota I, Kawata S, Kato T. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM. Biochem. Biophys. Res. Commun. 374: 576-580 (2008). *
Daimon Y, Yamanishi K, Murakami Y, Kirishima T, Ito Y, Minami M, Okanoue T. Novel single nucleotide polymorphisms of the cytokeratin 19 pseudogene are associated with primary biliary cirrhosis. Hepatol. Res. 25: 281-286 (2003).
Daksis JI, Erikson GH. Heteropolymeric triplex-based genomic assay(R) to detect pathogens or single-nucleotide polymorphisms in human genomic samples. PLoS ONE 2: e305 (2007). *
Dalal A, Pradhan M, Tiwari D, Behari S, Singh U, Mallik GK, Das V, Agarwal S. MTHFR 677C-->T and 1298A-->C polymorphisms: evaluation of maternal genotypic risk and association with level of neural tube defect. Gynecol. Obstet. Invest. 63: 146-150 (2006).
Dalal I, Karban A, Wine E, Eliakim R, Shirin H, Fridlender M, Shaoul R, Leshinsky-Silver E, Levine A. Polymorphisms in the TNF-alpha promoter and variability in the granulomatous response in patients with Crohn's disease. Pediatr. Res. 59: 825-828 (2006). *
Daley D, Lemire M, Akhabir L, Chan-Yeung M, He JQ, McDonald T, Sandford A, Stefanowicz D, Tripp B, Zamar D, Bosse Y, Ferretti V, Montpetit A, Tessier MC, Becker A, Kozyrskyj AL, Beilby J, McCaskie PA, Musk B, Warrington N, James A, Laprise C, et al. Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum. Genet. 125: 445-459 (2009). *
Dallos T, Avbelj M, Barak L, Zapletalova J, Pribilincova Z, Krajcirova M, Kostalova L, Battelino T, Kovacs L. CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease. Neuro. Endocrinol. Lett. 29: 334-340 (2008).
Daly AK. Significance of the minor cytochrome P450 3A isoforms. Clin. Pharmacokinet. 45: 13-31 (2006).
Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CP. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology 132: 272-281 (2007). *
Daly AK, King BP, Leathart JB. Genotyping for cytochrome P450 polymorphisms. Methods Mol. Biol. 320: 193-207 (2006).
Daly M, Ross P, Giblin L, Buckley F. Polymorphisms within the lactoferrin gene promoter in various cattle breeds. Anim. Biotechnol. 17: 33-42 (2006).
Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat. Genet. 29: 229-232 (2001). *
Dambacher J, Staudinger T, Seiderer J, Sisic Z, Schnitzler F, Pfennig S, Hofbauer K, Konrad A, Tillack C, Otte JM, Diebold J, Goke B, Ochsenkuhn T, Lohse P, Brand S. Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Inflamm. Bowel Dis. 13: 71-82 (2007). *
Damiani G, Campo I, Zorzetto M, Bozzi V, Disabella E, Caroli A, Ferrarotti I, D'Annunzio G, Pasi A, Martinetti M, Cuccia M. Pro-inflammatory variants of DRB1 and RAGE genes are associated with susceptibility to pediatric type 1 diabetes: a new hypothesis on the adaptive role of autoimmunity. Riv. Biol. 100: 285-304 (2007).
Damle BD, Uderman H, Biswas P, Crownover P, Lin C, Glue P. Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. Br. J. Clin. Pharmacol. 68: 682-689 (2009). *
Dan H, Liu W, Zhou Y, Wang J, Chen Q, Zeng X. Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation Oct 20 [Epub ahead of print] (2009). *
Danforth KN, Rodriguez C, Hayes RB, Sakoda LC, Huang WY, Yu K, Calle EE, Jacobs EJ, Chen BE, Andriole GL, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW. TNF polymorphisms and prostate cancer risk. Prostate 68: 400-407 (2008).
Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lemann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourie B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm. Bowel Dis. 13: 19-23 (2007). *
Daniels G. The molecular genetics of blood group polymorphism. Hum. Genet. Aug 29 [Epub ahead of print] (2009). *
Daniels G. The molecular genetics of blood group polymorphism. Transpl. Immunol. 14: 143-153 (2005).
Danik JS, Pare G, Chasman DI, Zee RY, Kwiatkowski DJ, Parker A, Miletich JP, Ridker PM. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17,686 women: the Women�s Genome Health Study. Circ. Cardiovasc. Genet. 2: 134-141 (2009).
Danik JS, Pare G, Chasman DI, Zee RY, Kwiatkowski DJ, Parker A, Miletich JP, Ridker PM. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17,686 women: The Women's Genome Health Study. Circ. Cardiovasc. Genet. 2: 134-141 (2009).
Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis. Markers. 12: 127-133 (1995).
Danko IM, Chaschin NA. Association of CYP2E1 gene polymorphism with predisposition to cancer development. Exp. Oncol. 27: 248-256 (2005).
Dannlowski U, Ohrmann P, Bauer J, Kugel H, Baune BT, Hohoff C, Kersting A, Arolt V, Heindel W, Deckert J, Suslow T. Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav. 6: 672-676 (2007).
Dapprich J, Ferriola D, Magira EE, Kunkel M, Monos D. SNP-specific extraction of haplotype-resolved targeted genomic regions. Nucleic Acids Res. 36: e94 (2008). *
Daroszewska A, Ralston SH. Genetics of Paget's disease of bone. Clin. Sci. (Lond.) 109: 257-263 (2005). *
Daroszewski J, Pawlak E, Karabon L, Frydecka I, Jonkisz A, Slowik M, Bolanowski M. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 JO31 and CT60 gene polymorphisms. Eur. J. Endocrinol. 161: 787-793 (2009).
Darrah R, McKone E, O'Connor C, Rodgers C, Genatossio A, McNamara S, Gibson R, Elborn JS, Ennis M, Gallagher CG, Kalsheker N, Aitken M, Wiese D, Dunn J, Smith P, Pace R, Londono D, Goddard KA, Knowles MR, Drumm ML. EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates and cystic fibrosis pulmonary disease severity. Physiol. Genomics Dec 22 [Epub ahead of print] (2009). *
Das JC, Paul N. Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian J. Pediatr. 74: 287-290 (2007). *
Das KM. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294 (2004). *
Das KM, Eastwood MA. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease. Clin. Pharmacol. Ther. 18: 514-520 (1975).
Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC. Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 53: 3300-3306 (2004). *
Daser A, Mitchison H, Mitchison A, Muller B. Non-classical-MHC genetics of immunological disease in man and mouse. The key role of pro-inflammatory cytokine genes. Cytokine 8: 593-597 (1996).
Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, Karakitsos P. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol. Carcinog. 48: 563-569 (2009). *
Dastani Z, Pajukanta P, Marcil M, Rudzicz N, Ruel I, Bailey SD, Lee JC, Lemire M, Faith J, Platko J, Rioux J, Hudson TJ, Gaudet D, Engert JC, Genest J. Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjects. Eur. J. Hum. Genet. Oct 21 [Epub ahead of print] (2009).
Date Y, Seki N, Kamizono S, Higuchi T, Hirata T, Miyata K, Ohkuni M, Tatsuzawa O, Yokota S, Joo K, Ueda K, Sasazuki T, Kimura A, Itoh K, Kato H. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum. 42: 2577-2582 (1999). *
Dattani MT. The candidate gene approach to the diagnosis of monogenic disorders. Horm. Res. 71 Suppl. 2: 14-21 (2009).
Davey R, Savva G, Dicks J, Roberts IN. MPP: a microarray-to-phylogeny pipeline for analysis of gene and marker content datasets. Bioinformatics 23: 1023-1025 (2007). *
David G, Morvan M, Gagne K, Kerdudou N, Willem C, Devys A, Bonneville M, Follea G, Bignon JD, Retiere C. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 128: 172-184 (2009). *
David SP, Munafo MR, Murphy MF, Walton RT, Johnstone EC. The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob. Res. 9: 225-231 (2007). *
David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, Walton RT, Grasby PM. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25: 2586-2590 (2005). *
Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, Cai Q, Sun L, Duncan E, Wang N, Yu Q, Xu A, Fu Y, Brown MA, Xu H. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 60: 3263-3268 (2009). *
Davies JA, Bowen DJ. The association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13. Haematologica 92: 240-243 (2007). *
Davies MH, Elias E, Acharya S, Cotton W, Faulder GC, Fryer AA, Strange RC. GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut 34: 549-553 (1993). *
Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, Judah DJ, Dinsdale D, Edwards RE, Greaves P, Gant TW, Smith AG. Hepatic gene expression in protoporphyic fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am. J. Pathol. 166: 1041-1053 (2005). *
Davila I, Mullol J, Ferrer M, Bartra J, del Cuvillo A, Montoro J, Jauregui I, Sastre J, Valero A. Genetic aspects of allergic rhinitis. J. Investig. Allergol. Clin. Immunol. 19 Suppl. 1: 25-31 (2009).
Davila S, Hibberd ML, Hari Dass R, Wong HE, Sahiratmadja E, Bonnard C, Alisjahbana B, Szeszko JS, Balabanova Y, Drobniewski F, van Crevel R, van de Vosse E, Nejentsev S, Ottenhoff TH, Seielstad M. Genetic association and expression studies indicate a role of Toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet. 4: e1000218 (2008). *
Davis CD. Vitamin D and cancer: current dilemmas and future research needs. Am. J. Clin. Nutr. 88: 565S-569S (2008). *
Davis CF, Dorak MT. An extensive analysis of the hereditary hemochromatosis gene HFE and neighboring histone genes: associations with childhood leukemia. Ann. Hematol. Oct 6 [Epub ahead of print] (2009). *
Davis MW, Hammarlund M. Single-nucleotide polymorphism mapping. Methods Mol. Biol. 351: 75-92 (2006).
Davis SR, Quinlivan EP, Shelnutt KP, Ghandour H, Capdevila A, Coats BS, Wagner C, Shane B, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW, Gregory JF 3rd. Homocysteine synthesis is elevated but total remethylation is unchanged by the methylenetetrahydrofolate reductase 677C->T polymorphism and by dietary folate restriction in young women. J. Nutr. 135: 1045-1050 (2005). *
Davis SR, Quinlivan EP, Shelnutt KP, Maneval DR, Ghandour H, Capdevila A, Coats BS, Wagner C, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW, Gregory JF 3rd. The methylenetetrahydrofolate reductase 677C->T polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women. J. Nutr. 135: 1040-1044 (2005). *
Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, Shane B, Bailey LB, Gregory JF 3rd. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am. J. Physiol. Endocrinol. Metab. 286: E272-E279 (2004). *
Daw EW, Heath SC, Lu Y. Single-nucleotide polymorphism versus microsatellite markers in a combined linkage and segregation analysis of a quantitative trait. BMC Genet. 6 Suppl. 1: S32 (2005). *
Daw EW, Plunkett J, Feitosa M, Gao X, Van Brunt A, Ma D, Czajkowski J, Province MA, Borecki I. A framework for analyzing both linkage and association: an analysis of Genetic Analysis Workshop 16 simulated data. BMC Proc. 3 Suppl. 7: S98 (2009). *
Daw EW, Yu R. The feasibility of oligogenic combined segregation and linkage analysis in CEPH pedigrees. BMC Proc. 1 Suppl. 1: S108 (2007). *
Dawkins R, Leelayuwat C, Gaudieri S, Tay G, Hui J, Cattley S, Martinez P, Kulski J. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol. Rev. 167: 275-304 (1999).
Dawkins RL, Leaver A, Cameron PU, Martin E, Kay PH, Christiansen FT. Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum. Immunol. 26: 91-97 (1989).
Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26: 1021-1028 (2006). *
Day CP. Genetic studies to identify hepatic fibrosis genes and SNPs in human populations. Methods Mol. Med. 117: 315-332 (2005).
Day IN. dbSNP in the detail and copy number complexities. Hum. Mutat. 31: 2-4 (2009). *
Day TG, Ramanan AV, Hinks A, Lamb R, Packham J, Wise C, Punaro M, Donn RP. Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis. Arthritis Rheum. 58: 2142-2146 (2008). *
Dayangac-Erden D, Karaduman A, Erdem-Yurter H. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch. Dermatol. Res. 299: 487-491 (2007). *
de Alvarenga MP, Pavarino-Bertelli EC, Goloni-Bertollo EM. Comparing techniques for the identification of the MTHFR A1298C polymorphism. J. Biomol. Tech. 19: 103-105 (2008).
de Andrade M, Allen AS, Brinza D, Cheng R, Da Y, de Vries AR, Ewhida A, Feng Z, Jung H, Hsieh HJ, Kohler K, Liu Y, Liu-Mares W, Luan J, Marquard V, Nolte IM, Oh S, Platt A, Qin X, Yoo YJ, Yuan A, Tian X, Won S. Summary of contributions to GAW15 Group 13: candidate gene association studies. Genet. Epidemiol. 31 Suppl. 1: S110-S117 (2007).
de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richardson A, Walsh EC, Gao X, Galver L, Hart J, Hafler DA, Pericak-Vance M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38: 1166-1172 (2006). *
de Buhr MF, Hedrich HJ, Westendorf AM, Obermeier F, Hofmann C, Zschemisch NH, Buer J, Bumann D, Goyert SM, Bleich A. Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflamm. Bowel Dis. 15: 1824-1836 (2009). *
de Cid R, Ramos MD, Aparisi L, Garcia C, Mora J, Estivill X, Farre A, Casals T. Independent contribution of common CFTR variants to chronic pancreatitis. Pancreas Oct 2 [Epub ahead of print] (2009).
De Cosmo S, Minenna A, Zhang YY, Thompson R, Miscio G, Vedovato M, Rauseo A, Saller A, Mastroianno S, Pellegrini F, Trevisan R, Fioretto P, Doria A, Trischitta V. Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. Am. J. Kidney Dis. 53: 273-280 (2009).
De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; on behalf of the BENEDICT Study Group. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from Benedict. Diabetes 58: 2920-2929 (2009).
De Diego C, Alcantara M, Valle J, Repiso A, Carrobles JM, Martinez-Castro P. Influence of smoking habits and CARD15 mutations on the onset of Crohn�s disease. Scand. J. Gastroenterol. 41: 1209-1211 (2006). *
de Faria IC, de Faria EJ, Toro AA, Ribeiro JD, Bertuzzo CS. Association of TGF-beta1, CD14, IL-4, IL-4R and ADAM33 gene polymorphisms with asthma severity in children and adolescents. J. Pediatr. (Rio J.) 84: 203-210 (2008).
De Gobbi M, Viprakasit V, Hughes JR, Fisher C, Buckle VJ, Ayyub H, Gibbons RJ, Vernimmen D, Yoshinaga Y, de Jong P, Cheng JF, Rubin EM, Wood WG, Bowden D, Higgs DR. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 312: 1215-1217 (2006). *
de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun. 5: 313-314 (2004). *
De Iudicibus S, Stocco G, Martelossi S, Drigo I, Norbedo S, Lionetti P, Pozzi E, Barabino A, Decorti G, Bartoli F, Ventura A. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. Gut 56: 1319-1320 (2007). *
De Jager PL, Graham R, Farwell L, Sawcer S, Richardson A, Behrens TW, Compston A, Hafler DA, Kere J, Vyse TJ, Rioux JD. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus. Genes Immun. 7: 327-334 (2006). *
De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S; International MS Genetics Consortium, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41: 776-782 (2009). *
De Jager PL, Richardson A, Vyse TJ, Rioux JD. Genetic variation in Toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum. 54: 1279-1282 (2006). *
de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 59: 549-555 (2002).
de Jong BA, Westendorp RG, Bakker AM, Huizinga TW. Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production. Genes Immun. 3: 25-29 (2002). *
de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH. Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase. Gut 52: 547-551 (2003). *
de Jong MM, Niens M, Nolte IM, Te Meerman GJ, van der Graaf WT, Mulder MJ, van der Steege G, Bruinenberg M, Schaapveld M, Sijmons RH, Hofstra RM, de Vries EG, Kleibeuker JH. The human leukocyte antigen region and colorectal cancer risk. Dis. Colon Rectum 48: 303-306 (2005). *
de Jongh BM, Bruining GJ, Schreuder GM, Schuurman RK, Radder JK, van Loghem E, Meera Khan P, Hauptmann G, van Rood JJ. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study. Hum. Immunol. 10: 5-21 (1984).
de Jongh CM, John SM, Bruynzeel DP, Calkoen F, van Dijk FJ, Khrenova L, Rustemeyer T, Verberk MM, Kezic S. Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis 58: 269-277 (2008).
De Juan D, Mart�n-Villa JM, Gomez-Reino JJ, Vicario JL, Corell A, Martinez-Laso J, Benmammar D, Arnaiz-Villena A. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum. Genet. 91: 579-584 (1993).
de Kort S, Hokken-Koelega A. The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age. Eur. J. Endocrinol. 162: 49-52 (2010).
de la Concha EG, Arroyo R, Crusius JB, Campillo JA, Martin C, Varela de Seijas E, Pena AS, Claveria LE, Fernandez-Arquero M. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J. Neuroimmunol. 80: 172-178 (1997).
De la Concha EG, Fernandez-Arquero M, Gual L, Vigil P, Martinez A, Urcelay E, Ferreira A, Garcia-Rodriguez MC, Fontan G. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J. Immunol. 169: 4637-4643 (2002). *
de la Concha EG, Fernandez-Arquero M, Lopez-Nava G, Martin E, Allcock RJ, Conejero L, Paredes JG, Diaz-Rubio M. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 119: 1491-1495 (2000). *
de la Concha EG, Fernandez-Arquero M, Martinez A, Vigil P, Vidal F, Lopez-Nava G, Diaz-Rubio M, Garcia-Paredes J. Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis. Dig. Dis. Sci. 44: 2324-2329 (1999). *
De la Concha EG, Fernandez-Arquero M, Vigil P, Lazaro F, Ferreira A, Garcia-Rodriguez MC, Fontan G. Tumor necrosis factor genomic polymorphism in Spanish IgA deficiency patients. Tissue Antigens 55: 359-363 (2000). *
de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA. Celiac disease and TNF promoter polymorphisms. Hum. Immunol. 61: 513-517 (2000).
de la Fontaine L, Schwarz M, Plischke H, Kleindienst N, Gruber R. Lack of association of the CD14/C-159T polymorphism with susceptibility and serological activity parameters of rheumatoid arthritis. Scand. J. Rheumatol. 35: 20-22 (2006). *
de la Fontaine L, Schwarz MJ, Riedel M, Dehning S, Douhet A, Spellmann I, Kleindienst N, Zill P, Plischke H, Gruber R, Muller N. Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms. Psychiatry Res. 144: 39-47 (2006).
De la Fuente MK, Alvarez KP, Letelier AJ, Bellolio F, Acuna ML, Leon FS, Pinto E, Carvallo P, Lopez-Kostner F. Mutational screening of the APC gene in Chilean families with familial adenomatous polyposis: nine novel truncating mutations. Dis. Colon Rectum 50: 2142-2148 (2007). *
de la Paz Bettinotti M, Kolek A, Brunnler G, Haas P, Paul C, Hochberger M, Bartova A, Kimura A, Sasazuki T, Albert ED. Polymorphism of the 5' flanking region of the HLA-DQA1 gene in coeliac disease. Eur. J. Immunogenet. 20: 399-407 (1993).
de la Red G, Tassies D, Espinosa G, Monteagudo J, Bove A, Plaza J, Cervera R, Reverter JC. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. Thromb. Haemost. 101: 312-316 (2009).
de la Torre MS, Torres C, Nieto G, Vergara S, Carrero AJ, Mac�as J, Pineda JA, Caruz A, Fibla J. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J. Infect. Dis. 197: 405-410 (2008). *
De La Vega FM, Isaac H, Collins A, Scafe CR, Halldorsson BV, Su X, Lippert RA, Wang Y, Laig-Webster M, Koehler RT, Ziegle JS, Wogan LT, Stevens JF, Leinen KM, Olson SJ, Guegler KJ, You X, Xu LH, Hemken HG, Kalush F, Itakura M, Zheng Y, de The G, et al. The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern. Genome Res. 15: 454-462 (2005). *
de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams BJ, de Groot PG, van Heerde WL. Annexin A5 polymorphism (-1C>T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann. Rheum. Dis. 65: 1468-1472 (2006). *
de Lau LM, Koudstaal PJ, van Meurs JB, Uitterlinden AG, Hofman A, Breteler MM. Methylenetetrahydrofolate reductase C677T genotype and PD. Ann. Neurol. 57: 927-930 (2005).
de Lima TH, Sass N, Mattar R, Moron AF, Torloni MR, Franchim CS, Daher S. Cytokine gene polymorphisms in preeclampsia and eclampsia. Hypertens. Res. 32: 565-569 (2009).
De Luca V, Likhodi O, Kennedy JL, Wong AH. Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism: analysis of suicidality in schizophrenia and bipolar disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144B: 370-374 (2007).
de Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R. Influence of Lys656Asn polymorphism of leptin receptor gene on insulin resistance in patients with diabetes mellitus type 2. Diabetes Res. Clin. Pract. 81: e9-e11 (2008).
de Luis DA, Gonzalez Sagrado M, Vallejo LA, Gil Carcedo LM, Izaola O, Cuellar L, Terroba MC, Aller R. Influence of G308A polymorphism of tumor necrosis factor-alpha gene on inflammatory markers in postsurgical head and neck cancer patients with early enteral nutrition. Nutrition 23: 529-532 (2007). *
de Luis DA, Pacheco D, Aller R, Gonzalez Sagrado M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T. Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion. Obes. Surg. Jun 20 [Epub ahead of print] (2008). *
de Luis DA, Pacheco D, Aller R, Gonzalez Sagrado M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T, Perez Castrillon JL. Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion. Obes. Surg. May 17 [Epub ahead of print] (2008).
de Luis DA, Perez Castrillon JL, Duenas A. Leptin and obesity. Minerva Med. 100: 229-236 (2009).
de Luis DA, Sagrado MG, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion. Nutrition 24: 300-304 (2008). *
de Messias-Reason IJ, Boldt AB, Moraes Braga AC, Von Rosen Seeling Stahlke E, Dornelles L, Pereira-Ferrari L, Kremsner PG, Kun JF. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J. Infect. Dis. 196: 1379-1385 (2007). *
de Oca EP, Rangel-Villalobos H, Gallegos-Arreola MP, Sandoval L, Figuera LE. SNPs in human beta-defensin 1 gene (DEFB1): frequencies in a Mexican population and new PCR-RFLPs assays. Int. J. Immunogenet. 33: 339-342 (2006). *
de Paula Sabino A, Ribeiro DD, Carvalho MD, Cardoso J, Dusse LM, Fernandes AP. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul. Fibrinolysis 17: 271-275 (2006).
de Pontual L, Pelet A, Clement-Ziza M, Trochet D, Antonarakis SE, Attie-Bitach T, Beales PL, Blouin JL, Dastot-Le Moal F, Dollfus H, Goossens M, Katsanis N, Touraine R, Feingold J, Munnich A, Lyonnet S, Amiel J. Epistatic interactions with a common hypomorphic Ret allele in syndromic Hirschsprung disease. Hum. Mutat. 28: 790-796 (2007).
De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig. Liver Dis. 39 Suppl. 1: S65-S71 (2007).
de Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW. Pharmacogenetics of thiopurine therapy in paediatric IBD patients. Aliment. Pharmacol. Ther. 23: 1137-1141 (2006). *
de Ridder L, Weersma RK, Dijkstra G, van der Steege G, Benninga MA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm. Bowel Dis. 13: 1083-1092 (2007). *
de Rijke B, van Horssen-Zoetbrood A, Veenbergen S, Fredrix H, de Witte T, van de Wiel-van Kemenade E, Dolstra H. Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens. J. Immunol. Methods 329: 125-137 (2008). *
de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Defesche JC, Bossuyt PM, Michels RP, Bleker OP, Roseboom TJ. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famine. Diabetes Care 29: 1052-1057 (2006). *
de Sa AR, Moreira PR, Xavier GM, Sampaio I, Kalapothakis E, Dutra WO, Gomez RS. Association of CD14, IL1B, IL6, IL10 and TNFA functional gene polymorphisms with symptomatic dental abscesses. Int. Endod. J. 40: 563-572 (2007).
De Silva NM, Steele A, Shields B, Knight B, Parnell K, Weedon MN, Hattersley AT, Frayling TM. The transcription factor 7-like 2 (TCF7L2) gene is associated with type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies. Diabet. Med. 24: 1067-1072 (2007). *
de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB Jr, Barros SP, Line SR. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis. J. Clin. Periodontol. 32: 207-211 (2005). *
De Souza TB, Mentz EF, Brenol CV, Xavier RM, Brenol JC, Chies JA, Simon D. Association between the aggrecan gene and rheumatoid arthritis. J. Rheumatol. 35: 2325-2328 (2008).
De Souza VR, Cabrera WK, Galvan A, Ribeiro OG, De Franco M, Vorraro F, Starobinas N, Massa S, Dragani TA, Iba�ez OM. Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice. Int. J. Cancer 124: 1478-1482 (2009). *
De Staercke C, Lally C, Austin H, Winston C, Dowling N, Williams B, Craig Hooper W. The lack of association between four point mutations in the promoter region of the Toll-like 4 receptor gene and myocardial infarction. Thromb. Res. 119: 105-110 (2007). *
De Tomaso AW. Sea squirts and immune tolerance. Dis. Model Mech. 2: 440-445 (2009). *
de Villiers JN, Treurnicht FK, Warnich L, Carr J, van Rensburg SJ, Kotze MJ. Analysis of viral and genetic factors in South African patients with multiple sclerosis. Metab. Brain Dis. 21: 163-169 (2006). *
De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R, Marzotto A, Gloghini A, Bartoli E, Beltrami CA, Ferraccioli G. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome. Arthritis Rheum. 40: 318-331 (1997).
De Vita S, Ferraccioli GF, Dolcetti R, Marzotto A, Pivetta B, Pomponi F, Boiocchi M. The role of molecular analyses of B-cell and T-cell clonality in the study of B-cell lymphomagenesis. Clin. Exp. Rheumatol. 14 Suppl. 14: S21-S29 (1996).
De Vos M. Joint involvement associated with inflammatory bowel disease. Dig. Dis. 27: 511-515 (2009).
De Vos M. Joint involvement in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 36-42 (2004). *
de Vries DR, Ter Linde JJ, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3). Am. J. Gastroenterol. 104: 281-285 (2009).
de Vries HS, Plantinga TS, van Krieken JH, Stienstra R, van Bodegraven AA, Festen EA, Weersma RK, Crusius JB, Linskens RK, Joosten LA, Netea MG, de Jong DJ. Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease. PLoS One 4: e7818 (2009). *
de Vries N, Prinsen CF, Mensink EB, van Riel PL, van't Hof MA, van de Putte LB. A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis. Ann. Rheum. Dis. 52: 327-331 (1993). *
De Zorzi M, Caggiari L, Ahlenstiel G, Rehermann B, De Re V. Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles. Tissue Antigens 71: 490-492 (2008). *
de-Madaria E, Martinez J, Sempere L, Lozano B, Sanchez-Paya J, Uceda F, Perez-Mateo M. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood. Pancreas 37: 295-301 (2008).
Deakin S, Guernier S, James RW. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin. Pharmacogenet. Genomics 17: 451-457 (2007).
Dealberto MJ. Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Med. Hypotheses 68: 259-267 (2007).
Dean JC, Robertson Z, Reid V, Wang Q, Hailey H, Moore S, Rasalam AD, Turnpenny P, Lloyd D, Shaw D, Little J. A high frequency of the MTHFR 677C>T polymorphism in Scottish women with epilepsy: possible role in pathogenesis. Seizure 17: 269-275 (2008).
Deans DC, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, Grimble RF, Fearon KC. Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am. J. Clin. Nutr. 89: 1164-1172 (2009). *
Deban L, Jarva H, Lehtinen MJ, Bottazzi B, Bastone A, Doni A, Jokiranta TS, Mantovani A, Meri S. Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation. J. Immunol. 181: 8433-8440 (2008). *
Debler J, Schiemann U, Seybold U, Mussack T, Landauer N, Ladurner R, Gross M. Heat-shock protein HSP70-2 genotypes in patients with Crohn's disease: a more severe clinical course with intestinal complications in presence of the PstI-polymorphism. Eur. J. Med. Res. 8: 120-124 (2003).
Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y. Polymorphisms of the human NRAMP1 gene are associated with response to Bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J. Urol. 175: 1506-1511 (2006).
Decorti G, De Iudicibus S, Stocco G, Martelossi S, Drigo I, Bartoli F, Ventura A. Glucocorticoid receptor polymorphisms in inflammatory bowel disease. Gut 55: 1053-1054 (2006). *
Dedoussis GV, Maumus S, Choumerianou DM, Skoumas J, Pitsavos C, Stefanadis C, Visvikis-Siest S. Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients. Genet. Test. 10: 192-199 (2006).
Dedoussis GV, Maumus S, Skoumas J, Choumerianou DM, Pitsavos C, Stefanadis C, Visvikis-Siest S. Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia. J. Clin. Lab. Anal. 20: 98-104 (2006).
Dedoussis GV, Panagiotakos DB, Vidra NV, Louizou E, Chrysohoou C, Germanos A, Mantas Y, Tokmakidis S, Pitsavos C, Stefanadis C; for the CARDIOGENE Study group. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE study. Genet. Med. 7: 411-416 (2005).
Dedoussis GV, Vidra N, Butler J, Papoutsakis C, Yannakoulia M, Hirschhorn JN, Lyon HN. Peroxisome proliferator-activated receptor-gamma (PPARgamma) Pro12Ala polymorphism and risk for pediatric obesity. Clin. Chem. Lab. Med. 47: 1047-1050 (2009). *
Deeb SS, Brunzell JD. The role of the PGC1alpha Gly482Ser polymorphism in weight gain due to intensive diabetes therapy. PPAR Res. 2009: 649286 (2009). *
Deeken JF, Cormier T, Price DK, Sissung TM, Steinberg SM, Tran K, Liewehr DJ, Dahut WL, Miao X, Figg WD. A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J. Dec 29 [Epub ahead of print] (2009).
Deeken JF, Slack R, Marshall JL. Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: to test or not to test, that is the question. Cancer 113: 1502-1510 (2008). *
Deghaide NH, Rodrigues MD, Castelli EC, Mendes-Junior CT, Figueiredo JF, Donadi EA. Tumor necrosis factor region polymorphisms are associated with AIDS and with cytomegalovirus retinitis. AIDS 23: 1641-1647 (2009).
Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 36: 345-356 (1992).
Degli-Esposti MA, Leelayuwat C, Dawkins RL. Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: possible relevance to autoimmune disease. Eur. J. Immunogenet. 19: 121-127 (1992).
Deguara J, Burnand KG, Berg J, Green P, Lewis CM, Chinien G, Waltham M, Taylor P, Stern RF, Solomon E, Smith A. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum. Mol. Genet. 16: 3002-3007 (2007). *
Deguchi M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population. J. Soc. Gynecol. Investig. 12: 208-213 (2005).
Dehaghani AS, Kashef MA, Ghaemenia M, Sarraf Z, Khaghanzadeh N, Fattahi MJ, Ghaderi A. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases. J. Reprod. Med. 54: 25-31 (2009).
Dehan C, Tran Van D, Delacour H, Deroudilhe G, Fritsch N, Chiappini J, Dardare E, Gardet V. Diabetic ketoacidosis with a fatal issue: is it a MODY3 (maturity-onset diabetes of the young type 3)? Ann. Biol. Clin. (Paris) 66: 189-193 (2008).
Dehghan A, Yang Q, Peters A, Basu S, Bis JC, Rudnicka AR, Kavousi M, Chen MH, Baumert J, Lowe GD, McKnight B, Tang W, de Maat M, Larson MG, Eyhermendy S, McArdle WL, Lumley T, Pankow JS, Hofman A, Massaro JM, Rivadeneira F, Kolz M, Taylor KD, et al. Association of novel genetic loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ. Cardiovasc. Genet. 2: 125-133 (2009).
Dehus O, Bunk S, von Aulock S, Hermann C. IL-10 release requires stronger Toll-like receptor 4-triggering than TNF: a possible explanation for the selective effects of heterozygous TLR4 polymorphism Asp(299)Gly on IL-10 release. Immunobiology 213: 621-627 (2008).
Deighton C, Criswell LA. Recent advances in the genetics of rheumatoid arthritis. Curr. Rheumatol. Rep. 8: 394-400 (2006).
Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117: 289-300 (2006). *
Dekker MJ, van den Akker EL, Koper JW, Manenschijn L, Geleijns K, Ruts L, van Rijs W, Tio-Gillen AP, van Doorn PA, Lamberts SW, Jacobs BC. Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barre syndrome. J. Peripher. Nerv. Syst. 14: 75-83 (2009).
Del Giudice G, Michetti P. Inflammation, immunity and vaccines for Helicobacter pylori. Helicobacter 9 Suppl. 1: 23-28 (2004).
Del Pozo N, Lopez-Mejias R, Fernandez-Arquero M, Ferreira A, Garcia-Rodriguez MC, de la Concha EG, Fontan G, Urcelay E, Nunez C. Lack of evidence of a role of the XBP1 and PRDM1 polymorphisms in Spanish patients with IgA deficiency. Hum. Immunol. 70: 950-952 (2009).
Del Rio R, Noubade R, Subramanian M, Saligrama N, Diehl S, Rincon M, Teuscher C. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3. Genes Immun. 9: 115-121 (2008). *
Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D. Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145: 287-292 (1999).
Delanghe JR, Duprez DA, De Buyzere ML, Bergez BM, Callens BY, Leroux-Roels GG, Clement DL. Haptoglobin polymorphism and complications in established essential arterial hypertension. J. Hypertens. 11: 861-867 (1993).
Delanghe JR, Duprez DA, De Buyzere ML, Bergez BM, Claeys LR, Leroux-Roels GG, Clement DL. Refractory hypertension is associated with the haptoglobin 2-2 phenotype. J. Cardiovasc. Risk 2: 131-136 (1995).
Delanghe JR, Langlois MR. Haptoglobin polymorphism and body iron stores. Clin. Chem. Lab. Med. 40: 212-216 (2002).
Delanghe JR, Langlois MR, Boelaert JR, Van Acker J, Van Wanzeele F, van der Groen G, Hemmer R, Verhofstede C, De Buyzere M, De Bacquer D, Arendt V, Plum J. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 12: 1027-1032 (1998).
Delanghe JR, Langlois MR, De Buyzere ML, Torck MA. Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism. Clin. Chem. 53: 1397-1400 (2007). *
Delany AM, McMahon DJ, Powell JS, Greenberg DA, Kurland ES. Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis. Osteoporos. Int. 19: 969-978 (2008).
Delcourt C. Application of nutrigenomics in eye health. Forum Nutr. 60: 168-175 (2007).
Delgado JC, Baena A, Thim S, Goldfeld AE. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J. Immunol. 176: 1090-1097 (2006). *
Delgado M, Robledo G, Rueda B, Varela N, O'Valle F, Hernandez-Cortes P, Caro M, Orozco G, Gonzalez-Rey E, Martin J. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells. Arthritis Rheum. 58: 1010-1019 (2008). *
Delgado-Escueta AV, White R, Greenberg DA, Treiman LJ. Looking for epilepsy genes: clinical and molecular genetic studies. Adv. Neurol. 44: 77-95 (1986).
Delgado-Vega AM, Anaya JM. Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun. Rev. 6: 402-408 (2007).
Delgado-Vega AM, Castiblanco J, Gomez LM, Diaz-Gallo LM, Rojas-Villarraga A, Anaya JM. BCL2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann. Rheum. Dis. Mar 11 [Epub ahead of print] (2009).
Deligezer U, Akisik EE, Yaman F, Erten N, Dalay N. MTHFR C677 T gene polymorphism in lymphoproliferative diseases. J. Clin. Lab. Anal. 20: 37-41 (2006).
Dellinger R, Fang JL, Chen G, Weinberg R, Lazarus P. Importance of UDP-glucuronosyl transferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform. Drug Metab. Dispos. 34: 943-949 (2006). *
Delrieu O, Bowman C. Visualizing gene determinants of disease in drug discovery. Pharmacogenomics 7: 311-329 (2006).
Deluca DS, Beisswanger E, Wermter J, Horn PA, Hahn U, Blasczyk R. MaHCO: an ontology of the major histocompatibility complex for immunoinformatic applications and text mining. Bioinformatics 25: 2064-2070 (2009).
Deluca DS, Blasczyk R. The immunoinformatics of cancer immunotherapy. Tissue Antigens 70: 265-271 (2007). *
Dema B, Fernandez-Arquero M, Maluenda C, Polanco I, Figueredo MA, de la Concha EG, Urcelay E, Nunez C. Lack of association of NKX2-3, IRGM and ATG16L1 inflammatory bowel diseases susceptibility variants with celiac disease. Hum. Immunol. 70: 946-949 (2009).
Dema B, Martinez A, Fernandez-Arquero M, Maluenda C, Polanco I, Angeles Figueredo M, de la Concha EG, Urcelay E, Nunez C. Autoimmune disease association signals in CIITA and KIAA0350 are not involved in celiac disease susceptibility. Tissue Antigens 73: 326-329 (2009). *
Dema B, Mart�nez A, Fernandez-Arquero M, Maluenda C, Polanco I, de la Concha EG, Urcelay E, Nunez C. Lack of replication of celiac disease risk variants reported in a Spanish population using an independent Spanish sample. Genes Immun. 10: 659-661 (2009).
Dema B, Martinez A, Fernandez-Arquero M, Maluenda C, Polanco I, Figueredo MA, de la Concha EG, Urcelay E, Nun Ez C. The IL6-174G/C polymorphism is associated with celiac disease susceptibility in girls. Hum. Immunol. Jan 23 [Epub ahead of print] (2009).
Dema B, Martinez A, Fernandez-Arquero M, Maluenda C, Polanco I, Figueredo MA, de la Concha EG, Urcelay E, Nunez C. The IL6-174G/C polymorphism is associated with celiac disease susceptibility in girls. Hum. Immunol. 70: 191-194 (2009).
Dema B, Mart�nez A, Fernandez-Arquero M, Maluenda C, Polanco I, G de la Concha E, Urcelay E, Nunez C. Association of IL18RAP and CCR3 with celiac disease in the Spanish population. J. Med. Genet. 46: 617-619 (2009).
Dema B, Martinez A, Polanco I, Maluenda C, Fernandez-Arquero M, de la Concha EG, Urcelay E, Nunez C. ICAM1 R241 is not associated with celiac disease in the Spanish population. Hum. Immunol. 69: 675-678 (2008).
Demacq C, de Souza AP, Machado AA, Gerlach RF, Tanus-Santos JE. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. Clin. Chim. Acta 365: 183-187 (2006). *
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva WA, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clin. Chem. Lab. Med. 46: 57-63 (2008). *
Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Silverman EK. IL10 polymorphisms are associated with airflow obstruction in severe alpha 1-antitrypsin deficiency. Am. J. Respir. Cell. Mol. Biol. 38: 114-120 (2008). *
DeMeo DL, Lange C, Silverman EK, Senter JM, Drazen JM, Barth MJ, Laird N, Weiss ST. Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet. Epidemiol. 23: 335-348 (2002).
Deming SL, Zheng W, Xu WH, Cai Q, Ruan Z, Xiang YB, Shu XO. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Cancer Epidemiol. Biomarkers Prev. 17: 563-570 (2008). *
Demirag MD, Onen HI, Karaoguz MY, Dogan I, Karakan T, Ekmekci A, Guz G. Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease. Dig. Dis. Sci. 52: 3399-3403 (2007). *
Demirci FY, Manzi S, Ramsey-Goldman R, Kenney M, Shaw PS, Dunlop-Thomas CM, Kao AH, Rhew EY, Bontempo F, Kammerer C, Kamboh MI. Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J. Rheumatol. 34: 1708-1711 (2007).
Demirci H, Yurtcu E, Ergun MA, Yazici AC, Karasu C, Yetkin I. Calpain 10 SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions. Genet.Test. 12: 305-309 (2008).
Demokan S, Suoglu Y, Gozeler M, Demir D, Dalay N. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer. Mol. Biol. Rep. Nov 8 [Epub ahead of print] (2009). *
Demoly P, Guglielmi P, Guglielmi L. Drug allergy and hypersensitivity. Risk factors. Bull. Acad. Natl. Med. 190: 1733-1742 (2006).
Dempfle A, Hein R, Beckmann L, Scherag A, Nguyen TT, Schafer H, Chang-Claude J. Comparison of the power of haplotype-based versus single- and multilocus association methods for gene x environment (gene x sex) interactions and application to gene x smoking and gene x sex interactions in rheumatoid arthritis. BMC Proc. 1 Suppl. 1: S73 (2007). *
Denden S, Haj Khelil A, Perrin P, Daimi H, Leban N, Ouaja A, Mahdouani K, Hlioui L, Lefranc G, Ben Chibani J. Alpha 1 antitrypsin polymorphism in the Tunisian population with special reference to pulmonary disease. Pathol. Biol. (Paris) 56: 106-110 (2008).
Deng G, Zhou G, Zhang R, Zhai Y, Zhao W, Yan Z, Deng C, Yuan X, Xu B, Dong X, Zhang X, Zhang X, Yao Z, Shen Y, Qiang B, Wang Y, He F. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 134: 716-726.e2 (2008). *
Deniz M, Bayazit YA, Celenk F, Karabulut H, Yilmaz A, Gunduz B, Saridogan C, Dagli M, Erdal E, Menevse A. Significance of serotonin transporter gene polymorphism in tinnitus. Otol. Neurotol. 31: 19-24 (2010).
Deniz-Naranjo MC, Munoz-Fernandez C, Alemany-Rodriguez MJ, Perez-Vieitez MC, Aladro-Benito Y, Irurita-Latasa J, S�nchez-Garc�a F. Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain. Eur. J. Neurol. 15: 1080-1084 (2008).
Dennison E, Syddall H, Fall C, Brandi ML, Cooper C. Evidence of sexual dimorphism in relationships between estrogen receptor polymorphisms and bone mass: the Hertfordshire study. J. Rheumatol. 32: 2400-2404 (2005).
Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, Lagarde J, Alioto T, Manzano C, Chrast J, Dike S, Wyss C, Henrichsen CN, Holroyd N, Dickson MC, Taylor R, Hance Z, Foissac S, Myers RM, Rogers J, Hubbard T, Harrow J, Guigo R, et al. Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res. 17: 746-759 (2007). *
Depner M, Kormann MS, Klopp N, Illig T, Vogelberg C, Weiland SK, von Mutius E, Combadiere C, Kabesch M. CX3CR1 polymorphisms are associated with atopy but not asthma in German children. Int. Arch. Allergy Immunol. 144: 91-94 (2007).
Derakhshan F, Naderi N, Farnood A, Firouzi F, Habibi M, Rezvany MR, Javeri A, Bahari A, Balaii H, Rad MG, Aghazadeh R, Zali MR. Frequency of three common mutations of CARD15/NOD2 gene in Iranian IBD patients. Indian J. Gastroenterol. 27: 8-11 (2008). *
Derbel S, Doumaguet C, Hubert D, Mosnier-Pudar H, Grabar S, Chelly J, Bienvenu T. Calpain 10 and development of diabetes mellitus in cystic fibrosis. J. Cyst. Fibros. 5: 47-51 (2006).
Deretic V, Master S, Singh S. Autophagy gives a nod and a wink to the inflammasome and Paneth cells in Crohn's disease. Dev. Cell 15: 641-642 (2008). *
Derijk R, de Kloet ER. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 28: 263-270 (2005).
Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, Detera-Wadleigh SD. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28: 2383-2388 (2001).
Derijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J. Clin. Endocrinol. Metab. 91: 5083-5089 (2006). *
Derijks LJ, Wong DR. Pharmacogenetics of thiopurines in inflammatory bowel disease. Curr. Pharm. Des. Oct 15 [Epub ahead of print] (2009).
Dervieux T, Meyer G, Barham R, Matsutani M, Barry M, Boulieu R, Neri B, Seidman E. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy. Clin. Chem. 51: 2074-2084 (2005). *
Dervieux T, Wessels JA, van der Straaten T, Penrod N, Moore JH, Guchelaar HJ, Kremer JM. Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis. Pharmacogenet. Genomics Oct 24 [Epub ahead of print] (2009).
Derwinger K, Wettergren Y, Odin E, Carlsson G, Gustavsson B. A study of the MTHFR gene polymorphism C677T in colorectal cancer. Clin. Colorectal Cancer 8: 43-48 (2008).
Deshmukh A, Rodrigue KM, Kennedy KM, Land S, Jacobs BS, Raz N. Synergistic effects of the MTHFR C677T polymorphism and hypertension on spatial navigation. Biol. Psychol. 80: 240-245 (2009).
Deshmukh H, Kim-Howard X, Nath SK. Replication of recently identified associated single-nucleotide polymorphisms from six autoimmune diseases in Genetic Analysis Workshop 16 rheumatoid arthritis data. BMC Proc. 3 Suppl. 7: S31 (2009). *
Devasena A, Chaubal PC, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28: 1455-1462 (2007). *
Dewald G, Lange CE, Schmeel E, Kreysel HW. HLA-linked complement polymorphisms (C2, BF) in psoriasis. Arch. Dermatol. Res. 275: 301-304 (1983).
Dewan A, Liu M, Hartman S, Zhang S, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314: 989-992 (2006). *
Dewar JC, Wilkinson J, Wheatley A, Thomas NS, Doull I, Morton N, Lio P, Harvey JF, Liggett SB, Holgate ST, Hall IP. The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J. Allergy Clin. Immunol. 100: 261-265 (1997). *
Dezsofi A, Szebeni B, Hermann CS, Kapitany A, Veres G, Sipka S, Korner A, Madacsy L, Korponay-Szabo I, Rajczy K, Arato A. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J. Pediatr. Gastroenterol. Nutr. 47: 283-287 (2008). *
Dhifallah IB, Houman H, Khanfir M, Hamzaoui K. Endothelial nitric oxide synthase gene polymorphism is associated with Behcet's disease in Tunisian population. Hum. Immunol. 69: 661-665 (2008).
Dhiman N, Ovsyannikova IG, Vierkant RA, Ryan JE, Shane Pankratz V, Jacobson RM, Poland GA. Associations between SNPs in Toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 26: 1731-1736 (2008). *
Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C, Hurme M, Mocchegiani E, Rea M, Lio D, Candore G, Caruso C. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res. Rev. 8: 36-42 (2009).
Di Nisio M, Di Febbo C, Moretta V, Guglielmi MD, Stuppia L, Cuccurullo F, Porreca E. Effects of Toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. Thromb. Haemost. 98: 642-646 (2007).
Di Pierro E, Cappellini MD, Mazzucchelli R, Moriondo V, Mologni D, Poma BZ, Riva A. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria. Exp. Hematol. 33: 584-591 (2005). *
Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V, Di Daniele N, De Lorenzo A. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr. Pharm. Des. 14: 2699-2706 (2008).
Di WL, Hennekam RC, Callard RE, Harper JI. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins. Br. J. Dermatol. 161: 404-412 (2009). *
Di YM, Chan E, Wei MQ, Liu JP, Zhou SF. Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes. AAPS J. 11: 469-480 (2009).
Di YM, Chow VD, Yang LP, Zhou SF. Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr. Drug Metab. Sep 1 [Epub ahead of print] (2009).
Diakite M, Clark TG, Auburn S, Campino S, Fry AE, Green A, Morris AP, Richardson A, Jallow M, Sisay-Joof F, Pinder M, Kwiatkowski DP, Rockett KA. A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Hum. Genet. 125: 105-109 (2009). *
Diamanti AP, Rosado MM, Carsetti R, Valesini G. B cells in SLE: different biological drugs for different pathogenic mechanisms. Autoimmun. Rev. 7: 143-148 (2007).
Diamond B. Autoimmunity. Immunol. Rev. 204: 5-8 (2005). *
Dias R, Chan L, Metherell L, Pearce S, Clark A. Isolated Addison's is unlikely to be caused by mutations in MC2R, MRAP or StAR, three genes responsible for familial glucocorticoid deficiency. Eur. J. Endocrinol. Nov 10 [Epub ahead of print] (2009).
Diaz S, Echeverria MG, It V, Posik DM, Rogberg-Munoz A, Pena NL, Peral-Garcia P, Vega-Pla JL, Giovambattista G. Development of an ELA-DRA gene typing method based on pyrosequencing technology. Tissue Antigens 72: 464-468 (2008). *
Dick DM, Plunkett J, Hamlin D, Nurnberger J Jr, Kuperman S, Schuckit M, Hesselbrock V, Edenberg H, Bierut L. Association analyses of the serotonin transporter gene with lifetime depression and alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Psychiatr. Genet. 17: 35-38 (2007).
Dickel DE, Veenstra-Vanderweele J, Bivens NC, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder. Biol. Psychiatry 61: 322-329 (2007).
Dickel DE, Veenstra-Vanderweele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch. Gen. Psychiatry 63: 778-785 (2006). *
Dickinson AM. Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics. Best Pract. Res. Clin. Haematol. 20: 189-207 (2007).
Dickinson AM. Non-HLA genetics and predicting outcome in HSCT. Int. J. Immunogenet. 35: 375-380 (2008). *
Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev. Mol. Med. 9: 1-19 (2007).
Dickinson AM, Holler E. Polymorphisms of cytokine and innate immunity genes and GVHD. Best Pract. Res. Clin. Haematol. 21: 149-164 (2008).
Dickinson AM, Middleton PG. Beyond the HLA typing age: genetic polymorphisms predicting transplant outcome. Blood Rev. 19: 333-340 (2005).
Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E; Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br. J. Haematol. 127: 479-490 (2004). *
Dickinson J, Perera D, van der Mei A, Ponsonby AL, Polanowski A, Thomson R, Taylor B, McKay J, Stankovich J, Dwyer T. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 vitamin D receptor variant in this interaction. Mult. Scler. 15: 563-570 (2009). *
Dicksved J, Floistrup H, Bergstrom A, Rosenquist M, Pershagen G, Scheynius A, Roos S, Alm JS, Engstrand L, Braun-Fahrlander C, von Mutius E, Jansson JK. Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl. Environ. Microbiol. 73: 2284-2289 (2007). *
Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syvanen AC. An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum. Mol. Genet. 16: 3008-3016 (2007). *
Dideberg V, Louis E, Farnir F, Bertoli S, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, Bours V. Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study. Pharmacogenet. Genomics 16: 369-373 (2006).
Dideberg V, Theatre E, Farnir F, Vermeire S, Rutgeerts P, Vos MD, Belaiche J, Franchimont D, Gossum AV, Louis E, Bours V. The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease. Pharmacogenet. Genomics 16: 727-734 (2006).
Diego CD, Alcantara M, Valle J, Perez-Grueso MJ, Munoz-Rosas C, Carrobles JM, Martinez-Castro P. Frequency of CARD15 polymorphisms in patients with Crohn's disease from Toledo, Spain: genotype-phenotype correlation. Genet. Test. 10: 178-185 (2006).
Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, de la Serna AR, Fernandez-Gutierrez B, Castaneda S, Largo R, Joven B, Narvaez J, Navarro F, Marenco JL, Vicario JL, Blanco FJ, Fernandez-Lopez JC, Caliz R, Collado-Escobar MD, Carreno L, Lopez-Longo J, et al. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum. 58: 1264-1274 (2008). *
Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin. Endocrinol. (Oxf.) 54: 197-204 (2001). *
Dienes HP. Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity. Veroff. Pathol. 132: 1-107 (1989).
Dienes HP. Liver histology in autoimmune hepatitis - diagnostic implications. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 51 (2004). *
Dietrich CG, Geier A. It takes more than one: is a single UGT polymorphism enough to bother detoxification? Hepatology 42: 1462 (2005). *
Dietrich CG, Geier A, Oude Elferink RP. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52: 1788-1795 (2003). *
Dieude P, Garnier S, Michou L, Petit-Teixeira E, Glikmans E, Pierlot C, Lasbleiz S, Bardin T, Prum B, Cornelis F; European Consortium on Rheumatoid Arthritis Families. Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res. Ther. 7: R1200-R1207 (2005). *
Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, Granel B, Sibilia J, Cabane J, Mouthon L, Cracowski JL, Carpentier PH, Hachulla E, Meyer O, Kahan A, Boileau C, Allanore Y. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum. 60: 225-233 (2009). *
Dieude P, Guedj M, Wipff J, Avouac J, Hachulla E, Diot E, Granel B, Sibilia J, Cabane J, Meyer O, Mouthon L, Kahan A, Boileau C, Allanore Y. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum. 58: 2183-2188 (2008). *
Dieude P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E, Granel B, Sibilia J, Tiev K, Mouthon L, Cracowski JL, Carpentier PH, Amoura Z, Fajardy I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore Y. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum. 60: 2472-2479 (2009). *
Dieude P, Osorio J, Petit-Teixeira E, Moreno S, Garnier S, Cailleau-Moindrault S, Stalens C, Lasbleiz S, Bardin T, Prum B, Cornelis F. A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum. 50: 413-419 (2004). *
Dieude P, Teixeira VH, Pierlot C, Cornelis F, Petit-Teixeira E; ECRAF. Testing for linkage and association with rheumatoid arthritis a PTPN22 promoter polymorphism reported to be associated and linked with type 1 diabetes in the Caucasian population. Ann. Rheum. Dis. 67: 900-901 (2008).
Dijk DJ, Archer SN. PERIOD3, circadian phenotypes, and sleep homeostasis. Sleep Med. Rev. Aug 27 [Epub ahead of print] (2009).
Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, Sluiter WJ, Limburg PC, Derksen RH, van de Winkel JG, Kallenberg CG. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum. 43: 2793-2800 (2000). *
Dijstelbloem HM, Scheepers RH, Oost WW, Stegeman CA, van der Pol WL, Sluiter WJ, Kallenberg CG, van de Winkel JG, Tervaert JW. Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum. 42: 1823-1827 (1999). *
Dikmen M, Gunes HV, Degirmenci I, Ozdemir G, Basaran A. Are the angiotensin-converting enzyme gene and activity risk factors for stroke? Arq. Neuropsiquiatr. 64: 211-216 (2006). *
Dilger K, Cascorbi I, Grunhage F, Hohenester S, Sauerbruch T, Beuers U. Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis. Liver Int. 26: 285-290 (2006). *
Dilmec F, Ozgonul A, Uzunkoy A, Akkafa F. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int. J. Immunogenet. 35: 317-321 (2008). *
Dilmec F, Uzer E, Akkafa F, Kose E, van Kuilenburg AB. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population. J. Diabetes Complications Jan 29 [Epub ahead of print] (2009).
Dima I, Vlachopoulos C, Alexopoulos N, Baou K, Vasiliadou C, Antoniades C, Aznaouridis K, Stefanadi E, Tousoulis D, Stefanadis C. Association of arterial stiffness with the angiotensin-converting enzyme gene polymorphism in healthy individuals. Am. J. Hypertens. 21: 1354-1358 (2008).
Dimasi DP, Chen JY, Hewitt AW, Klebe S, Davey R, Stirling J, Thompson E, Forbes R, Tan TY, Savarirayan R, Mackey DA, Healey PR, Mitchell P, Burdon KP, Craig JE. Novel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes. Hum. Genet. Aug 28 [Epub ahead of print] (2009). *
Dimberg J, Dienus O, Lofgren S, Hugander A, Wagsater D. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. Int. J. Colorectal Dis. 22: 1195-1200 (2007). *
Dimberg J, Dienus O, Lofgren S, Hugander A, Wagsater D. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients. Int. J. Oncol. 31: 97-102 (2007). *
Dimberg J, Hugander A, Lofgren S, Wagsater D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int. J. Mol. Med. 19: 11-15 (2007). *
Dincel E, Sepici-Dincel A, Sepici V, Ozsoy H, Sepici B. Hip fracture risk and different gene polymorphisms in the Turkish population. Clinics 63: 645-650 (2008). *
Dincic E, Zivkovic M, Stankovic A, Obradovic D, Alavantic D, Kostic V, Raicevic R. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population. J. Neuroimmunol. 177: 146-150 (2006).
Ding B, Padyukov L, Lundstrom E, Seielstad M, Plenge RM, Oksenberg JR, Gregersen PK, Alfredsson L, Klareskog L. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 60: 30-38 (2009). *
Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 361: 1152-1163 (2009). *
Ding H, Cheng H, Fu Z, Yan L, Yang G. Relationship of large multifunctional proteasome 7 gene polymorphism with susceptibility to type 1 diabetes mellitus and DR3 gene. Chin. Med. J. (Engl.) 114: 1263-1266 (2001).
Ding S, Li L, Zhu X. Polymorphism of the interferon-gamma gene and risk of tuberculosis in a southeastern Chinese population. Hum. Immunol. 69: 129-133 (2008).
Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, Lin YH, Pei-Ei W, Shen CY. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 30: 43-49 (2009). *
Ding Y, Cong L, Ionita-Laza I, Lo SH, Zheng T. Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm. BMC Proc. 1 Suppl. 1: S13 (2007). *
Ding Y, Shen H, Wang X, Fan X, Wu X, Yang X. The polymorphism of HLA-DR and -DQ allelic genes associated with intrahepatic cholestasis of pregnancy. Genet. Test. 12: 215-220 (2008).
Ding Y, Xia B, Lu M, Zhang Y, Li J, Ye M, Luo H, Yu J, Zhang X, Tan J. MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population. Clin. Exp. Immunol. 142: 193-198 (2005). *
Diogenes ME, Bezerra FF, Cabello GM, Cabello PH, Mendonca LM, Oliveira Junior AV, Donangelo CM. Vitamin D receptor gene FokI polymorphisms influence bone mass in adolescent football (soccer) players. Eur. J. Appl. Physiol. Sep 16 [Epub ahead of print] (2009).
Diosdado B, Stepniak DT, Monsuur AJ, Franke L, Wapenaar MC, Mearin ML, Koning F, Wijmenga C. No genetic association of the human prolyl endopeptidase gene found in the Dutch celiac disease population. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G495-G500 (2005). *
Dissanayaka NN, Silburn PA, O'Sullivan JD, Mellick GD. Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease. Mov. Disord. 24: 111-115 (2009).
Dissanayeke SR, Levin S, Pienaar S, Wood K, Eley B, Beatty D, Henderson H, Anderson S, Levin M. Polymorphic variation in TIRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groups. PLoS One 4: e6698 (2009). *
Distante S, Elmberg M, Foss Haug KB, Ovstebo R, Berg JP, Kierulf P, Hultcrantz R, Bell H. Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis. Scand. J. Gastroenterol. 38: 871-877 (2003). *
Dittmar M, Bischofs C, Matheis N, Poppe R, Kahaly GJ. A novel mutation in the DNASE1 gene is related with protein instability and decreased enzyme activity in thyroid autoimmunity. J. Autoimmun. 32: 7-13 (2009).
Dittmar M, Ide M, Wurm M, Kahaly GJ. Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur. J. Endocrinol. 159: 55-60 (2008).
Dittmar M, Kaczmarczyk A, Bischofs C, Kahaly GJ. The proinflammatory cytokine TNF-alpha -308 AA genotype is associated with polyglandular autoimmunity. Immunol. Invest. 38: 255-267 (2009).
Divac A, Nikolic A, Mitic-Milikic M, Nagorni-Obradovic L, Petrovic-Stanojevic N, Dopudja-Pantic V, Nadaskic R, Savic A, Radojkovic D. CFTR mutations and polymorphisms in adults with disseminated bronchiectasis: a controversial issue. Thorax 60: 85 (2005). *
Diwakar L, Rudresh Kumar KJ, Bachnalkar A, Ravindranath V, Christopher R, Nagaraja D. The influence of MTR A2756G polymorphism on plasma homocysteine in young south Indians. Clin. Chim. Acta 395: 172-174 (2008). *
Dixit M, Choudhuri G, Keshri LJ, Mittal B. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J. Gastroenterol. Hepatol. 21: 847-849 (2006). *
Dixit M, Choudhuri G, Mittal B. Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Dig. Liver Dis. 38: 397-403 (2006).
Dixit M, Choudhuri G, Saxena R, Mittal B. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Can. J. Gastroenterol. 21: 569-575 (2007). *
Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, Taylor J, Burnett E, Gut I, Farrall M, Lathrop GM, Abecasis GR, Cookson WO. A genome-wide association study of global gene expression. Nat. Genet. 39: 1202-1207 (2007). *
Dixon PH, van Mil S, Chambers J, Strautnieks S, Thompson R, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson LA, Marschall HU, Molokhia M, Moore G, Linton K, Williamson C. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58: 537-544 (2009). *
Dizier MH, Clerget-Darpoux F, Hochez J. Segregation analysis of two genetic markers in IDDM families under two-locus models. Genet. Epidemiol. 6: 71-75 (1989).
Djarmati A, Dobricic V, Kecmanovic M, Marsh P, Jancic-Stefanovic J, Klein C, Djuric M, Romac S. MECP2 mutations in Serbian Rett syndrome patients. Acta Neurol. Scand. 116: 413-419 (2007). *
Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 48: 87-92 (1996).
Djilali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum. Immunol. 49: 22-27 (1996).
Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. Hum. Immunol. 59: 176-182 (1998).
Djilali-Saiah I, Caillat-Zucman S, Schmitz J, Chaves-Vieira ML, Bach JF. Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in celiac disease. Hum. Immunol. 40: 8-16 (1994).
Djilali-Saiah I, Ouellette P, Caillat-Zucman S, Debray D, Kohn JI, Alvarez F. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum. Immunol. 62: 1356-1362 (2001).
Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J. Hepatol. 40: 904-909 (2004).
Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43: 187-189 (1998). *
Djuric T, Zivkovic M, Stankovic A, Dincic E, Raicevic R, Alavantic D. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. J. Neurol. Sci. 267: 62-65 (2008).
Dlugos AM, Hamidovic A, Palmer AA, de Wit H. Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology (Berl.) 206: 501-511 (2009).
Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation 80: 1773-1782 (2005).
Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska-Rodziewicz A, Kapelski P, Kaczmarkiewicz-Fass M, Hauser J. Dopamine receptor D(1) gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 53: 46-50 (2006).
Dobreva ZG, Stanilova SA, Miteva LD. The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism. Cell. Mol. Biol. Lett. 14: 609-621 (2009).
Dobrin S. Comparison of HapMap data on Affymetrix and Illumina platforms: expanding the power of studies and a not so unexpected synergy. Pharmacogenomics 8: 199-201 (2007).
Dobrovolna M, Vrana M, Brdicka R, Loudova M. Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors. Cas. Lek. Cesk. 145: 32-35 (2006).
Doetschman T. Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol. Biol. 530: 1-11 (2009).
Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A. Polymorphisms in the vitamin D receptor gene and risk of lung cancer. Med. Sci. Monit. 15: BR232-BR242 (2009).
Doggrell SA. Bradykinin B2 receptors as a target in diabetic nephropathy. Curr. Opin. Investig. Drugs 7: 251-255 (2006).
Dogru D, Ozbas Gerceker F, Yalcin E, Cobanoglu N, Pekcan S, Ozcelik U, Kiper N, Ozguc M. The role of TAP1 and TAP2 gene polymorphism in idiopathic bronchiectasis in children. Pediatr. Pulmonol. 42: 237-241 (2007).
Doherty DG, Underhill JA, Donaldson PT, Manabe K, Mieli-Vergani G, Eddleston AL, Vergani D, Demaine AG, Williams R. Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity 18: 243-249 (1994).
Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes 56: 2829-2833 (2007). *
Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, Pavlovic S. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther. Drug Monit. 28: 800-806 (2006).
Dolan C, O'halloran A, Bradley DG, Croke DT, Evans A, O'Brien JK, Dicker P, Shields DC. Genetic stratification of pathogen-response-related and other variants within a homogeneous Caucasian Irish population. Eur. J. Hum. Genet. 13: 798-806 (2005). *
Dolley G, Lamarche B, Despres JP, Bouchard C, Perusse L, Vohl MC. Myeloperoxidase gene sequence variations are associated with low-density-lipoprotein characteristics. J. Hum. Genet. 53: 439-446 (2008). *
Dominguez M, Bastos E, Silva S, Rossi B. Molecular research methods in the detection of germinal mutations in hereditary colorectal cancer. Rev. Gastroenterol. Peru 29: 247-253 (2009).
Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68: 193-209 (2006). *
Donaghue KC, Margan SH, Chan AK, Holloway B, Silink M, Rangel T, Bennetts B. The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents. Diabet. Med. 22: 1315-1320 (2005). *
Donaldson P. HLA system and other genetic markers in PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 71-72. October 15-16 (2003). *
Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48: 397-402 (2001). *
Donaldson P, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver disease. Hepatology 20: 225-239 (1994).
Donaldson P, Veeramani S, Baragiotta A, Floreani A, Venturi C, Pearce S, Wilson V, Jones D, James O, Taylor J, Newton J, Bassendine M. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin. Gastroenterol. Hepatol. 5: 755-760 (2007).
Donaldson PT. Immunogenetics in liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 23-24. September 12 - 13 (2003). *
Donaldson PT. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J. Hepatol. 31: 366-368 (1999). *
Donaldson PT. Genetics in autoimmune hepatitis. Semin. Liver Dis. 22: 353-364 (2002). *
Donaldson PT. The role of genetics in immunopathogenesis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 47-48 (2004). *
Donaldson PT. Chapter 17. Immunogenetics of autoimmune liver disease: risk factors for susceptibility and progression. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 221-234 (2007). *
Donaldson PT, Clare M, Constantini PK, Hadzic N, Mieli-Vergani G, Howard E, Kelley D. HLA and cytokine gene polymorphisms in biliary atresia. Liver 22: 213-219 (2002). *
Donaldson PT, Czaja AJ. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis. Clin. Liver Dis. 6: 419-437 (2002).
Donaldson PT, Norris S. Immunogenetics in PSC. Best Pract. Res. Clin. Gastroenterol. 15: 611-627 (2001). *
Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. J. Hepatol. 32: 882-886 (2000). *
Donders GG, Babula O, Bellen G, Linhares IM, Witkin SS. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG 115: 1225-1231 (2008).
Donfack J, Schneider DH, Tan Z, Kurz T, Dubchak I, Frazer KA, Ober C. Variation in conserved non-coding sequences on chromosome 5q and susceptibility to asthma and atopy. Respir. Res. 6: 145 (2005). *
Dong C, He L, Li J, Ye F, He M, Wang Y. Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25: 447-451 (2008).
Dong DM, Yao M, Liu B, Sun CY, Jiang YQ, Wang YS. Association between the -1306C/T polymorphism of matrix metalloproteinase-2 gene and lumbar disc disease in Chinese young adults. Eur. Spine J. 16: 1958-1961 (2007). *
Dong GP, Yu ZS, Liang L, Zou CC, Fu JF, Wang CL. IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus. Int. J. Immunogenet. 34: 75-79 (2007). *
Dong H, Wang J, Hirose A, Nozaki Y, Takahashi M, Ono M, Akisawa N, Iwasaki S, Saibara T, Onishi S. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population? J. Hepatol. 46: 915-920 (2007). *
Dong J, Huang ZW, Piao JH, Gong J. Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women. Wei Sheng Yan Jiu 35: 196-200 (2006).
Dong JJ, Zhao JJ, Lee KO, Lir MC, Chan SW, Liao L. Distribution of polymorphism in endothelial nitric oxide synthase gene in Singapore Chinese and its association with diabetic nephropathy. Zhonghua Yi Xue Za Zhi 87: 3415-3417 (2007).
Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299: 2423-2436 (2008). *
Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Caan BJ, Potter JD, Peters U. Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol. Biomarkers Prev. 17: 2755-2765 (2008). *
Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin FM, Makar KW, Carlson CS, Caan BJ, Potter JD, Peters U. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol. Biomarkers Prev. 18: 2540-2548 (2009). *
Dong Q, Xu B, Tan Y, Liu Z, Tian L, Zhang B, Lin CK, Kung HF, Sung JJ, He ML. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations. Biomed. Pharmacother. 63: 658-662 (2009).
Dong X, Zhou G, Zhai Y, Zhang H, Yang H, Zhi L, Zhang X, Chu J, He F. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers. Cancer Epidemiol. 33: 265-270 (2009).
Dong Y, Xu Z, Lin P. Association among serous and cerebrospinal fluid TNF-alpha level, gene polymorphisms of TNF-alpha and multiple sclerosis in Han nationality of southern China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 677-679 (2006).
Dongiovanni P, Fracanzani AL, Cairo G, Megazzini CP, Gatti S, Rametta R, Fargion S, Valenti L. Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Am. J. Pathol. Dec 17 [Epub ahead of print] (2009). *
Dongxia L, Qi H, Lisong L, Jincheng G. Association of peroxisome proliferator-activated receptor-gamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome. Circ. J. 72: 551-557 (2008). *
Donn R, Payne D, Ray D. Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis. Clin. Endocrinol. (Oxf.) 67: 342-345 (2007). *
Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CE. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J. Invest. Dermatol. 123: 484-487 (2004). *
Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82: 4130-4132 (1997). *
Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82: 143-146 (1997). *
Doorduyn Y, Van Pelt W, Siezen CL, Van Der Horst F, Van Duynhoven YT, Hoebee B, Janssen R. Novel insight in the association between Salmonellosis or Campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol. Infect. 136: 1225-1234 (2008).
Dorak MT. Role of natural killer cells and killer immunoglobulin-like receptor polymorphisms: association of HLA and KIRs. Methods Mol. Med. 134: 123-144 (2007).
Dorak MT, Shao W, Machulla HK, Lobashevsky ES, Tang J, Park MH, Kaslow RA. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun. 7: 450-467 (2006). *
Dorak MT, Yee LJ, Tang J, Shao W, Lobashevsky ES, Jacobson LP, Kaslow RA. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma. J. Med. Virol. 76: 302-310 (2005). *
Doria A, Wojcik J, Xu R, Gervino EV, Hauser TH, Johnstone MT, Nolan D, Hu FB, Warram JH. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. JAMA 300: 2389-2397 (2008). *
Doring F, Rimbach G, Lodge JK. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life. 56: 615-620 (2004). *
Dork T, Stuhrmann M. Polymorphisms of the human beta-defensin-1 gene. Mol. Cell. Probes 12: 171-173 (1998).
Dorne JL. Metabolism, variability and risk assessment. Toxicology Nov 19 [Epub ahead of print] (2009). *
Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res. Ther. 6: R199-R207 (2004). *
Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis. Markers 22: 355-359 (2006).
Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes. Mol. Genet. Metab. 88: 280-284 (2006). *
Dosenko VE, Zagoriy VY, Haytovich NV, Gordok OA, Moibenko AA. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim. Pol. 53: 299-302 (2006). *
Dotan I. Disease behavior in adult patients: are there predictors for stricture or fistula formation? Dig. Dis. 27: 206-211 (2009).
Dotan I. Inflammatory bowel diseases: in search of novel cytokines and genes. Harefuah. 145: 817-819, 861 (2006).
Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J. Rheumatol. 31: 1756-1762 (2004).
Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, Harley JB, Merrill J, Kimberly RP, Alarcon GS, Brown EE, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Vila LM, Gaffney PM, James JA, Moser KL, Alarcon-Riquelme ME, Vyse TJ, et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun. 10: 457-469 (2009).
Douraghi M, Talebkhan Y, Zeraati H, Ebrahimzadeh F, Nahvijoo A, Morakabati A, Ghafarpour M, Esmaili M, Bababeik M, Oghalaie A, Rakhshani N, Hosseini ME, Mohagheghi MA, Mohammadi M. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Digestion 80: 200-207 (2009).
Douroudis K, Laine AP, Heinonen M, Hermann R, Lipponen K, Veijola R, Simell O, Knip M, Uibo R, Ilonen J, Kisand K. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum. Immunol. 70: 536-539 (2009).
Douroudis K, Nemvalts V, Rajasalu T, Kisand K, Uibo R. The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens 74: 417-419 (2009). *
Douroudis K, Prans E, Haller K, Nemvalts V, Rajasalu T, Tillmann V, Kisand K, Uibo R. Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 72: 425-430 (2008). *
Douroudis K, Prans E, Kisand K, Nemvalts V, Uibo R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults. Clin. Chim. Acta 403: 226-228 (2009). *
Douroudis K, Prans E, Uibo R. CTLA-4 promoter polymorphisms are associated with latent autoimmune diabetes in adults. Hum. Immunol. 70: 921-924 (2009).
Douroudis K, Tarassi K, Athanassiades T, Giannakopoulos F, Kominakis A, Thalassinos N, Papasteriades Ch. HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population. Tissue Antigens 69: 592-596 (2007). *
Downie-Doyle S, Bayat N, Rischmueller M, Lester S. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis Rheum. 54: 2434-2440 (2006). *
Downie-Doyle S, Lester S, Bardy P, Gordon T, Rischmueller M, Pile K. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjogren's syndrome. Genes Immun. 3 Suppl. 1: S63-S65 (2002). *
Doxiadis GG, de Groot N, Bontrop RE. Impact of endogenous intronic retroviruses on major histocompatibility complex class II diversity and stability. J. Virol. 82: 6667-6677 (2008). *
Doxiadis GG, de Groot N, Claas FH, Doxiadis II, van Rood JJ, Bontrop RE. A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 104: 8907-8912 (2007). *
Doxiadis GG, de Groot N, de Groot NG, Doxiadis II, Bontrop RE. Reshuffling of ancient peptide binding motifs between HLA-DRB multigene family members: old wine served in new skins. Mol. Immunol. 45: 2743-2751 (2008). *
Doxiadis GG, Heijmans CM, Otting N, Bontrop RE. MIC gene polymorphism and haplotype diversity in rhesus macaques. Tissue Antigens 69: 212-219 (2007). *
Doxiadis II, de Fijter JW, Mallat MJ, Haasnoot GW, Ringers J, Persijn GG, Claas FH. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation 83: 1207-1213 (2007).
Doyle WJ, Casselbrant ML, Li-Korotky HS, Cullen Doyle AP, Lo CY, Turner R, Cohen S. The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness. J. Infect. Dis. 201: 199-206 (2010). *
Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J. Immunol. 174: 7085-7095 (2005). *
Drain S, Catherwood MA, Orr N, Galligan L, Rea IM, Hodkinson C, Drake MB, Kettle PJ, Morris TC, Alexander HD. ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma. Leuk. Lymphoma 50: 566-570 (2009).
Drake TA, Schadt EE, Lusis AJ. Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice. Mamm. Genome 17: 466-479 (2006). *
Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Singapore Med. J. 49: 924-929 (2008). *
Dresch C, Xavier R, Brenol JC, Nardi NB, Chies JA. Analysis of two T-cell receptor BV gene segment polymorphisms in caucasoid Brazilian patients with rheumatoid arthritis. Immunol. Lett. 90: 77-80 (2003).
Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet. Test. 8: 417-420 (2004).
Drevinek P, Baldwin A, Dowson CG, Mahenthiralingam E. Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia. BMC Microbiol. 8: 44 (2008). *
Drigo SA, Cunha-Neto E, Ianni B, Cardoso MR, Braga PE, Fae KC, Nunes VL, Buck P, Mady C, Kalil J, Goldberg AC. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect. 8: 598-603 (2006). *
Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, Smyth CM, Keeling PWN, O�Donoghue D, O�Sullivan M, O�Morain C, Mahmud N, Wikstrom AC, Kelleher D, McManus R. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 130: 341-348 (2006). *
Drosos AA, Moutsopoulos HM. Rheumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin. Exp. Rheumatol. 13 Suppl. 12: S7-S12 (1995).
Drozdzik A. The effect of environmental and genetic factors in the pathogenesis of periodontitis. Ann. Acad. Med. Stetin. 54: 118-126 (2008).
Drozdzik A, Kurzawski M, Lener A, Kozak M, Banach J, Drozdzik M. Matrix metalloproteinase-3 gene polymorphism in renal transplant patients with gingival overgrowth. J. Periodontal Res. Sep 23 [Epub ahead of print] (2009).
Drozdzik A, Kurzawski M, Safronow K, Banach J. Polymorphism in interleukin-1beta gene and the risk of periodontitis in a Polish population. Adv. Med. Sci. 51 Suppl. 1: 13-17 (2006).
Drozdzik M, Rudas T, Pawlik A, Gornik W, Kurzawski M, Herczynska M. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis. Pharmacogenomics J. 7: 404-407 (2007). *
Drozdzik M, Rudas T, Pawlik A, Kurzawski M, Czerny B, Gornik W, Herczynska M. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs. Eur. J. Clin. Pharmacol. 62: 933-937 (2006). *
Drozdzik M, Stefankiewicz J, Kurzawa R, Gornik W, Baczkowski T, Kurzawski M. Association of the MDR1 (ABCB1) gene 3435C>T polymorphism with male infertility. Pharmacol. Rep. 61: 690-696 (2009). *
Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR; Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N. Engl. J. Med. 353: 1443-1453 (2005). *
Drzewoski J, Sliwinska A, Przybylowska K, Sliwinski T, Kasznicki J, Zurawska-Klis M, Kosmalski M, Majsterek I. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease. Kardiol. Pol. 66: 1042-1048 (2008).
du Cheyron D, Fradin S, Ramakers M, Terzi N, Guillotin D, Bouchet B, Daubin C, Charbonneau P. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients. Crit. Care Med. 36: 3178-3183 (2008).
Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul. Immunol. Inflamm. 17: 249-256 (2009).
Du L, Yang P, Hou S, Lin X, Zhou H, Huang X, Wang L, Kijlstra A. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin. Immunol. 127: 43-48 (2008). *
Du L, Yang P, Hou S, Zhou H, Kijlstra A. No association of CTLA-4 polymorphisms with susceptibility to Behcet's disease. Br. J. Ophthalmol. 93: 1378-1381 (2009).
Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J. Viral Hepat. 13: 618-624 (2006). *
Du WT, Zhao HF, Xu JH, Gu DS, Xue F, Ge J, Dong XW, Chen ZP, Zhou ZP, Yang RC. The role of TIM-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum. Immunol. 70: 398-402 (2009).
Du Y, Zhang QY, Ruan LR, Liang CC, Li QR, He W. The relationship between abnormal apoptosis and Fas expression of thymocytes from patients with myasthenia gravis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 19: 450-453 (2003).
Du Z, Sharma SK, Spellman S, Reed EF, Rajalingam R. KIR2DL5 alleles mark certain combination of activating KIR genes. Genes Immun. 9: 470-480 (2008).
Du ZQ, Fan B, Zhao X, Amoako R, Rothschild MF. Association analyses between type 2 diabetes genes and obesity traits in pigs. Obesity (Silver Spring) 17: 323-329 (2009). *
Duan ZX, Zhu PF, Dong H, Gu W, Yang C, Liu Q, Wang ZG, Jiang JX. Functional significance of the TLR4/11367 polymorphism identified in Chinese Han population. Shock 28: 160-164 (2007). *
Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, Fakiola M, Nancy Miller E, Blackwell JM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur. J. Hum. Genet. 13: 829-834 (2005). *
Dubinsky MC. Optimizing immunomodulator therapy for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 506-511 (2003).
Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I, Quiros A, Silber G, Wahbeh G, Katzir L, Vasiliauskas E, Bahar R, Otley A, Mack D, Evans J, Rosh J, Hemker MO, Leleiko N, Crandall W, Langton C, Landers C, Taylor KD, Targan SR, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin. Gastroenterol. Hepatol. 6: 1105-1111 (2008).
Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A, Dutridge D, Wahbeh G, Silber G, Bahar R, Mengesha E, Targan SR, Taylor KD, Rotter JI. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm. Bowel Dis. 13: 511-515 (2007). *
Dubois V, Favre-Victoire I, Giannoli C. Three new HLA-B alleles determined by sequence-based typing: B*9551, B*5161 and B*5317. Tissue Antigens Oct 21 [Epub ahead of print] (2009). *
Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124: 1265-1276 (2003). *
Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C. FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits. Biomed. Pharmacother. 62: 153-157 (2008).
Duckworth L, Hsu L, Feng H, Wang J, Sylvester JE, Kissoon N, Sandler E, Lima JJ. Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatr. Pulmonol. 42: 332-338 (2007).
Ducros V, Barro C, Yver J, Pernod G, Polack B, Carpentier P, Desruets MD, Bosson JL. Should plasma homocysteine be used as a biomarker of venous thromboembolism? A case-control study. Clin. Appl. Thromb. Hemost. 15: 517-522 (2009).
Dudkiewicz M, Malanowski P, Czerwin Ski J, Pawlowski K. An approach to predicting hematopoietic stem cell transplantation outcome using HLA-mismatch information mapped on protein structure data. Biol. Blood Marrow Transplant. 15: 1014-1025 (2009).
Duell EJ, Holly EA, Kelsey KT, Bracci PM. Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Int. J. Cancer 126: 790-795 (2009). *
Duerr RH. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132: 2045-2049 (2007). *
Duerr RH, Barmada MM, Zhang L, Achkar JP, Cho JH, Hanauer SB, Brant SR, Bayless TM, Baldassano RN, Weeks DE. Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. Hum. Mol. Genet. 11: 2599-2606 (2002). *
Duetsch G, Illig T, Loesgen S, Rohde K, Klopp N, Herbon N, Gohlke H, Altmueller J, Wjst M. STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study. Hum. Mol. Genet. 11: 613-621 (2002). *
Duffin KC, Freeny IC, Schrodi SJ, Wong B, Feng BJ, Soltani-Arabshahi R, Rakkhit T, Goldgar DE, Krueger GG. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J. Invest. Dermatol. 129: 2777-2783 (2009). *
Duffin KC, Krueger GG. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. J. Invest. Dermatol. 129: 827-833 (2009). *
Duffy DL, Montgomery GW, Chen W, Zhao ZZ, Le L, James MR, Hayward NK, Martin NG, Sturm RA. A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation. Am. J. Hum. Genet. 80: 241-252 (2007). *
Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun. 4: 245-250 (2003). *
Duggal P, Gillanders EM, Mathias RA, Ibay GP, Klein AP, Baffoe-Bonnie AB, Ou L, Dusenberry IP, Tsai YY, Chines PS, Doan BQ, Bailey-Wilson JE. Identification of tag single-nucleotide polymorphisms in regions with varying linkage disequilibrium. BMC Genet. 6 Suppl. 1: S73 (2005). *
Dugoujon JM, Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 22: 245-260 (1995).
Duijts L, Bakker-Jonges LE, Mook-Kanamori DO, Labout JA, Hofman A, van Duijn CM, van Dongen JJ, Hooijkaas H, Moll HA, Jaddoe VW. Variation in the insulin-like growth factor-1 gene is associated with lymphocyte subset counts in neonates: the Generation R Study. Clin. Endocrinol. (Oxf.) 70: 53-59 (2009). *
Dukkipati VS, Blair HT, Garrick DJ, Murray A. 'Ovar-Mhc' - ovine major histocompatibility complex: structure and gene polymorphisms. Genet. Mol. Res. 5: 581-608 (2006). *
Duley JA, Florin TH. Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides. Ther. Drug Monit. 27: 647-654 (2005).
Dultz G, Matheis N, Dittmar M, Bender K, Kahaly GJ. CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity. Horm. Metab. Res. 41: 426-429 (2009).
Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly GJ. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 19: 143-148 (2009).
Dunbar SA, Jacobson JW. Rapid screening for 31 mutations and polymorphisms in the cystic fibrosis transmembrane conductance regulator gene by Lminex xMAP suspension array. Methods Mol. Med. 114: 147-171 (2005).
Dundar M, Caglayan AO, Saatci C, Karaca H, Baskol M, Tahiri S, Ozkul Y. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population. Cancer Genet. Cytogenet. 177: 95-97 (2007).
Dundar U, Solak M, Kavuncu V, Ozdemir M, Cakir T, Yildiz H, Evcik D. Evidence of association of vitamin D receptor Apa I gene polymorphism with bone mineral density in postmenopausal women with osteoporosis. Clin. Rheumatol. 28: 1187-1191 (2009). *
Dunne C, McGuigan C, Crowley J, Hagan R, Rooney G, Kelleher J, Hutchinson M, Lawlor E. Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis. Tissue Antigens 68: 257-262 (2006). *
Dunnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, Brauch H, Baisch C, Gilbert M, Harth V, Spickenheuer A, Rabstein S, Pesch B, Bruning T, Ko YD, Hamann U. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade. Int. J. Cancer 125: 596-602 (2009). *
Dunnwald M, Zuberi AR, Stephens K, Le R, Sundberg JP, Fleckman P, Dale BA. The ichq mutant mouse, a model for the human skin disorder harlequin ichthyosis: mapping, keratinocyte culture, and consideration of candidate genes involved in epidermal growth regulation. Exp. Dermatol. 12: 245-254 (2003). *
Dunstan SJ, Ho VA, Duc CM, Lanh MN, Phuong CX, Luxemburger C, Wain J, Dudbridge F, Peacock CS, House D, Parry C, Hien TT, Dougan G, Farrar J, Blackwell JM. Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J. Infect. Dis. 183: 1156-1160 (2001). *
Duntas LH. Thyroid disease and lipids. Thyroid 12: 287-293 (2002).
Dupont HL. Systematic review: the epidemiology and clinical features of travellers' diarrhoea. Aliment. Pharmacol. Ther. 30: 187-196 (2009). *
Duprez L, Parma J, Van Sande J, Rodien P, Dumont JE, Vassart G, Abramowicz M. TSH receptor mutations and thyroid disease. Trends Endocrinol. Metab. 9: 133-140 (1998). *
Durand E, Boutin P, Meyre D, Charles MA, Clement K, Dina C, Froguel P. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 53: 2483-2486 (2004). *
Durand JP, el-Zaatari FA, Krieg AM, Taurog JD. Restriction fragment length polymorphism of T cell receptor alpha and beta chain genes in patients with ankylosing spondylitis. J. Rheumatol. 15: 1115-1158 (1988).
Durand V, Pers JO, Renaudineau Y, Saraux A, Youinou P, Jamin C. Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function. J. Leukoc. Biol. 69: 233-240 (2001). *
Durga J, van Boxtel MP, Schouten EG, Bots ML, Kok FJ, Verhoef P. Folate and the methylenetetrahydrofolate reductase 677C-->T mutation correlate with cognitive performance. Neurobiol. Aging 27: 334-343 (2006).
Duricova D, Pedersen N, Lenicek M, Hradsky O, Bronsky J, Adamcova M, Elkjaer M, Andersen PS, Vitek L, Larsen K, Lukas M, Nevoral J, Wewer V, Munkholm P. Infliximab dependency in children with Crohn's disease. Aliment. Pharmacol. Ther. 29: 792-799 (2009). *
Durinovic-Bello I, Jelinek E, Schlosser M, Eiermann T, Boehm BO, Karges W, Marchand L, Polychronakos C. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals. Diabetes 54: S18-S24 (2005). *
Durinovic-Bello I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun. Jan 7 [Epub ahead of print] (2010).
Duroudier NP, Tulah AS, Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 64: 823-839 (2009). *
Durrant C, Morris AP. Linkage disequilibrium mapping via cladistic analysis of phase-unknown genotypes and inferred haplotypes in the Genetic Analysis Workshop 14 simulated data. BMC Genet. 6 Suppl. 1: S100 (2005). *
Durston S, Fossella JA, Mulder MJ, Casey BJ, Ziermans TB, Vessaz MN, VAN Engeland H. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J. Am. Acad. Child. Adolesc. Psychiatry 47: 61-67 (2008).
Dursun A, Durakbasi-Dursun HG, Dursun R, Baris S, Akduman L. Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behcet's disease with or without ocular involvement. Inflamm. Res. Mar 3 [Epub ahead of print] (2009). *
Dusinska M, Dzupinkova Z, Wsolova L, Harrington V, Collins AR. Possible involvement of XPA in repair of oxidative DNA damage deduced from analysis of damage, repair and genotype in a human population study. Mutagenesis 21: 205-211 (2006). *
Duthie A, Doherty DG, Donaldson PT, Scott-Jupp R, Tanner MS, Eddleston AL, Mowat AP. The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis. J. Hepatol. 23: 532-537 (1995). *
Dutra LA, Costa PG, Velasco LF, Amato AA, Barra GB. Allele-specific PCR assay to genotype SNP rs7903146 in TCF7L2 gene for rapid screening of diabetes susceptibility. Arq. Bras. Endocrinol. Metabol. 52: 1362-1366 (2008). *
Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS. Implications of cytokine gene polymorphisms on the orchestration of the immune response: lessons learned from oral diseases. Cytokine Growth Factor Rev. 20: 223-232 (2009).
Dutt A, Beroukhim R. Single nucleotide polymorphism array analysis of cancer. Curr. Opin. Oncol. 19: 43-49 (2007).
Dutt SS, Chen N, Darbary HK, Swede H, Petrelli NJ, Stoler DL, Anderson GR. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age. Mutat. Res. 645: 27-32 (2008).
Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 63: 13-20 (2004). *
Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch. Dermatol. 127: 64-68 (1991).
Duymaz-Tozkir J, Gul A, Uyar FA, Ozbek U, Saruhan-Direskeneli G. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behcet's disease. Clin. Exp. Rheumatol. 21: S15-S18 (2003).
Duymaz-Tozkir J, Yilmaz V, Uyar FA, Hajeer AH, Saruhan-Direskeneli G, Gul A. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behcet's disease. J. Rheumatol. 32: 93-97 (2005).
Duzgun N, Duman T, Haydardedeoglu FE, Tutkak H. Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens Sep 8 [Epub ahead of print] (2009). *
Duzgun N, Duman T, Haydardedeoglu FE, Tutkak H. The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin. Rheumatol. 26: 915-919 (2007). *
Dvornyk V, Long JR, Liu PY, Shen H, Recker RR, Deng HW. Polymorphisms of the vitamin D receptor gene predict the onset of surgical menopause in Caucasian females. Gynecol. Endocrinol. 22: 552-556 (2006).
Dwivedi M, Gupta K, Gulla KC, Laddha NC, Hajela K, Begum R. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo. Br. J. Dermatol. 161: 63-69 (2009). *
Dworacka M, Winiarska H, Jagodzinski PP. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients. Diabetes Res. Clin. Pract. 77: 258-262 (2007).
Dybdahl M, Vogel U, Frentz G, Wallin H, Nexo BA. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 8: 77-81 (1999). *
Dyment DA, Steckley JL, Morrison K, Willer CJ, Cader MZ, DeLuca GC, Sadovnick AD, Risch N, Ebers GC; Canadian Collaborative Study Group. TCR beta polymorphisms and multiple sclerosis. Genes Immun. 5: 337-342 (2004). *
Dyment DA, Steckley JL, Willer CJ, Armstrong H, Sadovnick AD, Risch N, Ebers GC. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. J. Neuroimmunol. 123: 193-198 (2002).
Dysager L, Jensen LH, Lindebjerg J, Jakobsen A. The prognostic importance of thymidylate gene polymorphism in colon cancer stage II. Int. J. Colorectal Dis. 23: 1267 (2008). *
Early SB, Huyett P, Brown-Steinke K, Borish L, Steinke JW. Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB. Genes Immun. 10: 341-349 (2009). *
Eastell T, Hinks A, Thomson W. SNPs in the FOXP3 gene region show no association with juvenile idiopathic arthritis in a UK Caucasian population. Rheumatology (Oxford) 46: 1263-1265 (2007). *
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093 (2007). *
Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann. Rheum. Dis. 55: 34-39 (1996). *
Ebinc FA, Derici U, Gonen S, Reis KA, Erten Y, Bali M, Sindel S, Arinsoy T. TGF-beta1 gene polymorphisms and peritoneal equilibration test results in CAPD patients. Ren. Fail. 30: 15-19 (2008).
Economopoulos KP, Sergentanis TN. Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk. Int. J. Cancer Sep 8 [Epub ahead of print] (2009). *
Edberg JC, Langefeld CD, Wu J, Moser KL, Kaufman KM, Kelly J, Bansal V, Brown WM, Salmon JE, Rich SS, Harley JB, Kimberly RP. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum. 46: 2132-2140 (2002). *
Edberg JC, Wainstein E, Wu J, Csernok E, Sneller MC, Hoffman GS, Keystone EC, Gross WL, Kimberly RP. Analysis of FcgammaRII gene polymorphisms in Wegener's granulomatosis. Exp. Clin. Immunogenet. 14: 183-195 (1997).
Edenberg HJ, Bierut LJ, Boyce P, Cao M, Cawley S, Chiles R, Doheny KF, Hansen M, Hinrichs T, Jones K, Kelleher M, Kennedy GC, Liu G, Marcus G, McBride C, Murray SS, Oliphant A, Pettengill J, Porjesz B, Pugh EW, Rice JP, Rubano T, Shannon S, et al. Description of the data from the Collaborative Study on the Genetics of Alcoholism (COGA) and single-nucleotide polymorphism genotyping for Genetic Analysis Workshop 14. BMC Genet. 6 Suppl. 1: S2 (2005). *
Eder T, Mayer R, Langsenlehner U, Renner W, Krippl P, Wascher TC, Pummer K, Kapp KS. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study. Eur. J. Cancer 43: 472-475 (2007). *
Edfeldt K, Bennet AM, Eriksson P, Frostegard J, Wiman B, Hamsten A, Hansson GK, Faire Ud U, Yan ZQ. Association of hypo-responsive Toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25: 1447-1453 (2004). *
Edgar KS, Woodside JV, Skidmore P, Cardwell C, Farelll K, McKinley MC, Youngl IS, Whitehead AS, Gey F, Yarnell JW, Evans A. Thiol and cardiovascular risk factor status in a male northern Irish population. Int. J. Vitam. Nutr. Res. 78: 208-216 (2008).
Edinur HA, Zafarina Z, Sp�nola H, Nurhaslindawaty AR, Panneerchelvam S, Norazmi MN. HLA polymorphism in six Malay sub-ethnic groups in Malaysia. Hum. Immunol. 70: 518-526 (2009).
Edwards AO, Chen D, Fridley BL, James KM, Wu Y, Abecasis G, Swaroop A, Othman M, Branham K, Iyengar SK, Sivakumaran TA, Klein R, Klein BE, Tosakulwong N. Toll-like receptor polymorphisms and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 49: 1652-1659 (2008). *
Edwards G. Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J. 2 Suppl. 1: S8 (2003). *
Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Genes Immun. 5: 36-40 (2004). *
Efferth T. Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases. Ageing Res. Rev. 2: 11-24 (2003).
Efrati E, Adler L, Krivoy N, Sprecher E. Distribution of TPMT risk alleles for thioupurine toxicity in the Israeli population. Eur. J. Clin. Pharmacol. 65: 257-262 (2009).
Efthimiou P. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications. Semin. Arthritis Rheum. 36: 168-172 (2006). *
Egan JB, Jacobs ET, Mart�nez ME, Gerner EW, Jurutka PW, Thompson PA. Presence of a TA haplotype in the APC gene containing the common 1822 polymorphism and colorectal adenoma. Cancer Res. 68: 6006-6013 (2008). *
Egan JB, Thompson PA, Vitanov MV, Bartik L, Jacobs ET, Haussler MR, Gerner EW, Jurutka PW. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol. Carcinog. Dec 30 [Epub ahead of print] (2009).
Egan LJ, Derijks LJ, Hommes DW. Pharmacogenomics in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 4: 21-28 (2006). *
Egea R, Casillas S, Fernandez E, Senar MA, Barbadilla A. MamPol: a database of nucleotide polymorphism in the Mammalia class. Nucleic Acids Res. 35: D624-D629 (2007). *
Egido J, Ortiz A. ACE gene polymorphism and the prognosis and treatment of overt diabetic nephropathy. Nat. Clin. Pract. Nephrol. 4: 472-473 (2008).
Egli RJ, Southam L, Wilkins JM, Lorenzen I, Pombo-Suarez M, Gonzalez A, Carr A, Chapman K, Loughlin J. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum. 60: 2055-2064 (2009). *
Eguchi T, Maruyama T, Ohno Y, Morii T, Hirao K, Hirose H, Kawabe H, Saito I, Hayashi M, Saruta T. Possible association of tumor necrosis factor receptor 2 gene polymorphism with severe hypertension using the extreme discordant phenotype design. Hypertens. Res. 32: 775-779 (2009).
Ehling R, Gassner Ch, Lutterotti A, Strasser-Fuchs S, Kollegger H, Kristoferitsch W, Reindl M, Berger T. Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis. Tissue Antigens 63: 28-33 (2004). *
Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, Strassburg CP. Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39: 970-977 (2004). *
Eichelbaum M, Fromm MF, Schwab M. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther. Drug Monit. 26: 180-185 (2004).
Eid AJ, Brown RA, Paya CV, Razonable RR. Association between Toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 84: 511-516 (2007).
Eid AJ, Brown RA, Razonable RR. Toll-like receptor-2 Arg753Gln polymorphism and herpes virus infections in transplantation. Transplantation 82: 1383-1385 (2006).
Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, Ammann RW, Goldmann SF, Vuitton DA, Gottstein B, Kern P. HLA and alveolar echinococcosis. Tissue Antigens 52: 124-129 (1998).
Eike MC, Becker T, Humphreys K, Olsson M, Lie BA. Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun. 10: 56-67 (2009). *
Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH; IBSEN study group, Dahl-Jorgensen K, Ronningen KS, Joner G, Flato B, Bergquist A, Thorsby E, Forre O, Kvien TK, Undlien DE, Lie BA. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann. Rheum. Dis. 67: 1287-1291 (2008).
Eike MC, Olsson M, Undlien DE, Dahl-Jorgensen K, Joner G, Ronningen KS, Thorsby E, Lie BA. Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families. Genes Immun. 10: 141-150 (2009). *
Einstein MH, Leanza S, Chiu LG, Schlecht NF, Goldberg GL, Steinberg BM, Burk RD. Genetic variants in TAP are associated with high-grade cervical neoplasia. Clin. Cancer Res. 15: 1019-1023 (2009). *
Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis. 37: 1496-1505 (2003). *
Eizaguirre C, Yeates SE, Lenz TL, Kalbe M, Milinski M. MHC-based mate choice combines good genes and maintenance of MHC polymorphism. Mol. Ecol. 18: 3316-3329 (2009).
Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44: 2220-2226 (2001). *
Ek J, Hansen SP, Lajer M, Nicot C, Boesgaard TW, Pruhova S, Johansen A, Albrechtsen A, Yderstraede K, Lauenborg J, Parrizas M, Boj SF, Jorgensen T, Borch-Johnsen K, Damm P, Ferrer J, Lebl J, Pedersen O, Hansen T. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4alpha gene (HNF4A) associates with late-onset diabetes. Diabetes 55: 1869-1873 (2006). *
Eklof V, Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Palmqvist R. The reduced folate carrier (RFC1) 80G > A and folate hydrolase 1 (FOLH1) 1561C > T polymorphisms and the risk of colorectal cancer: a nested case-referent study. Scand. J. Clin. Lab. Invest. 68: 393-401 (2008).
Eklund C, Huttunen R, Syrjanen J, Laine J, Vuento R, Hurme M. Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia. Scand. J. Infect. Dis. 38: 1069-1073 (2006). *
Eklund CM. Proinflammatory cytokines in CRP baseline regulation. Adv. Clin. Chem. 48: 111-136 (2009).
Ekstrom M, Silveira A, Bennermo M, Eriksson P, Tornvall P. Coagulation factor VII and inflammatory markers in patients with coronary heart disease. Blood Coagul. Fibrinolysis 18: 473-477 (2007).
Ekstrom PO, Bjorheim J, Gaudernack G, Giercksky KE. Population screening of single-nucleotide polymorphisms exemplified by analysis of 8000 alleles. J. Biomol. Screen. 7: 501-506 (2002). *
El Achhab Y, Meyre D, Bouatia-Naji N, Berraho M, Deweirder M, Vatin V, Delplanque J, Serhier Z, Lyoussi B, Nejjari C, Froguel P, Chikri M. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population. Diabetes Metab. 35: 37-42 (2009).
El Awady MK, Karim AM, Hanna LS, El Husseiny LA, El Sahar M, Menem HA, Meguid NA. Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals. Cancer Biomark. 5: 233-240 (2009).
El Mokhtari NE, Ott SJ, Nebel A, Schaefer A, Rosenstiel P, Foerster M, Nothnagel M, Simon R, Schreiber S. Role of NOD2/CARD15 in coronary heart disease. BMC Genet. 8: 76 (2007). *
El Mokhtari NE, Ott SJ, Nebel A, Simon R, Schreiber S. A functional variant in the CARD4 gene and risk of premature coronary heart disease. Int. J. Immunogenet. 33: 307-311 (2006). *
El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol. Invest. 37: 661-674 (2008). *
El-Chennawi FA, Kamel HA, Mosaad YM, El-Sherbini SM, El-Billey NA. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology 11: 227-234 (2006).
El-Magadmi M, Alansari A, Teh LS, Ordi J, Gul A, Inanc M, Bruce I, Hajeer A. Association of the A561C E-selectin polymorphism with systemic lupus erythematosus in 2 independent populations. J. Rheumatol. 28: 2650-2652 (2001).
El-Samahy MH, Shaheen MA, Saddik DE, Abdel Fattah NS, El-Sawi MA, Mahran MZ, Shehab AA. Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia. Int. J. Dermatol. Mar 18 [Epub ahead of print] (2009).
El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N, Hermann J. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology 113: 695-700 (2006).
El-Sohemy A. Nutrigenetics. Forum Nutr. 60: 25-30 (2007).
Elahi E, Khodadad A, Kupershmidt I, Ghasemi F, Alinasab B, Naghizadeh R, Eason RG, Amini M, Esmaili M, Esmaeili Dooki MR, Sanati MH, Davis RW, Ronaghi M, Thorstenson YR. A haplotype framework for cystic fibrosis mutations in Iran. J. Mol. Diagn. 8: 119-127 (2006). *
Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim. Biophys. Acta 1792: 163-172 (2009).
Elahi MM, Asotra K, Matata BM, Mastana SS. Tumour necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim. Biophys. Acta Jan 26 [Epub ahead of print] (2009). *
Elahi MM, Gilmour A, Matata BM, Mastana SS. A variant of position -308 of the tumour necrosis factor alpha gene promoter and the risk of coronary heart disease. Heart Lung Circ. 17: 14-18 (2008).
Elamin NE, Elbashir MI, Elkhidir IM, Elghazali G, Blasczyk R, Horn PA. Identification of four new HLA-Cw alleles in the Sudanese population. Tissue Antigens 69: 270-272 (2007). *
Elbaz A, Dufouil C, Alperovitch A. Interaction between genes and environment in neurodegenerative diseases. C. R. Biol. 330: 318-328 (2007). *
Elbein SC, Chu WS, Das SK, Yao-Borengasser A, Hasstedt SJ, Wang H, Rasouli N, Kern PA. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 50: 1621-1630 (2007). *
Elbein SC, Das SK, Hallman DM, Hanis CL, Hasstedt SJ. Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) study Cohort. Diabetes 58: 268-274 (2009). *
Elce A, Boccia A, Cardillo G, Giordano S, Tomaiuolo R, Paolella G, Castaldo G. Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis. Clin. Chem. 55: 1372-1379 (2009). *
Elder JT. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun. 10: 201-209 (2009). *
Elder JT, Bruce AT, Gudjonsson JE, Johnston A, Stuart PE, Tejasvi T, Voorhees JJ, Abecasis GR, Nair RP. Molecular dissection of psoriasis: integrating genetics and biology. J. Invest. Dermatol. Oct 8 [Epub ahead of print] (2009). *
Eleftherohorinou H, Wright V, Hoggart C, Hartikainen AL, Jarvelin MR, Balding D, Coin L, Levin M. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One 4: e8068 (2009). *
Elia J, Capasso M, Zaheer Z, Lantieri F, Ambrosini P, Berrettini W, Devoto M, Hakonarson H. Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A. Psychiatr. Genet. 19: 134-141 (2009).
Eliopoulos DG, Mavroudi I, Pontikoglou C, Ximeri M, Stavroulaki E, Pyrovolaki K, Velegraki M, Spanoudakis M, Goulielmos G, Papadaki HA. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia. Eur. J. Haematol. Jul 14 [Epub ahead of print] (2009).
Ellegren H. Characteristics, causes and evolutionary consequences of male-biased mutation. Proc. Biol. Sci. 274: 1-10 (2007). *
Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB. Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum. Genet. 121: 451-457 (2007). *
Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J. Invest. Dermatol. 116: 452-455 (2001). *
Elmaagacli AH, Koldehoff M, Landt O, Beelen DW. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant. 41: 821-826 (2008).
Elmgreen J, Sorensen H, Berkowicz A. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease. Acta Med. Scand. 215: 375-378 (1984).
Eloranta ML, Hakli T, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 38: 648-652 (2003). *
Eloranta ML, Heiskanen J, Hiltunen M, Helisalmi S, Mannermaa A, Heinonen S. Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 35: 966-968 (2000). *
Eloranta ML, Heiskanen JT, Hiltunen MJ, Mannermaa AJ, Punnonen KR, Heinonen ST. Multidrug resistance 3 gene mutation 1712delT and estrogen receptor alpha gene polymorphisms in Finnish women with obstetric cholestasis. Eur. J. Obstet. Gynecol. Reprod. Biol. 104: 109-112 (2002).
Eloranta ML, Heiskanen JT, Hiltunen MJ, Mannermaa AJ, Punnonen KR, Heinonen ST. Multidrug resistance 3 gene mutation 1712delT and estrogen receptor alpha gene polymorphisms in Finnish women with obstetric cholestasis. Eur. J. Obstet. Gynecol. Reprod. Biol. 105: 132-135 (2002).
Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic. Res. 41: 770-778 (2007). *
Elvevag B, Weinberger DR. Introduction: genes, cognition and neuropsychiatry. Cogn. Neuropsychiatry 14: 261-276 (2009).
Emerenciano M, Bungaro S, Cazzaniga G, Dorea MD, Coser VM, Magalhaes IQ, Biondi A, Pombo-de-Oliveira MS. ETV6-RUNX1 fusion gene and additional genetic changes in infant leukemia: a genome-wide analysis. Cancer Genet. Cytogenet. 193: 86-92 (2009).
Emily M, Mailund T, Hein J, Schauser L, Schierup MH. Using biological networks to search for interacting loci in genome-wide association studies. Eur. J. Hum. Genet. 17: 1231-1240 (2009).
Emingil G, Berdeli A, Baylas H, Saygan BH, Gurkan A, Kose T, Atilla G. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. J. Periodontol. 78: 1968-1977 (2007).
Emmerich F, Bal G, Barakat A, Milz J, Muhle C, Martinez-Gamboa L, Dorner T, Salama A. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br. J. Haematol. 136: 309-314 (2007). *
Emoto C, Murase S, Iwasaki K. Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage. Xenobiotica 36: 671-683 (2006). *
Enerback C, Enlund F, Inerot A, Samuelsson L, Wahlstrom J, Swanbeck G, Martinsson T. S gene (Corneodesmosin) diversity and its relationship to psoriasis; high content of cSNP in the HLA-linked S gene. J. Invest. Dermatol. 114: 1158-1163 (2000). *
Enerback C, Nilsson S, Enlund F, Inerot A, Samuelsson L, Wahlstrom J, Swanbeck G, Martinsson T. Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Arch. Dermatol. Res. 292: 525-530 (2000). *
Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun. 5: 426-430 (2004). *
Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR, Kitts CL. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol. Ecol. 57: 239-250 (2006). *
Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T, Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutuculer N, Camcioglu Y, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124: 1289-1302.e4 (2009). *
Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M, Gabbas A, Serpe R, Madeddu C, Scarpa A, Cocco P. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol. Oncol. 26: 98-103 (2008).
Ennis S, Jomary C, Mullins R, Cree A, Chen X, Macleod A, Jones S, Collins A, Stone E, Lotery A. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 372: 1828-1834 (2008). *
Enomoto H, Noguchi E, Iijima S, Takahashi T, Hayakawa K, Ito M, Kano T, Aoki T, Suzuki Y, Koga M, Tamari M, Shiohara T, Otsuka F, Arinami T. Single nucleotide polymorphism-based genome-wide linkage analysis in Japanese atopic dermatitis families. BMC Dermatol. 7: 5 (2007). *
Eny KM, El-Sohemy A, Cornelis MC, Sung YK, Bae SC. Catalase and PPARgamma2 genotype and risk of systemic lupus erythematosus in Koreans. Lupus 14: 351-355 (2005).
Eoli M, Pandolfo M, Amoroso A, Salmaggi A, Zaffaroni M, Gasparini P, DiDonato S, Milanese C, Zeviani M. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur. J. Hum. Genet. 3: 303-311 (1995).
Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE. The mouse genome database (MGD): new features facilitating a model system. Nucleic Acids Res. 35: D630-D637 (2007). *
Epplein M, Wilkens LR, Tiirikainen M, Dyba M, Chung FL, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L. Urinary isothiocyanates, glutathione S-transferase M1, T1, and P1 polymorphisms, and risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 18: 314-320 (2009).
Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch. Otolaryngol. Head Neck Surg. 133: 705-709 (2007).
Erbek SS, Yurtcu E, Erbek S, Sahin FI. Matrix metalloproteinase-9 promoter gene polymorphism (-1562C>T) in nasal polyposis. Am. J. Rhinol. Allergy 23: 568-570 (2009).
Erdal ME, Tursen U, Kaya TI, Kanik A, Derici E, Ikizoglu G. Association between catechol-O-methyltransferase polymorphism and psoriasis. Int. J. Dermatol. 43: 312-314 (2004). *
Erdal N, Herken H, Yilmaz M, Erdal E, Bayazit YA. The A218C polymorphism of tryptophan hydroxylase gene and migraine. J. Clin. Neurosci. 14: 249-251 (2007).
Erdelyi DJ, Kamory E, Zalka A, Semsei AF, Csokay B, Andrikovics H, Tordai A, Borgulya G, Magyarosy E, Galantai I, Fekete G, Falus A, Szalai C, Kovacs GT. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia. Cell. Immunol. 244: 121-124 (2006). *
Erdogan M, Karadeniz M, Berdeli A, Alper G, Caglayan O, Yilmaz C. The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients. J. Endocrinol. Invest. 31: 624-629 (2008).
Erdogan M, Karadeniz M, Berdeli A, Tamsel S, Yilmaz C. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients. Int. J. Immunogenet. 36: 283-288 (2009). *
Erdogan M, Karadeniz M, Eroglu Z, Tezcanli B, Selvi N, Yilmaz C. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Res. Clin. Pract. 78: 355-359 (2007).
Erdogan M, Karadeniz M, Ozbek M, Ozgen AG, Berdeli A. Interleukin-10 gene polymorphismin patients with papillary thyroid cancer in Turkish population. J. Endocrinol. Invest. 31: 750-754 (2008).
Ereqat S, Nasereddin A, Azmi K, Abdeen Z, Amin R. Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res. 2009: 874126 (2009). *
Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet. Cytogenet. 165: 114-120 (2006).
Ergen A, Isbir S, Tekeli A, Isbir T. Investigation of ABCA1 C69T and G-191C polymorphisms in coronary artery disease. In Vivo 22: 187-190 (2008).
Erichsen HC, Peters U, Eck P, Welch R, Schoen RE, Yeager M, Levine M, Hayes RB, Chanock S. Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr. Cancer 60: 652-659 (2008). *
Erikci AA, Karagoz B, Ozyurt M, Ozturk A, Kilic S, Bilgi O. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker? Hematology 14: 101-105 (2009).
Eriksson JG. The role of genes in growth and later health. Nestle Nutr. Workshop Ser. Pediatr. Program 61: 69-77 (2008).
Erken E, Gunesacar R, Ozer HT. Investigation of C5a receptor gene 450 C/T polymorphism in Turkish patients with familial Mediterranean fever. Mol. Biol. Rep. Aug 6 [Epub ahead of print] (2009). *
Erlich H, Bugawan T, Begovich A, Scharf S. Analysis of HLA class II polymorphism using polymerase chain reaction. Arch. Pathol. Lab. Med. 117: 482-485 (1993).
Erlich HA. HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus. Baillieres Clin. Endocrinol. Metab. 5: 395-411 (1991).
Erlich HA. HLA class II polymorphism and genetic susceptibility to insulin-dependent diabetes mellitus. Curr. Top. Microbiol. Immunol. 164: 41-55 (1990).
Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96-103 (1990).
Erlich HA, Lohman K, Mack SJ, Valdes AM, Julier C, Mirel D, Noble JA, Morahan GE, Rich SS; for the Type I Diabetes Genetics Consortium. Association analysis of SNPs in the IL4R locus with type I diabetes. Genes Immun. 10: S33-S41 (2009).
Erlich HA, Valdes AM, Julier C, Mirel D, Noble JA. Evidence for association of the TCF7 locus with type I diabetes. Genes Immun. 10: S54-S59 (2009).
Ermakov S, Malkin I, Kobyliansky E, Livshits G. Variation in femoral length is associated with polymorphisms in RUNX2 gene. Bone 38: 199-205 (2006).
Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, Bont L. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 119: 1086-1091 (2007). *
Eroglu A, Egin Y, Cam R, Akar N. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Ann. Hematol. 88: 73-76 (2009). *
Eroglu A, Sertkaya-Karasoy D, Eroglu N, Akar N. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies. J. BUON 13: 61-64 (2008).
Eroglu A, Ulu A, Cam R, Kurtman C, Akar N. Prevalence of factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients. J. Thromb. Thrombolysis 23: 31-34 (2007). *
Eroglu Z, Cetinkalp S, Erdogan M, Kosova B, Karadeniz M, Kutukculer A, Gunduz C, Tetik A, Topcuoglu N, Ozgen AG, Tuzun M. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. J. Diabetes Complications 22: 186-190 (2008).
Ertam I, Itirli G, Onay H, Alper S, Ozkinay F. Interleukin-1 receptor antagonist and tumour necrosis factor-alpha gene polymorphisms in Turkish patients with allergic contact dermatitis. Contact Dermatitis 61: 86-90 (2009).
Ertas FS, Hasan T, Ozdol C, Gulec S, Atmaca Y, Tulunay C, Karabulut H, Kocum HT, Dincer I, Kose KS, Erol C. Relationship between angiotensin-converting enzyme gene polymorphism and severity of aortic valve calcification. Mayo Clin. Proc. 82: 944-950 (2007). *
Ertunc D, Aban M, Tok EC, Tamer L, Arslan M, Dilek S. Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis. Hum. Reprod. 20: 2157-2161 (2005).
Eryuksel E, Ceyhan BB, Bircan R, Avsar M, Cirakoglu B. Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients. J. Asthma 46: 335-338 (2009).
Erzin Y, Koksal V, Altun S, Dobrucali A, Aslan M, Erdamar S, Goksel S, Dirican A, Kocazeybek B. Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia. J. Gastroenterol. 43: 705-710 (2008). *
Esaki M, Furuse M, Matsumoto T, Aoyagi K, Jo Y, Yamagata H, Nakano H, Fujishima M. Polymorphism of heat-shock protein gene HSP70-2 in Crohn disease: possible genetic marker for two forms of Crohn disease. Scand. J. Gastroenterol. 34: 703-707 (1999). *
Escher R, Jones A, Hagos F, Carmichael C, Horwitz M, Olopade OI, Scott HS. Chromosome band 16q22-linked familial AML: exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms. Genes Chromosomes Cancer 41: 278-282 (2004). *
Eshaque B, Dixon B. Technology platforms for molecular diagnosis of cystic fibrosis. Biotechnol. Adv. 24: 86-93 (2006). *
Eskandari HG, Unal M, Ozturk OG, Vayisoglu Y, Muslu N. Leukotriene C4 synthase A-444C gene polymorphism in patients with allergic rhinitis. Otolaryngol. Head Neck Surg. 134: 997-1000 (2006).
Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1: 151-155 (1999). *
Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesboue R, Martin JP, Lesavre P. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 43: 1329-1332 (1993).
Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana FJ, Sjostrand M, Eloranta ML, N� Gabhann J, Winqvist O, Sundelin B, Jefferies CA, Rozell B, Kuchroo VK, Wahren-Herlenius M. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J. Exp. Med. 206: 1661-1671 (2009). *
Espinosa G, Arostegui JI, Plaza S, Rius J, Cervera R, Yague J, Font J. Behcet's disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin. Exp. Rheumatol. 23: S64-S66 (2005).
Espinoza JL, Takami A, Onizuka M, Sao H, Akiyama H, Miyamura K, Okamoto S, Inoue M, Kanda Y, Ohtake S, Fukuda T, Morishima Y, Kodera Y, Nakao S; Japan Marrow Donor Program. NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies. Haematologica 94: 1427-1434 (2009). *
Esplin MS. Preterm birth: a review of genetic factors and future directions for genetic study. Obstet. Gynecol. Surv. 61: 800-806 (2006).
Essid R, Mousli M, Aoun K, Abdelmalek R, Mellouli F, Kanoun F, Derouin F, Bouratbine A. Identification of Cryptosporidium species infecting humans in Tunisia. Am. J. Trop. Med. Hyg. 79: 702-705 (2008).
Esteban E, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Vona G, Harich N, Luna F, Saetta AA, Bissar N, Moral P. An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: data on the Mediterranean region. Am. J. Hum. Biol. 17: 690-695 (2005).
Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Amiri HM, Rashidi A, Solgi G, Parivar K, Nikbin B, Amirzargar A. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Eur. J. Intern. Med. 20: 424-428 (2009).
Esterle L, Jehan F, Sabatier JP, Garabedian M. Higher milk requirements for bone mineral accrual in adolescent girls bearing specific Caucasian genotypes in the VDR promoter. J. Bone Miner. Res. 24: 1389-1397 (2009). *
Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Joossens S, Vlietinck R, Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am. J. Gastroenterol. 99: 299-305 (2004). *
Esteve E, Villuendas G, Mallolas J, Vendrell J, Lopez-Bermejo A, Rodriguez M, Recasens M, Ricart W, San Millan JL, Escobar-Morreale H, Richart C, Fernandez-Real JM. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin. Endocrinol. (Oxf.) 65: 88-91 (2006). *
Etokebe GE, Abrahamsen TG, Bogen B, Spurkland A. Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography. Scand. J. Immunol. 59: 496-503 (2004). *
Eun IS, Park WW, Suh KT, Kim JI, Lee JS. Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis. Eur. Spine J. 18: 1936-1940 (2009). *
Eussen SJ, Vollset SE, Hustad S, Midttun O, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Ferrari P, Agudo A, Sala N, Capella G, Del Giudice G, Palli D, Boeing H, Weikert C, Bueno-de-Mesquita HB, Buchner FL, Carneiro F, Berrino F, Vineis P, et al. Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev. 19: 28-38 (2010).
Evangelou E, Chapman K, Meulenbelt I, Karassa FB, Loughlin J, Carr A, Doherty M, Doherty S, Gomez-Reino JJ, Gonzalez A, Halldorsson BV, Hauksson VB, Hofman A, Hart DJ, Ikegawa S, Ingvarsson T, Jiang Q, Jonsdottir I, Jonsson H, Kerkhof HJ, et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum. 60: 1710-1721 (2009). *
Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J. Mol. Med. 79: 198-204 (2001). *
Evans D, Beil FU. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women. BMC Med. Genet. 7: 66 (2006). *
Evans J, Collins M, Jennings C, van der Merwe L, Soderstrom I, Olsson T, Levitt NS, Lambert EV, Goedecke JH. The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease. Eur. J. Endocrinol. 157: 633-640 (2007). *
Evans TI, Han J, Singh R, Moxley G. The genotypic distribution of shared-epitope DRB1 alleles suggests a recessive mode of inheritance of the rheumatoid arthritis disease-susceptibility gene. Arthritis Rheum. 38: 1754-1761 (1995).
Everett B, Cameron B, Li H, Vollmer-Conna U, Davenport T, Hickie I, Wakefield D, Vernon S, Reeves WC, Lloyd AR. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun. 8: 699-702 (2007). *
Eynon N, Meckel Y, Sagiv M, Yamin C, Amir R, Sagiv M, Goldhammer E, Duarte JA, Oliveira J. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scand. J. Med. Sci. Sports Apr 20 [Epub ahead of print] (2009).
Eyre S, Bowes J, Potter C, Worthington J, Barton A. Association of the FCRL3 gene with RA: a further example of population specificity? Arthritis Res. Ther. 8: R117 (2006). *
Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D, Worthington J, Barton A. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum. 54: 3417-3422 (2006). *
Eyre-Walker A, Woolfit M, Phelps T. The distribution of fitness effects of new deleterious amino acid mutations in humans. Genetics 173: 891-900 (2006). *
Ezquieta B, Oyarzabal M, Barrio R, Luzuriaga C, Hermoso F, Lechuga JL, Quinteiro S, Rodr�guez A, Labarta JI, Gutierrez Macias A, Gallego M, Bellon JM. Monogenic and polygenic models detected in steroid 21-hydroxylase deficiency-related paediatric hyperandrogenism. Horm. Res. 71: 28-37 (2008).
Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab. 35: 214-219 (2009).
Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY. Interleukin-10 -592C/A, -819C/T, and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes patients. Clin. Endocrinol. (Oxf.) 70: 401-407 (2009). *
Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin. Endocrinol. (Oxf.) 68: 542-546 (2008). *
Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J. Diabetes Complications 22: 331-338 (2008).
Ezzikouri S, El Feydi AE, Benazzouz M, Afifi R, El Kihal L, Hassar M, Akil A, Pineau P, Benjelloun S. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Infect. Genet. Evol. 9: 877-881 (2009).
Ezzikouri S, El Feydi AE, Chafik A, Benazzouz M, El Kihal L, Afifi R, Hassar M, Pineau P, Benjelloun S. The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol. Res. 37: 748-754 (2007). *
Faa G. The role of the pathologist in the diagnosis and monitoring of Wilson's disease. Pathologica 88: 102-110 (1996).
Faa V, Bettoli PP, Demurtas M, Zanda M, Ferri V, Cao A, Rosatelli MC. A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening. J. Mol. Diagn. 8: 499-503 (2006). *
Faber KN, Muller M, Jansen PL. Drug transport proteins in the liver. Adv. Drug Deliv. Rev. 55: 107-124 (2003). *
Fabre EE, Raynaud-Simon A, Golmard JL, Hebert M, Dulcire X, Succari M, Myara J, Durand D, Nivet-Antoine V. Gene polymorphisms of oxidative stress enzymes: prediction of elderly renutrition. Am. J. Clin. Nutr. 87: 1504-1512 (2008). *
Fabris A, Catamo E, Segat L, Morgutti M, Claudio Arraes L, de Lima-Filho JL, Crovella S. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS 23: 177-182 (2009).
Fabris C, Smirne C, Fangazio S, Toniutto P, Burlone M, Minisini R, Bitetto D, Falleti E, Cerutti A, Pirisi M. Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C. Hepatol. Res. 39: 795-804 (2009). *
Fabris C, Toniutto P, Bitetto D, Fattovich G, Falleti E, Fontanini E, Cussigh A, Minisini R, Occhino G, Pirisi M. Gene polymorphism at the interleukin 6 -174 G>C locus affects the outcome of chronic hepatitis B. J. Infect. 59: 144-145 (2009).
Fabris C, Toniutto P, Bitetto D, Minisini R, Fornasiere E, Smirne C, Pirisi M. Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation. J. Gastroenterol. 42: 543-549 (2007). *
Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Fumolo E, Avellini C, Minisini R, Pirisi M. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin. Exp. Res. 33: 102-107 (2009). *
Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, Jenmalm MC, Mai XM, Nilsson L, Zdolsek HA, Bjorksten B, Soderkvist P, Vaarala O. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J. Allergy Clin. Immunol. 114: 561-567 (2004). *
Fahmy ME, Fattouh AM, Hegazy RA, Essawi ML. ACE gene polymorphism in Egyptian children with idiopathic nephrotic syndrome. Bratisl. Lek. Listy. 109: 298-301 (2008).
Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM, Fontaine P. CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. Eur. J. Immunogenet. 29: 251-257 (2002).
Fakhfakh F, Maalej A, Makni H, Abid M, Jouida J, Zouali M, Ayadi H. Analysis of immunoglobulin VH and TCR cbeta polymorphisms in a large family with thyroid autoimmune disorder. Exp. Clin. Immunogenet. 16: 185-191 (1999).
Fakhoury M, Andreu-Gallien J, Mahr A, Medard Y, Azougagh S, Vilmer E, Jacqz-Aigrain E. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia? J. Clin. Pharm. Ther. 32: 633-639 (2007). *
Fakler JW, Schmitt-Egenolf M, Vejbaesya S, Boehncke WH, Sterry W, Eiermann TH. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum. Immunol. 40: 299-302 (1994).
Falchetti A, Sferrazza C, Cepollaro C, Gozzini A, Del Monte F, Masi L, Napoli N, Di Fede G, Cannone V, Cusumano G, Pandolfo MC, Rini GB, Tanini A, Brandi ML. FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif. Tissue Int. 80: 15-20 (2007). *
Falk A, Olsson C, Ahrne S, Molin G, Adawi D, Jeppsson B. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand. J. Gastroenterol. 42: 973-985 (2007). *
Fallang LE, Bergseng E, Hotta K, Berg-Larsen A, Kim CY, Sollid LM. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat. Immunol. 10: 1096-1101 (2009). *
Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fumolo E, Fornasiere E, Bragagnini W, Pinato DJ, Minisini R, Pirisi M. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease. Oncology 77: 304-313 (2009).
Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 77: 918-936 (2005). *
Falorni A. Immunologic and genetic aspects of latent autoimmune diabetes in the adult. Minerva Endocrinol. 28: 297-312 (2003).
Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, Yu WP, Chen K. Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer. Zhonghua Yu Fang Yi Xue Za Zhi 40: 13-17 (2006).
Fan H, Zhang F, Hu J, Liu D, Zhao Z. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study. J. Exp. Clin. Cancer Res. 27: 24 (2008).
Fan J, Ionita-Laza I, McQueen MB, Devlin B, Purcell S, Faraone SV, Allen MH, Bowden CL, Calabrese JR, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TB, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel JK, Sachs GS, Thase ME, Molay FB, et al. Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 153B: 29-37 (2009).
Fan J, Shi D, Dai J, Zhu L, Qin J, Shao Z, Qiu X, Xu Z, Chen D, Jiang Q. Genetic polymorphism of PITX1 in susceptibility to knee osteoarthritis in a Chinese Han population: a case-control study. Rheumatol. Int. Jan 7 [Epub ahead of print] (2010).
Fan JH, Gao LB, Pan XM, Li C, Liang WB, Liu J, Li Y, Zhang L. Association between IRF-5 polymorphisms and risk of acute coronary syndrome. DNA Cell Biol. Sep 24 [Epub ahead of print] (2009).
Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, Stoecker W, Zhong R. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J. Gastroenterol. Hepatol. 20: 249-255 (2005). *
Fan L, Zhu Y, Zhong R, Tu X, Chen Q, Zhou L, Liu H, Kong X. Study on the relationship of CTLA-4 -318, +49 polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in a Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21: 440-443 (2004).
Fan LY, Tu XQ, Cheng QB, Zhu Y, Feltens R, Pfeiffer T, Zhong RQ. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J. Gastroenterol. 10: 3056-3059 (2004). *
Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ. Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J. Gastroenterol. 11: 2768-2772 (2005). *
Fan LY, Wang WJ, Wang Q, Zong M, Yang L, Zhang H, Sun LS, Lu TB, Han J. A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. Tissue Antigens 72: 469-473 (2008). *
Fan LY, Zhong RQ, Tu XQ, Thomas P, Ralph F, Zhu Y, Zhou L. Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population. Zhonghua Gan Zang Bing Za Zhi 12: 160-162 (2004).
Fan LY, Zhong RQ, Tu XQ, Zhu Y, Gong CL, Zhou L, Zhao ZX, Ralph F, Thomas P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese. Zhonghua Yi Xue Za Zhi 83: 1852-1855 (2003).
Fan LY, Zhu Y, Zhong RQ, Tu XQ, Ye WM, Chen QB, Zeng WJ, Kong XT. Genetic association between interleukins gene polymorphisms with primary biliary cirrhosis in Chinese population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26: 505-509 (2004).
Fan XY, Li JZ, Yao SQ, Yan JD, Li CL, Ma QK. Relationship between pneumoconiosis and the polymorphisms of HLA-DRB1*, DQB1* genes. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23: 278-281 (2005).
Fan Y, Yang R, Yu L, Wu M, Shi S, Ren M, Han Y, Hu J, Zhao S. Identification of a novel missense mutation in Wilson's disease gene. Chin. Med. J. (Engl.) 110: 887-890 (1997).
Fanen P, Clain J, Labarthe R, Hulin P, Girodon E, Pagesy P, Goossens M, Edelman A. Structure-function analysis of a double-mutant cystic fibrosis transmembrane conductance regulator protein occurring in disorders related to cystic fibrosis. FEBS Lett. 452: 371-374 (1999). *
Fang F, Yao L, Yu XJ, Yu L, Wu Q, Yu L. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res. Treat. Dec 25 [Epub ahead of print] (2009).
Fang F, Yu L, Zhong Y, Yao L. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med. Oncol. Dec 14 [Epub ahead of print] (2009). *
Fang M, Chen R, Cai Q, Duan S, Lv K, Cheng N, Sun S. Association of HLA genes with ankylosing spondylitis in Han population of eastern China. Scand. J. Immunol. 65: 559-566 (2007). *
Fang Y, Rivadeneira F, van Meurs JB, Pols HA, Ioannidis JP, Uitterlinden AG. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Bone 39: 938-945 (2006).
Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, Pols HA, Uitterlinden AG. Vitamin D binding protein genotype and osteoporosis. Calcif. Tissue Int. 85: 85-93 (2009). *
Fang Y, van Meurs JB, Rivadeneira F, van Schoor NM, van Leeuwen JP, Lips P, Pols HA, Uitterlinden AG. Vitamin D receptor gene haplotype is associated with body height and bone size. J. Clin. Endocrinol. Metab. 92: 1491-1501 (2007). *
Fanta S, Niemi M, Jonsson S, Karlsson MO, Holmberg C, Neuvonen PJ, Hoppu K, Backman JT. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms. Pharmacogenet. Genomics 18: 77-90 (2008).
Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. TNFalpha promoter polymorphisms. Methods Mol. Med. 98: 47-58 (2004).
Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G. Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 97: 3707-3712 (2001). *
Faria EJ, Faria IC, Ribeiro JD, Ribeiro AF, Hessel G, Bertuzzo CS. Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis. J. Bras. Pneumol. 35: 334-342 (2009).
Farinati F, Cardin R, Bortolami M, Nitti D, Basso D, de Bernard M, Cassaro M, Sergio A, Rugge M. Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int. J. Cancer 123: 51-55 (2008). *
Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta Oncol. 48: 971-976 (2009).
Farjadian S, Ghaderi A. HLA class II similarities in Iranian Kurds and Azeris. Int. J. Immunogenet. 34: 457-463 (2007). *
Farjadian S, Kiyanimanesh N, Abbaszadegan A, Lotfazar M. HLA class I gene polymorphism in Iranian patients with Papillon-Lefevre syndrome. Iran. J. Immunol. 4: 241-245 (2007).
Farjadian S, Lotfazar M, Ghaderi A. Analysis of human leukocyte antigen class II gene polymorphism in Iranian patients with Papillon-Lefevre syndrome: a family study. Iran. J. Immunol. 5: 171-176 (2008).
Farjadian S, Ota M, Inoko H, Ghaderi A. The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Mol. Biol. Rep. 36: 1943-1950 (2009). *
Farkas G Jr, Hofner P, Balog A, Takacs T, Szabolcs A, Farkas G, Mandi Y. Relevance of transforming growth factor-beta1, interleukin-8, and tumor necrosis factor-alpha polymorphisms in patients with chronic pancreatitis. Eur. Cytokine Netw. 18: 26-32 (2007).
Farnaud S, Patel A, Evans RW. Modelling of a metal-containing hepcidin. Biometals 19: 527-533 (2006). *
Farnood A, Naderi N, Moghaddam SJ, Noorinayer B, Firouzi F, Aghazadeh R, Daryani NE, Zali MR. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int. J. Colorectal Dis. 22: 999-1003 (2007). *
Farrell GC. Drugs and steatohepatitis. Semin. Liver Dis. 22: 185-194 (2002).
Fatini C, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, Generini S, Pignone A, Abbate R, Matucci-Cerinic M. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am. J. Med. 112: 540-544 (2002). *
Fatini C, Guiducci S, Abbate R, Matucci-Cerinic M. Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism. Curr. Rheumatol. Rep. 6: 149-155 (2004).
Faucz F, Gimenez J, Ramos M, Pereira-Ferrari L, Estivill X, Raskin S, Casals T, Culpi L. Cystic fibrosis in a southern Brazilian population: characteristics of 90% of the alleles. Clin. Genet. 72: 218-223 (2007). *
Faux JA, Moffatt MF, Lalvani A, Dekker J, Warrell DA, Cookson WO. Sensitivity to bee and wasp venoms: association with specific IgE responses to the bee and wasp venom and HLA DRB1 and DPB1. Clin. Exp. Allergy 27: 578-583 (1997).
Fava C, Montagnana M, Guerriero M, Almgren P, von Wowern F, Minuz P, Melander O. Chromosome 2q12, the ADRA2B I/D polymorphism and metabolic syndrome. J. Hypertens. 27: 1794-1803 (2009).
Fava M, Mischoulon D. Folate in depression: efficacy, safety, differences in formulations, and clinical issues. J. Clin. Psychiatry 70 Suppl. 5: 12-17 (2009).
Favaloro EJ. Diagnostic issues in thrombophilia: a laboratory scientist's view. Semin. Thromb. Hemost. 31: 11-16 (2005).
Favorova OO, Favorov AV, Boiko AN, Andreewski TV, Sudomoina MA, Alekseenkov AD, Kulakova OG, Gusev EI, Parmigiani G, Ochs MF. Three allele combinations associated with multiple sclerosis. BMC Med. Genet. 7: 63 (2006). *
Favre N, Abergel A, Blanc P, Sapin V, Roszyk L, Gallot D. Unusual presentation of severe intrahepatic cholestasis of pregnancy leading to fetal death. Obstet. Gynecol. 114: 491-493 (2009).
Fawwaz S, Nikamo P, Torn C, Landin-Olsson M, Lernmark A, Alarcon-Riquelme M, Kockum I; the Diabetes Incidence in Sweden Study Group. No evidence of association of the PDCD1 gene with type 1 diabetes. Diabet. Med. 24: 1473-1477 (2007). *
Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S. The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis. J. Neurol. Sci. 245: 35-39 (2006).
Fazili Z, Pfeiffer CM, Zhang M, Jain RB, Koontz D. Influence of 5,10-methylenetetrahydrofolate reductase polymorphism on whole-blood folate concentrations measured by LC-MS/MS, microbiologic assay, and Bio-Rad radioassay. Clin. Chem. 54: 197-201 (2008). *
Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, Gonzalez S, Lopez-Larrea C. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum. Immunol. 64: 816-822 (2003).
Fdez-Morera JL, Tunon A, Rodriguez-Rodero S, Rodrigo L, Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Lahoz CH, Lopez-Larrea C. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A. Tissue Antigens 67: 409-414 (2006). *
Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M, Delgado C, Lopez-Guerrero JA, Alcina A. OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68: 446-449 (2006). *
Fedetz M, Matesanz F, Caro-Maldonado A, Smirnov II, Chvorostinka VN, Moiseenko TA, Alcina A. The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population. Tissue Antigens 67: 430-433 (2006). *
Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M, Arnal C, Lucas M, Izquierdo G, Delgado C, Alcina A, Matesanz F. Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population. Tissue Antigens 74: 244-247 (2009). *
Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 48: 1956-1963 (2003). *
Feghhi M, Nikzamir A, Esteghamati A, Farahi F, Nakhjavani M, Rashidi A. The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes. Diabetes Res. Clin. Pract. 81: e1-e4 (2008).
Fei BY, Lv HX, Yang JM, Ye ZY. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 41: 44-47 (2008).
Fei H, Scharf S, Erlich H, Peebles C, Tan E, Fox R. Relationship between HLA D region gene and primary Sjogren's syndrome. Zhonghua Yi Xue Za Zhi 71: 555-559 (1991).
Fei HM, Kang H, Scharf S, Erlich H, Peebles C, Fox R. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjogren's syndrome and autoantibody production. J. Clin. Lab. Anal. 5: 382-391 (1991).
Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide association study. Arthritis Res. Ther. 11: R66 (2009). *
Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr. Opin. Gastroenterol. 20: 560-564 (2004).
Feitsma AL, Toes RE, Begovich AB, Chokkalingam AP, de Vries RR, Huizinga TW, van der Helm-van Mil AH. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients. Rheumatology (Oxford) 46: 1092-1095 (2007). *
Feix A, Fritsche-Polanz R, Kletzmayr J, Vychytil A, Horl WH, Sunder-Plassmann G, Fodinger M. Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. Am. J. Kidney Dis. 38: 956-964 (2001).
Fekete A, Viklicky O, Hubacek JA, Rusai K, Erdei G, Treszl A, Vitko S, Tulassay T, Heemann U, Reusz G, Szabo AJ. Association between heat shock protein 70s and Toll-like receptor polymorphisms with long-term renal allograft survival. Transpl. Int. 19: 190-196 (2006). *
Feld J, Heathcote E. Epidemiology of autoimmune liver disease. J. Gastroenterol. Hepatol. 18: 1118-1128 (2003). *
Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury. Hepatology 43: S194-S206 (2006). *
Felder TK, Oberkofler H, Weitgasser R, Mackevics V, Krempler F, Paulweber B, Patsch W. The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int. J. Obes. (Lond.) 31: 1099-1103 (2007). *
Felderbauer P, Karakas E, Fendrich V, Bulut K, Horn T, Lebert R, Holland-Letz T, Schmitz F, Bartsch D, Schmidt WE. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am. J. Gastroenterol. 103: 368-374 (2008). *
Felderbauer P, Karakas E, Fendrich V, Bulut K, Werner I, Dekomien G, Klein W, Bartsch D, Schmidt WE. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene. Exp. Clin. Endocrinol. Diabetes 115: 527-529 (2007).
Felderbauer P, Klein W, Bulut K, Ansorge N, Dekomien G, Werner I, Epplen JT, Schmitz F, Schmidt WE. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis? Scand. J. Gastroenterol. 41: 343-348 (2006). *
Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947 (2007). *
Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79: 439-448 (2006). *
Fend F, Langer R, Hann von Weyhern CW, Schulz S, Miethke T. Molecular diagnosis of mycobacterial infections. Verh. Dtsch. Ges. Pathol. 91: 135-139 (2007).
Feng ML, Guo XJ, Zhang JY, Xie JH, Chen L, Lu Q, Yang JH, Ji Y, Qian KC. Study on the haplotypes of MICA and MICB microsatellite and HLA-B locus in the Guangzhou Han population. Tissue Antigens 64: 281-285 (2004). *
Feng R, Li Y, Zhao D, Wang C, Niu Y, Sun C. Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis. Acta Diabetol. 46: 339-343 (2009).
Feng RN, Li Y, Sun CH. TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis. Diabetes Res. Clin. Pract. 85: e4-e7 (2009).
Feng XB, Shen N, Luo WQ, Zhang LH, Qian J, Sun L, Chen SL. OAZ gene polymorphism in Chinese patients with systemic lupus erythematosus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21: 430-434 (2004).
Feng XZ, Hou P, Zhu L, Yu L, Zhang H. Correlation of TFRC polymorphism with the susceptibility and clinicopathologic phenotypes of IgA nephropathy. Beijing Da Xue Xue Bao 40: 369-373 (2008).
Feng Y, Zheng P, Zhao H, Wu K. SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. J. Dig. Dis. 10: 181-187 (2009). *
Ferec C, Le Marechal C, Audrezet MP, Farinha CM, Amaral MD, Gallati S, Sanz J, Steiner B, Mouchel N, Harris A, Schwarz MJ. Analysis of genomic CFTR DNA. J. Cyst. Fibros. 3 Suppl. 2: 7-10 (2004).
Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Dig. Liver Dis. 40: 723-730 (2008).
Ferguson LR, Han DY, Huebner C, Petermann I, Barclay ML, Gearry RB, McCulloch A, Demmers PS. Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand Caucasian population. Gastroenterol. Res. Pract. 2009:591704 (2009).
Ferguson LR, Huebner C, Petermann I, Gearry RB, Barclay ML, Demmers P, McCulloch A, Han DY. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J. Gastroenterol. 14: 4652-4661 (2008). *
Ferguson LR, Philpott M, Dryland P. Nutrigenomics in the whole-genome scanning era: Crohn's disease as example. Cell. Mol. Life Sci. 64: 3105-3118 (2007). *
Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res. 622: 70-83 (2007).
Ferguson LR, Shelling AN, Lauren D, Heyes JA, McNabb WC; Nutrigenomics New Zealand. Nutrigenomics and gut health. Mutat. Res. 622: 1-6 (2007).
Fernandes Filho JA, Vedeler CA, Myhr KM, Nyland H, Pandey JP. TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity 35: 377-380 (2002).
Fernandes H, Koneru B, Fernandes N, Hameed M, Cohen MC, Raveche E, Cohen S. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation 73: 1886-1891 (2002).
Fernandes KS, Brum DG, Sandrim VC, Guerreiro CT, Barreira AA, Tanus-Santos JE. Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease. J. Neuroimmunol. 214: 128-131 (2009).
Fernandez L, Fernandez-Arquero M, Gual L, Lazaro F, Maluenda C, Polanco I, Figueredo MA, Gomez de la Concha E. Triplet repeat polymorphism in the transmembrane region of the MICA gene in celiac disease. Tissue Antigens 59: 219-222 (2002). *
Fernandez L, Martinez A, Mendoza JL, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Diaz-Rubio M, de la Concha EG. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm. Bowel Dis. 11: 739-743 (2005). *
Fernandez L, Mendoza JL, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Pena AS, Diaz-Rubio M, de la Concha EG. IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm. Bowel Dis. 10: 715-722 (2004). *
Fernandez L, Nunez C, Mendoza JL, Urcelay E, Fernandez-Arquero M, Taxonera C, Diaz-Rubio M, de la Concha EG, Martinez A. A recombined haplotype in the major histocompatibility region contains a cluster of genes conferring high susceptibility to ulcerative colitis in the Spanish population. Inflamm. Bowel Dis. 11: 785-791 (2005). *
Fernandez LL, Scheibe RM. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE? Arq. Neuropsiquiatr. 63: 1-6 (2005).
Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L, Figueredo MA, de la Concha EG. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 53: 1361-1363 (1999).
Fernandez-Arquero M, Caldes T, Casado E, Maluenda C, Figueredo MA, De La Concha EG. Polymorphism within the HLA-DQB1*02 promoter associated with susceptibility to coeliac disease. Eur. J. Immunogenet. 25: 1-3 (1998).
Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 50: 328-329 (2004). *
Fernandez-Mestre M, Sanchez K, Balbas O, Gendzekhzadze K, Ogando V, Cabrera M, Layrisse Z. Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum. Immunol. 70: 532-535 (2009).
Fernandez-Mestre MT, Vargas V, Montagnani S, Cotua M, Ogando V, Layrisse Z. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis. Hum. Immunol. 65: 54-59 (2004).
Fernandez-Moreira D, Ugalde C, Smeets R, Rodenburg RJ, Lopez-Laso E, Ruiz-Falco ML, Briones P, Martin MA, Smeitink JA, Arenas J. X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann. Neurol. 61: 73-83 (2007). *
Fernandez-Peralta AM, Daimiel L, Nejda N, Iglesias D, Medina Arana V, Gonzalez-Aguilera JJ. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy. Int. J. Colorectal Dis. Aug 11 [Epub ahead of print] (2009). *
Fernando MM, Stevens CR, Sabeti PC, Walsh EC, McWhinnie AJ, Shah A, Green T, Rioux JD, Vyse TJ. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet. 3: e192 (2007). *
Ferrante L, Opdal SH, Vege A, Rognum TO. TNF-alpha promoter polymorphisms in sudden infant death. Hum. Immunol. 69: 368-373 (2008).
Ferrante M, Declerck S, Coopmans T, De Hertogh G, Van Assche G, Penninckx F, Rutgeerts P, Geboes K, D'Hoore A, Vermeire S. Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: a role for serological markers and microbial pattern recognition receptor genes? Journal of Crohn's and Colitis 2: 142-151 (2008).
Ferrante M, Pierik M, Henckaerts L, Joossens M, Claes K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Van Assche G, Vermeire S. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm. Bowel Dis. 12: 870-878 (2006). *
Ferraresso M, Tirelli A, Ghio L, Grillo P, Martina V, Torresani E, Edefonti A. Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients. Pediatr. Transplant. 11: 296-300 (2007). *
Ferrari MM, Biondi ML, Rossi G, Grijuela B, Gaita S, Perugino G, Vigano P. Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis. Acta Obstet. Gynecol. Scand. 85: 212-217 (2006).
Ferrari S, Bonjour JP, Rizzoli R. The vitamin D receptor gene and calcium metabolism. Trends Endocrinol. Metab. 9: 259-265 (1998). *
Ferraris A, D'Amato G, Nobili V, Torres B, Marcellini M, Dallapiccola B. Combined test for UGT1A1 -3279T-->G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients. Genet. Test. 10: 121-125 (2006).
Ferraris A, Torres B, Knafelz D, Barabino A, Lionetti P, de Angelis GL, Iacono G, Papadatou B, D'Amato G, Di Ciommo V, Dallapiccola B, Castro M. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. Inflamm. Bowel Dis. 12: 355-361 (2006).
Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G, Figueiredo C, Trindade E, Seruca R, Carneiro F, Amil J, Machado JC, Tavarela-Veloso F. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm. Bowel Dis. 11: 331-339 (2005). *
Ferreira AC, Gomes KB, Sampaio IB, Oliveira VC, Pardini VC, Godard AL. Type 1 diabetes susceptibility determined by HLA alleles and CTLA-4 and insulin genes polymorphisms in Brazilians. Arq. Bras. Endocrinol. Metabol. 53: 368-373 (2009).
Ferreira PE, Veiga MI, Cavaco I, Martins JP, Andersson B, Mushin S, Ali AS, Bhattarai A, Ribeiro V, Bjorkman A, Gil JP. Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa. Ther. Drug Monit. 30: 10-15 (2008).
Ferreiro-Neira I, Calaza M, Alonso-Perez E, Marchini M, Scorza R, Sebastiani GD, Blanco FJ, Rego I, Pullmann R, Pullmann R, Kallenberg CG, Bijl M, Skopouli FN, Mavromati M, Migliaresi S, Barizzone N, Ruzickova S, Dostal C, Schmidt RE, Witte T, et al. Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun. 8: 429-438 (2007). *
Ferreiros-Vidal I, D'Alfonso S, Papasteriades C, Skopouli FN, Marchini M, Scorza R, Migliaresi S, Sebastiani GD, Endreffy E, Mavromati M, Kappou-Rigatou I, Ruzickova S, Dostal C, Schmidt RE, Witte T, Gomez-Reino JJ, Gonzalez A. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun. 8: 138-146 (2007). *
Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, Liz M, Martin J, Ordi J, Vicario JL, Gonzalez A. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum. 50: 2590-2597 (2004). *
Ferrer A, Nazabal M, Companioni O, Fernandez de Cossio ME, Camacho H, Cintado A, Benitez J, Casalvilla R, Sautie M, Villareal A, Diaz T, Marrero A, Fernandez de Cossio J, Hodelin A, Leal L, Ballester L, Novoa LI, Middleton D, Duenas M. HLA class I polymorphism in the Cuban population. Hum. Immunol. 68: 918-927 (2007).
Ferrer-Admetlla A, Bosch E, Sikora M, Marques-Bonet T, Ramirez-Soriano A, Muntasell A, Navarro A, Lazarus R, Calafell F, Bertranpetit J, Casals F. Balancing selection is the main force shaping the evolution of innate immunity genes. J. Immunol. 181: 1315-1322 (2008). *
Ferrera F, Rizzi M, Sprecacenere B, Balestra P, Sessarego M, Di Carlo A, Filaci G, Gabrielli A, Ravazzolo R, Indiveri F. AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis. Clin. Immunol. 122: 13-17 (2007). *
Ferretti M, Gattorno M, Chiocchetti A, Mesturini R, Orilieri E, Bensi T, Sormani MP, Cappellano G, Cerutti E, Nicola S, Biava A, Bardelli C, Federici S, Ceccherini I, Baldi M, Santoro C, Dianzani I, Martini A, Dianzani U. The 423Q polymorphism of the X-linked inhibitor of apoptosis gene influences monocyte function and is associated with periodic fever. Arthritis Rheum. 60: 3476-3484 (2009). *
Ferroni P, Palmirotta R, Martini F, Riondino S, Savonarola A, Spila A, Ciatti F, Sini V, Mariotti S, Del Monte G, Roselli M, Guadagni F. Determinants of homocysteine levels in colorectal and breast cancer patients. Anticancer Res. 29: 4131-4138 (2009).
Ferstl B, Zacher T, Lauer B, Blagitko-Dorfs N, Carl A, Wassmuth R. Allele-specific quantification of HLA-DQB1 gene expression by real-time reverse transcriptase-polymerase chain reaction. Genes Immun. 5: 405-416 (2004). *
Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N, Syafruddin D, Kibiki G, Cristea T, Hijmans A, Hamann L, Israel S, Elghazali G, Troye-Blomberg M, Kumpf O, Maiga B, Dolo A, Doumbo O, Hermsen CC, Stalenhoef AF, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U.S.A. 104: 16645-16650 (2007). *
Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG. Functional consequences of Toll-like receptor 4 polymorphisms. Mol. Med. 14: 346-352 (2008). *
Festen EA, Goyette P, Scott R, Annese V, Zhernakova A, Brant SR, Cho JH, Silverberg MS, Taylor KD, de Jong DJ, Stokkers PC, McGovern D, Palmieri O, Achkar JP, Xavier RJ, Duerr RH, Daly MJ, Wijmenga C, Weersma RK, Rioux JD. Genetic variants in the region harbouring IL2/IL21 associated to ulcerative colitis. Gut 58: 799-804 (2009). *
Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude JC, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am. J. Gastroenterol. Oct 27 [Epub ahead of print] (2009). *
Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Ollier W, Sachs JA. New HLA DNA polymorphisms associated with autoimmune diseases. Nature 322: 64-67 (1986). *
Feuk L, Marshall CR, Wintle RF, Scherer SW. Structural variants: changing the landscape of chromosomes and design of disease studies. Hum. Mol. Genet. 15 Suppl. 1: R57-R66 (2006). *
Feuz J, Wisser J, Heufelder A, Joba W, Zimmermann R, von Mandach U. Vitamin D receptor genotype BB is associated with higher serum osteocalcin in first pregnancy. J. Perinat. Med. 37: 491-495 (2009).
Fialho RN, Martins L, Pinheiro JP, Bettencourt BF, Couto AR, Santos MR, Peixoto MJ, Garrett F, Leal J, Tomas AM, Bruges-Armas J. Role of HLA, KIR and cytokine gene polymorphisms in leptospirosis. Hum. Immunol. 70: 915-920 (2009).
Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Sowinski J, Nowak J. Association of the CYP27B1 C(-1260)A polymorphism with autoimmune Addison's disease. Exp. Clin. Endocrinol. Diabetes Dec 8 [Epub ahead of print] (2009).
Fidan Yaylali G, Akin F, Turgut S, Kursunluoglu R. IGF-1 gene polymorphism in obese patients with insulin resistance. Mol. Biol. Rep. Aug 13 [Epub ahead of print] (2009). *
Fidder HH, Figer A, Geva R, Flex D, Schayek H, Avidan B, Meir SB, Friedman E. Genetic analyses in consecutive Israeli Jewish colorectal cancer patients. Am. J. Gastroenterol. 100: 1376-1380 (2005). *
Fidder HH, Heijmans R, Chowers Y, Bar-Meir S, Avidan B, Pena AS, Crusius JB. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease. Int. J. Immunogenet. 33: 81-85 (2006). *
Fiedler T, Buning C, Reuter W, Pitre G, Gentz E, Schmidt H, Buttner J, Ockenga J, Gerloff T, Meisel C, Lochs H, Roots I, Kopke K, Johne A. Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease. Eur. J. Clin. Pharmacol. 63: 917-925 (2007). *
Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clin. Pharmacol. Ther. 78: 551-558 (2005). *
Fiehn C. Methotrexate in rheumatology. Z. Rheumatol. Oct 17 [Epub ahead of print] (2009).
Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes 54: 1588-1591 (2005). *
Field SF, Nejentsev S, Walker NM, Howson JM, Godfrey LM, Jolley JD, Hardy MP, Todd JA. Sequencing-based genotyping and association analysis of the MICA and MICB genes in type 1 diabetes. Diabetes 57: 1753-1756 (2008). *
Field T, Anasetti C. Selection of unrelated donors for hematopoietic cell transplantation. Curr. Hematol. Rep. 4: 270-275 (2005).
Fife MS, Gathercole L, Ogilvie EM, Stock CJ, Mack LF, Donn RP, Thomson W, Woo P. No evidence for genetic association of interferon regulatory factor 1 in juvenile idiopathic arthritis. Arthritis Rheum. 56: 972-976 (2007). *
Fife MS, Gutierrez A, Ogilvie EM, Stock CJ, Samuel JM, Thomson W, Mack LF, Lewis CM, Woo P. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis (sJIA). Arthritis Res. Ther. 8: R148 (2006). *
Fife MS, Ogilvie EM, Kelberman D, Samuel J, Gutierrez A, Humphries SE, Woo P. Novel IL-6 haplotypes and disease association. Genes Immun. 6: 367-370 (2005). *
Figge A, Matern S, Lammert F. Molecular genetics of cholesterol cholelithiasis: identification of human and murine gallstone genes. Z. Gastroenterol. 40: 425-432 (2002).
Figueiredo C, Horn PA, Blasczyk R, Seltsam A. Regulating MHC expression for cellular therapeutics. Transfusion 47: 18-27 (2007).
Figueiredo JC, Levine AJ, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter J, Limburg PJ, Hopper J, Jenkins MA, Le Marchand L, Baron JA, Haile RW. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control Dec 27 [Epub ahead of print] (2009). *
Figueroa C, Peralta A, Herrera L, Castro P, Gutierrez A, Valenzuela J, Aguillon JC, Quera R, Hermoso MA. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease. Eur. Cytokine Netw. 17: 125-130 (2006).
Filer C, Ho P, Smith RL, Griffiths C, Young HS, Worthington J, Bruce IN, Barton A. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 58: 3705-3709 (2008). *
Filippi PD, Badulli C, Cuccia M, De Silvestri A, Dametto E, Pasi A, Garaventa A, Prever AB, Todesco A, Trizzino A, Danesino C, Martinetti M, Arico M. Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. Br. J. Haematol. 132: 784-787 (2006). *
Filippini N, Zarei M, Beckmann CF, Galluzzi S, Borsci G, Testa C, Bonetti M, Beltramello A, Ghidoni R, Benussi L, Binetti G, Frisoni GB. Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers. J. Magn. Reson. Imaging 29: 1021-1026 (2009).
Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, Medras M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 11: 134-139 (2008).
Fimmers R, Neugebauer M, Dennert J, Wienker T, Baur MP. Association and sibpair analysis for the HLA, Gm, Km, and insulin polymorphisms in multiplex IDDM families. Genet. Epidemiol. 6: 107-112 (1989).
Fingas CD, Katsounas A, Kahraman A, Siffert W, Jochum C, Gerken G, Nuckel H, Canbay A. Prognostic assessment of three single-nucleotide polymorphisms (GNB3 825C>T, BCL2-938C>A, MCL1-386C>G) in extrahepatic cholangiocarcinoma. Cancer Invest. Dec 7 [Epub ahead of print] (2009).
Fingert JH, Oh K, Chung M, Scheetz TE, Andorf JL, Johnson RM, Sheffield VC, Stone EM. Association of a novel mutation in the retinol dehydrogenase 12 (RDH12) gene with autosomal dominant retinitis pigmentosa. Arch. Ophthalmol. 126: 1301-1307 (2008). *
Fiocco U, Sfriso P, Oliviero F, Pagnin E, Scagliori E, Campana C, Cozzi L, Punzi L. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun. Rev. 8: 76-82 (2008).
Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D'Errico-Grigioni A. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl. 15: 1821-1825 (2009).
Fiorillo MT, Greco G, Maragno M, Potolicchio I, Monizio A, Dupuis ML, Sorrentino R. The naturally occurring polymorphism Asp116-->His116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition. Eur. J. Immunol. 28: 2508-2516 (1998). *
Fiorito M, Torrente I, De Cosmo S, Guida V, Colosimo A, Prudente S, Flex E, Menghini R, Miccoli R, Penno G, Pellegrini F, Tassi V, Federici M, Trischitta V, Dallapiccola B. Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome. Obesity (Silver Spring) 15: 2889-2895 (2007). *
Fiotti N, Altamura N, Fisicaro M, Carraro N, Adovasio R, Sarra VM, Uxa L, Guarnieri G, Baxter BT, Giansante C. MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. Atherosclerosis 182: 287-292 (2005).
Fiotti N, Altamura N, Fisicaro M, Carraro N, Uxa L, Grassi G, Torelli L, Gobbato R, Guarnieri G, Timothy Baxter B, Giansante C. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26: 1330-1336 (2006). *
Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C, Zorzon M. MMP-9 microsatellite polymorphism and multiple sclerosis. J. Neuroimmunol. 152: 147-153 (2004).
Firneisz G, Lakatos PL, Szalay F, Polli C, Glant TT, Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. Am. J. Med. Genet. 108: 23-28 (2002). *
Fischer GF, Mayr WR. Molecular genetics of the HLA complex. Wien. Klin. Wochenschr. 113: 814-824 (2001).
Fischer M, Wetherill LF, Carr LG, You M, Crabb DW. Association of the aldehyde dehydrogenase 2 promoter polymorphism with alcohol consumption and reactions in an American Jewish population. Alcohol Clin. Exp. Res. 31: 1654-1659 (2007). *
Fischer S, Lakatos PL, Group TH, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Szilvasi A, Tulassay Z, Osztovits J, Papp J, Demeter P, Schwab R, Tordai A, Andrikovics H. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgery in Hungarian patients with inflammatory bowel diseases. Scand. J. Gastroenterol. 42: 726-733 (2007). *
Fischer-Maas L, Schneppenheim R, Oyen F, Grabhorn E, Richter A, Fischer L, Ganschow R. Analysis of the CC chemokine receptor 5Delta32 polymorphism in pediatric liver transplant recipients. Pediatr. Transplant. 12: 769-772 (2008).
Fischer-Rosinsky A, Fisher E, Kovacs P, Bluher M, Mohlig M, Pfeiffer AF, Boeing H, Spranger J. Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS ONE 3: e3852 (2008). *
Fishbein T, Novitskiy G, Mishra L, Matsumoto C, Kaufman S, Goyal S, Shetty K, Johnson L, Lu A, Wang A, Hu F, Kallakury B, Lough D, Zasloff M. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 57: 323-330 (2008). *
Fisher E, Li Y, Burwinkel B, Kuhr V, Hoffmann K, Mohlig M, Spranger J, Pfeiffer A, Boeing H, Schrezenmeir J, Doring F. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm. Metab. Res. 38: 341-345 (2006).
Fisher E, Schulze MB, Stefan N, Haring HU, Doring F, Joost HG, Al-Hasani H, Boeing H, Pischon T. Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity (Silver Spring) 17: 330-334 (2009). *
Fisher MC, Cronstein BN. Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J. Rheumatol. 36: 539-545 (2009).
Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, Sanderson J, Mansfield J, Annese V, Forbes A, Lewis CM, Schreiber S, Rioux JD, Mathew CG. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum. Mutat. 27: 778-785 (2006).
Fisher SA, Moody A, Mirza MM, Cuthbert AP, Hampe J, Macpherson A, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex disease. Ann. Hum. Genet. 67: 377-390 (2003). *
Fishman S, Lurie Y, Peretz H, Morad T, Grynberg E, Blendis LM, Leshno M, Brazowski E, Rosner G, Halpern Z, Oren R. Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C. Liver Int. 26: 279-284 (2006). *
Fiten P, Vandenbroeck K, Dubois B, Van Coillie E, Nelissen I, Van Damme J, Ligers A, Hillert J, Andersson M, Olsson T, Opdenakker G. Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. J. Neuroimmunol. 95: 195-201 (1999).
Fitzgerald SM, Goyal RK, Osborne WR, Roy JD, Wilson JW, Ferrell RE. Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter. Hum. Genet. 119: 276-283 (2006). *
Flachsbart F, Caliebe A, Kleindorp R, Blanche H, von Eller-Eberstein H, Nikolaus S, Schreiber S, Nebel A. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 106: 2700-2705 (2009). *
Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE. Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes 54: 582-586 (2005). *
Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvanne M. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 105: 1440-1445 (2002). *
Flavell DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller G, Talmud PJ, Staels B, Humphries SE. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 43: 673-680 (2000). *
Fleer A, Krediet TG. Innate immunity: Toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn. Neonatology 92: 145-157 (2007).
Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med. Genet. 9: 30 (2008). *
Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia 31: 864-870 (1988).
Flintoft L. Human genetics. No simple answer to complex disease. Nat. Rev. Genet. 5: 886 (2004). *
Floreani A, Carderi I, Paternoster D, Soardo G, Azzaroli F, Esposito W, Variola A, Tommasi AM, Marchesoni D, Braghin C, Mazzella G. Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment. Pharmacol. Ther. 23: 1649-1653 (2006). *
Floreani A, Carderi I, Variola A, Rizzotto ER, Nicol J, Bergasa NV. A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Hepatology 43: 1152-1154 (2006). *
Floreani A, Lazzari R, Macchi V, Porzionato A, Variola A, Colavito D, Leon A, Guido M, Baldo V, De Caro R, Bergasa NV. Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis. J. Gastroenterol. Sep 4 [Epub ahead of print] (2009). *
Flores AC, Marcos CY, Paladino N, Capucchio M, Theiler G, Arruvito L, Pardo R, Habegger A, Williams F, Middleton D, Fainboim L. KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. Tissue Antigens 69: 568-576 (2007). *
Flores C, Ma SF, Maresso K, Ober C, Garcia JG. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet. Epidemiol. 31: 296-305 (2007).
Flores C, Ma SF, Maresso K, Wade MS, Villar J, Garcia JG. IL6 gene-wide haplotype is associated with susceptibility to acute lung injury. Transl. Res. 152: 11-17 (2008). *
Flores C, Maca-Meyer N, Perez-Mendez L, Sanguesa R, Espinosa E, Muriel A, Blanco J, Villar J. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population. Genes Immun. 7: 141-149 (2006). *
Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51: 1100-1110 (2008). *
Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355: 241-250 (2006). *
Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J. Clin. Endocrinol. Metab. 92: 1502-1509 (2007). *
Florez JC, Saxena R, Winckler W, Burtt NP, Almgren P, Bengtsson Bostrom K, Tuomi T, Gaudet D, Ardlie KG, Daly MJ, Altshuler D, Hirschhorn JN, Groop L. The Kruppel-like factor 11 (KLF11) Q62R polymorphism is not associated with type 2 diabetes in 8,676 people. Diabetes 55: 3620-3624 (2006). *
Florez JC, Sjogren M, Agapakis CM, Burtt NP, Almgren P, Lindblad U, Berglund G, Tuomi T, Gaudet D, Daly MJ, Ardlie KG, Hirschhorn JN, Altshuler D, Groop L. Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes. Diabetologia 50: 1209-1217 (2007). *
Florez O, Zafra G, Morillo C, Martin J, Gonzalez CI. Interleukin-1 gene cluster polymorphism in Chagas disease in a Colombian case-control study. Hum. Immunol. 67: 741-748 (2006).
Flori L, Delahaye NF, Iraqi FA, Hernandez-Valladares M, Fumoux F, Rihet P. TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso. Genes Immun. 6: 472-480 (2005). *
Flotho C, Steinemann D, Mullighan CG, Neale G, Mayer K, Kratz CP, Schlegelberger B, Downing JR, Niemeyer CM. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11. Oncogene 26: 5816-5821 (2007). *
Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, Macary PA, Rankin A, Lehner PJ, Ouwehand WH, Allen JM, Watkins NA, Smith KG. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11: 1056-1058 (2005). *
Flugge J, Krusekopf S, Goldammer M, Osswald E, Terhalle W, Malzahn U, Roots I. Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur. J. Clin. Pharmacol. 63: 997-1005 (2007).
Flugge J, Laschinski G, Roots I, Krusekopf S. Vitamin D receptor poly(A) microsatellite and colorectal cancer risk in Caucasians. Int. J. Colorectal Dis. 24: 171-175 (2009). *
Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 24: 1587-1600 (2009). *
Fodil-Cornu N, Kozij N, Wu Q, Rozen R, Vidal SM. Methylenetetrahydrofolate reductase (MTHFR) deficiency enhances resistance against cytomegalovirus infection. Genes Immun. 10: 662-666 (2009).
Foerster J, Nolte I, Junge J, Bruinenberg M, Schweiger S, Spaar K, van der Steege G, Ehlert C, Mulder M, Kalscheuer V, Blumenthal-Barby E, Winter J, Seeman P, Stander M, Sterry W, Te Meerman G. Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis. J. Invest. Dermatol. 124: 99-102 (2005). *
Fojt�kova M, Cejkova P, Becvar R, Vencovsky J, Tomasova Studynkova J, Cerna M. Polymorphism of the extrapituitary prolactin promoter and systemic sclerosis. Rheumatol. Int. Dec 19 [Epub ahead of print] (2009). *
Fojt�kova M, Stolfa J, Novota P, Cejkova P, Dostal C, Cerna M. HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population. Rheumatol. Int. 29: 1293-1299 (2009). *
Foley PJ, McGrath DS, Puscinska E, Petrek M, Kolek V, Drabek J, Lympany PA, Pantelidis P, Welsh KI, Zielinski J, du Bois RM. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 25: 272-277 (2001). *
Folhoffer A, Ferenci P, Csak T, Horvath A, Hegedus D, Firneisz G, Osztovits J, Pal Kosa J, Willheim-Polli C, Szonyi L, Abonyi M, Laszlo Lakatos P, Szalay F. Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson's disease. Eur. J. Gastroenterol. Hepatol. 19: 105-111..
Folsom AR, Cushman M, Heckbert SR, Ohira T, Rasmussen-Torvik L, Tsai MY. Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism. J. Thromb. Haemost. 5: 1674-1678 (2007). *
Folsom AR, Peacock JM, Boerwinkle E, Cushman M. beta2-Adrenergic receptor polymorphism and venous thromboembolism. Thromb. Haemost. 99: 240 (2008).
Folwaczny M, Glas J, Torok HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin. Exp. Immunol. 135: 330-335 (2004). *
Folwaczny M, Glas J, Torok HP, Mauermann D, Folwaczny C. The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease. Eur. J. Oral Sci. 112: 316-319 (2004).
Fondon JW 3rd, Garner HR. Molecular origins of rapid and continuous morphological evolution. Proc. Natl. Acad. Sci. U.S.A. 101: 18058-18063 (2004). *
Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, Spagnolo P, Pantelidis P, Leoni P, McHugh N, Stock CJ, Shi-Wen X, Denton CP, Black CM, Welsh KI, du Bois RM, Abraham DJ. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N. Engl. J. Med. 357: 1210-1220 (2007). *
Fonseca JE, Cavaleiro J, Teles J, Sousa E, Andreozzi VL, Antunes M, Amaral-Turkman MA, Canhao H, Mourao AF, Lopes J, Caetano-Lopes J, Weinmann P, Sobral M, Nero P, Saavedra MJ, Malcata A, Cruz M, Melo R, Brana A, Miranda L, Patto JV, Barcelos A, et al. Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumour necrosis factor alpha gene promoter. Arthritis Res. Ther. 9: R37 (2007). *
Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea AI, Cervera R, Ingelmo M, Vives J, Yague J. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology (Oxford) 41: 1025-1030 (2002). *
Font J, Ramos-Casals M, Brito-Zeron P, Nardi N, Ibanez A, Suarez B, Jimenez S, Tassies D, Garcia-Criado A, Ros E, Sentis J, Reverter JC, Lozano F. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 46: 76-80 (2007). *
Fontaine-Bisson B, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J. Nutrigenet. Nutrigenomics 1: 215-223 (2008).
Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am. J. Clin. Nutr. 86: 768-774 (2007). *
Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A. NF-kappaB -49Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis 204: 465-470 (2009).
Fontalba A, Gutierrez O, Fernandez-Luna JL. NLRP2, an inhibitor of the NF-kappaB pathway, is transcriptionally activated by NF-kappaB and exhibits a nonfunctional allelic variant. J. Immunol. 179: 8519-8524 (2007). *
Fontalba A, Gutierrez O, Llorca J, Mateo I, Berciano J, Fernandez-Luna JL, Combarros O. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women. Dement. Geriatr. Cogn. Disord. 26: 247-250 (2008).
Fontalba A, Martinez-Taboada V, Gutierrez O, Pipaon C, Benito N, Balsa A, Blanco R, Fernandez-Luna JL. Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity. J. Immunol. 179: 4867-4873 (2007). *
Fontana L, Bosviel R, Delort L, Guy L, Chalabi N, Kwiatkowski F, Satih S, Rabiau N, Boiteux JP, Chamoux A, Bignon YJ, Bernard-Gallon DJ. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res. 28: 1853-1856 (2008).
Footz T, Somerville MJ, Tomaszewski R, Elyas B, Backhouse CJ. Integration of combined heteroduplex/restriction fragment length polymorphism analysis on an electrophoresis microchip for the detection of hereditary haemochromatosis. Analyst 129: 25-31 (2004). *
Forabosco P, Gorman JD, Cleveland C, Kelly JA, Fisher SA, Ortmann WA, Johansson C, Johanneson B, Moser KL, Gaffney PM, Tsao BP, Cantor RM, Alarcon-Riquelme ME, Behrens TW, Harley JB, Lewis CM, Criswell LA. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun. 7: 609-614 (2006). *
Forbes LV, Brown LJ, Scott RS. HLA-DQ beta typing and non-Asp57 alleles in IDDM and nondiabetic subjects in New Zealand. Diabetes Care 16: 1179-1183 (1993).
Forchap SL, Anandacoomarasamy A, Wicks J, Di Virgilio F, Baricordi OR, Rubbini M, Trotta F, Wiley J, Manolios N. P2X gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus. Tissue Antigens 72: 487-490 (2008). *
Ford AQ, Heller NM, Stephenson L, Boothby MR, Keegan AD. An atopy-associated polymorphism in the ectodomain of the IL-4Ralpha chain (V50) regulates the persistence of STAT6 phosphorylation. J. Immunol. 183: 1607-1616 (2009).
Foreman JE, Blizard DA, Gerhard G, Mack HA, Lang DH, Van Nimwegen KL, Vogler GP, Stout JT, Shihabi ZK, Griffith JW, Lakoski JM, McClearn GE, Vandenbergh DJ. Serum alkaline phosphatase activity is regulated by a chromosomal region containing the alkaline phosphatase 2 (Akp2) gene in C57BL/6J and DBA/2J mice. Physiol. Genomics 23: 295-303 (2005). *
Forges T, Pellanda H, Diligent C, Monnier P, Gueant JL. Do folates have an impact on fertility? Gynecol. Obstet. Fertil. 36: 930-939 (2008).
Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC. Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors. J. Clin. Hypertens. (Greenwich) 10: 459-466 (2008).
Fornage M, Doris PA. Single-nucleotide polymorphism genotyping for disease association studies. Methods Mol. Med. 108: 159-172 (2004).
Forones NM, de Lima JM, de Souza LG, da Silva ID. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J. Gastrointest. Cancer 39: 118-123 (2008).
Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjoras M, Boberg KM, Alseth I. Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma. Carcinogenesis 30: 1147-1154 (2009). *
Forsti A, Lei H, Tavelin B, Enquist K, Palmqvist R, Altieri A, Hallmans G, Hemminki K, Lenner P. Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer. Ann. Oncol. 18: 1990-1994 (2007). *
Forsythe ME, Love DC, Lazarus BD, Kim EJ, Prinz WA, Ashwell G, Krause MW, Hanover JA. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. U.S.A. 103: 11952-11957 (2006). *
Forte GI, Ragonese P, Salemi G, Scola L, Candore G, D'Amelio M, Crivello A, DI Benedetto N, Nuzzo D, Giacalone A, Lio D, Caruso C. Search for genetic factors associated with susceptibility to multiple sclerosis. Ann. N. Y. Acad. Sci. 1067: 264-269 (2006). *
Forte GI, Scola L, Misiano G, Milano S, Mansueto P, Vitale G, Bellanca F, Sanacore M, Vaccarino L, Rini GB, Caruso C, Cillari E, Lio D, Mansueto S. Relevance of interferon-gamma, tumor necrosis factor-alpha and interleukin 10 gene polymorphisms for Mediterranean spotted fever susceptibility. Clin. Vaccine Immunol. 16: 811-815 (2009). *
Forthal DN, Landucci G, Bream J, Jacobson LP, Phan TB, Montoya B. FcgammaRIIa genotype predicts progression of HIV infection. J. Immunol. 179: 7916-7923 (2007). *
Fortunato G, Calcagno G, Bresciamorra V, Salvatore E, Filla A, Capone S, Liguori R, Borelli S, Gentile I, Borrelli F, Borgia G, Sacchetti L. Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J. Interferon Cytokine Res. 28: 141-152 (2008).
Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; for the DAIS investigators. Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes. Pharmacogenetics 14: 823-829 (2004).
Fountas L, Moutsatsou P, Kastanias I, Tamouridis N, Tzanela M, Anapliotou M, Sekeris CE. The contribution of vitamin D receptor gene polymorphisms in osteoporosis and familial osteoporosis. Osteoporos. Int. 10: 392-398 (1999). *
Fourgeux C, Martine L, Bjorkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L. Primary open angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Invest. Ophthalmol. Vis. Sci. 50: 5712-5717 (2009). *
Fowler EV, Eri R, Hume G, Johnstone S, Pandeya N, Lincoln D, Templeton D, Radford-Smith GL. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J. Med. Genet. 42: 523-528 (2005). *
Fox MF, Lahbib F, Pratt W, Attwood J, Gum J, Kim Y, Swallow DM. Regional localization of the intestinal mucin gene MUC3 to chromosome 7q22. Ann. Hum. Genet. 56: 281-287 (1992).
Fox RI, Luppi M, Kang HI, Pisa P. Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Semin. Immunopathol. 13: 217-231 (1991).
Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, Staal FW, Gallo R, Pei-Ping H, Le CS. Viral genomes in lymphomas of patients with Sjogren's syndrome. J. Autoimmun. 2: 449-455 (1989).
Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin. Cancer Res. 15: 2559-2566 (2009). *
Fraile A, Collado MD, Mataran L, Martin J, Nieto A. TAP1 and TAP2 polymorphism in Spanish patients with ankylosing spondylitis. Exp. Clin. Immunogenet. 17: 199-204 (2000).
Frakking FN, van de Wetering MD, Brouwer N, Dolman KM, Geissler J, Lemkes B, Caron HN, Kuijpers TW. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur. J. Cancer 42: 909-916 (2006). *
Frances F, Verdu F, Portoles O, Castello A, Sorl� JV, Guillen M, Corella D. PPAR-alpha L162V and PGC-1 G482S gene polymorphisms, but not PPAR-gamma P12A, are associated with alcohol consumption in a Spanish Mediterranean population. Clin. Chim. Acta 398: 70-74 (2008). *
Francesca F, Mariateresa P, Alessandra P, Brigida LM, Carmen A, Francesca F, Mattia G, Marcella Z, Michele D, Giuseppina MM, Valeria UM. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with incontinentia pigmenti. Hum. Mutat. 30: 1284-1291 (2009).
Franceschi DS, Mazini PS, Rudnick CC, Sell AM, Tsuneto LT, Ribas ML, Peixoto PR, Visentainer JE. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int. J. Infect. Dis. 13: 493-498 (2009).
Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992 (2004). *
Franciotta D, Cuccia M, Dondi E, Piccolo G, Cosi V. Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis. J. Neurol. Sci. 190: 11-16 (2001). *
Francis DA, Batchelor JR, McDonald WI, Dodi IA, Hing SN, Hern JE, Downie AW. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland. Tissue Antigens 29: 7-12 (1987).
Francisco G, Menezes PR, Eluf-Neto J, Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur. J. Hum. Genet. 16: 724-734 (2008). *
Francks C, Tozzi F, Farmer A, Vincent JB, Rujescu D, St Clair D, Muglia P. Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13. Mol. Psychiatry Sep 16 [Epub ahead of print] (2008).
Franco-Lopez E, Gonzalez-Escribano MF, Aguilera I, Pascasio JM, Pareja F, Bernardos A, Nunez-Roldan A. Lack of association of recipient MCP-1 gene promoter polymorphism with acute graft rejection after orthotopic liver transplantation. Transplant. Proc. 37: 1496-1498 (2005). *
Frangolias DD, Ruan J, Wilcox PJ, Davidson AG, Wong LT, Berthiaume Y, Hennessey R, Freitag A, Pedder L, Corey M, Sweezey N, Zielenski J, Tullis E, Sandford AJ. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease. Am. J. Respir. Cell. Mol. Biol. 29: 390-396 (2003). *
Frank B, Niesler B, Bondy B, Spath M, Pongratz DE, Ackenheil M, Fischer C, Rappold G. Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin. Rheumatol. 23: 338-344 (2004).
Frank MB, Itoh K, Fujisaku A, Pontarotti P, Mattei MG, Neas BR. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am. J. Hum. Genet. 52: 183-191 (1993). *
Franke A, Hampe J, Rosenstiel P, Becker C, Wagner F, Hasler R, Little RD, Huse K, Ruether A, Balschun T, Wittig M, Elsharawy A, Mayr G, Albrecht M, Prescott NJ, Onnie CM, Fournier H, Keith T, Radelof U, Platzer M, Mathew CG, Stoll M, Krawczak M, et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS ONE. 2: e691 (2007). *
Franke A, Ruether A, Wedemeyer N, Karlsen TH, Nebel A, Schreiber S. No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population. Gut 55: 1679-1680 (2006). *
Franke B, Vasquez AA, Johansson S, Hoogman M, Romanos J, Boreatti-Hummer A, Heine M, Jacob CP, Lesch KP, Casas M, Ribases M, Bosch R, Sanchez-Mora C, Gomez-Barros N, Fernandez-Castillo N, Bayes M, Halmoy A, Halleland H, Landaas ET, Fasmer OB, et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology Nov 4 [Epub ahead of print] (2009).
Franke L, de Kovel CG, Aulchenko YS, Trynka G, Zhernakova A, Hunt KA, Blauw HM, van den Berg LH, Ophoff R, Deloukas P, van Heel DA, Wijmenga C. Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays. Am. J. Hum. Genet. 82: 1316-1333 (2008). *
Franke L, Jansen RC. eQTL analysis in humans. Methods Mol. Biol. 573: 311-328 (2009).
Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 50: 2451-2460 (2007). *
Fransen K, Fenech M, Fredrikson M, Dabrosin C, Soderkvist P. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol. Carcinog. 45: 833-840 (2006). *
Franzen O, Jerlstrom-Hultqvist J, Castro E, Sherwood E, Ankarklev J, Reiner DS, Palm D, Andersson JO, Andersson B, Svard SG. Draft genome sequencing of giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species? PLoS Pathog. 5: e1000560 (2009). *
Fraser Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm. Bowel Dis. 13: 1063-1068 (2007). *
Fraser H, Xie X. Common polymorphic transcript variation in human disease. Genome Res. 19: 567-575 (2009). *
Fraser R, Walker JJ, Ekbote UV, Martin KL, McShane P, Orsi NM. Interleukin-4 -590 (C>T), Toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia. BJOG 115: 1052-1056 (2008). *
Freathy RM, Lonnen KF, Steele AM, Minton JA, Frayling TM, Hattersley AT, Macleod KM. The impact of the angiotensin-converting enzyme insertion/deletion polymorphism on severe hypoglycemia in type 2 diabetes. Rev. Diabet. Stud. 3: 76-81 (2006). *
Freathy RM, Ring SM, Shields B, Galobardes B, Knight B, Weedon MN, Smith GD, Frayling TM, Hattersley AT. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum. Mol. Genet. 18: 2922-2927 (2009). *
Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B, Shields B, Parnell KS, Groves CJ, Ring SM, Pembrey ME, Ben-Shlomo Y, Strachan DP, Power C, Jarvelin MR, McCarthy MI, Davey Smith G, Hattersley AT, Frayling TM. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. Am. J. Hum. Genet. 80: 1150-1161 (2007). *
Fredericks S, Jorga A, Macphee IA, Reboux S, Shiferaw E, Moreton M, Carter ND, Holt DW, Johnston A. Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements. Clin. Transplant. 21: 252-257 (2007). *
Fredericks S, Moreton M, Reboux S, Carter ND, Goldberg L, Holt DW, Macphee IA. Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. Transplantation 82: 705-708 (2006).
Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum. Mutat. 28: 856-865 (2007).
Fredriksson H, Ikonen T, Autio V, Matikainen MP, Helin HJ, Tammela TL, Koivisto PA, Schleutker J. Identification of germline MLH1 alterations in familial prostate cancer. Eur. J. Cancer 42: 2802-2806 (2006). *
Fredriksson J, Anevski D, Almgren P, Sjogren M, Lyssenko V, Carlson J, Isomaa B, Taskinen MR, Groop L, Orho-Melander M. Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality. PLoS ONE 2: e285 (2007). *
Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol. Dial. Transplant. 22: 1131-1135 (2007).
Freimuth RR, Xiao M, Marsh S, Minton M, Addleman N, Van Booven DJ, McLeod HL, Kwok PY. Polymorphism discovery in 51 chemotherapy pathway genes. Hum. Mol. Genet. 14: 3595-3603 (2005). *
Freitas AI, Mendonca I, Guerra G, Brion M, Reis RP, Carracedo A, Brehm A. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Thromb. Res. 122: 648-656 (2008). *
Frenzel H, Hampe J, Huse K, Mascheretti SM, Croucher PP, Lynch NJ, Siebert R, Platzer M, Schreiber S. Mutation detection and physical mapping of the CD11 gene cluster in association with inflammatory bowel disease. Immunogenetics 53: 835-842 (2002). *
Freson K, Stolarz K, Aerts R, Brand E, Brand-Herrmann SM, Kawecka-Jaszcz K, Kuznetsova T, Tikhonoff V, Thijs L, Vermylen J, Staessen JA, Van Geet C; for the European Project on Genes in Hypertension Investigators. -391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies. J. Hypertens. 25: 117-125 (2007).
Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, Jockel KH, Siffert W, Schmid KW. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer. Clin. Cancer Res. 11: 5071-5077 (2005). *
Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S, Triolo G, Valentini G, Ferraccioli G. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann. Rheum. Dis. 66: 1210-1215 (2007). *
Friberg C, Bjorck K, Nilsson S, Inerot A, Wahlstrom J, Samuelsson L. Analysis of chromosome 5q31-32 and psoriasis: confirmation of a susceptibility locus but no association with SNPs within SLC22A4 and SLC22A5. J. Invest. Dermatol. 126: 998-1002 (2006). *
Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, Seitz C, Palmason H, Scherag A, Windemuth-Kieselbach C, Schimmelmann BG, Wewetzer C, Meyer J, Warnke A, Lesch KP, Reinhardt R, Herpertz-Dahlmann B, Linder M, Hinney A, et al. Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol. Psychiatry 12: 923-933 (2007).
Friedman DJ, Kunzli BM, A-Rahim YI, Sevigny J, Berberat PO, Enjyoji K, Csizmadia E, Friess H, Robson SC. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. U.S.A. 106: 16788-16793 (2009). *
Friedman SL. Hepatic fibrogenesis. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper�s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 24. October 20 - 21 (2003). *
Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 98-105 (2004). *
Friedrich FW, Bausero P, Sun Y, Treszl A, Kramer E, Juhr D, Richard P, Wegscheider K, Schwartz K, Brito D, Arbustini E, Waldenstrom A, Isnard R, Komajda M, Eschenhagen T, Carrier L; for the EUROGENE Heart Failure Project. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. Eur. Heart J. 30: 1648-1655 (2009).
Frieling T. Functional and inflammatory bowel disorders. Med. Klin. (Munich) 101 Suppl. 1: 139-142 (2006).
Fries S, Grosser T, Price TS, Lawson JA, Kapoor S, Demarco S, Pletcher MT, Wiltshire T, Fitzgerald GA. Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2. Gastroenterology 130: 55-64 (2006). *
Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L, Giofre MR, Maggio A, Mattaliano A, Macaluso A, Cottone M. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am. J. Gastroenterol. 100: 2730-2736 (2005). *
Friese MA, Jones EY, Fugger L. MHC II molecules in inflammatory diseases: interplay of qualities and quantities. Trends Immunol. 26: 559-561 (2005). *
Frigoul A, Lefranc MP. MICA: standardized IMGT allele nomenclature, polymorphisms and diseases. Recent Res. Devel. Human Genet. 3: 95-145 (2005). *
Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J. Clin. Invest. 114: 1343-1353 (2004). *
Friso S, Choi SW. Gene-nutrient interactions in one-carbon metabolism. Curr. Drug Metab. 6: 37-46 (2005). *
Friso S, Girelli D, Trabetti E, Olivieri O, Guarini P, Pignatti PF, Corrocher R, Choi SW. The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 14: 938-943 (2005). *
Fritsche LG, Freitag-Wolf S, Bettecken T, Meitinger T, Keilhauer CN, Krawczak M, Weber BH. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum. Mutat. 30: 1048-1053 (2009). *
Fritzler MJ. Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15: 422-427 (2006).
Fritzler MJ, Fritzler ML. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr. Med. Chem. 13: 2503-2512 (2006).
Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 25: 423-429 (2004). *
Fromm MF. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv. Drug Deliv. Rev. 54: 1295-1310 (2002). *
Frosk P, Burgess S, Dyck T, Jobse R, Spriggs EL. The use of ancestral haplotypes in the molecular diagnosis of familial breast cancer. Genet. Test. 11: 208-215 (2007).
Frudakis TN, Thomas MJ, Ginjupalli SN, Handelin B, Gabriel R, Gomez HJ. CYP2D6*4 polymorphism is associated with statin-induced muscle effects. Pharmacogenet. Genomics 17: 695-707 (2007).
Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58: 163-170 (2008).
Frydecka I, Daroszewski J, Suwalska K, Zoledziowska M, Tutak A, Slowik M, Potoczek S, Dobosz T. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region. Arch. Immunol. Ther. Exp. (Warsz.) 52: 369-374 (2004).
Fryer AA, Spiteri MA, Bianco A, Hepple M, Jones PW, Strange RC, Makki R, Tavernier G, Smilie FI, Custovic A, Woodcock AA, Ollier WE, Hajeer AH. The -403 G-->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 1: 509-514 (2000). *
Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin. Biochem. 42: 1174-1177 (2009). *
Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A, Andersen V, Oxholm P, Karup Pedersen F, Friis J, et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34: 17-22 (1989).
Fugger L, Morling N, Ryder LP, Jakobsen BK, Andersen V, Oxholm P, Dalhoff K, Heilmann C, Karup Pedersen F, Friis J, et al. Restriction fragment length polymorphism of two HLA-B-associated transcripts genes in five autoimmune diseases. Hum. Immunol. 30: 27-31 (1991).
Fugger L, Morling N, Ryder LP, Jakobsen BK, Svejgaard A, Spies T, Strominger JL. Restriction fragment length polymorphism (RFLP) of two HLA-B-associated transcripts (BATs) genes in healthy Danes. Tissue Antigens 36: 57-61 (1990).
Fugger L, Morling N, Ryder LP, Platz P, Georgsen J, Jakobsen BK, Svejgaard A, Dalhoff K, Ranek L. NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand. J. Immunol. 30: 185-189 (1989).
Fuhr U, Jetter A, Kirchheiner J. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach. Clin. Pharmacol. Ther. 81: 270-283 (2007). *
Fujiki K, Ishiguro H, Ko SB, Mizuno N, Suzuki Y, Takemura T, Yamamoto A, Yoshikawa T, Kitagawa M, Hayakawa T, Sakai Y, Takayama T, Saito M, Kondo T, Naruse S. Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. J. Med. Genet. 41: e55 (2004). *
Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K. Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers 14: 49-54 (2009).
Fujimoto M, Sato S. B lymphocytes and systemic sclerosis. Curr. Opin. Rheumatol. 17: 746-751 (2005).
Fujimura T, Hirose S, Jiang Y, Kodera S, Ohmuro H, Zhang D, Hamano Y, Ishida H, Furukawa S, Shirai T. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int. Immunol. 10: 1467-1472 (1998). *
Fujio K, Okamoto A, Araki Y, Shoda H, Tahara H, Tsuno NH, Takahashi K, Kitamura T, Yamamoto K. Gene therapy of arthritis with TCR isolated from the inflamed paw. J. Immunol. 177: 8140-8147 (2006). *
Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y. Novel single nucleotide polymorphism of UGT1A7 gene in Japanese. Drug Metab. Pharmacokinet. 21: 75-78 (2006).
Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y. Novel single nucleotide polymorphism of UGT1A9 gene in Japanese. Drug Metab. Pharmacokinet. 21: 79-81 (2006).
Fujita N, Saitoh T, Kageyama S, Akira S, Noda T, Yoshimori T. Differential involvement of ATG16L1 in Crohn's disease and canonical autophagy: analysis of the organization of the ATG16L1 complex in fibroblasts. J. Biol. Chem. 284: 32602-32609 (2009). *
Fujita S, Baba H, Yamamoto S, Akasu T, Moriya Y, Sugno K. Allelic status of chromosomes 17p, 18q, 22p, 3p and their clinical usefulness in colorectal cancer. Anticancer Res. 26: 2833-2840 (2006).
Fukata M, Vamadevan AS, Abreu MT. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin. Immunol. 21: 242-253 (2009). *
Fukazawa T, Kikuchi S, Miyagishi R, Niino M, Yabe I, Hamada T, Sasaki H. CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese. J. Neuroimmunol. 159: 225-229 (2005).
Fukazawa T, Kikuchi S, Niino M, Yabe I, Miyagishi R, Fukaura H, Hamada T, Tashiro K. Susceptibility genes for multiple sclerosis. Nippon Rinsho 61: 1311-1316 (2003).
Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, Tashiro K. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J. Neurol. Sci. 166: 47-52 (1999).
Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I, Tsukishima E, Sasaki H, Hamada T, Nishimura Y, Tashiro K, Kira J. Both the HLA-DPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55: 199-205 (2000). *
Fukazawa T, Yanagawa T, Kikuchi S, Yabe I, Sasaki H, Hamada T, Miyasaka K, Gomi K, Tashiro K. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J. Neurol. Sci. 171: 49-55 (1999). *
Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Inui K. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin. Pharmacol. Ther. 80: 331-345 (2006). *
Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet. Genomics 18: 413-423 (2008).
Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T, Endo Y, Hongo M, Itoyama Y, Yanai K, Tashiro M, Aoki M. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage 47: 946-951 (2009).
Fukui T, Yamamoto S, Nakano K, Tsujikawa M, Morimura H, Nishida K, Ohguro N, Fujikado T, Irifune M, Kuniyoshi K, Okada AA, Hirakata A, Miyake Y, Tano Y. ABCA4 gene mutations in Japanese patients with Stargardt disease and retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 43: 2819-2924 (2002). *
Fukui Y, Hizawa N, Takahashi D, Maeda Y, Jinushi E, Konno S, Nishimura M. Association between nonspecific airway hyperresponsiveness and Arg16Gly beta2-adrenergic receptor gene polymorphism in asymptomatic healthy Japanese subjects. Chest 130: 449-454 (2006). *
Fukusaki T, Ohara N, Hara Y, Yoshimura A, Yoshiura K. Evidence for association between a Toll-like receptor 4 gene polymorphism and moderate/severe periodontitis in the Japanese population. J. Periodontal. Res. 42: 541-545 (2007).
Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M, Kamakura S, Kitakaze M, Tomoike H, Saito Y, Sawada J. Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metab. Pharmacokinet. 19: 239-244 (2004). *
Fukushima-Uesaka H, Saito Y, Maekawa K, Saeki M, Kamatani N, Kajio H, Kuzuya N, Yasuda K, Sawada J. Novel genetic variations and haplotypes of hepatocyte nuclear factor 4alpha (HNF4A) found in Japanese type II diabetic patients. Drug Metab. Pharmacokinet. 21: 337-346 (2006). *
Fukushima-Uesaka H, Saito Y, Tohkin M, Maekawa K, Hasegawa R, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Kajio H, Kuzuya N, Yasuda K, Sawada J. Genetic variations and haplotype structures of the ABC transporter gene ABCC1 in a Japanese population. Drug Metab. Pharmacokinet. 22: 48-60 (2007). *
Fukutani T, Hiromatsu Y, Kaku H, Miyake I, Mukai T, Imamura Y, Kohno S, Takane N, Shoji S, Otabe S, Yamada K. A polymorphism of interferon-gamma gene associated with changes of anti-thyrotropin receptor antibodies induced by antithyroid drug treatment for Graves' disease in Japanese patients. Thyroid 14: 93-97 (2004).
Fumagalli A, Ferrari M, Soriani N, Gessi A, Foglieni B, Martina E, Manitto MP, Brancato R, Dean M, Allikmets R, Cremonesi L. Mutational scanning of the ABCR gene with double-gradient denaturing-gradient gel electrophoresis (DG-DGGE) in Italian Stargardt disease patients. Hum. Genet. 109: 326-338 (2001). *
Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Riva S, Clerici M, Bresolin N, Sironi M. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J. Exp. Med. 206: 1395-1408 (2009). *
Fumic K, Beluzic R, Cuk M, Pavkov T, Kloor D, Baric I, Mijic I, Vugrek O. Functional analysis of human S-adenosylhomocysteine hydrolase isoforms SAHH-2 and SAHH-3. Eur. J. Hum. Genet. 15: 347-351 (2007). *
Funakoshi Y, Omori H, Katoh T. Association between bone mineral density and lifestyle factors or vitamin D receptor gene polymorphism in adult male workers: a cross-sectional study. Environ. Health Prev. Med. 14: 328-335 (2009). *
Fung E, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, Wicker LS, Todd JA. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 10: 188-191 (2009). *
Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim. Biophys. Acta 1794: 860-871 (2009). *
Fung MM, Chen Y, Lipkowitz MS, Salem RM, Bhatnagar V, Mahata M, Nievergelt CM, Rao F, Mahata SK, Schork NJ, Brophy VH, O'Connor DT; for the AASK Co-Investigators. Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol. Dial. Transplant. 24: 3677-3686 (2009).
Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus. Wien. Klin. Wochenschr. 117: 707-710 (2005).
Funke S, Morava E, Czako M, Vida G, Ertl T, Kosztolanyi G. Influence of genetic polymorphisms on bone disease of preterm infants. Pediatr. Res. 60: 607-612 (2006). *
Funkhouser SW, Concannon P, Charmley P, Vredevoe DL, Hood L. Differences in T cell receptor restriction fragment length polymorphisms in patients with rheumatoid arthritis. Arthritis Rheum. 35: 465-471 (1992).
Furihata S, Ito T, Kamatani N. Test of association between haplotypes and phenotypes in case-control studies: examination of validity of the application of an algorithm for samples from cohort or clinical trials to case-control samples using simulated and real data. Genetics 174: 1505-1516 (2006). *
Furihata T, Satoh T, Yamamoto N, Kobayashi K, Chiba K. Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers. Pharm. Res. 24: 2327-2332 (2007). *
Furugaki K, Shirasawa S, Ishikawa N, Ito K, Ito K, Kubota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J. Hum. Genet. 49: 166-168 (2004). *
Furuichi T, Maeda K, Chou CT, Liu YF, Liu TC, Miyamoto Y, Takahashi A, Mori K, Ikari K, Kamatani N, Kurosawa H, Inoue H, Tsai SF, Ikegawa S. Association of the MSX2 gene polymorphisms with ankylosing spondylitis in Japanese. J. Hum. Genet. 53: 419-424 (2008). *
Furukawa A, Uchida K, Ishige Y, Ishige I, Kobayashi I, Takemura T, Yokoyama T, Iwai K, Watanabe K, Shimizu S, Ishida N, Suzuki Y, Suzuki T, Yamada T, Ito T, Eishi Y. Characterization of Propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism. Microb. Pathog. 46: 80-87 (2009). *
Furukawa M, Sakamoto A, Kita Y, Ohishi Y, Matsumura R, Tsubata R, Tsubata T, Iwamoto I, Saito Y, Sumida T. T-cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands and kidneys from alymphoplasia (aly) mutant mice: a new model for Sjogren's syndrome. Br. J. Rheumatol. 35: 1223-1230 (1996). *
Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, Yano N, Sugahiro J, Ogata M, Ohgawara H, Omori Y, Iwamoto Y, Bell GI. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 46: 1652-1657 (1997).
Furuta T, Sugimoto M, Shirai N, Matsushita F, Nakajima H, Kumagai J, Senoo K, Kodaira C, Nishino M, Yamade M, Ikuma M, Watanabe H, Umemura K, Ishizaki T, Hishida A. Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori. Aliment. Pharmacol. Ther. 26: 693-703 (2007). *
Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kamatani N, Kotake S. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Clin. Rheumatol. 26: 2137-2141 (2007). *
Furuya T, Joe B, Salstrom JL, Hashiramoto A, Dobbins DE, Wilder RL, Remmers EF. Polymorphisms of the tumor necrosis factor alpha locus among autoimmune disease susceptible and resistant inbred rat strains. Genes Immun. 2: 229-232 (2001). *
Furuya T, Urano T, Ikari K, Kotake S, Inoue S, Hara M, Momohara S, Kamatani N, Yamanaka H. A1330V polymorphism of low-density lipoprotein receptor-related protein 5 gene and self-reported incident fractures in Japanese female patients with rheumatoid arthritis. Mod. Rheumatol. 19: 140-146 (2009). *
Furuyama H, Chiba S, Okabayashi T, Yokota SI, Nonaka M, Imai T, Fujii N, Matsumoto H. Single nucleotide polymorphisms and functional analysis of MxA promoter region in multiple sclerosis. J. Neurol. Sci. 249: 153-157 (2006). *
Furuyama S, Uehara Y, Zhang B, Baba Y, Abe S, Iwamoto T, Miura SI, Saku K. Genotypic effect of ABCG1 gene promoter -257T>G polymorphism on coronary artery disease severity in Japanese men. J. Atheroscler. Thromb. 16: 194-200 (2009). *
Gaasenbeek M, Howarth K, Rowan AJ, Gorman PA, Jones A, Chaplin T, Liu Y, Bicknell D, Davison EJ, Fiegler H, Carter NP, Roylance RR, Tomlinson IP. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res. 66: 3471-3479 (2006). *
Gabele E, Muhlbauer M, Paulo H, Johann M, Meltzer C, Leidl F, Wodarz N, Wiest R, Scholmerich J, Hellerbrand C. Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis. World J. Gastroenterol. 15: 5558-5562 (2009). *
Gaber SA, Mazzola G, Berrino M, Canale L, Cornaglia M, Ghali I, Sergio Curtoni E, Amoroso A. Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children. Diabetes Care 17: 1341-1344 (1994).
Gacka M, Bednarska-Chabowska D, Dobosz T, Szymaniec S, Jakobsche U, Lebioda A, Adamiec R. The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma and immunological processes in patients with type 2 diabetes and insulin resistance. Przegl. Lek. 64: 393-397 (2007).
Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin - a soluble pattern recognition molecule. Mol. Immunol. 41: 113-121 (2004). *
Gaedigk A, Ndjountche L, Divakaran K, Dianne Bradford L, Zineh I, Oberlander TF, Brousseau DC, McCarver DG, Johnson JA, Alander SW, Wayne Riggs K, Steven Leeder J. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin. Pharmacol. Ther. 81: 242-251 (2007). *
Gaens K, van der Kallen C, van Greevenbroek M, Feskens E, Stehouwer C, Schalkwijk C. Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study. Ann. N. Y. Acad. Sci. 1126: 162-165 (2008). *
Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, Rohlf KE, Ockenden TC, Messner RP, King RA, Rich SS, Behrens TW. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc. Natl. Acad. Sci. U.S.A. 95: 14875-14879 (1998). *
Gaffney PM, Langefeld CD, Graham RR, Ortmann WA, Williams AH, Rodine PR, Moser KL, Behrens TW. Fine-mapping chromosome 20 in 230 systemic lupus erythematosus sib pair and multiplex families: evidence for genetic epistasis with chromosome 16q12. Am. J. Hum. Genet. 78: 747-758 (2006). *
Gage BF, Lesko LJ. Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J. Thromb. Thrombolysis 25: 45-51 (2008).
Gagnon F, Hajage D, Plancoulaine S, Tezenas du Montcel S. Modeling of PTPN22 and HLA-DRB1 susceptibility to rheumatoid arthritis. BMC Proc. 1 Suppl. 1: S14 (2007). *
Gai X, Lan X, Luo Z, Wang F, Liang Y, Zhang H, Zhang W, Hou J, Huang M. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients. Clin. Chim. Acta 408: 105-109 (2009). *
Gaj P, Habior A, Mikula M, Ostrowski J. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Med. Genet. 9: 81 (2008). *
Galanakis E, Kofteridis D, Stratigi K, Petraki E, Vazgiourakis V, Fragouli E, Mamoulakis D, Boumpas DT, Goulielmos GN. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Hum. Immunol. 69: 279-283 (2008).
Galbraith GM, Pandey JP. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum. Genet. 96: 433-436 (1995).
Gale CP, Grant PJ. The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics. Gene 340: 251-260 (2004). *
Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations. Curr. Gastroenterol. Rep. 6: 44-51 (2004).
Galicia JC, Tai H, Komatsu Y, Shimada Y, Akazawa K, Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun. 5: 513-516 (2004). *
Galicia JC, Tai H, Komatsu Y, Shimada Y, Ikezawa I, Yoshie H. Interleukin-6 receptor gene polymorphisms and periodontitis in a non-smoking Japanese population. J. Clin. Periodontol. 33: 704-709 (2006). *
Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E. CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course. Eur. J. Neurol. 14: 162-167 (2007).
Galimberti D, Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E, Cortini F, Piola M, Leone M, Dianzani U, D'Alfonso S, Monaco F, Bresolin N, Scarpini E. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis. J. Neurol. Sci. 267: 86-90 (2008).
Gallagher CJ, Kadlubar FF, Muscat JE, Ambrosone CB, Lang NP, Lazarus P. The UGT2B17 gene deletion polymorphism and risk of prostate cancer: a case-control study in Caucasians. Cancer Detect. Prev. 32: 186-187 (2008).
Gallego PH, Craig ME, Duffin AC, Bennetts B, Jenkins AJ, Hofer S, Lam A, Donaghue KC. Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes. Diabetes Care 31: 1585-1589 (2008). *
Gallegos-Arreola MP, Garc�a-Ortiz JE, Figuera LE, Puebla-Perez AM, Morgan-Villela G, Zuniga-Gonzalez GM. Association of the 677C ->T polymorphism in the MTHFR gene with colorectal cancer in Mexican patients. Cancer Genomics Proteomics 6: 183-188 (2009).
Gallegos-Arreola MP, Peralta-Leal V, Morgan-Villela G, Puebla-Perez AM. Frequency of TS1494del6 polymorphism in colorectal patients from west of Mexico. Rev. Invest. Clin. 60: 21-30 (2008).
Gallicchio L, Kalesan B, Huang HY, Strickland P, Hoffman SC, Helzlsouer KJ. Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in Washington county, Maryland. PPAR Res. 2008: 276581 (2008). *
Galocha B, de Castro JA. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum. 58: 401-412 (2008). *
Galvan A, Falvella FS, Frullanti E, Spinola M, Incarbone M, Nosotti M, Santambrogio L, Conti B, Pastorino U, Gonzalez-Neira A, Dragani TA. Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer. Carcinogenesis Dec 18 [Epub ahead of print] (2009). *
Galvan-Portillo MV, Onate-Ocana LF, Perez-Perez GI, Chen J, Herrera-Goepfert R, Chihu-Amparan L, Flores-Luna L, Mohar-Betancourt A, Lopez-Carrillo L. Dietary folate and vitamin B12 intake before diagnosis decreases gastric cancer mortality risk among susceptible MTHFR 677TT carriers. Nutrition Jul 2 [Epub ahead of print] (2009).
Galvani AP, Novembre J. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes Infect. 7: 302-309 (2005). *
Galvez-Rosas A, Gonzalez-Huerta C, Borgonio-Cuadra VM, Duarte-Salazar C, Lara-Alvarado L, de Los Angeles Soria-Bastida M, Cortes-Gonzalez S, Ramon-Gallegos E, Miranda-Duarte A. A COL2A1 gene polymorphism is related with advanced stages of osteoarthritis of the knee in Mexican Mestizo population. Rheumatol. Int. Sep 16 [Epub ahead of print] (2009). *
Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. Human sulfotransferases and their role in chemical metabolism. Toxicol. Sci. 90: 5-22 (2006). *
Gambelunghe G, Brozzetti A, Ghaderi M, Candeloro P, Tortoioli C, Falorni A. MICA gene polymorphism in the pathogenesis of type 1 diabetes. Ann. N. Y. Acad. Sci. 1110: 92-98 (2007). *
Gambelunghe G, Brozzetti AL, Ghaderi M, Tortoioli C, Falorni A. MICA A8: a new allele within MHC class I chain-related A transmembrane region with eight GCT repeats. Hum. Immunol. 67: 1005-1007 (2006).
Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 84: 3701-3707 (1999). *
Gambelunghe G, Gerli R, Bartoloni Bocci E, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 44: 287-292 (2005). *
Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 43: 507-514 (2000). *
Gambelunghe G, Ghaderi M, Gharizadeh B, Brozzetti A, Tortoioli C, Del Sindaco P, Sanjeevi CB, Hjelmstrom P, Sirsjo A, Nyren P, Santeusanio F, Falorni A. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease. Eur. J. Immunogenet. 31: 73-76 (2004). *
Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A; Umbria Type 1 Diabetes Registry. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J. Clin. Endocrinol. Metab. 86: 3754-3760 (2001). *
Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol. Int. Sep 25 [Epub ahead of print] (2009). *
Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 45: 1097-1107 (2007). *
Gammon DC, Bhatt MS, Patel B, Anderson M, Van Horn A, Glantz MJ. Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism. J. Oncol. Pharm. Pract. 14: 153-156 (2008).
Gandini S, Raimondi S, Gnagnarella P, Dore JF, Maisonneuve P, Testori A. Vitamin D and skin cancer: a meta-analysis. Eur. J. Cancer 45: 634-641 (2009). *
Gandjbakhch F, Fajardy I, Ferre B, Dubucquoi S, Flipo RM, Roger N, Solau-Gervais E. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population. J. Rheumatol. 36: 881-886 (2009).
Gangwar R, Manchanda PK, Mittal RD. Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide. Genetica 136: 163-169 (2009). *
Gangwar R, Mandhani A, Mittal RD. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in North Indian population. Ann. Surg. Oncol. 16: 2028-2034 (2009). *
Gangwar R, Mittal B, Mittal RD. Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer. Int. J. Biol. Markers 24: 11-16 (2009).
Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Matsuo K, Takezaki T, Tajima K. MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J. Hum. Genet. 54: 414-418 (2009).
Gao F, Zhang R, Hu C, Fang QC, Wang CR, Ma XJ, Lu JX, Xu J, Jia WP, Xiang KS. Association of -6735T-->C variant of glucokinase-associated dual-specificity phosphatase 12 gene with type 2 diabetes in Chinese. Zhonghua Yi Xue Za Zhi 88: 2250-2253 (2008).
Gao H, Zhang Z, Zhang J, Zhao N, Li Q, Bai M. Association of LT-alpha Ala252Gly gene polymorphism and the genetic predisposition of coronary heart disease in Chinese. Mol. Biol. Rep. 37: 47-50 (2010). *
Gao HK, Zhou ZG, Li Y, Chen YQ. Toll-like receptor 4 Asp299Gly polymorphism is associated with an increased risk of pancreatic necrotic infection in acute pancreatitis: a study in the Chinese population. Pancreas 34: 295-298 (2007).
Gao J, Arbman G, He L, Qiao F, Zhang Z, Zhao Z, Rosell J, Sun XF. MANBA polymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations. Acta Oncol. 47: 372-378 (2008). *
Gao J, Lin Y, Qiu C, Liu Y, Ma Y, Liu Y. Association between HLA-DQA1, -DQB1 gene polymorphisms and susceptibility to asthma in northern Chinese subjects. Chin. Med. J. (Engl.) 116: 1078-1082 (2003).
Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, Wang ZL, Jia CR, Carstensen J, Sun XF. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand. J. Gastroenterol. 42: 345-350 (2007). *
Gao J, Shan G, Sun B, Thompson PJ, Gao X. Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis. Thorax 61: 466-471 (2006). *
Gao JX, Xu DL, Shao YH, Lao WY, Lin S, Zhang B. Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population. Nan Fang Yi Ke Da Xue Xue Bao 27: 219-222 (2007).
Gao L, Li K, Li F, Li H, Liu L, Wang L, Zhang Z, Gao T, Liu Y. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J. Dermatol. Sci. Oct 30 [Epub ahead of print] (2009).
Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 14: 15-23 (2010).
Gao LB, Rao L, Wang YY, Liang WB, Li C, Xue H, Zhou B, Sun H, Li Y, Lv ML, Du XJ, Zhang L. The association of Interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 30: 295-299 (2009). *
Gao M, Cao Q, Luo LH, Wu ML, Hu WL, Si JM. NOD2/CARD15 gene polymorphisms and susceptibility to Crohn's disease in Chinese Han population. Zhonghua Nei Ke Za Zhi 44: 210-212 (2005).
Gao N, Qiao HL, Jia LJ, Tian X, Zhang YW. Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy. Eur. J. Clin. Pharmacol. 64: 971-977 (2008). *
Gao PS, Mathias RA, Plunkett B, Togias A, Barnes KC, Beaty TH, Huang SK. Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population. J. Allergy Clin. Immunol. 115: 982-988 (2005). *
Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, Wang SY, Tong LX. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J. Gastroenterol. 15: 5610-5619 (2009). *
Gao X, Gordon D, Zhang D, Browne R, Helms C, Gillum J, Weber S, Devroy S, Swaney S, Dobbs M, Morcuende J, Sheffield V, Lovett M, Bowcock A, Herring J, Wise C. CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis. Am. J. Hum. Genet. 80: 957-965 (2007). *
Gao X, Single RM, Karacki P, Marti D, O'Brien SJ, Carrington M. Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. Hum. Immunol. 67: 152-158 (2006).
Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol. 32: 361-369 (2008).
Gao XH, Barnardo MC, Winsey S, Ahmad T, Cook J, Agudelo JD, Zhai N, Powell JJ, Fuggle SV, Wojnarowska F. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated � J. Invest. Dermatol. 125: 895-899 (2005). *
Gao XJ, Ball EJ, Dombrausky L, Olsen NJ, Pincus T, Khan MA, Wolfe F, Stastny P. Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am. J. Med. 85: 14-16 (1988).
Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu Y, Guo B, Shen Y, Landi D, Landi S, Zhou Y, Liu H. An insertion/deletion polymorphism at miRNA-122 binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30: 2064-2069 (2009). *
Gao Y, Pan X, Su T, Mo Z, Cao Y, Gao F. Glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk: a meta-analysis and HuGE review. Eur. J. Cancer 45: 3303-3314 (2009). *
Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, Kladny J, Gronwald J, Gorski B, Cybulski C, Lubinski J, Debniak T. Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res. Treat. 115: 629-633 (2009).
Garat A, Cauffiez C, Renault N, Lo-Guidice JM, Allorge D, Chevalier D, Houdret N, Chavatte P, Loriot MA, Gala JL, Broly F. Characterisation of novel defective thiopurine S-methyltransferase allelic variants. Biochem. Pharmacol. 76: 404-415 (2008). *
Garaulet M, Corbalan MD, Madrid JA, Morales E, Baraza JC, Lee YC, Ordovas JM. CLOCK gene is implicated in weight reduction in obese patients participating in a dietary programme based on the Mediterranean diet. Int. J. Obes. (Lond.) Jan 12 [Epub ahead of print] (2010).
Garaulet M, Lee YC, Shen J, Parnell LD, Arnett DK, Tsai MY, Lai CQ, Ordovas JM. CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am. J. Clin. Nutr. 90: 1466-1475 (2009). *
Garcia AN, Muniz MT, Souza E Silva HR, da Silva HA, Athayde-Junior L. Cyp46 polymorphisms in Alzheimer's disease: a review. J. Mol. Neurosci. 39: 342-345 (2009).
Garcia Borras S, Diez C, Cotorruelo C, Pellizon O, Biondi C, Beloscar J, Bottasso O, Racca A. HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection. Ann. Clin. Biochem. 43: 214-216 (2006).
Garcia D, Angel B, Carrasco E, Albala C, Santos JL, Perez-Bravo F. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Res. Clin. Pract. 77: 134-140 (2007).
Garcia DD, Oyarzun AA, Angel BB, Carrasco PE, Perez BF. Association of GHRd3 variant of growth hormone receptor gene with autoimmunity in type 1 diabetes. Rev. Med. Chil. 137: 609-616 (2009).
Garcia-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D, Kogevinas M, Dosemeci M, Figueroa J, Chatterjee N, Tardon A, Serra C, Carrato A, Garcia-Closas R, Murta-Nascimento C, Rothman N, Chanock SJ. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet. 3: e29 (2007). *
Garcia-Garcia AB, Gonzalez C, Real JT, Martin de Llano JJ, Gonzalez-Albert V, Civera M, Chaves FJ, Ascaso JF, Carmena R. Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia. Pharmacogenet. Genomics 15: 211-218 (2005).
Garcia-Gonzalez MA, Aisa MA, Strunk M, Benito R, Piazuelo E, Jimenez P, Sopena F, Lanas A. Relevance of IL-1 and TNF gene polymorphisms on IL-1beta and TNF-alpha gastric mucosal production. Hum. Immunol. 70: 935-945 (2009).
Garcia-Gonzalez MA, Strunk M, Piazuelo E, Benito R, Santolaria S, Jimenez P, Sopena F, Pascual C, Simon MA, Sainz R, Lanas A. TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. Genes Immun. 7: 640-646 (2006). *
Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Nunez-Roldan A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 28: 89-93 (2001). *
Garcia-Lozano JR, Torres B, Fernandez O, Orozco G, Alvarez-Marquez A, Garcia A, Gonzalez-Gay MA, Garcia A, Nunez-Roldan A, Martin J, Gon Zalez-Escribano MF. Caspase 7 influences susceptibility to rheumatoid arthritis. Rheumatology (Oxford) 46: 1243-1247 (2007). *
Garcia-Martin E, Ayuso P, Luengo A, Martinez C, Agundez JA. Genetic variability of histamine receptors in patients with Parkinson's disease. BMC Med. Genet. 9: 15 (2008). *
Garcia-Martin E, Garcia-Menaya J, Sanchez B, Martinez C, Rosendo R, Agundez JA. Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis. Clin. Exp. Allergy 37: 1175-1182 (2007). *
Garcia-Martin E, Mendoza JL, Martinez C, Taxonera C, Urcelay E, Ladero JM, de la Concha EG, Diaz-Rubio M, Agundez JA. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J. Gastroenterol. 12: 615-620 (2006). *
Garcia-Moruja C, Rueda P, Torres C, Alcam� J, Luque F, Caruz A. Molecular phenotype of CXCL12beta 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression. Curr. HIV Res. 7: 384-389 (2009).
Garcia-Unzueta MT, Riancho JA, Zarrabeitia MT, Sanudo C, Berja A, Valero C, Pesquera C, Paule B, Gonzalez-Macias J, Amado JA. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. Horm. Metab. Res. 40: 219-224 (2008).
Gardiner A, Richards KA, Sant AJ, Arneson LS. Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide. Int. Immunol. 19: 1103-1113 (2007). *
Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD. Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int. 102: 1694-1699 (2008).
Gardner MS, Rowland MD, Siu AY, Bundy JL, Wagener DK, Stephenson JL. Comprehensive defensin assay for saliva. Anal. Chem. 81: 557-566 (2009). *
Garenc C, Aubert S, Laroche J, Girouard J, Vohl MC, Bergeron J, Rousseau F, Julien P. Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians. J. Hum. Genet. 49: 691-700 (2004). *
Garg PK, Khajuria R, Kabra M, Shastri SS. Association of SPINK1 gene mutation and CFTR gene polymorphisms in patients with pancreas divisum presenting with idiopathic pancreatitis. J. Clin. Gastroenterol. Jul 10 [Epub ahead of print] (2009).
Gargiulo S, Torrini M, Ollila S, Nasti S, Pastorino L, Cusano R, Bonelli L, Battistuzzi L, Mastracci L, Bruno W, Savarino V, Sciallero S, Borgonovo G, Nystrom M, Bianchi-Scarra G, Mareni C, Ghiorzo P. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. Fam. Cancer 8: 547-553 (2009). *
Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol. Immunol. 40: 73-84 (2003). *
Garred P, Madsen HO. Genetic susceptibility to sepsis: a possible role for mannose-binding lectin. Curr. Infect. Dis. Rep. 6: 367-373 (2004).
Garred P, Madsen HO, Halberg P, Petersen J, Kronborg G, Svejgaard A, Andersen V, Jacobsen S. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 42: 2145-2152 (1999). *
Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S, Volck B, Svejgaard A, Andersen V. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J. Rheumatol. 25: 1462-1465 (1998).
Garrido P, Almeida J, Romero JM, Canton J, Sandberg Y, Barcena P, Lima M, Langerak AW, Orfao A, Ruiz-Cabello F. Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis. Hum. Immunol. 69: 101-107 (2008).
Garrity-Park MM, Loftus EV Jr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am. J. Gastroenterol. 103: 407-415 (2008). *
Garrote J, Arranz E, Gomez-Gonzalez E, Leon A, Farre C, Calvo C, Bernardo D, Fernandez-Salazar L, Blanco-Quiros A. IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients. Allergol. Immunopathol. (Madr.) 33: 245-249 (2005).
Garrote JA, Arranz E, Telleria JJ, Castro J, Calvo C, Blanco-Quiros A. TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population. Immunogenetics 54: 551-555 (2002). *
Garte S. Human population genetic diversity as a function of SNP type from HapMap data. Am. J. Hum. Biol. Sep 9 [Epub ahead of print] (2009).
Garte S. Dose effects in gene environment interaction: an enzyme kinetics based approach. Med. Hypotheses 67: 488-492 (2006).
Garten Y, Altman RB. Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics 10 Suppl. 2: S6 (2009). *
Garza Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the Toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 7: 70 (2007). *
Gasche C, Nemeth M, Grundtner P, Willheim-Polli C, Ferenci P, Schwarzenbacher R. Evolution of Crohn's disease-associated Nod2 mutations. Immunogenetics 60: 115-120 (2008). *
Gasser RB, Hu M, Chilton NB, Campbell BE, Jex AJ, Otranto D, Cafarchia C, Beveridge I, Zhu X. Single-strand conformation polymorphism (SSCP) for the analysis of genetic variation. Nat. Protoc. 1: 3121-3128 (2006). *
Gast A, Bermejo JL, Flohr T, Stanulla M, Burwinkel B, Schrappe M, Bartram CR, Hemminki K, Kumar R. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 21: 320-325 (2007).
Gathany AH, Hartge P, Davis S, Cerhan JR, Severson RK, Cozen W, Rothman N, Chanock SJ, Wang SS. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control Apr 28 [Epub ahead of print] (2009). *
Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J, Wunsch-Filho V. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28: 819-826 (2006).
Gatti D, Maki A, Chesler EJ, Kirova R, Kosyk O, Lu L, Manly KF, Williams RW, Perkins A, Langston MA, Threadgill DW, Rusyn I. Genome-level analysis of genetic regulation of liver gene expression networks. Hepatology 46: 548-557 (2007). *
Gaucher EA, De Kee DW, Benner SA. Application of DETECTER, an evolutionary genomic tool to analyze genetic variation, to the cystic fibrosis gene family. BMC Genomics 7: 44 (2006). *
Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet. Epidemiol. 31: 383-395 (2007). *
Gaudet MM, Chanock S, Dunning A, Driver K, Brinton LA, Lissowska J, Peplonska B, Pharoah P, Garcia-Closas M. HSD17B1 genetic variants and hormone receptor-defined breast cancer. Cancer Epidemiol. Biomarkers Prev. 17: 2766-2772 (2008). *
Gaudet MM, Gammon MD, Bensen JT, Sagiv SK, Shantakumar S, Teitelbaum SL, Eng SM, Neugut AI, Santella RM. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York. Breast Cancer Res. Treat. 108: 93-99 (2008).
Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, et al. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev. 18: 1610-1616 (2009).
Gaudieri S, Rauch A, Pfafferott K, Barnes E, Cheng W, McCaughan G, Shackel N, Jeffrey GP, Mollison L, Baker R, Furrer H, Gunthard HF, Freitas E, Humphreys I, Klenerman P, Mallal S, James I, Roberts S, Nolan D, Lucas M. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology 49: 1069-1082 (2009).
Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157: 451-456 (2001).
Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN, Jackson AU, Duren WL, Chines PS, Narisu N, Bonnycastle LL, Luo J, Tong M, Sprau AG, Pugh EW, Doheny KF, Valle TT, Abecasis GR, Tuomilehto J, Bergman RN, Collins FS, Boehnke M, Mohlke KL. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 57: 3136-3144 (2008). *
Gaussem P, Ishida BY, Fontana P, Pullinger CR, Khane JP, Aiach M, Bachelot-Loza C, Gandrille S. No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro. J. Cell. Mol. Med. 13: 601-603 (2009).
Gava A, Furlan A, Navaglia F, Miorin M, Razetti M, Basso D, Plebani M, Punzi L. Utility of denaturing high performance liquid chromatography (DHPLC) for the diagnosis of mevalonate kinase deficiency in periodic fevers of autoinflammatory nature suspicion. Reumatismo 61: 187-196 (2009).
Gawronska-Szklarz B, Wrzesniewska J, Starzynska T, Pawlik A, Safranow K, Ferenc K, Drozdzik M. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. Eur. J. Clin. Pharmacol. 61: 375-379 (2005). *
Gay S, Muller PK, Meigel WN, Kuhn K. The polymorphism of collagen. New viewpoints on the structure and function of connective tissue. Hautarzt. 27: 196-205 (1976).
Gayathri SB, Radha V, Vimaleswaran KS, Mohan V. Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian Indian population (CURES-41). Metab. Syndr. Relat. Disord. Nov 9 [Epub ahead of print] (2009).
Gaysina D, Cohen S, Craddock N, Farmer A, Hoda F, Korszun A, Owen MJ, Craig IW, McGuffin P. No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 699-706 (2008).
Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R. HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum. Immunol. 65: 39-46 (2004).
Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, Archimandritis AJ, Anagnou NP. Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease. Inflamm. Bowel Dis. 14: 1323-1330 (2008). *
Gazouli M, Koundourakis A, Ikonomopoulos J, Gialafos EJ, Rapti A, Gorgoulis VG, Kittas C. CARD15/NOD2, CD14, and Toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 23-29 (2006).
Gazouli M, Mantzaris G, Archimandritis AJ, Nasioulas G, Anagnou NP. Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J. Gastroenterol. 11: 7525-7530 (2005). *
Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J. Gastroenterol. 11: 681-685 (2005). *
Gazouli M, Sechi L, Paccagnini D, Sotgiu S, Arru G, Nasioulas G, Vassilopoulos D. NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients. Can. J. Neurol. Sci. 35: 491-494 (2008).
Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, Papaconstantinou I, Kostakis A, Anagnou NP, Nikiteas N. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int. J. Colorectal Dis. 24: 145-150 (2009). *
Gazouli M, Zacharatos P, Gorgoulis V, Mantzaris G, Papalambros E, Ikonomopoulos J. The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population. Gastroenterology 126: 367-369 (2004). *
Gazouli M, Zacharatos P, Mantzaris GJ, Barbatis C, Ikonomopoulos I, Archimandritis AJ, Lukas JC, Papalambros E, Gorgoulis V. Association of NOD2/CARD15 variants with Crohn's disease in a Greek population. Eur. J. Gastroenterol. Hepatol. 16: 1177-1182 (2004).
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401 (2009). *
Ge D, Zhang K, Need AC, Martin O, Fellay J, Telenti A, Goldstein D. WGAViewer: a software for genomic annotation of whole genome association studies. Genome Res. 18: 640-643 (2008). *
Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J. Gastroenterol. Hepatol. 20: 1149-1157 (2005). *
Gearry RB, Lea RA, Roberts RL, Chambers GK, Barclay ML, Kennedy MA. CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn�s disease in New Zealand? Gut 55: 580 (2006). *
Gearry RB, Roberts RL, Barclay ML, Kennedy MA. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics 14: 779-781 (2004).
Geese WJ, Achanzar W, Rubin C, Hariharan N, Cheng P, Tomlinson L, Ordway N, Dracopoli NC, Delmonte T, Hui L, Krishnan B, Cosma G, Ranade K. Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonists. Pharmacogenet. Genomics 18: 903-910 (2008).
Gefel D, Maslovsky I, Hillel J. Application of single nucleotide polymorphisms (SNPs) for the detection of genes involved in the control of complex diseases. Harefuah. 147: 449-454, 476 (2008).
Gehmert S, Velapatino B, Herrera P, Balqui J, Santivanez L, Cok J, Vargas G, Combe J, Passaro DJ, Wen S, Meyer F, Berg DE, Gilman RH. Interleukin-1 beta single-nucleotide polymorphism's C allele is associated with elevated risk of gastric cancer in Helicobacter pylori-infected Peruvians. Am. J. Trop. Med. Hyg. 81: 804-810 (2009).
Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, Siewert E, Gartung C, Lorenzen J, Bosserhoff AK, Brugmann M, Gressner AM, Matern S, Lammert F. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int. 24: 285-294 (2004). *
Geier MS, Torok VA, Allison GE, Ophel-Keller K, Gibson RA, Munday C, Hughes RJ. Dietary omega-3 polyunsaturated fatty acid does not influence the intestinal microbial communities of broiler chickens. Poult. Sci. 88: 2399-2405 (2009).
Geiger EV, Doehring A, Kirchhof A, Lotsch J. Functional variants of the human 5-lipoxygenase gene and their genetic diagnosis. Prostaglandins Leukot. Essent. Fatty Acids 80: 255-262 (2009). *
Gel'tser BI, Kochetkova EA, Grigor'eva OIu, Al'bavichus SA, Bubnov Oiu. Relations between VDR3 and COL1A1 genes and markers of bone tissue metabolism in patients with chronic obstructive pulmonary disease. Ter. Arkh. 78: 17-20 (2006).
Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, Bull P, Bunce M, Welsh K, Marshall SE, Borysiewicz L. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J. Virol. 77: 1927-1939 (2003). *
Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. U.S.A. 103: 12831-12836 (2006). *
Gelderman KA, Hultqvist M, Olsson LM, Bauer K, Pizzolla A, Olofsson P, Holmdahl R. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid. Redox Signal. 9: 1541-1568 (2007).
Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R, Holmdahl R. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 117: 3020-3028 (2007). *
Geldmacher C, Metzler IS, Tovanabutra S, Asher TE, Gostick E, Ambrozak DR, Petrovas C, Schuetz A, Ngwenyama N, Kijak G, Maboko L, Hoelscher M, McCutchan F, Price DA, Douek DC, Koup RA. Minor viral and host genetic polymorphisms can dramatically impact the biological outcome of an epitope-specific CD8 T cell response. Blood 114: 1553-1562 (2009). *
Gellekink H, Blom HJ, van der Linden IJ, den Heijer M. Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels. Eur. J. Hum. Genet. 15: 103-109 (2007). *
Geller B, Tillman R, Bolhofner K, Hennessy K, Cook EH. GAD1 single nucleotide polymorphism is in linkage disequilibrium with a child bipolar I disorder phenotype. J. Child. Adolesc. Psychopharmacol. 18: 25-29 (2008).
Gelmetti AP, Freitas AC, Woronik V, Barros RT, Bonfa E, Monteiro RC. Polymorphism of the FcgRIIa IgG receptor in patients with lupus nephritis and glomerulopathy. J. Rheumatol. 33: 523-530 (2006).
Gemma R, Suda T, Nakamura H. Immunoregulatory genes in autoimmune thyroid disease. Nippon Rinsho 57: 1737-1742 (1999).
Gemmati D, De Mattei M, Catozzi L, Della Porta M, Serino ML, Ambrosio C, Cuneo A, Friso S, Krampera M, Orioli E, Zeri G, Ongaro A. DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? Am. J. Hematol. 84: 526-529 (2009).
Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E, Witkin SS; The MAP Study Group. Relationship between a Toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 116: 152-156 (2004).
Genc MR, Vardhana S, Delaney ML, Witkin SS, Onderdonk AB; The MAP Study Group. TNFA-308G>A polymorphism influences the TNF-alpha response to altered vaginal flora. Eur. J. Obstet. Gynecol. Reprod. Biol. 134: 188-191 (2007).
Genc S, Genc K, Sercan O, Kizildag S, Gulay Z, Atay T, Dundar B, Sakizli M, Buyukgebiz A. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population. J. Pediatr. Endocrinol. Metab. 17: 731-735 (2004).
Gencik M, Borgmann S, Zahn R, Albert E, Sitter T, Epplen JT, Fricke H. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin. Exp. Immunol. 117: 412-417 (1999). *
Gencik M, Meller S, Borgmann S, Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int. 58: 2473-2477 (2000). *
Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H, Epplen JT. The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin. Immunol. 94: 9-12 (2000). *
Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study. Transpl. Immunol. 16: 194-199 (2006).
Geng J, Zhang YW, Huang GC, Chen LB. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: a meta-analysis. World J. Gastroenterol. 14: 6733-6737 (2008). *
Genkinger JM, Platz EA, Hoffman SC, Strickland P, Huang HY, Comstock GW, Helzlsouer KJ. C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival. Mech. Ageing Dev. 127: 371-377 (2006).
Gentil P, de Lima Lins TC, Lima RM, de Abreu BS, Grattapaglia D, Bottaro M, de Oliveira RJ, Pereira RW. Vitamin-D-receptor genotypes and bone-mineral density in postmenopausal women: interaction with physical activity. J. Aging Phys. Act. 17: 31-45 (2009).
Genvigir FD, Hirata MH, Hirata RD. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics 10: 997-1005 (2009).
George Priya Doss C, Rajasekaran R, Sudandiradoss C, Ramanathan K, Purohit R, Sethumadhavan R. A novel computational and structural analysis of nsSNPs in CFTR gene. Genomic Med. 2: 23-32 (2008). *
Georgopoulos A, Bloomfield H, Collins D, Brousseau ME, Ordovas JM, O'Connor JJ, Robins SJ, Schaefer EJ. Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the veterans affairs HDL intervention trial (VA-HIT). Atherosclerosis 194: 169-174 (2007).
Geraghty DE, Daza R, Williams LM, Vu Q, Ishitani A. Genetics of the immune response: identifying immune variation within the MHC and throughout the genome. Immunol. Rev. 190: 69-85 (2002). *
Gergely Jr P, Blazsek A, Weiszhar Z, Pazar B, Poor G. Lack of genetic association of the Toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondylarthropathies in a Hungarian population. Rheumatology (Oxford) 45: 1194-1196 (2006). *
Gerger A, Hofmann G, Langsenlehner U, Renner W, Weitzer W, Wehrschutz M, Wascher T, Samonigg H, Krippl P. Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk. Int. J. Colorectal Dis. 24: 159-163 (2009). *
Gerger A, Renner W, Langsenlehner T, Hofmann G, Knechtel G, Szkandera J, Samonigg H, Krippl P, Langsenlehner U. Association of interleukin-10 gene variation with breast cancer prognosis. Breast Cancer Res. Treat. May 13 [Epub ahead of print] (2009).
Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. Eur. J. Hum. Genet. 15: 619-627 (2007). *
Gerli G, Vanelli C, Turri O, Erario M, Gardellini A, Pugliano M, Biondi ML. SDF1-3'A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events. Clin. Chem. 51: 2411-2414 (2005). *
Gerloff T. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution. Naunyn. Schmiedebergs Arch. Pharmacol. 369: 69-77 (2004). *
Gerner EW, Meyskens FL Jr. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin. Cancer Res. 15: 758-761 (2009). *
Gerra G, Leonardi C, Cortese E, D'Amore A, Lucchini A, Strepparola G, Serio G, Farina G, Magnelli F, Zaimovic A, Mancini A, Turci M, Manfredini M, Donnini C. Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144B: 771-775 (2007).
Gervasini G. Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising. Curr. Drug Metab. 10: 547-566 (2009).
Gervasini G, Carrillo JA, Garcia M, San Jose C, Cabanillas A, Benitez J. Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Cancer 107: 2850-2857 (2006). *
Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations. Ther. Drug Monit. 27: 819-821 (2005).
Geuken E, Buis CI, Visser DS, Blokzijl H, Moshage H, Nemes B, Leuvenink HG, de Jong KP, Peeters PM, Slooff MJ, Porte RJ. Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am. J. Transplant. 5: 1875-1885 (2005). *
Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1157-G1163 (2006). *
Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, Eker E, Ozturk M, Engin F, Yilmazer S. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J. Exp. Med. 212: 275-282 (2007). *
Ghabanbasani MZ, Gu XX, Spaepen M, Vandevyver C, Raus J, Marynen P, Carton H, Cassiman JJ. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis. J. Neuroimmunol. 59: 77-82 (1995).
Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Mohammad Pezeshki A, Doroudchi M, Dehaghani AS. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res. Treat. 86: 1-7 (2004). *
Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, Falorni A. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J. Clin. Endocrinol. Metab. 91: 4107-4111 (2006). *
Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, Ghaderi A. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population. Immunol. Lett. 96: 277-281 (2005).
Ghatak A, Faheem O, Thompson PD. The genetics of statin-induced myopathy. Atherosclerosis Nov 27 [Epub ahead of print] (2009).
Ghazouani L, Abboud N, Khlifa SB, Perret C, Nicaud V, Cambien F, Almawi WY, Mahjoub T. P-selectin gene polymorphisms and risk of coronary heart disease among Tunisians. J. Thromb. Thrombolysis 28: 314-319 (2009).
Ghazouani L, Abboud N, Mtiraoui N, Zammiti W, Addad F, Amin H, Almawi WY, Mahjoub T. Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease. J. Thromb. Thrombolysis 27: 191-197 (2009).
Ghazouani L, Khalifa SB, Abboud N, Addad F, Khalfallah AB, Brahim N, Mediouni M, Almawi WY, Mahjoub T. -308G>A and -1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease. Clin. Chem. Lab. Med. 47: 1247-1251 (2009). *
Ghazouani L, Khalifa SB, Abboud N, Perret C, Nicaud V, Khalfallah AB, Alamawi WY, Cambien F, Mahjoub T. Association of three polymorphisms selected from a genome-wide association study with coronary heart disease in the Tunisian population. J. Thromb. Thrombolysis 29: 114-118 (2010).
Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta32 deletion. J. Vasc. Surg. 40: 995-1000 (2004).
Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin. Cancer Res. 8: 3820-3823 (2002). *
Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33: 2408-2412 (2002). *
Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res. 7: 2344-2346 (2001). *
Ghisdal L, Baron C, Le Meur Y, Lionet A, Halimi JM, Rerolle JP, Glowacki F, Lebranchu Y, Drouet M, Noel C, El Housni H, Cochaux P, Wissing KM, Abramowicz D, Abramowicz M. TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 20: 2459-2467 (2009).
Ghodke Y, Chopra A, Joshi K, Patwardhan B. Are thymidylate synthase and methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients? Clin. Rheumatol. 27: 787-789 (2008). *
Ghosh D, Skinner MA, Laing WA. Pharmacogenomics and nutrigenomics: synergies and differences. Eur. J. Clin. Nutr. 61: 567-574 (2007). *
Ghosh J, Joshi G, Pradhan S, Mittal B. Investigation of TNFA 308G > A and TNFB 252G > A polymorphisms in genetic susceptibility to migraine. J. Neurol. Dec 25 [Epub ahead of print] (2009).
Ghosh K, Shetty S. Immune response to FVIII in hemophilia A: an overview of risk factors. Clin. Rev. Allergy Immunol. 37: 58-66 (2009). *
Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur. J. Clin. Pharmacol. 63: 537-546 (2007). *
Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med. Genet. 6: 11 (2005). *
Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, Muti E, Malavolta M, Costarelli L, Piacenza F, Tesei S, Mocchegiani E. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol. Genet. Metab. 94: 98-104 (2008). *
Giacconi R, Caruso C, Malavolta M, Lio D, Balistreri CR, Scola L, Candore G, Muti E, Mocchegiani E. Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res. Rev. 7: 306-318 (2008).
Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, Lio D, Mocchegiani E. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology 7: 347-356 (2006). *
Giacconi R, Cipriano C, Muti E, Costarelli L, Maurizio C, Saba V, Gasparini N, Malavolta M, Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6: 407-413 (2005). *
Giachino DF, Regazzoni S, Bardessono M, Marchi MD, Gregori D, Study TP. Modeling the role of genetic factors in characterizing extraintestinal manifestations in Crohns disease patients: does this improve outcome predictions? Curr. Med. Res. Opin. 23: 1657-1665 (2007).
Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol. Genomics 20: 87-96 (2004). *
Giambra V, Cianci R, Lolli S, Mattioli C, Tampella G, Cattalini M, Kilic SS, Pandolfi F, Plebani A, Frezza D. Allele *1 of HS1.2 enhancer associates with aelective IgA deficiency and IgM concentration. J. Immunol. 183: 8280-8285 (2009).
Giambra V, Martinez-Labarga C, Giufre' M, Modiano D, Simpore' J, Gisladottir BK, Francavilla R, Zhelezova G, Kilic SS, Crawford M, Biondi G, Rickards O, Frezza D. Immunoglobulin enhancer HS1,2 polymorphism: a new powerful anthropogenetic marker. Ann. Hum. Genet. 70: 946-950 (2006). *
Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, Gilardini C, Zonenschain D, Nespoli A, Braga M. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J. Gastroenterol. 16: 167-175 (2010). *
Giardina E, Capon F, De Rosa MC, Mango R, Zambruno G, Orecchia A, Chimenti S, Giardina B, Novelli G. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann. Hum. Genet. 68: 639-645 (2004). *
Giardina E, Novelli G, Costanzo A, Nistico S, Bulli C, Sinibaldi C, Sorgi ML, Chimenti S, Pallone F, Taccari E, Borgiani P. Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J. Invest. Dermatol. 122: 1106-1107 (2004). *
Giardina E, Pietrangeli I, Martinez-Labarga C, Martone C, de Angelis F, Spinella A, De Stefano G, Rickards O, Novelli G. Haplotypes in SLC24A5 gene as ancestry informative markers in different populations. Curr. Genomics 9: 110-114 (2008). *
Gibbons LJ, Thomson W, Zeggini E, Worthington J, Barton A, Eyre S, Donn R, Hinks A. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis. Rheumatology (Oxford) 44: 1390-1393 (2005). *
Gibbs D, Yang Z, Constantine R, Ma X, Yang X, Chen H, Jorgenson A, Hau V, Dewan A, Zeng J, Harmon J, Buehler J, Brand JM, Hoh J, Cameron DJ, Dixit M, Tong Z, Zhang K. Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. Vision Res. 48: 685-689 (2008).
Gibbs JR, Singleton A. Application of genome-wide single nucleotide polymorphism typing: simple association and beyond. PLoS Genet. 2: e150 (2006). *
Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166: 3915-3922 (2001). *
Gibson AW, Li FJ, Wu J, Edberg JC, Su K, Cafardi J, Wiener H, Tiwari H, Kimberly RP, Davis RS. The FCRL3 -169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+B cells. Arthritis Rheum. 60: 3510-3512 (2009). *
Gibson NJ. Application of oligonucleotide arrays to high-content genetic analysis. Expert Rev. Mol. Diagn. 6: 451-464 (2006).
Gidvani V, Ramkissoon S, Sloand EM, Young NS. Cytokine gene polymorphisms in acquired bone marrow failure. Am. J. Hematol. 82: 721-724 (2007). *
Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T, Mewes HW, Wichmann HE, Weinberger KM, Adamski J, Illig T, Suhre K. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 4: e1000282 (2008). *
Gil-Carrasco F, Vargas-Alarcon G, Zuniga J, Tinajero-Castaneda O, Hernandez-Martinez B, Hernandez-Pacheco G, Rodr�guez-Reyna TS, Hesiquio R, Gamboa R, Granados J. HLA-DRB and HLA-DQB loci in the genetic susceptibility to develop glaucoma in Mexicans. Am. J. Ophthalmol. 128: 297-300 (1999). *
Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 165: 1-13 (2007). *
Gilissen LP, Derijks LJ, Bos LP, Verhoeven HM, Bus PJ, Hooymans PM, Engels LG. Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients. Eur. J. Gastroenterol. Hepatol. 16: 705-710 (2004).
Gill RM, Lee TH, Utter GH, Reed WF, Wen L, Chafets D, Busch MP. The TNFalpha (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood 111: 3880-3883 (2008). *
Gilliam AC. Scleroderma. Curr. Dir. Autoimmun. 10: 258-279 (2008).
Ginger RS, Askew SE, Ogborne RM, Wilson S, Ferdinando D, Dadd T, Smith AM, Kazi S, Szerencsei RT, Winkfein RJ, Schnetkamp PP, Green MR. SIC24A5 encodes a trans-Golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis. J. Biol. Chem. 283: 5486-5495 (2008). *
Giordano M, Bolognesi E, D'Alfonso S, Lessi M, Zavattari P, Oderda G, Clot F, Percopo S, Casari G, Greco L, Tosi R, Momigliano-Richiardi P. Linkage disequilibrium between intra-locus variants in the aminopeptidase N gene and test of their association with coeliac disease. Ann. Hum. Genet. 63: 207-215 (1999).
Giordano M, Godi M, Mellone S, Petri A, Vivenza D, Tiradani L, Carlomagno Y, Ferrante D, Arrigo T, Corneli G, Bellone S, Giacopelli F, Santoro C, Bona G, Momigliano-Richiardi P. A functional common polymorphism in the vitamin D-responsive element of the GH1 promoter contributes to isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 93: 1005-1012 (2008). *
Giordano M, Marano C, Mellai M, Limongelli MG, Bolognesi E, Clerget-Darpoux F, Momigliano-Richiardi P, Greco L. A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. Genes Immun. 7: 606-608 (2006). *
Giovannoni L. TNFA locus is associated with beta degrees 39 thalassemia in Corsica and Sardinia. Eur. Cytokine Netw. 19: 196-203 (2008).
Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J. Nutr. 132: 2350S-2355S (2002). *
Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 12: 970-979 (2003). *
Giraldo A, Gomez A, Salguero G, Garcia H, Aristizabal F, Gutierrez O, Angel LA, Padron J, Martinez C, Martinez H, Malaver O, Florez L, Barvo R. MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome) - description of four novel mutations. Fam. Cancer 4: 285-290 (2005). *
Giraldo PC, Babula O, Goncalves AK, Linhares IM, Amaral RL, Ledger WJ, Witkin SS. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet. Gynecol. 109: 1123-1128 (2007).
Girard H, Butler LM, Villeneuve L, Millikan RC, Sinha R, Sandler RS, Guillemette C. UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat. Res. 644: 56-63 (2008).
Girard H, Court MH, Bernard O, Fortier LC, Villeneuve L, Hao Q, Greenblatt DJ, Von Moltke LL, Perussed L, Guillemette C. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 14: 501-515 (2004).
Girard H, Thibaudeau J, Court MH, Fortier LC, Villeneuve L, Caron P, Hao Q, von Moltke LL, Greenblatt DJ, Guillemette C. UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver. Hepatology 42: 448-457 (2005). *
Girard H, Villeneuve L, Court M, Fortier LC, Caron P, Hao Q, Vonmoltke L, Greenblatt D, Guillemette C. The novel UGT1A9 intronic polymorphism I399 appears as a predictor of SN-38 glucuronidation levels in liver microsomes. Drug Metab. Dispos. 34: 1220-1228 (2006). *
Giraud C, Cuq P, Tasrini J, Cerene A, Bastide G, Puel P. Hypoplasia of the abdominal aorta. Review of the literature apropos of 4 cases. Arch. Mal. Coeur. Vaiss. 78: 931-937 (1985).
Giraud M, Beaurain G, Eymard B, Tranchant C, Gajdos P, Garchon HJ. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun. 5: 398-404 (2004). *
Giraud M, Eymard B, Tranchant C, Gajdos P, Garchon HJ. Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis. Genes Immun. 5: 80-83 (2004). *
Giraud M, Vandiedonck C, Garchon HJ. Genetic factors in autoimmune myasthenia gravis. Ann. N. Y. Acad. Sci. 1132: 180-192 (2008). *
Girona J, Guardiola M, Cabre A, Manzanares JM, Heras M, Ribalta J, Masana L. The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients. Clin. Chem. Lab. Med. 46: 453-457 (2008).
Gironi M, Guerini FR, Beghi E, Antonini G, Martinelli-Boneschi F, Ceresa L, Morino S, Agliardi C, Ferrante P, Nemni R. HLA-DRB1 polymorphisms distribution in chronic dysimmune polyneuropathy. Neuromuscul. Disord. 18: 967-969 (2008).
Giscombe R, Wang X, Huang D, Lefvert AK. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis. J. Rheumatol. 29: 950-953 (2002). *
Giusti B, Sestini I, Saracini C, Sticchi E, Bolli P, Magi A, Gori AM, Marcucci R, Gensini GF, Abbate R. High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism. Biochem. Genet. 46: 406-423 (2008). *
Giza S. HLADQB105 association with Hashimotos thyroiditis in children of Northern Greek origin. Indian Pediatr. 45: 493-496 (2008). *
Gjurow D, Grzelewski T, Sobocinska A, Stelmach I. Tumor necrosis factor inhibitors in pediatric asthma. Recent Pat. Inflamm. Allergy Drug Discov. 3: 143-148 (2009).
Gladd DA, Olech E. Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes. Curr. Rheumatol. Rep. 11: 43-51 (2009).
Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Torok HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Goke B, Ochsenkuhn T, Mussack T, Folwaczny M, Muller-Myhsok B, Brand S. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am. J. Gastroenterol. 103: 682-691 (2008). *
Glas J, Maier K, Wetzke M, Henninger M, Weiss EH, Folwaczny M. MICA*055: a new allele with eight GCT repeats in the exon 5 microsatellite. Tissue Antigens 72: 410-411 (2008). *
Glas J, Martin K, Brunnler G, Kopp R, Folwaczny C, Weiss EH, Albert ED. MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens 58: 243-249 (2001). *
Glas J, Seiderer J, Pasciuto G, Tillack C, Diegelmann J, Pfennig S, Konrad A, Schmechel S, Wetzke M, Torok HP, Stallhofer J, Jurgens M, Griga T, Klein W, Epplen JT, Schiemann U, Mussack T, Lohse P, Goke B, Ochsenkuhn T, et al. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. Am. J. Gastroenterol. 104: 665-672 (2009). *
Glas J, Seiderer J, Wetzke M, Konrad A, Torok HP, Schmechel S, Tonenchi L, Grassl C, Dambacher J, Pfennig S, Maier K, Griga T, Klein W, Epplen JT, Schiemann U, Folwaczny C, Lohse P, Goke B, Ochsenkuhn T, Muller-Myhsok B, Folwaczny M, Mussack T, Brand S. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS ONE 2: e819 (2007). *
Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Goke B, Ochsenkuhn T, Muller-Myhsok B, Brand S. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am. J. Gastroenterol. 104: 1737-1744 (2009). *
Glas J, Torok HP, Schiemann U, Folwaczny C. MDR1 gene polymorphism in ulcerative colitis. Gastroenterology 126: 367 (2004). *
Glas J, Torok HP, Tonenchi L, Hamann S, Malachova O, Euba A, Folwaczny C, Folwaczny M. A645G (Lys216Glu) polymorphism of the bactericidal/permeability-increasing protein gene in periodontal disease. Int. J. Immunogenet. 33: 255-260 (2006). *
Glas J, Torok HP, Tonenchi L, Kapser J, Schiemann U, Muller-Myhsok B, Folwaczny M, Folwaczny C. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflamm. Bowel Dis. 11: 1031-1037 (2005). *
Glas J, Torok HP, Tonenchi L, Muller-Myhsok B, Mussack T, Wetzke M, Klein W, Epplen JT, Griga T, Schiemann U, Lohse P, Seiderer J, Schnitzler F, Brand S, Ochsenkuhn T, Folwaczny M, Folwaczny C. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm. Bowel Dis. 12: 606-611 (2006). *
Glas J, Torok HP, Tonenchi L, Wetzke M, Beynon V, Teshome MY, Cotofana S, Schiemann U, Griga T, Klein W, Epplen JT, Folwaczny C, Folwaczny M, Mussack T, Weiss EH. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Int. Immunol. 19: 621-626 (2007). *
Glas J, Torok HP, Unterhuber H, Radlmayr M, Folwaczny C. The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin. Immunol. 106: 197-200 (2003). *
Glas J, Werner AI, Brunnler G, Witter K, Scholz S, Weiss EH, Albert ED. Linkage disequilibria between HLA-B, C1_4_1, MICA and MICB. Tissue Antigens 58: 411-418 (2001). *
Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism Dec 30 [Epub ahead of print] (2009). *
Glass EJ. Genetic variation and responses to vaccines. Anim. Health Res. Rev. 5: 197-208 (2004).
Gleeson D, Bradley MP, Jones J, Peck RJ, Bond SK, Teare MD, Duff GW. Cytokine gene polymorphisms in heavy drinkers with and without decompensated liver disease: a case-control study. Am. J. Gastroenterol. 103: 3039-3046 (2008). *
Glinsky GV. Disease phenocode analysis identifies SNP-guided microRNA maps (MirMaps) associated with human "master" disease genes. Cell Cycle 7: 3680-3694 (2008). *
Gloria-Bottini F, Bottini N, Renzetti G, Bottini E. ACP1 and Th class of immunological disease: evidence of interaction with gender. Int. Arch. Allergy Immunol. 143: 170-176 (2007).
Gloria-Bottini F, Lucarelli P, Saccucci P, Cozzoli E, Cerminara C, Curatolo P, Bottini E. Genetic polymorphism and idiopathic generalized epilepsy. Evidence of interaction between haptoglobin and ACP1 systems. Neuropediatrics 39: 357-358 (2008).
Gloria-Bottini F, Magrini A, Pietropolli A, Bergamaschi A, Bottini E. Smoking and human reproduction: the effect of adenylate kinase genetic polymorphism. Am. J. Perinatol. 26: 117-121 (2009).
Glossop JR, Dawes PT, Hassell AB, Mattey DL. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes. J. Rheumatol. 32: 1673-1678 (2005).
Glossop JR, Dawes PT, Nixon NB, Mattey DL. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res. Ther. 7: R1227-R1234 (2005). *
Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J. Rheumatol. 30: 1406-1409 (2003).
Glowacka D, Loesch C, Johnson KT, Mann K, Esser J, Morgenthaler NG, Siffert W, Schmid KW, Eckstein AK. The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease. Horm. Metab. Res. 41: 430-435 (2009).
Gloyn AL, Mackay DJ, Weedon MN, McCarthy MI, Walker M, Hitman G, Knight BA, Owen KR, Hattersley AT, Frayling TM. Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes: a comparative genomic and tagging single nucleotide polymorphism approach. Diabetes 55: 2272-2276 (2006). *
Glueck CJ, Freiberg RA, Boppana S, Wang P. Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis. J. Bone Joint Surg. Am. 90: 2220-2229 (2008).
Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J. Neuroinflammation 5: 36 (2008). *
Godde R, Rohde K, Becker C, Toliat MR, Entz P, Suk A, Muller N, Sindern E, Haupts M, Schimrigk S, Nurnberg P, Epplen JT. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips. J. Mol. Med. 83: 486-494 (2005). *
Godeiro-Junior C, Aguiar PM, Fel�cio AC, Barsottini OG, Silva SM, Borges V, Andrade LA, Ferraz HB. PINK1 polymorphism IVS1 -7 A-->G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinsons Disease. Neurosci. Lett. Nov 25 [Epub ahead of print] (2009).
Godschalk PC, Bergman MP, Gorkink RF, Simons G, van den Braak N, Lastovica AJ, Endtz HP, Verbrugh HA, van Belkum A. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barre syndrome by high-throughput AFLP analysis. BMC Microbiol. 6: 32 (2006). *
Godschalk PC, van Belkum A, van den Braak N, van Netten D, Ang CW, Jacobs BC, Gilbert M, Endtz HP. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipo-oligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barre syndrome. J. Clin. Microbiol. 45: 2316-2320 (2007). *
Goeb V, Dieude P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornelis F, Le Loet X, Vittecoq O. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Rheumatology (Oxford) 47: 1208-1212 (2008). *
Goeb V, Dieude P, Vittecoq O, Mejjad O, Menard JF, Thomas M, Gilbert D, Boumier P, Pouplin S, Daragon A, Fardellone P, Tron F, Cornelis F, Le Loet X. Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis. Arthritis Res. Ther. 7: R1056-R1062 (2005). *
Goedecke V, Crane AM, Jaakkola E, Kaluza W, Laiho K, Weeks DE, Wilson J, Kauppi M, Kaarela K, Tuomilehto J, Wordsworth BP, Brown MA. Interleukin 10 polymorphisms in ankylosing spondylitis. Genes Immun. 4: 74-76 (2003). *
Goel A, Boland CR. Recent insights into the pathogenesis of colorectal cancer. Curr. Opin. Gastroenterol. 26: 47-52 (2010). *
Goertsches R, Baranzini SE, Morcillo C, Nos C, Camina M, Oksenberg JR, Montalban X, Comabella M. Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis. Mult. Scler. 14: 412-414 (2008). *
Goertz B, Fassbender WJ, Williams JC, Marzeion AM, Bretzel RG, Stracke H, Berliner MN. Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin. Exp. Rheumatol. 21: 333-339 (2003).
Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 7: 475-483 (2006).
Gohlke H, Ferrari U, Koczwara K, Bonifacio E, Illig T, Ziegler AG. SLC30A8 (ZnT8) polymorphism is associated with young age at type 1 diabetes onset. Rev. Diabet. Stud. 5: 25-27 (2008). *
Goin-Kochel RP, Porter AE, Peters SU, Shinawi M, Sahoo T, Beaudet AL. The MTHFR 677C-->T polymorphism and behaviors in children with autism: exploratory genotype-phenotype correlations. Autism Res. 2: 98-108 (2009).
Golab-Janowska M, Honczarenko K, Gawronska-Szklarz B, Potemkowski A. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia. Neurol. Neurochir. Pol. 41: 113-121 (2007).
Golbahar J, Aminzadeh MA, Al-Shboul QM, Kassab S, Rezaian GR. Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia. Nutr. Metab. Cardiovasc. Dis. 17: 462-467 (2007).
Goldberg AC, Bittencourt PL, Oliveira LC, Ramasawmy R, Marin ML, Palacios SA, Kalil J, Porta G. Autoimmune hepatitis in Brazil: an overview. Scand. J. Immunol. 66: 208-216 (2007). *
Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L. The role of membrane glycoprotein PC-1/ENPP1 in the pathogenesis of insulin resistance and related abnormalities. Endocr. Rev. 29: 62-75 (2008). *
Goldman AS, Miles SE, Rudloff HE, Palkowetz KH, Schmalstieg FC Jr. Immunodeficiency due to a unique protracted developmental delay in the B-cell lineage. Clin. Diagn. Lab. Immunol. 6: 161-167 (1999).